1	Progress	NNP	O	Progress	_	0	SENT_1	[p1l558t82r659b108],
2	in	IN	O	in	_	0	SENT_1	[p1l669t81r691b103],
3	Neuro	NNP	O	Neuro	prep_in	1	SENT_1	[p1l702t81r1043b108],
4	.	.	O	.	_	0	SENT_1	[p1l702t81r1043b108],

1	—	NN	O	—	_	0	SENT_2	[p1l702t81r1043b108],
2	.	.	O	.	_	0	SENT_2	[p1l702t81r1043b108],

1	Psychopharmacology	NNP	O	Psychopharmacology	_	0	SENT_3	[p1l702t81r1043b108],
2	81	CD	NUMBER	81	num	1	SENT_3	[p1l1052t82r1070b103],
3	Biological	JJ	O	biological	amod	4	SENT_3	[p1l1080t81r1195b108],
4	Psychiatry	NNP	O	Psychiatry	dep	1	SENT_3	[p1l1206t81r1330b108],
5	32	CD	NUMBER	32	number	6	SENT_3	[p1l1339t82r1368b103],
6	(	CD	NUMBER	(	num	7	SENT_3	[p1l1379t81r1458b108],
7	2008	CD	DATE	2008	dep	4	SENT_3	[p1l1379t81r1458b108],
8	)	CD	NUMBER	)	num	9	SENT_3	[p1l1379t81r1458b108],
9	1491-1495	CD	DATE	1491-1495	dep	1	SENT_3	[p1l1471t82r1600b103],

1	Contents	NNS	O	contents	_	0	SENT_4	[p1l785t191r918b215],
2	lists	NNS	O	list	dep	1	SENT_4	[p1l933t191r990b215],
3	available	JJ	O	available	amod	2	SENT_4	[p1l1004t191r1129b215],
4	at	IN	O	at	_	0	SENT_4	[p1l1143t194r1170b215],
5	ScienceDirect	NNP	O	ScienceDirect	prep_at	3	SENT_4	[p1l1184t191r1388b215],

1	Progress	NNP	O	Progress	_	0	SENT_5	[p1l565t265r772b320],
2	in	IN	O	in	_	0	SENT_5	[p1l790t263r836b308],
3	Neuro-Psychopharmacology	NNP	O	Neuro-Psychopharmacology	prep_in	1	SENT_5	[p1l854t262r1556b320],
4	82	CD	NUMBER	82	num	3	SENT_5	[p1l1571t265r1609b309],

1	Biological	JJ	O	biological	amod	4	SENT_6	[p1l832t328r1068b386],
2	Psychiatry	NNP	O	Psychiatry	nn	4	SENT_6	[p1l1086t328r1342b386],
3	journal	NN	O	journal	nn	4	SENT_6	[p1l607t407r731b437],
4	homepage	NN	O	homepage	_	0	SENT_6	[p1l750t407r945b437],
5	:	:	O	:	_	0	SENT_6	[p1l750t407r945b437],
6	www	NN	O	www	dep	4	SENT_6	[p1l965t407r1563b436],
7	.	.	O	.	_	0	SENT_6	[p1l965t407r1563b436],

1	e	LS	O	e	dep	3	SENT_7	[p1l965t407r1563b436],
2	|	SYM	O	|	dep	3	SENT_7	[p1l965t407r1563b436],
3	sevier.com/locate/pnpbp	NN	O	sevier.com/locate/pnpbp	_	0	SENT_7	[p1l965t407r1563b436],

1	Association	NNP	O	Association	_	0	SENT_8	[p1l6t570r295b614],
2	between	IN	O	between	_	0	SENT_8	[p1l317t569r535b614],
3	dopamine-related	JJ	O	dopamine-related	amod	4	SENT_8	[p1l557t569r1012b625],
4	polymorphisms	NNS	O	polymorphism	prep_between	1	SENT_8	[p1l1035t569r1431b625],
5	and	CC	O	and	_	0	SENT_8	[p1l1454t569r1545b614],
6	plasma	NN	O	plasma	nn	7	SENT_8	[p1l1569t569r1748b625],
7	concentrations	NNS	O	concentration	conj_and	1	SENT_8	[p1l1770t570r2144b614],
8	of	IN	O	of	_	0	SENT_8	[p1l8t640r61b686],
9	prolactin	NN	O	prolactin	prep_of	7	SENT_8	[p1l77t640r302b697],
10	during	IN	O	during	dep	1	SENT_8	[p1l324t640r491b697],
11	risperidone	NN	O	risperidone	nn	12	SENT_8	[p1l513t640r801b697],
12	treatment	NN	O	treatment	pobj	10	SENT_8	[p1l824t647r1077b686],
13	in	IN	O	in	dep	1	SENT_8	[p1l1099t641r1145b685],
14	schizophrenic	JJ	O	schizophrenic	amod	15	SENT_8	[p1l1168t640r1519b697],
15	patients	NNS	O	patient	pobj	13	SENT_8	[p1l1541t641r1743b697],

1	Norio	NNP	PERSON	Norio	nn	2	SENT_9	[p1l8t743r116b778],
2	Yasui-Furul	NNP	PERSON	Yasui-Furul	_	0	SENT_9	[p1l133t743r425b778],
3	<	JJR	O	<	amod	4	SENT_9	[p1l133t743r425b778],
4	ori	NN	O	orus	dep	2	SENT_9	[p1l133t743r425b778],
5	“	NN	O	“	dep	4	SENT_9	[p1l437t737r494b784],
6	'	''	O	'	_	0	SENT_9	[p1l437t737r494b784],
7	*	RB	O	*	advmod	4	SENT_9	[p1l437t737r494b784],
8	,	,	O	,	_	0	SENT_9	[p1l437t737r494b784],
9	Manabu	NNP	PERSON	Manabu	nn	10	SENT_9	[p1l512t743r673b778],
10	Saito	NNP	PERSON	Saito	appos	4	SENT_9	[p1l691t743r786b778],
11	3	CD	NUMBER	3	dep	2	SENT_9	[p1l798t735r848b784],
12	"	``	O	"	punct	11	SENT_9	[p1l798t735r848b784],
13	’	NN	O	’	dep	11	SENT_9	[p1l798t735r848b784],
14	,	,	O	,	_	0	SENT_9	[p1l798t735r848b784],
15	Shoko	NNP	PERSON	Shoko	nn	16	SENT_9	[p1l867t743r987b778],
16	Tsuchimine	NNP	PERSON	Tsuchimine	appos	2	SENT_9	[p1l1000t743r1229b778],
17	3	CD	NUMBER	3	dep	16	SENT_9	[p1l1242t742r1265b784],
18	,	,	O	,	_	0	SENT_9	[p1l1242t742r1265b784],
19	Taku	NNP	PERSON	Taku	nn	20	SENT_9	[p1l1282t743r1376b778],
20	Nakagami	NNP	PERSON	Nakagami	appos	2	SENT_9	[p1l1393t743r1591b787],
21	"	``	O	"	punct	20	SENT_9	[p1l1602t735r1653b784],
22	3	CD	NUMBER	3	dep	20	SENT_9	[p1l1602t735r1653b784],
23	,	,	O	,	_	0	SENT_9	[p1l1602t735r1653b784],
24	Yasushi	NNP	PERSON	Yasushi	nn	26	SENT_9	[p1l6t796r155b831],
25	Sato	NNP	PERSON	Sato	nn	26	SENT_9	[p1l173t798r256b831],
26	ab	NN	O	ab	appos	2	SENT_9	[p1l267t788r318b837],
27	,	,	O	,	_	0	SENT_9	[p1l267t788r318b837],
28	Norio	NNP	PERSON	Norio	nn	29	SENT_9	[p1l336t797r445b831],
29	Sugawara	NNP	PERSON	Sugawara	appos	2	SENT_9	[p1l463t798r653b840],
30	3	CD	NUMBER	3	dep	29	SENT_9	[p1l665t795r689b837],
31	,	,	O	,	_	0	SENT_9	[p1l665t795r689b837],
32	Sunao	NNP	PERSON	Sunao	nn	33	SENT_9	[p1l707t798r826b831],
33	Kaneko	NNP	PERSON	Kaneko	appos	2	SENT_9	[p1l845t796r990b831],
34	3	CD	NUMBER	3	number	35	SENT_9	[p1l1003t795r1018b812],
35	3	CD	NUMBER	3	dep	33	SENT_9	[p1l6t871r15b881],
36	Department	NNP	ORGANIZATION	Department	dep	2	SENT_9	[p1l26t873r166b899],
37	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l174t872r200b899],
38	Neuropsychiatry	NNP	ORGANIZATION	Neuropsychiatry	prep_of	36	SENT_9	[p1l204t872r398b899],
39	,	,	O	,	_	0	SENT_9	[p1l204t872r398b899],
40	Hirosaki	NNP	ORGANIZATION	Hirosaki	nn	42	SENT_9	[p1l409t872r505b894],
41	University	NNP	ORGANIZATION	University	nn	42	SENT_9	[p1l516t872r632b899],
42	School	NNP	ORGANIZATION	School	appos	2	SENT_9	[p1l641t872r717b894],
43	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l726t872r751b899],
44	Medicine	NNP	ORGANIZATION	Medicine	prep_of	42	SENT_9	[p1l756t872r866b897],
45	,	,	O	,	_	0	SENT_9	[p1l756t872r866b897],
46	Hirosaki	NNP	LOCATION	Hirosaki	appos	2	SENT_9	[p1l877t872r973b894],
47	036-8562	CD	NUMBER	036-8562	num	46	SENT_9	[p1l983t873r1100b897],
48	,	,	O	,	_	0	SENT_9	[p1l983t873r1100b897],
49	japan	NN	LOCATION	japan	nn	51	SENT_9	[p1l1106t873r1175b899],
50	‘’	NNP	O	‘’	nn	51	SENT_9	[p1l6t902r16b917],
51	Department	NNP	ORGANIZATION	Department	appos	2	SENT_9	[p1l27t908r167b934],
52	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l176t907r201b934],
53	Psychiatry	NNP	ORGANIZATION	Psychiatry	nn	55	SENT_9	[p1l206t907r328b934],
54	,	,	O	,	_	0	SENT_9	[p1l206t907r328b934],
55	Hirosaki	NNP	LOCATION	Hirosaki	prep_of	51	SENT_9	[p1l339t907r536b929],
56	.	.	O	.	_	0	SENT_9	[p1l339t907r536b929],

1	—	NN	O	—	_	0	SENT_10	[p1l339t907r536b929],
2	.	.	O	.	_	0	SENT_10	[p1l339t907r536b929],

1	Aiseikai	NNP	LOCATION	Aiseikai	nn	4	SENT_11	[p1l339t907r536b929],
2	Hospital	NNP	LOCATION	Hospital	nn	4	SENT_11	[p1l545t907r645b934],
3	,	,	O	,	_	0	SENT_11	[p1l545t907r645b934],
4	Hirosaki	NNP	LOCATION	Hirosaki	_	0	SENT_11	[p1l656t907r752b929],
5	036-8562	CD	NUMBER	036-8562	num	4	SENT_11	[p1l762t908r879b932],
6	,	,	O	,	_	0	SENT_11	[p1l762t908r879b932],
7	japan	NN	LOCATION	japan	appos	4	SENT_11	[p1l886t908r955b934],

1	ARTICLE	NN	O	article	_	0	SENT_12	[p1l6t1042r206b1066],
2	INFO	NN	O	info	nn	3	SENT_12	[p1l251t1042r360b1066],
3	ABSTRACT	NN	O	abstract	dep	1	SENT_12	[p1l691t1042r935b1066],

1	Article	NNP	O	Article	nn	2	SENT_13	[p1l6t1123r82b1145],
2	history	NN	O	history	_	0	SENT_13	[p1l99t1123r184b1150],
3	-	:	O	-	_	0	SENT_13	[p1l99t1123r184b1150],
4	‘	CD	NUMBER	‘	num	5	SENT_13	[p1l99t1123r184b1150],
5	Hyperprolactinemia	NN	O	hyperprolactinemia	dep	2	SENT_13	[p1l707t1125r978b1155],
6	is	VBZ	O	be	cop	9	SENT_13	[p1l999t1125r1018b1149],
7	an	DT	O	a	det	9	SENT_13	[p1l1040t1132r1071b1149],
8	inevitable	JJ	O	inevitable	amod	9	SENT_13	[p1l1093t1125r1226b1149],
9	consequence	NN	O	consequence	rcmod	5	SENT_13	[p1l1247t1132r1421b1155],
10	of	IN	O	of	_	0	SENT_13	[p1l1442t1125r1470b1149],
11	treatment	NN	O	treatment	prep_of	9	SENT_13	[p1l1488t1128r1624b1149],
12	with	IN	O	with	_	0	SENT_13	[p1l1644t1125r1706b1149],
13	antipsychotic	JJ	O	antipsychotic	amod	14	SENT_13	[p1l1727t1125r1908b1155],
14	agents	NNS	O	agent	prep_with	11	SENT_13	[p1l1928t1128r2015b1155],
15	to	TO	O	to	_	0	SENT_13	[p1l2036t1128r2062b1149],
16	some	DT	O	some	det	17	SENT_13	[p1l2084t1132r2154b1149],
17	extent	NN	O	extent	prep_to	14	SENT_13	[p1l6t1169r91b1189],
18	Received	VBN	O	receive	partmod	17	SENT_13	[p1l7t1193r112b1214],
19	30	CD	DATE	30	num	20	SENT_13	[p1l123t1194r152b1214],
20	December	NNP	DATE	December	dobj	18	SENT_13	[p1l163t1193r285b1214],
21	2007	CD	DATE	2007	num	20	SENT_13	[p1l294t1194r354b1214],
22	Received	VBN	O	receive	partmod	20	SENT_13	[p1l7t1228r112b1250],
23	in	IN	O	in	_	0	SENT_13	[p1l123t1229r145b1250],
24	revised	JJ	O	revised	amod	25	SENT_13	[p1l156t1228r242b1250],
25	form	NN	O	form	prep_in	22	SENT_13	[p1l252t1228r309b1250],
26	29	CD	DATE	29	num	25	SENT_13	[p1l320t1230r348b1250],
27	April	NNP	DATE	April	tmod	25	SENT_13	[p1l358t1229r417b1255],
28	2008	CD	DATE	2008	num	27	SENT_13	[p1l427t1230r487b1250],
29	Accepted	JJ	O	accepted	amod	30	SENT_13	[p1l6t1264r116b1291],
30	7	CD	DATE	7	dep	25	SENT_13	[p1l127t1266r139b1286],
31	May	NNP	DATE	May	tmod	25	SENT_13	[p1l151t1266r202b1291],
32	2008	CD	DATE	2008	num	31	SENT_13	[p1l212t1265r271b1286],
33	Available	JJ	O	available	amod	25	SENT_13	[p1l6t1300r115b1322],
34	online	NN	O	online	prep	25	SENT_13	[p1l126t1300r200b1322],
35	15	CD	DATE	15	dep	34	SENT_13	[p1l212t1301r237b1322],
36	May	NNP	DATE	May	tmod	22	SENT_13	[p1l249t1301r300b1327],
37	2008	CD	DATE	2008	num	36	SENT_13	[p1l310t1301r369b1322],

1	because	IN	O	because	_	0	SENT_14	[p1l7t1417r113b1441],
2	prolactin	NN	O	prolactin	prep_because	7	SENT_14	[p1l124t1417r244b1447],
3	response	NN	O	response	nsubjpass	7	SENT_14	[p1l254t1424r374b1447],
4	to	TO	O	to	_	0	SENT_14	[p1l383t1420r409b1441],
5	antipsychotics	NNS	O	antipsychotic	prep_to	3	SENT_14	[p1l419t1417r612b1447],
6	is	VBZ	O	be	auxpass	7	SENT_14	[p1l622t1417r642b1441],
7	related	VBN	O	relate	_	0	SENT_14	[p1l652t1417r745b1441],
8	to	TO	O	to	_	0	SENT_14	[p1l755t1420r780b1441],
9	dopamine	NN	O	dopamine	nn	10	SENT_14	[p1l791t1417r926b1447],
10	blockade	NN	O	blockade	prep_to	7	SENT_14	[p1l936t1417r1062b1441],
11	.	.	O	.	_	0	SENT_14	[p1l936t1417r1062b1441],

1	Recent	JJ	O	recent	amod	2	SENT_15	[p1l1073t1418r1163b1441],
2	studies	NNS	O	study	nsubj	4	SENT_15	[p1l1173t1417r1267b1441],
3	have	VBP	O	have	aux	4	SENT_15	[p1l1278t1417r1340b1441],
4	suggested	VBN	O	suggest	_	0	SENT_15	[p1l1350t1417r1483b1447],
5	that	IN	O	that	complm	12	SENT_15	[p1l7t1457r61b1481],
6	polymorphisms	NNS	O	polymorphism	nsubjpass	12	SENT_15	[p1l73t1457r284b1487],
7	of	IN	O	of	_	0	SENT_15	[p1l296t1457r324b1481],
8	the	DT	O	the	det	10	SENT_15	[p1l332t1457r375b1481],
9	dopamine	NN	O	dopamine	nn	10	SENT_15	[p1l387t1457r523b1487],
10	receptors	NNS	O	receptor	prep_of	6	SENT_15	[p1l535t1460r660b1487],
11	are	VBP	O	be	auxpass	12	SENT_15	[p1l672t1464r713b1481],
12	associated	VBN	O	associate	ccomp	4	SENT_15	[p1l724t1457r863b1481],
13	with	IN	O	with	_	0	SENT_15	[p1l874t1457r936b1481],
14	therapeutic	JJ	O	therapeutic	amod	15	SENT_15	[p1l947t1457r1103b1487],
15	response	NN	O	response	prep_with	12	SENT_15	[p1l1115t1464r1234b1487],
16	to	TO	O	to	_	0	SENT_15	[p1l1246t1461r1272b1481],
17	antipsychotics	NNS	O	antipsychotic	prep_to	12	SENT_15	[p1l1283t1457r1483b1487],
18	.	.	O	.	_	0	SENT_15	[p1l1283t1457r1483b1487],

1	Thus	RB	O	thus	advmod	4	SENT_16	[p1l6t1497r77b1525],
2	,	,	O	,	_	0	SENT_16	[p1l6t1497r77b1525],
3	we	PRP	O	we	nsubj	4	SENT_16	[p1l87t1504r127b1521],
4	studied	VBD	O	study	_	0	SENT_16	[p1l137t1497r236b1521],
5	the	DT	O	the	det	6	SENT_16	[p1l246t1497r289b1521],
6	effects	NNS	O	effect	dobj	4	SENT_16	[p1l299t1497r385b1521],
7	of	IN	O	of	_	0	SENT_16	[p1l395t1497r424b1521],
8	major	JJ	O	major	amod	9	SENT_16	[p1l430t1497r509b1527],
9	polymorphisms	NNS	O	polymorphism	prep_of	6	SENT_16	[p1l518t1497r729b1527],
10	of	IN	O	of	_	0	SENT_16	[p1l740t1497r768b1521],
11	dopamine-related	JJ	O	dopamine-related	amod	12	SENT_16	[p1l774t1497r1017b1527],
12	genes	NNS	O	gene	prep_of	9	SENT_16	[p1l1027t1504r1103b1527],
13	on	IN	O	on	_	0	SENT_16	[p1l1113t1504r1146b1521],
14	plasma	NN	O	plasma	nn	15	SENT_16	[p1l1156t1497r1252b1527],
15	concentration	NN	O	concentration	prep_on	4	SENT_16	[p1l1261t1497r1449b1521],
16	of	IN	O	of	_	0	SENT_16	[p1l1459t1497r1487b1521],
17	gﬁgzfggsé	NN	O	gﬁgzfggsé	nn	18	SENT_16	[p1l1599t1474r1723b1536],
18	prolactin	NN	O	prolactin	prep_of	15	SENT_16	[p1l7t1537r134b1567],
19	.	.	O	.	_	0	SENT_16	[p1l7t1537r134b1567],

1	Subjects	NNS	O	subject	nsubj	5	SENT_17	[p1l148t1537r259b1567],
2	were	VBD	O	be	cop	5	SENT_17	[p1l272t1544r339b1561],
3	174	CD	NUMBER	174	num	5	SENT_17	[p1l353t1538r397b1561],
4	schizophrenic	JJ	O	schizophrenic	amod	5	SENT_17	[p1l410t1537r598b1567],
5	patients	NNS	O	patient	_	0	SENT_17	[p1l611t1537r719b1567],
6	(	IN	O	(	_	0	SENT_17	[p1l732t1537r775b1567],
7	68	CD	NUMBER	68	num	8	SENT_17	[p1l732t1537r775b1567],
8	males	NNS	O	male	prep_(	5	SENT_17	[p1l790t1537r874b1565],
9	,	,	O	,	_	0	SENT_17	[p1l790t1537r874b1565],
10	106	CD	NUMBER	106	num	11	SENT_17	[p1l887t1538r934b1561],
11	females	NNS	O	female	appos	8	SENT_17	[p1l947t1537r1061b1567],
12	)	CD	NUMBER	)	dep	11	SENT_17	[p1l947t1537r1061b1567],
13	receiving	VBG	O	receive	partmod	5	SENT_17	[p1l1075t1537r1198b1567],
14	3	CD	NUMBER	3	num	15	SENT_17	[p1l1211t1538r1225b1561],
15	mg	NN	O	mg	dobj	13	SENT_17	[p1l1240t1544r1282b1567],
16	twice	RB	O	twice	advmod	17	SENT_17	[p1l1295t1537r1368b1561],
17	daily	RB	SET	daily	advmod	13	SENT_17	[p1l1381t1537r1447b1567],
18	of	IN	O	of	_	0	SENT_17	[p1l1459t1537r1487b1561],
19	gene	NN	O	gene	nn	20	SENT_17	[p1l1599t1546r1660b1567],
20	risperidone	NN	O	risperidone	prep_of	13	SENT_17	[p1l7t1576r161b1606],
21	for	IN	O	for	_	0	SENT_17	[p1l176t1576r214b1600],
22	at	IN	DURATION	at	quantmod	24	SENT_17	[p1l227t1579r252b1600],
23	least	JJS	DURATION	least	mwe	22	SENT_17	[p1l266t1576r328b1600],
24	4	CD	DURATION	4	num	25	SENT_17	[p1l341t1577r358b1600],
25	weeks	NNS	NUMBER	week	prep_for	20	SENT_17	[p1l371t1576r463b1600],
26	.	.	O	.	_	0	SENT_17	[p1l371t1576r463b1600],

1	Sample	NN	O	sample	nn	2	SENT_18	[p1l478t1576r576b1606],
2	collections	NNS	O	collection	nsubjpass	4	SENT_18	[p1l591t1576r734b1600],
3	were	VBD	O	be	auxpass	4	SENT_18	[p1l748t1583r815b1600],
4	conducted	VBN	O	conduct	_	0	SENT_18	[p1l830t1576r970b1600],
5	12	CD	NUMBER	12	num	6	SENT_18	[p1l986t1577r1015b1600],
6	h	NN	O	h	dobj	4	SENT_18	[p1l1031t1576r1047b1600],
7	after	IN	O	after	_	0	SENT_18	[p1l1061t1576r1124b1600],
8	the	DT	O	the	det	10	SENT_18	[p1l1137t1576r1180b1600],
9	bedtime	NN	O	bedtime	nn	10	SENT_18	[p1l1194t1576r1306b1600],
10	dosing	NN	O	dosing	prep_after	4	SENT_18	[p1l1320t1576r1415b1606],
11	.	.	O	.	_	0	SENT_18	[p1l1320t1576r1415b1606],

1	Five	CD	NUMBER	five	num	3	SENT_19	[p1l1431t1576r1483b1600],
2	dopamine-related	JJ	O	dopamine-related	amod	3	SENT_19	[p1l7t1616r250b1646],
3	polymorphisms	NNS	O	polymorphism	nsubj	4	SENT_19	[p1l261t1616r473b1646],
4	(	VBP	O	(	_	0	SENT_19	[p1l484t1616r584b1646],
5	Taq1A	NN	O	taq1a	dobj	4	SENT_19	[p1l484t1616r584b1646],
6	,	,	O	,	_	0	SENT_19	[p1l484t1616r584b1646],
7	-141	CD	NUMBER	-141	num	9	SENT_19	[p1l595t1617r672b1640],
8	C	NN	O	c	nn	9	SENT_19	[p1l595t1617r672b1640],
9	ins/del	NN	O	ins/del	appos	5	SENT_19	[p1l682t1616r772b1646],
10	for	IN	O	for	_	0	SENT_19	[p1l783t1616r821b1640],
11	DRD2	NN	O	drd2	prep_for	9	SENT_19	[p1l831t1617r913b1643],
12	.	.	O	.	_	0	SENT_19	[p1l831t1617r913b1643],

1	Ser9Gly	RB	O	ser9gly	advmod	2	SENT_20	[p1l924t1616r1029b1646],
2	for	IN	O	for	_	0	SENT_20	[p1l1039t1616r1077b1640],
3	DRD3	NN	O	drd3	pobj	2	SENT_20	[p1l1087t1617r1169b1643],
4	.	.	O	.	_	0	SENT_20	[p1l1087t1617r1169b1643],

1	48	CD	NUMBER	48	num	3	SENT_21	[p1l1180t1617r1213b1640],
2	bp	NN	O	bp	nn	3	SENT_21	[p1l1224t1616r1257b1646],
3	VNTR	NN	O	vntr	nsubjpass	12	SENT_21	[p1l1267t1617r1343b1640],
4	for	IN	O	for	_	0	SENT_21	[p1l1353t1616r1391b1640],
5	DRD4	NN	O	drd4	prep_for	3	SENT_21	[p1l1401t1617r1483b1644],
6	,	,	O	,	_	0	SENT_21	[p1l1401t1617r1483b1644],
7	Val158Met	NN	O	val158met	appos	5	SENT_21	[p1l6t1656r153b1680],
8	for	IN	O	for	_	0	SENT_21	[p1l167t1656r204b1680],
9	COMT	NNP	O	COMT	prep_for	7	SENT_21	[p1l217t1656r309b1686],
10	)	CD	NUMBER	)	num	9	SENT_21	[p1l217t1656r309b1686],
11	were	VBD	O	be	auxpass	12	SENT_21	[p1l322t1663r389b1680],
12	identiﬁed	VBN	O	identiﬁed	_	0	SENT_21	[p1l403t1656r539b1680],
13	.	.	O	.	_	0	SENT_21	[p1l403t1656r539b1680],

1	The	DT	O	the	det	7	SENT_22	[p1l552t1656r601b1680],
2	mean	JJ	O	mean	amod	7	SENT_22	[p1l615t1663r690b1680],
3	(	NN	O	(	nn	7	SENT_22	[p1l703t1656r779b1686],
4	iSD	NN	O	isd	nn	7	SENT_22	[p1l703t1656r779b1686],
5	)	CD	NUMBER	)	num	7	SENT_22	[p1l703t1656r779b1686],
6	plasma	NN	O	plasma	nn	7	SENT_22	[p1l793t1656r889b1686],
7	concentration	NN	O	concentration	nsubj	13	SENT_22	[p1l903t1656r1090b1680],
8	of	IN	O	of	_	0	SENT_22	[p1l1104t1656r1132b1680],
9	prolactin	NN	O	prolactin	prep_of	7	SENT_22	[p1l1142t1656r1262b1686],
10	in	IN	O	in	_	0	SENT_22	[p1l1276t1656r1301b1680],
11	females	NNS	O	female	prep_in	9	SENT_22	[p1l1315t1656r1418b1680],
12	was	VBD	O	be	cop	13	SENT_22	[p1l1431t1663r1483b1680],
13	Polymorphism	NN	MISC	polymorphism	dep	18	SENT_22	[p1l6t1699r182b1726],
14	signiﬁcantly	RB	O	signiﬁcantly	advmod	15	SENT_22	[p1l710t1695r874b1725],
15	higher	JJR	O	higher	amod	13	SENT_22	[p1l903t1695r991b1725],
16	than	IN	O	than	_	0	SENT_22	[p1l1020t1695r1081b1719],
17	males	NNS	O	male	prep_than	13	SENT_22	[p1l1111t1695r1188b1719],
18	(	VBP	O	(	_	0	SENT_22	[p1l1219t1695r1285b1725],
19	54.3	CD	NUMBER	54.3	num	22	SENT_22	[p1l1219t1695r1285b1725],
20	$	$	MONEY	$	amod	22	SENT_22	[p1l1310t1696r1383b1719],
21	27.2	CD	MONEY	27.2	number	20	SENT_22	[p1l1310t1696r1383b1719],
22	ng/ml	NN	O	ng/ml	nsubj	28	SENT_22	[p1l1414t1695r1492b1725],
23	versus	CC	O	versus	prep	22	SENT_22	[p1l1521t1702r1607b1719],
24	126.8:70.2	CD	NUMBER	126.8:70.2	num	25	SENT_22	[p1l1639t1696r1791b1719],
25	ng/ml	NN	O	ng/ml	dep	23	SENT_22	[p1l1822t1695r1906b1725],
26	,	,	O	,	_	0	SENT_22	[p1l1822t1695r1906b1725],
27	p	NN	O	p	appos	25	SENT_22	[p1l1935t1696r2047b1725],
28	<	JJR	O	<	xcomp	18	SENT_22	[p1l1935t1696r2047b1725],
29	0.001	CD	NUMBER	0.001	num	30	SENT_22	[p1l1935t1696r2047b1725],
30	)	NN	O	)	nsubj	18	SENT_22	[p1l2073t1695r2087b1725],
31	.	.	O	.	_	0	SENT_22	[p1l2073t1695r2087b1725],

1	No	DT	O	no	det	4	SENT_23	[p1l2118t1696r2154b1719],
2	dopamine-related	JJ	O	dopamine-related	amod	4	SENT_23	[p1l6t1734r249b1764],
3	Prolactin	NN	O	prolactin	nn	4	SENT_23	[p1l263t1734r369b1756],
4	polymorphisms	NNS	O	polymorphism	nsubj	5	SENT_23	[p1l950t1734r1161b1764],
5	differed	VBD	O	differ	_	0	SENT_23	[p1l1179t1734r1284b1758],
6	the	DT	O	the	det	8	SENT_23	[p1l1302t1734r1344b1758],
7	plasma	NN	O	plasma	nn	8	SENT_23	[p1l1362t1734r1458b1764],
8	concentration	NN	O	concentration	dobj	5	SENT_23	[p1l1476t1734r1663b1758],
9	of	IN	O	of	_	0	SENT_23	[p1l1680t1734r1708b1758],
10	prolactin	NN	O	prolactin	prep_of	8	SENT_23	[p1l1723t1734r1843b1764],
11	in	IN	O	in	_	0	SENT_23	[p1l1861t1734r1886b1758],
12	males	NNS	O	male	prep_in	5	SENT_23	[p1l1903t1734r1981b1758],
13	or	CC	O	or	_	0	SENT_23	[p1l1999t1741r2027b1758],
14	females	NNS	O	female	prep_in	5	SENT_23	[p1l2044t1734r2154b1758],
15	.	.	O	.	_	0	SENT_23	[p1l2044t1734r2154b1758],

1	Multiple	JJ	O	multiple	amod	4	SENT_24	[p1l6t1773r119b1803],
2	regression	NN	O	regression	nn	4	SENT_24	[p1l143t1773r282b1803],
3	Risperidone	NN	O	risperidone	nn	4	SENT_24	[p1l304t1769r446b1796],
4	analyses	NNS	O	analysis	nsubj	11	SENT_24	[p1l996t1773r1109b1803],
5	including	VBG	O	include	_	0	SENT_24	[p1l1133t1773r1259b1803],
6	plasma	NN	O	plasma	nn	8	SENT_24	[p1l1283t1773r1379b1803],
7	drug	NN	O	drug	nn	8	SENT_24	[p1l1403t1773r1465b1803],
8	concentration	NN	O	concentration	prep_including	4	SENT_24	[p1l1489t1773r1676b1797],
9	and	CC	O	and	_	0	SENT_24	[p1l1700t1773r1749b1797],
10	age	NN	O	age	prep_including	4	SENT_24	[p1l1773t1780r1818b1803],
11	revealed	VBD	O	reveal	_	0	SENT_24	[p1l1842t1773r1956b1797],
12	that	IN	O	that	complm	17	SENT_24	[p1l1980t1773r2034b1797],
13	plasma	NN	O	plasma	nn	14	SENT_24	[p1l2058t1773r2154b1803],
14	concentration	NN	O	concentration	nsubj	17	SENT_24	[p1l6t1812r193b1836],
15	of	IN	O	of	_	0	SENT_24	[p1l210t1812r238b1836],
16	prolactin	NN	O	prolactin	prep_of	14	SENT_24	[p1l252t1812r372b1842],
17	correlated	VBD	O	correlate	ccomp	11	SENT_24	[p1l6t1851r142b1875],
18	with	IN	O	with	_	0	SENT_24	[p1l155t1851r217b1875],
19	gender	NN	O	gender	nn	24	SENT_24	[p1l230t1851r325b1881],
20	(	NN	O	(	nn	24	SENT_24	[p1l337t1851r522b1881],
21	standardized	JJ	O	standardized	amod	24	SENT_24	[p1l337t1851r522b1881],
22	partial	JJ	O	partial	amod	24	SENT_24	[p1l536t1851r623b1881],
23	correlation	NN	O	correlation	nn	24	SENT_24	[p1l636t1851r784b1875],
24	coefﬁcients	NNS	O	coefﬁcients	prep_with	17	SENT_24	[p1l797t1851r949b1875],
25	(	NN	O	(	nn	27	SENT_24	[p1l963t1851r1143b1881],
26	beta	NN	O	beta	nn	27	SENT_24	[p1l963t1851r1143b1881],
27	)	NN	O	)	npadvmod	32	SENT_24	[p1l963t1851r1143b1881],
28	=	JJ	O	=	amod	27	SENT_24	[p1l963t1851r1143b1881],
29	0.551	CD	NUMBER	0.551	tmod	28	SENT_24	[p1l963t1851r1143b1881],
30	,	,	O	,	_	0	SENT_24	[p1l963t1851r1143b1881],
31	p	NN	O	p	appos	29	SENT_24	[p1l1155t1851r1281b1881],
32	<	JJR	O	<	amod	24	SENT_24	[p1l1155t1851r1281b1881],
33	0.001	CD	NUMBER	0.001	num	34	SENT_24	[p1l1155t1851r1281b1881],
34	)	NN	O	)	tmod	17	SENT_24	[p1l1155t1851r1281b1881],
35	and	CC	O	and	_	0	SENT_24	[p1l1295t1851r1344b1875],
36	negatively	RB	O	negatively	advmod	34	SENT_24	[p1l1358t1851r1498b1881],
37	with	IN	O	with	_	0	SENT_24	[p1l1514t1851r1576b1875],
38	age	NN	O	age	prep_with	36	SENT_24	[p1l1588t1858r1633b1881],
39	(	CD	NUMBER	(	num	41	SENT_24	[p1l1646t1851r1831b1881],
40	standardized	JJ	O	standardized	amod	41	SENT_24	[p1l1646t1851r1831b1881],
41	beta	NN	O	beta	npadvmod	46	SENT_24	[p1l1844t1851r2026b1879],
42	=	JJ	O	=	amod	41	SENT_24	[p1l1844t1851r2026b1879],
43	-0.202	CD	NUMBER	-0.202	tmod	42	SENT_24	[p1l1844t1851r2026b1879],
44	,	,	O	,	_	0	SENT_24	[p1l1844t1851r2026b1879],
45	p	NN	O	p	appos	43	SENT_24	[p1l2037t1851r2154b1881],
46	<	JJR	O	<	amod	38	SENT_24	[p1l2037t1851r2154b1881],
47	0.01	CD	NUMBER	0.01	num	48	SENT_24	[p1l2037t1851r2154b1881],
48	)	NN	O	)	tmod	17	SENT_24	[p1l2037t1851r2154b1881],
49	.	.	O	.	_	0	SENT_24	[p1l2037t1851r2154b1881],

1	No	DT	O	no	det	2	SENT_25	[p1l6t1891r42b1914],
2	correlations	NNS	O	correlation	nsubjpass	4	SENT_25	[p1l59t1890r219b1914],
3	were	VBD	O	be	auxpass	4	SENT_25	[p1l235t1897r302b1914],
4	found	VBN	O	find	_	0	SENT_25	[p1l320t1890r398b1914],
5	between	IN	O	between	_	0	SENT_25	[p1l415t1890r532b1914],
6	prolactin	NN	O	prolactin	nn	7	SENT_25	[p1l548t1890r669b1920],
7	concentration	NN	O	concentration	prep_between	4	SENT_25	[p1l686t1890r873b1914],
8	and	CC	O	and	_	0	SENT_25	[p1l893t1890r942b1914],
9	dopamine-related	JJ	O	dopamine-related	amod	10	SENT_25	[p1l966t1890r1209b1920],
10	polymorphisms	NNS	O	polymorphism	prep_between	4	SENT_25	[p1l1233t1890r1452b1920],
11	.	.	O	.	_	0	SENT_25	[p1l1233t1890r1452b1920],

1	These	DT	O	these	det	2	SENT_26	[p1l1475t1890r1553b1914],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_26	[p1l1578t1890r1686b1920],
3	suggest	VBP	O	suggest	_	0	SENT_26	[p1l1711t1893r1812b1920],
4	that	IN	O	that	complm	12	SENT_26	[p1l1835t1890r1890b1914],
5	plasma	NN	O	plasma	nn	7	SENT_26	[p1l1913t1890r2010b1920],
6	prolactin	NN	O	prolactin	nn	7	SENT_26	[p1l2034t1890r2154b1920],
7	concentrations	NNS	O	concentration	nsubj	12	SENT_26	[p1l422t1930r622b1954],
8	in	IN	O	in	_	0	SENT_26	[p1l641t1930r665b1954],
9	females	NNS	O	female	prep_in	7	SENT_26	[p1l679t1929r782b1954],
10	are	VBP	O	be	cop	12	SENT_26	[p1l792t1936r834b1954],
11	much	RB	O	much	advmod	12	SENT_26	[p1l844t1929r919b1954],
12	higher	JJR	O	higher	ccomp	3	SENT_26	[p1l930t1929r1017b1960],
13	than	IN	O	than	prep	12	SENT_26	[p1l1027t1929r1087b1954],
14	in	IN	O	in	pcomp	13	SENT_26	[p1l1098t1930r1123b1954],
15	males	NNS	O	male	pobj	14	SENT_26	[p1l1133t1929r1211b1954],
16	but	CC	O	but	_	0	SENT_26	[p1l1222t1929r1266b1954],
17	the	DT	O	the	det	19	SENT_26	[p1l1276t1929r1319b1954],
18	dopamine-related	JJ	O	dopamine-related	amod	19	SENT_26	[p1l1329t1929r1572b1960],
19	variants	NNS	O	variant	nsubjpass	23	SENT_26	[p1l1582t1930r1689b1954],
20	are	VBP	O	be	auxpass	23	SENT_26	[p1l1700t1936r1741b1954],
21	not	RB	O	not	neg	23	SENT_26	[p1l1752t1933r1796b1954],
22	predominantly	RB	O	predominantly	advmod	23	SENT_26	[p1l1806t1929r2007b1960],
23	associated	VBN	O	associate	conj_but	3	SENT_26	[p1l2016t1929r2154b1954],
24	with	IN	O	with	_	0	SENT_26	[p1l808t1969r870b1993],
25	plasma	NN	O	plasma	nn	26	SENT_26	[p1l882t1969r978b1999],
26	concentration	NN	O	concentration	prep_with	23	SENT_26	[p1l990t1969r1177b1993],
27	of	IN	O	of	_	0	SENT_26	[p1l1189t1969r1217b1993],
28	prolactin	NN	O	prolactin	prep_of	26	SENT_26	[p1l1225t1969r1352b1999],
29	.	.	O	.	_	0	SENT_26	[p1l1225t1969r1352b1999],

1	1	LS	NUMBER	1	_	0	SENT_27	[p1l11t2298r56b2348],
2	.	.	O	.	_	0	SENT_27	[p1l11t2298r56b2348],

1	Introduction	NN	O	introduction	_	0	SENT_28	[p1l80t2295r476b2348],

1	Hyperprolactinemia	NN	O	hyperprolactinemia	nsubjpass	4	SENT_29	[p1l108t2466r695b2531],
2	has	VBZ	O	have	aux	4	SENT_29	[p1l727t2466r822b2518],
3	been	VBN	O	be	auxpass	4	SENT_29	[p1l855t2466r995b2518],
4	assumed	VBN	O	assume	dep	15	SENT_29	[p1l1027t2466r1283b2518],
5	to	TO	O	to	aux	9	SENT_29	[p1l1315t2474r1371b2518],
6	be	VB	O	be	cop	9	SENT_29	[p1l1403t2466r1470b2518],
7	an	DT	O	a	det	9	SENT_29	[p1l1502t2481r1571b2518],
8	inevitable	JJ	O	inevitable	amod	9	SENT_29	[p1l1603t2466r1891b2518],
9	consequence	NN	O	consequence	xcomp	4	SENT_29	[p1l1924t2481r2051b2518, p1l11t2565r279b2616],
10	of	IN	O	of	_	0	SENT_29	[p1l303t2550r364b2602],
11	treatment	NN	O	treatment	prep_of	9	SENT_29	[p1l380t2558r674b2602],
12	with	IN	O	with	_	0	SENT_29	[p1l695t2550r830b2602],
13	antipsychotic	JJ	O	antipsychotic	amod	14	SENT_29	[p1l853t2550r1243b2616],
14	agents	NNS	O	agent	prep_with	11	SENT_29	[p1l1267t2558r1454b2616],
15	(	VBP	O	(	_	0	SENT_29	[p1l1479t2550r1685b2615],
16	Rubin	NNP	PERSON	Rubin	nsubj	15	SENT_29	[p1l1479t2550r1685b2615],
17	,	,	O	,	_	0	SENT_29	[p1l1479t2550r1685b2615],
18	1987	CD	DATE	1987	appos	16	SENT_29	[p1l1708t2553r1863b2610],
19	;	:	O	;	_	0	SENT_29	[p1l1708t2553r1863b2610],
20	Petty	NNP	O	Petty	dep	18	SENT_29	[p1l1892t2553r2051b2616],
21	,	,	O	,	_	0	SENT_29	[p1l1892t2553r2051b2616],
22	1999	CD	DATE	1999	num	23	SENT_29	[p1l13t2635r187b2700],
23	)	NN	O	)	appos	20	SENT_29	[p1l13t2635r187b2700],
24	.	.	O	.	_	0	SENT_29	[p1l13t2635r187b2700],

1	Major	JJ	O	major	amod	2	SENT_30	[p1l207t2636r378b2701],
2	effects	NNS	O	effect	nsubj	8	SENT_30	[p1l394t2635r581b2687],
3	of	IN	O	of	_	0	SENT_30	[p1l600t2635r661b2687],
4	hyperprolactinemia	NN	O	hyperprolactinemia	prep_of	2	SENT_30	[p1l672t2635r1248b2701],
5	in	IN	O	in	_	0	SENT_30	[p1l1267t2636r1321b2687],
6	women	NNS	O	woman	prep_in	4	SENT_30	[p1l1335t2650r1556b2687],
7	are	VBP	O	be	cop	8	SENT_30	[p1l1575t2650r1663b2687],
8	amenorrhea	NN	O	amenorrhea	_	0	SENT_30	[p1l1681t2635r2051b2695],
9	,	,	O	,	_	0	SENT_30	[p1l1681t2635r2051b2695],
10	galactorrhea	NN	O	galactorrhea	appos	8	SENT_30	[p1l9t2720r387b2786],
11	,	,	O	,	_	0	SENT_30	[p1l9t2720r387b2786],
12	cessation	NN	O	cessation	appos	8	SENT_30	[p1l406t2721r674b2773],
13	of	IN	O	of	_	0	SENT_30	[p1l692t2720r753b2773],
14	normal	JJ	O	normal	amod	17	SENT_30	[p1l763t2720r972b2773],
15	cyclic	JJ	O	cyclic	amod	17	SENT_30	[p1l990t2720r1150b2786],
16	ovarian	JJ	O	ovarian	amod	17	SENT_30	[p1l1167t2721r1382b2773],
17	function	NN	O	function	prep_of	12	SENT_30	[p1l1401t2720r1656b2781],
18	,	,	O	,	_	0	SENT_30	[p1l1401t2720r1656b2781],
19	loss	NN	O	loss	appos	8	SENT_30	[p1l1676t2720r1783b2773],
20	of	IN	O	of	_	0	SENT_30	[p1l1801t2720r1862b2773],
21	libido	NN	O	libido	prep_of	19	SENT_30	[p1l1873t2720r2051b2781],
22	,	,	O	,	_	0	SENT_30	[p1l1873t2720r2051b2781],
23	occasional	JJ	O	occasional	amod	24	SENT_30	[p1l10t2805r310b2858],
24	hirsutism	NN	O	hirsutism	appos	8	SENT_30	[p1l333t2805r611b2858],
25	and	CC	O	and	_	0	SENT_30	[p1l631t2805r737b2857],
26	long-term	JJ	O	long-term	amod	27	SENT_30	[p1l760t2805r1055b2871],
27	risk	NN	O	risk	conj_and	24	SENT_30	[p1l1076t2805r1182b2858],
28	of	IN	O	of	_	0	SENT_30	[p1l1202t2805r1263b2857],
29	osteoporosis	NN	O	osteoporosis	nn	31	SENT_30	[p1l1277t2806r1643b2871],
30	(	CD	NUMBER	(	num	31	SENT_30	[p1l1666t2805r1871b2870],
31	Rubin	NNP	PERSON	Rubin	prep_of	24	SENT_30	[p1l1666t2805r1871b2870],
32	,	,	O	,	_	0	SENT_30	[p1l1666t2805r1871b2870],
33	1987	CD	DATE	1987	appos	31	SENT_30	[p1l1892t2808r2047b2866],
34	;	:	O	;	_	0	SENT_30	[p1l1892t2808r2047b2866],
35	Petty	NNP	O	Petty	dep	8	SENT_30	[p1l10t2894r169b2956],
36	,	,	O	,	_	0	SENT_30	[p1l10t2894r169b2956],
37	1999	CD	DATE	1999	num	38	SENT_30	[p1l191t2891r366b2956],
38	)	NN	O	)	appos	35	SENT_30	[p1l191t2891r366b2956],
39	.	.	O	.	_	0	SENT_30	[p1l191t2891r366b2956],

1	The	DT	O	the	det	2	SENT_31	[p1l387t2891r494b2943],
2	effects	NNS	O	effect	nsubj	5	SENT_31	[p1l516t2890r704b2943],
3	in	IN	O	in	_	0	SENT_31	[p1l727t2891r781b2942],
4	men	NNS	O	man	prep_in	2	SENT_31	[p1l804t2906r932b2943],
5	include	VBP	O	include	_	0	SENT_31	[p1l955t2891r1168b2943],
6	impotence	NN	O	impotence	dobj	5	SENT_31	[p1l1191t2891r1513b2956],
7	,	,	O	,	_	0	SENT_31	[p1l1191t2891r1513b2956],
8	loss	NN	O	loss	dobj	5	SENT_31	[p1l1537t2891r1644b2943],
9	of	IN	O	of	_	0	SENT_31	[p1l1667t2890r1728b2943],
10	libido	NN	O	libido	prep_of	8	SENT_31	[p1l1743t2891r1921b2951],
11	,	,	O	,	_	0	SENT_31	[p1l1743t2891r1921b2951],
12	and	CC	O	and	_	0	SENT_31	[p1l1945t2891r2051b2943],
13	hypospermatogenesis	NN	O	hypospermatogenesis	nn	15	SENT_31	[p1l10t2976r648b3041],
14	(	CD	NUMBER	(	num	15	SENT_31	[p1l675t2976r881b3041],
15	Rubin	NNP	PERSON	Rubin	conj_and	6	SENT_31	[p1l675t2976r881b3041],
16	,	,	O	,	_	0	SENT_31	[p1l675t2976r881b3041],
17	1987	CD	DATE	1987	appos	15	SENT_31	[p1l908t2978r1063b3036],
18	;	:	O	;	_	0	SENT_31	[p1l908t2978r1063b3036],
19	Petty	NNP	O	Petty	dep	15	SENT_31	[p1l1095t2979r1254b3041],
20	,	,	O	,	_	0	SENT_31	[p1l1095t2979r1254b3041],
21	1999	CD	DATE	1999	num	22	SENT_31	[p1l1280t2976r1455b3041],
22	)	NN	O	)	appos	19	SENT_31	[p1l1280t2976r1455b3041],
23	.	.	O	.	_	0	SENT_31	[p1l1280t2976r1455b3041],

1	On	IN	O	on	_	0	SENT_32	[p1l1483t2978r1564b3028],
2	the	DT	O	the	det	4	SENT_32	[p1l1590t2976r1683b3028],
3	other	JJ	O	other	amod	4	SENT_32	[p1l1710t2976r1868b3028],
4	hand	NN	O	hand	prep_on	14	SENT_32	[p1l1892t2976r2051b3036],
5	,	,	O	,	_	0	SENT_32	[p1l1892t2976r2051b3036],
6	the	DT	O	the	det	8	SENT_32	[p1l9t3060r102b3112],
7	prolactin	NN	O	prolactin	nn	8	SENT_32	[p1l122t3060r383b3126],
8	response	NN	O	response	nsubjpass	14	SENT_32	[p1l403t3075r662b3126],
9	to	TO	O	to	_	0	SENT_32	[p1l682t3068r738b3112],
10	antipsychotic	JJ	O	antipsychotic	amod	11	SENT_32	[p1l758t3060r1148b3126],
11	drugs	NNS	O	drug	prep_to	8	SENT_32	[p1l1167t3060r1329b3126],
12	has	VBZ	O	have	aux	14	SENT_32	[p1l1351t3060r1446b3112],
13	been	VBN	O	be	auxpass	14	SENT_32	[p1l1466t3060r1606b3112],
14	regarded	VBN	O	regard	_	0	SENT_32	[p1l1627t3060r1885b3126],
15	as	IN	O	as	mark	24	SENT_32	[p1l1906t3075r1963b3112],
16	an	DT	O	a	det	17	SENT_32	[p1l1984t3075r2052b3112],
17	index	NN	O	index	nsubj	24	SENT_32	[p1l10t3145r172b3197],
18	of	IN	O	of	_	0	SENT_32	[p1l209t3145r270b3197],
19	antidopaminergic	JJ	O	antidopaminergic	amod	20	SENT_32	[p1l303t3145r823b3211],
20	activity	NN	O	activity	prep_of	17	SENT_32	[p1l863t3146r1078b3211],
21	of	IN	O	of	_	0	SENT_32	[p1l1117t3145r1178b3197],
22	antipsychotic	JJ	O	antipsychotic	amod	23	SENT_32	[p1l1211t3145r1602b3211],
23	drugs	NNS	O	drug	prep_of	20	SENT_32	[p1l1641t3145r1803b3211],
24	(	VBP	O	(	advcl	14	SENT_32	[p1l1845t3145r2051b3210],
25	Rubin	NNP	PERSON	Rubin	dobj	24	SENT_32	[p1l1845t3145r2051b3210],
26	,	,	O	,	_	0	SENT_32	[p1l1845t3145r2051b3210],
27	1987	CD	DATE	1987	num	28	SENT_32	[p1l13t3231r187b3296],
28	)	NN	O	)	appos	25	SENT_32	[p1l13t3231r187b3296],
29	.	.	O	.	_	0	SENT_32	[p1l13t3231r187b3296],

1	This	DT	O	this	nsubjpass	5	SENT_33	[p1l213t3230r333b3283],
2	has	VBZ	O	have	aux	5	SENT_33	[p1l361t3230r456b3283],
3	been	VBN	O	be	auxpass	5	SENT_33	[p1l482t3230r623b3283],
4	partially	RB	O	partially	advmod	5	SENT_33	[p1l648t3230r891b3296],
5	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_33	[p1l915t3230r1214b3283],
6	by	IN	O	by	_	0	SENT_33	[p1l1240t3230r1311b3296],
7	a	DT	O	a	det	9	SENT_33	[p1l1334t3246r1364b3283],
8	PET	NN	O	pet	nn	9	SENT_33	[p1l1390t3234r1497b3282],
9	study	NN	O	study	agent	5	SENT_33	[p1l1519t3230r1680b3296],
10	indicating	VBG	O	indicate	xcomp	5	SENT_33	[p1l1705t3230r1998b3296],
11	a	DT	O	a	det	13	SENT_33	[p1l2023t3246r2052b3283],
12	close	JJ	O	close	amod	13	SENT_33	[p1l10t3315r153b3368],
13	relationship	NN	O	relationship	dobj	10	SENT_33	[p1l198t3315r547b3381],
14	between	IN	O	between	_	0	SENT_33	[p1l591t3315r844b3368],
15	prolactin	NN	O	prolactin	nn	16	SENT_33	[p1l886t3315r1147b3381],
16	response	NN	O	response	prep_between	13	SENT_33	[p1l1191t3331r1451b3381],
17	and	CC	O	and	_	0	SENT_33	[p1l1494t3315r1601b3367],
18	dopamine	NN	O	dopamine	nn	20	SENT_33	[p1l1644t3315r1938b3381],
19	D2	NN	O	d2	nn	20	SENT_33	[p1l1982t3319r2051b3378],
20	receptor	NN	O	receptor	prep_between	13	SENT_33	[p1l10t3409r255b3466],
21	occupancy	NN	O	occupancy	nn	23	SENT_33	[p1l276t3416r585b3466],
22	(	CD	NUMBER	(	num	23	SENT_33	[p1l608t3401r949b3466],
23	Nordstrom	NNP	ORGANIZATION	Nordstrom	dep	16	SENT_33	[p1l608t3401r949b3466],
24	and	CC	O	and	_	0	SENT_33	[p1l972t3401r1078b3453],
25	Farde	NNP	PERSON	Farde	prep_between	13	SENT_33	[p1l1104t3401r1275b3461],
26	,	,	O	,	_	0	SENT_33	[p1l1104t3401r1275b3461],
27	1998	CD	DATE	1998	num	28	SENT_33	[p1l1298t3401r1473b3466],
28	)	NN	O	)	appos	25	SENT_33	[p1l1298t3401r1473b3466],
29	.	.	O	.	_	0	SENT_33	[p1l1298t3401r1473b3466],

1	Thus	RB	O	thus	advmod	11	SENT_34	[p1l1496t3401r1650b3461],
2	,	,	O	,	_	0	SENT_34	[p1l1496t3401r1650b3461],
3	the	DT	O	the	det	5	SENT_34	[p1l1674t3401r1767b3453],
4	prolactin	NN	O	prolactin	nn	5	SENT_34	[p1l1792t3401r2052b3466],
5	response	NN	O	response	nsubjpass	11	SENT_34	[p1l10t3501r269b3551],
6	to	TO	O	to	_	0	SENT_34	[p1l293t3494r349b3538],
7	antipsychotic	JJ	O	antipsychotic	amod	8	SENT_34	[p1l374t3486r764b3551],
8	drugs	NNS	O	drug	prep_to	5	SENT_34	[p1l787t3486r949b3551],
9	should	MD	O	should	aux	11	SENT_34	[p1l975t3486r1170b3538],
10	be	VB	O	be	auxpass	11	SENT_34	[p1l1194t3486r1261b3538],
11	evaluated	VBN	O	evaluate	_	0	SENT_34	[p1l1286t3486r1567b3538],
12	not	RB	O	not	neg	13	SENT_34	[p1l1593t3494r1688b3538],
13	only	RB	O	only	dobj	11	SENT_34	[p1l1711t3486r1837b3551],
14	from	IN	O	from	_	0	SENT_34	[p1l1860t3485r2000b3538],
15	a	DT	O	a	det	16	SENT_34	[p1l2023t3501r2052b3538],
16	clinical	JJ	O	clinical	prep_from	13	SENT_34	[p1l10t3570r214b3622],
17	but	CC	O	but	_	0	SENT_34	[p1l235t3570r332b3622],
18	also	RB	O	also	_	0	SENT_34	[p1l352t3570r465b3622],
19	a	DT	O	a	det	21	SENT_34	[p1l486t3585r516b3622],
20	pharmacological	JJ	O	pharmacological	amod	21	SENT_34	[p1l538t3570r1021b3636],
21	point	NN	O	point	conj_and	13	SENT_34	[p1l1043t3571r1197b3636],
22	of	IN	O	of	_	0	SENT_34	[p1l1216t3570r1277b3622],
23	view	NN	O	view	prep_of	21	SENT_34	[p1l1289t3571r1440b3623],
24	.	.	O	.	_	0	SENT_34	[p1l1289t3571r1440b3623],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_35	[p2l102t32r431b74],
2	:	:	O	:	_	0	SENT_35	[p2l102t32r431b74],
3	PET	NN	O	pet	dep	1	SENT_35	[p2l452t34r543b80],
4	,	,	O	,	_	0	SENT_35	[p2l452t34r543b80],
5	positron	JJ	O	positron	amod	7	SENT_35	[p2l563t32r758b84],
6	emission	NN	O	emission	nn	7	SENT_35	[p2l778t32r985b73],
7	tomography	NN	O	tomography	appos	3	SENT_35	[p2l1005t32r1304b84],
8	;	:	O	;	_	0	SENT_35	[p2l1005t32r1304b84],
9	DRD2	NN	O	drd2	dep	1	SENT_35	[p2l1327t34r1470b80],
10	,	,	O	,	_	0	SENT_35	[p2l1327t34r1470b80],
11	Dopamine	NN	O	dopamine	nn	13	SENT_35	[p2l1491t32r1731b84],
12	D2	NN	O	d2	nn	13	SENT_35	[p2l1751t34r1813b73],
13	Receptor	NN	O	receptor	appos	9	SENT_35	[p2l1834t34r2053b84],
14	;	:	O	;	_	0	SENT_35	[p2l1834t34r2053b84],
15	DRD3	NN	O	drd3	dep	1	SENT_35	[p2l10t104r152b150],
16	,	,	O	,	_	0	SENT_35	[p2l10t104r152b150],
17	Dopamine	NN	O	dopamine	appos	15	SENT_35	[p2l170t103r425b154],
18	;	:	O	;	_	0	SENT_35	[p2l170t103r425b154],
19	D3	NN	O	d3	dep	1	SENT_35	[p2l446t104r520b150],
20	,	,	O	,	_	0	SENT_35	[p2l446t104r520b150],
21	Receptor	NN	O	receptor	appos	19	SENT_35	[p2l537t105r756b154],
22	;	:	O	;	_	0	SENT_35	[p2l537t105r756b154],
23	DRD4	NN	O	drd4	dep	1	SENT_35	[p2l776t104r919b150],
24	,	,	O	,	_	0	SENT_35	[p2l776t104r919b150],
25	Dopamine	NN	O	dopamine	nn	27	SENT_35	[p2l936t103r1177b154],
26	D4	NN	O	d4	nn	27	SENT_35	[p2l1194t104r1258b143],
27	Receptor	NN	O	receptor	appos	23	SENT_35	[p2l1274t105r1493b154],
28	;	:	O	;	_	0	SENT_35	[p2l1274t105r1493b154],
29	VNTR	NNP	O	VNTR	dep	1	SENT_35	[p2l1510t104r1653b150],
30	,	,	O	,	_	0	SENT_35	[p2l1510t104r1653b150],
31	variable	JJ	O	variable	amod	32	SENT_35	[p2l1669t102r1855b144],
32	number	NN	O	number	appos	29	SENT_35	[p2l1872t102r2057b144],
33	of	IN	O	of	_	0	SENT_35	[p2l9t172r58b214],
34	tandem	JJ	O	tandem	amod	35	SENT_35	[p2l71t172r251b214],
35	repeat	NN	O	repeat	prep_of	32	SENT_35	[p2l270t179r431b225],
36	;	:	O	;	_	0	SENT_35	[p2l270t179r431b225],
37	COMT	NNP	O	COMT	dep	1	SENT_35	[p2l454t174r602b220],
38	,	,	O	,	_	0	SENT_35	[p2l454t174r602b220],
39	catechol-o-methyltransferase	NN	O	catechol-o-methyltransferase	appos	37	SENT_35	[p2l622t172r1324b225],
40	.	.	O	.	_	0	SENT_35	[p2l622t172r1324b225],

1	*	NN	O	*	_	0	SENT_36	[p2l52t242r73b267],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_36	[p2l107t242r453b294],
3	author	NN	O	author	dobj	2	SENT_36	[p2l471t242r635b284],
4	.	.	O	.	_	0	SENT_36	[p2l471t242r635b284],

1	Tel.	NNP	O	Tel.	_	0	SENT_37	[p2l652t241r836b294],
2	/	:	O	/	punct	3	SENT_37	[p2l652t241r836b294],
3	fax	NN	O	fax	dep	1	SENT_37	[p2l652t241r836b294],
4	:	:	O	:	_	0	SENT_37	[p2l652t241r836b294],
5	+81	CD	NUMBER	+81	num	6	SENT_37	[p2l858t244r936b283],
6	172	CD	NUMBER	172	dep	3	SENT_37	[p2l958t244r1034b283],
7	39	CD	NUMBER	39	num	8	SENT_37	[p2l1054t244r1111b283],
8	5352	CD	NUMBER	5352	dep	6	SENT_37	[p2l1131t244r1257b284],
9	.	.	O	.	_	0	SENT_37	[p2l1131t244r1257b284],

1	E	NN	O	e	nn	4	SENT_38	[p2l105t312r254b354],
2	—	CD	NUMBER	—	num	4	SENT_38	[p2l105t312r254b354],
3	mail	NN	O	mail	nn	4	SENT_38	[p2l105t312r254b354],
4	address	NN	O	address	_	0	SENT_38	[p2l272t312r456b354],
5	:	:	O	:	_	0	SENT_38	[p2l272t312r456b354],
6	yasufuru@cc.hirosaki—u.ac.jp	NN	O	yasufuru@cc.hirosaki—u.ac.jp	nn	9	SENT_38	[p2l474t312r1143b364],
7	(	CD	NUMBER	(	num	9	SENT_38	[p2l1163t312r1227b364],
8	N.	NNP	PERSON	N.	nn	9	SENT_38	[p2l1163t312r1227b364],
9	Yasui	NNP	PERSON	Yasui	dep	4	SENT_38	[p2l1245t312r1621b364],
10	.	.	O	.	_	0	SENT_38	[p2l1245t312r1621b364],

1	—	NN	O	—	_	0	SENT_39	[p2l1245t312r1621b364],
2	.	.	O	.	_	0	SENT_39	[p2l1245t312r1621b364],

1	Furukori	JJ	O	furukori	amod	2	SENT_40	[p2l1245t312r1621b364],
2	)	NN	O	)	_	0	SENT_40	[p2l1245t312r1621b364],
3	.	.	O	.	_	0	SENT_40	[p2l1245t312r1621b364],

1	0278-5846	CD	DURATION	0278-5846	_	0	SENT_41	[p2l9t450r308b503],
2	/	:	O	/	punct	1	SENT_41	[p2l9t450r308b503],
3	$	$	MONEY	$	nsubj	5	SENT_41	[p2l9t450r308b503],
4	—	CD	MONEY	—	num	3	SENT_41	[p2l331t476r355b481],
5	see	VBP	O	see	dep	1	SENT_41	[p2l377t463r450b493],
6	front	JJ	O	front	amod	7	SENT_41	[p2l471t451r587b493],
7	matter	NN	O	matter	dobj	5	SENT_41	[p2l605t457r764b493],
8	©	CD	NUMBER	©	num	11	SENT_41	[p2l782t454r820b493],
9	2008	CD	DATE	2008	num	11	SENT_41	[p2l840t453r957b493],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	11	SENT_41	[p2l979t451r1162b493],
11	Inc.	NNP	ORGANIZATION	Inc.	dep	7	SENT_41	[p2l1182t454r1261b493],
12	.	.	O	.	_	0	SENT_41	[p2l1182t454r1261b493],

1	All	DT	O	all	det	2	SENT_42	[p2l1280t451r1343b492],
2	rights	NNS	O	rights	nsubj	3	SENT_42	[p2l1365t451r1498b503],
3	reserved	VBN	O	reserve	_	0	SENT_42	[p2l1520t451r1731b493],
4	.	.	O	.	_	0	SENT_42	[p2l1520t451r1731b493],

1	doi	FW	O	doi	_	0	SENT_43	[p2l9t520r780b573],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_43	[p2l9t520r780b573],
3	/	:	O	/	punct	5	SENT_43	[p2l9t520r780b573],
4	j.	NN	O	j.	nn	5	SENT_43	[p2l9t520r780b573],
5	pnpbp	NN	O	pnpbp	dep	2	SENT_43	[p2l9t520r780b573],
6	.2008.05.006	CD	NUMBER	.2008.05.006	dep	2	SENT_43	[p2l9t520r780b573],

1	©	RB	O	©	advmod	2	SENT_44	[p2l1049t605r1093b649],
2	2008	CD	DATE	2008	_	0	SENT_44	[p2l1116t604r1251b650],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	4	SENT_44	[p2l1276t602r1488b650],
4	Inc.	NNP	ORGANIZATION	Inc.	dep	2	SENT_44	[p2l1511t605r1602b650],
5	.	.	O	.	_	0	SENT_44	[p2l1511t605r1602b650],

1	All	DT	O	all	det	2	SENT_45	[p2l1625t602r1698b649],
2	rights	NNS	O	rights	nsubj	3	SENT_45	[p2l1722t602r1876b662],
3	reserved	VBN	O	reserve	_	0	SENT_45	[p2l1901t602r2146b650],
4	.	.	O	.	_	0	SENT_45	[p2l1901t602r2146b650],

1	Risperidone	NNP	O	Risperidone	nsubjpass	3	SENT_46	[p2l149t902r506b969],
2	is	VBZ	O	be	auxpass	3	SENT_46	[p2l525t903r568b956],
3	known	VBN	O	know	_	0	SENT_46	[p2l588t902r794b956],
4	to	TO	O	to	aux	5	SENT_46	[p2l811t910r869b956],
5	have	VB	O	have	xcomp	3	SENT_46	[p2l887t902r1025b956],
6	a	DT	O	a	det	9	SENT_46	[p2l1044t918r1075b956],
7	potent	JJ	O	potent	amod	9	SENT_46	[p2l1092t910r1289b969],
8	serotonin	NN	O	serotonin	nn	9	SENT_46	[p2l1306t903r1588b956],
9	5HT2	NN	O	5ht2	dobj	5	SENT_46	[p2l1608t906r1754b966],
10	and	CC	O	and	_	0	SENT_46	[p2l1774t902r1883b956],
11	a	DT	O	a	det	13	SENT_46	[p2l1901t918r1932b956],
12	milder	JJR	O	milder	amod	13	SENT_46	[p2l1951t902r2149b956],
13	dopamine	NN	O	dopamine	conj_and	9	SENT_46	[p2l48t989r350b1055],
14	D2	NN	O	d2	dep	18	SENT_46	[p2l375t992r445b1052],
15	antagonistic	JJ	O	antagonistic	amod	16	SENT_46	[p2l471t990r837b1055],
16	activity	NN	O	activity	dep	14	SENT_46	[p2l860t990r1082b1055],
17	(	CD	NUMBER	(	dep	18	SENT_46	[p2l1105t989r1350b1055],
18	Schotte	NNP	PERSON	Schotte	dep	9	SENT_46	[p2l1105t989r1350b1055],
19	et	FW	O	et	nn	20	SENT_46	[p2l1375t997r1432b1042],
20	al.	FW	O	al.	dep	18	SENT_46	[p2l1454t989r1533b1050],
21	,	,	O	,	_	0	SENT_46	[p2l1454t989r1533b1050],
22	1995	CD	DATE	1995	num	23	SENT_46	[p2l1558t989r1737b1055],
23	)	NN	O	)	appos	20	SENT_46	[p2l1558t989r1737b1055],
24	.	.	O	.	_	0	SENT_46	[p2l1558t989r1737b1055],

1	Early	JJ	O	early	amod	2	SENT_47	[p2l1763t989r1913b1055],
2	studies	NNS	O	study	nsubj	3	SENT_47	[p2l1936t989r2146b1042],
3	reported	VBD	O	report	_	0	SENT_47	[p2l48t1075r306b1141],
4	adverse	JJ	O	adverse	amod	5	SENT_47	[p2l326t1075r556b1128],
5	effects	NNS	O	effect	dobj	3	SENT_47	[p2l577t1074r769b1128],
6	associated	VBN	O	associate	partmod	5	SENT_47	[p2l789t1075r1096b1128],
7	with	IN	O	with	_	0	SENT_47	[p2l1115t1075r1254b1128],
8	hyperprolactinemia	NN	O	hyperprolactinemia	nn	10	SENT_47	[p2l1274t1075r1866b1141],
9	(	CD	NUMBER	(	num	10	SENT_47	[p2l1885t1075r2147b1141],
10	Dickson	NNP	PERSON	Dickson	prep_with	6	SENT_47	[p2l1885t1075r2147b1141],
11	et	FW	O	et	nn	12	SENT_47	[p2l48t1168r105b1213],
12	al.	FW	O	al.	dep	10	SENT_47	[p2l119t1160r198b1222],
13	,	,	O	,	_	0	SENT_47	[p2l119t1160r198b1222],
14	1995	CD	DATE	1995	appos	12	SENT_47	[p2l213t1163r372b1221],
15	;	:	O	;	_	0	SENT_47	[p2l213t1163r372b1221],
16	Popli	NNP	O	Popli	dep	12	SENT_47	[p2l393t1160r541b1227],
17	et	FW	O	et	nn	18	SENT_47	[p2l558t1168r614b1213],
18	al.	FW	O	al.	dep	16	SENT_47	[p2l628t1160r882b1221],
19	,1998	CD	NUMBER	,1998	dep	16	SENT_47	[p2l628t1160r882b1221],
20	;	:	O	;	_	0	SENT_47	[p2l628t1160r882b1221],
21	Kim	NNP	PERSON	Kim	dep	12	SENT_47	[p2l902t1161r1022b1213],
22	et	FW	O	et	nn	23	SENT_47	[p2l1037t1168r1093b1213],
23	al.	FW	O	al.	dep	21	SENT_47	[p2l1107t1160r1186b1222],
24	,	,	O	,	_	0	SENT_47	[p2l1107t1160r1186b1222],
25	1999	CD	DATE	1999	num	26	SENT_47	[p2l1201t1160r1381b1226],
26	)	NN	O	)	appos	10	SENT_47	[p2l1201t1160r1381b1226],
27	.	.	O	.	_	0	SENT_47	[p2l1201t1160r1381b1226],

1	Except	IN	O	except	_	0	SENT_48	[p2l1399t1163r1598b1227],
2	for	IN	O	for	prepc_except_for	17	SENT_48	[p2l1612t1160r1695b1213],
3	a	DT	O	a	det	7	SENT_48	[p2l1709t1176r1739b1213],
4	retrospective	JJ	O	retrospective	amod	7	SENT_48	[p2l1755t1161r2146b1227],
5	analysis	NN	O	analysis	dep	4	SENT_48	[p2l48t1246r284b1313],
6	(	CD	NUMBER	(	num	5	SENT_48	[p2l316t1246r630b1313],
7	Kleinberg	NNP	PERSON	Kleinberg	pobj	17	SENT_48	[p2l316t1246r630b1313],
8	et	FW	O	et	nn	9	SENT_48	[p2l660t1254r717b1299],
9	al.	FW	O	al.	tmod	7	SENT_48	[p2l747t1246r826b1307],
10	,	,	O	,	_	0	SENT_48	[p2l747t1246r826b1307],
11	1999	CD	DATE	1999	num	12	SENT_48	[p2l857t1246r1037b1312],
12	)	NN	O	)	appos	9	SENT_48	[p2l857t1246r1037b1312],
13	,	,	O	,	_	0	SENT_48	[p2l857t1246r1037b1312],
14	it	PRP	O	it	nsubjpass	17	SENT_48	[p2l1070t1247r1111b1299],
15	has	VBZ	O	have	aux	17	SENT_48	[p2l1142t1246r1240b1299],
16	been	VBN	O	be	auxpass	17	SENT_48	[p2l1272t1246r1417b1299],
17	demonstrated	VBN	O	demonstrate	_	0	SENT_48	[p2l1448t1246r1869b1299],
18	that	IN	O	that	complm	49	SENT_48	[p2l1900t1246r2022b1299],
19	the	DT	O	the	det	23	SENT_48	[p2l2051t1246r2146b1299],
20	pronounced	JJ	O	pronounced	amod	23	SENT_48	[p2l48t1332r410b1399],
21	hyperprolactinemia	NN	O	hyperprolactinemia	nn	23	SENT_48	[p2l428t1332r1020b1399],
22	(	NN	O	(	nn	23	SENT_48	[p2l1036t1332r1312b1399],
23	Shiwach	NN	PERSON	shiwach	nsubjpass	49	SENT_48	[p2l1036t1332r1312b1399],
24	and	CC	O	and	_	0	SENT_48	[p2l1329t1332r1438b1386],
25	Carmody	NNP	PERSON	Carmody	conj_and	23	SENT_48	[p2l1456t1332r1738b1399],
26	,	,	O	,	_	0	SENT_48	[p2l1456t1332r1738b1399],
27	1998	CD	DATE	1998	appos	25	SENT_48	[p2l1754t1335r1913b1394],
28	;	:	O	;	_	0	SENT_48	[p2l1754t1335r1913b1394],
29	Caracci	NNP	PERSON	Caracci	dep	25	SENT_48	[p2l1936t1333r2146b1386],
30	and	CC	O	and	_	0	SENT_48	[p2l48t1418r157b1471],
31	Ananthamoorthy	NNP	O	Ananthamoorthy	dep	25	SENT_48	[p2l176t1418r704b1485],
32	,	,	O	,	_	0	SENT_48	[p2l176t1418r704b1485],
33	1999	CD	DATE	1999	appos	29	SENT_48	[p2l723t1421r883b1480],
34	;	:	O	;	_	0	SENT_48	[p2l723t1421r883b1480],
35	Lavalaye	NNP	O	Lavalaye	dep	25	SENT_48	[p2l908t1418r1159b1485],
36	et	FW	O	et	nn	37	SENT_48	[p2l1180t1426r1236b1471],
37	al.	FW	O	al.	dep	35	SENT_48	[p2l1255t1418r1334b1480],
38	,	,	O	,	_	0	SENT_48	[p2l1255t1418r1334b1480],
39	1999	CD	DATE	1999	appos	37	SENT_48	[p2l1354t1421r1514b1480],
40	;	:	O	;	_	0	SENT_48	[p2l1354t1421r1514b1480],
41	David	NNP	PERSON	David	dep	25	SENT_48	[p2l1539t1418r1708b1471],
42	et	FW	O	et	nn	43	SENT_48	[p2l1730t1426r1786b1471],
43	al.	FW	O	al.	dep	41	SENT_48	[p2l1805t1418r1884b1480],
44	,	,	O	,	_	0	SENT_48	[p2l1805t1418r1884b1480],
45	2000	CD	DATE	2000	num	46	SENT_48	[p2l1905t1418r2081b1484],
46	)	NN	O	)	appos	43	SENT_48	[p2l1905t1418r2081b1484],
47	is	VBZ	O	be	auxpass	49	SENT_48	[p2l2103t1419r2146b1471],
48	consistently	RB	O	consistently	advmod	49	SENT_48	[p2l48t1505r425b1571],
49	induced	VBN	O	induce	ccomp	17	SENT_48	[p2l471t1505r718b1558],
50	by	IN	O	by	_	0	SENT_48	[p2l766t1505r839b1571],
51	risperidone	NN	O	risperidone	nn	52	SENT_48	[p2l885t1505r1242b1571],
52	treatment	NN	O	treatment	agent	49	SENT_48	[p2l1289t1513r1603b1558],
53	compared	VBN	O	compare	_	0	SENT_48	[p2l1649t1505r1957b1571],
54	with	IN	O	with	prepc_compared_with	49	SENT_48	[p2l2004t1505r2147b1558],
55	conventional	JJ	O	conventional	amod	57	SENT_48	[p2l48t1591r437b1644],
56	antipsychotic	JJ	O	antipsychotic	amod	57	SENT_48	[p2l459t1591r860b1657],
57	agents	NNS	O	agent	pobj	49	SENT_48	[p2l881t1599r1090b1657],
58	.	.	O	.	_	0	SENT_48	[p2l881t1599r1090b1657],

1	Our	PRP$	O	we	poss	3	SENT_49	[p2l149t1679r260b1729],
2	previous	JJ	O	previous	amod	3	SENT_49	[p2l296t1677r553b1743],
3	studies	NNS	O	study	nsubj	5	SENT_49	[p2l592t1676r802b1729],
4	have	VBP	O	have	aux	5	SENT_49	[p2l840t1676r979b1729],
5	shown	VBN	O	show	_	0	SENT_49	[p2l1018t1676r1216b1729],
6	that	IN	O	that	complm	10	SENT_49	[p2l1253t1676r1374b1729],
7	dopamine	NN	O	dopamine	nn	9	SENT_49	[p2l1410t1676r1711b1743],
8	D2	NN	O	d2	nn	9	SENT_49	[p2l1750t1679r1829b1729],
9	receptors	NNS	O	receptor	nsubj	10	SENT_49	[p2l1868t1684r2146b1743],
10	(	VBP	O	(	ccomp	5	SENT_49	[p2l48t1762r266b1828],
11	DRD2	NN	O	drd2	dobj	10	SENT_49	[p2l48t1762r266b1828],
12	)	CD	NUMBER	)	num	13	SENT_49	[p2l48t1762r266b1828],
13	polymorphisms	NNS	O	polymorphism	nsubjpass	23	SENT_49	[p2l285t1762r756b1829],
14	such	JJ	O	such	_	0	SENT_49	[p2l777t1762r913b1815],
15	as	IN	O	as	_	0	SENT_49	[p2l931t1778r989b1815],
16	Taq	NN	O	taq	nn	17	SENT_49	[p2l1010t1765r1107b1829],
17	IA	NN	O	ia	prep_such_as	13	SENT_49	[p2l1124t1764r1181b1815],
18	and	CC	O	and	_	0	SENT_49	[p2l1201t1762r1310b1815],
19	—	NN	O	—	nn	21	SENT_49	[p2l1330t1794r1351b1799],
20	141C	NN	O	141c	nn	21	SENT_49	[p2l1364t1765r1498b1815],
21	Ins/Del	NN	O	ins/del	prep_such_as	13	SENT_49	[p2l1510t1762r1711b1829],
22	are	VBP	O	be	auxpass	23	SENT_49	[p2l1729t1778r1820b1815],
23	associated	VBN	O	associate	rcmod	11	SENT_49	[p2l1839t1762r2146b1815],
24	with	IN	O	with	_	0	SENT_49	[p2l46t1848r185b1902],
25	clinical	JJ	O	clinical	amod	26	SENT_49	[p2l215t1848r424b1902],
26	response	NN	O	response	prep_with	23	SENT_49	[p2l454t1864r721b1915],
27	to	TO	O	to	_	0	SENT_49	[p2l750t1856r808b1902],
28	antipsychotics	NNS	O	antipsychotic	prep_to	23	SENT_49	[p2l838t1849r1266b1915],
29	(	CD	NUMBER	(	amod	28	SENT_49	[p2l1296t1849r1519b1915],
30	Suzuki	NNP	PERSON	Suzuki	dep	29	SENT_49	[p2l1296t1849r1519b1915],
31	et	FW	O	et	nn	32	SENT_49	[p2l1549t1856r1606b1902],
32	al.	FW	O	al.	dep	30	SENT_49	[p2l1634t1849r1713b1910],
33	,	,	O	,	_	0	SENT_49	[p2l1634t1849r1713b1910],
34	2000	CD	DATE	2000	appos	30	SENT_49	[p2l1743t1851r1914b1910],
35	;	:	O	;	_	0	SENT_49	[p2l1743t1851r1914b1910],
36	Suzuki	NNP	PERSON	Suzuki	dep	34	SENT_49	[p2l1949t1848r2147b1902],
37	et	FW	O	et	nn	38	SENT_49	[p2l48t1942r105b1987],
38	al.	FW	O	al.	dep	36	SENT_49	[p2l127t1934r206b1996],
39	,	,	O	,	_	0	SENT_49	[p2l127t1934r206b1996],
40	2001b	JJ	O	2001b	amod	41	SENT_49	[p2l230t1934r456b2000],
41	)	NN	O	)	appos	36	SENT_49	[p2l230t1934r456b2000],
42	,	,	O	,	_	0	SENT_49	[p2l230t1934r456b2000],
43	respectively	RB	O	respectively	advmod	36	SENT_49	[p2l481t1934r851b2001],
44	,	,	O	,	_	0	SENT_49	[p2l481t1934r851b2001],
45	in	IN	O	in	_	0	SENT_49	[p2l877t1935r932b1987],
46	schizophrenic	JJ	O	schizophrenic	amod	47	SENT_49	[p2l957t1934r1374b2001],
47	patients	NNS	O	patient	prep_in	36	SENT_49	[p2l1398t1935r1638b2001],
48	treated	VBN	O	treat	partmod	47	SENT_49	[p2l1662t1934r1875b1987],
49	with	IN	O	with	_	0	SENT_49	[p2l1897t1934r2036b1987],
50	selective	JJ	O	selective	amod	52	SENT_49	[p2l2061t1950r2146b1987, p2l48t2021r241b2074],
51	DRD2	NN	O	drd2	nn	52	SENT_49	[p2l271t2023r438b2073],
52	antagonists	NNS	O	antagonist	prep_with	48	SENT_49	[p2l469t2021r826b2087],
53	.	.	O	.	_	0	SENT_49	[p2l469t2021r826b2087],

1	We	PRP	O	we	nsubj	3	SENT_50	[p2l853t2024r952b2074],
2	have	VBP	O	have	aux	3	SENT_50	[p2l982t2021r1120b2074],
3	reported	VBN	O	report	dep	15	SENT_50	[p2l1149t2021r1407b2087],
4	that	IN	O	that	complm	10	SENT_50	[p2l1436t2021r1557b2074],
5	neuroleptic	JJ	O	neuroleptic	amod	7	SENT_50	[p2l1584t2021r1926b2087],
6	malignant	JJ	O	malignant	amod	7	SENT_50	[p2l1954t2021r2146b2087, p2l48t2115r185b2160],
7	syndrome	NN	O	syndrome	nsubjpass	10	SENT_50	[p2l202t2107r501b2173],
8	is	VBZ	O	be	auxpass	10	SENT_50	[p2l520t2107r563b2160],
9	also	RB	O	also	advmod	10	SENT_50	[p2l582t2107r698b2160],
10	linked	VBN	O	link	ccomp	3	SENT_50	[p2l717t2107r902b2160],
11	with	IN	O	with	_	0	SENT_50	[p2l919t2107r1058b2160],
12	these	DT	O	these	det	14	SENT_50	[p2l1075t2107r1234b2160],
13	DRD2	NN	O	drd2	nn	14	SENT_50	[p2l1250t2109r1416b2159],
14	polymorphisms	NNS	O	polymorphism	prep_with	10	SENT_50	[p2l1435t2107r1905b2173],
15	(	VBP	O	(	_	0	SENT_50	[p2l1925t2107r2147b2173],
16	Suzuki	NNP	PERSON	Suzuki	dobj	15	SENT_50	[p2l1925t2107r2147b2173],
17	et	FW	O	et	nn	18	SENT_50	[p2l48t2200r105b2245],
18	al.	FW	O	al.	nsubj	15	SENT_50	[p2l124t2192r203b2253],
19	,	,	O	,	_	0	SENT_50	[p2l124t2192r203b2253],
20	2001a	JJ	O	2001a	amod	21	SENT_50	[p2l226t2192r446b2258],
21	)	NN	O	)	appos	18	SENT_50	[p2l226t2192r446b2258],
22	.	.	O	.	_	0	SENT_50	[p2l226t2192r446b2258],

1	These	DT	O	these	det	2	SENT_51	[p2l466t2192r640b2245],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_51	[p2l662t2192r903b2259],
3	suggest	VBP	O	suggest	_	0	SENT_51	[p2l925t2200r1150b2259],
4	that	IN	O	that	complm	18	SENT_51	[p2l1169t2192r1290b2245],
5	several	JJ	O	several	amod	7	SENT_51	[p2l1311t2192r1519b2245],
6	clinical	JJ	O	clinical	amod	7	SENT_51	[p2l1541t2192r1751b2245],
7	responses	NNS	O	response	nsubj	18	SENT_51	[p2l1773t2208r2068b2259],
8	to	TO	O	to	_	0	SENT_51	[p2l2089t2200r2146b2245],
9	selective	JJ	O	selective	amod	11	SENT_51	[p2l49t2278r309b2331],
10	DRD2	NN	O	drd2	nn	11	SENT_51	[p2l355t2281r523b2331],
11	antagonists	NNS	O	antagonist	prep_to	7	SENT_51	[p2l570t2279r916b2345],
12	are	VBP	O	be	cop	18	SENT_51	[p2l963t2294r1054b2331],
13	dependent	JJ	O	dependent	amod	18	SENT_51	[p2l1099t2278r1427b2345],
14	upon	IN	O	upon	_	0	SENT_51	[p2l1471t2294r1625b2345],
15	inter	NN	O	inter	prep_upon	13	SENT_51	[p2l1670t2278r2146b2331],
16	—	CD	NUMBER	—	num	15	SENT_51	[p2l1670t2278r2146b2331],
17	individual	JJ	O	individual	amod	18	SENT_51	[p2l1670t2278r2146b2331],
18	variation	NN	O	variation	ccomp	3	SENT_51	[p2l46t2365r315b2418],
19	of	IN	O	of	_	0	SENT_51	[p2l347t2364r409b2418],
20	target	NN	O	target	nn	22	SENT_51	[p2l433t2372r611b2431],
21	receptor	NN	O	receptor	nn	22	SENT_51	[p2l641t2372r893b2431],
22	function	NN	O	function	prep_of	18	SENT_51	[p2l923t2364r1187b2418],
23	.	.	O	.	_	0	SENT_51	[p2l923t2364r1187b2418],

1	Several	JJ	O	several	amod	2	SENT_52	[p2l1219t2364r1433b2418],
2	studies	NNS	O	study	nsubj	3	SENT_52	[p2l1466t2364r1677b2418],
3	supported	VBD	O	support	dep	6	SENT_52	[p2l1710t2364r2014b2431],
4	our	PRP$	O	we	poss	5	SENT_52	[p2l2047t2380r2149b2418],
5	ﬁndings	NNS	O	ﬁndings	dobj	3	SENT_52	[p2l48t2451r289b2517],
6	(	VBP	O	(	_	0	SENT_52	[p2l312t2451r705b2517],
7	Yamanouchi	NNP	PERSON	Yamanouchi	dobj	6	SENT_52	[p2l312t2451r705b2517],
8	et	FW	O	et	nn	9	SENT_52	[p2l727t2459r783b2504],
9	al.	FW	O	al.	nsubj	6	SENT_52	[p2l803t2451r882b2512],
10	,	,	O	,	_	0	SENT_52	[p2l803t2451r882b2512],
11	2003	CD	DATE	2003	appos	9	SENT_52	[p2l905t2454r1075b2512],
12	;	:	O	;	_	0	SENT_52	[p2l905t2454r1075b2512],
13	Wu	NNP	O	Wu	dep	11	SENT_52	[p2l1098t2454r1205b2504],
14	et	FW	O	et	nn	15	SENT_52	[p2l1227t2459r1283b2504],
15	al.	FW	O	al.	dep	13	SENT_52	[p2l1304t2451r1382b2512],
16	,	,	O	,	_	0	SENT_52	[p2l1304t2451r1382b2512],
17	2005	CD	DATE	2005	num	18	SENT_52	[p2l1406t2451r1594b2517],
18	)	NN	O	)	appos	15	SENT_52	[p2l1406t2451r1594b2517],
19	.	.	O	.	_	0	SENT_52	[p2l1406t2451r1594b2517],

1	In	IN	O	in	_	0	SENT_53	[p2l149t2540r205b2589],
2	addition	NN	O	addition	prep_in	6	SENT_53	[p2l241t2537r505b2598],
3	,	,	O	,	_	0	SENT_53	[p2l241t2537r505b2598],
4	several	JJ	O	several	amod	5	SENT_53	[p2l543t2537r752b2590],
5	studies	NNS	O	study	nsubj	6	SENT_53	[p2l789t2537r999b2590],
6	suggest	VBP	O	suggest	_	0	SENT_53	[p2l1037t2545r1262b2603],
7	that	IN	O	that	_	0	SENT_53	[p2l1296t2537r1417b2590],
8	the	DT	O	the	det	9	SENT_53	[p2l1452t2537r1547b2590],
9	polymorphisms	NNS	O	polymorphism	prep_that	6	SENT_53	[p2l1584t2537r2055b2603],
10	of	IN	O	of	_	0	SENT_53	[p2l2092t2536r2154b2590],
11	DRD3	NN	O	drd3	nn	13	SENT_53	[p2l48t2625r215b2675],
12	(	CD	NUMBER	(	num	13	SENT_53	[p2l246t2622r601b2688],
13	Scharfetter	NNP	O	Scharfetter	prep_of	9	SENT_53	[p2l246t2622r601b2688],
14	et	FW	O	et	nn	15	SENT_53	[p2l628t2630r684b2675],
15	al.	FW	O	al.	dep	13	SENT_53	[p2l711t2622r790b2684],
16	,	,	O	,	_	0	SENT_53	[p2l711t2622r790b2684],
17	1999	CD	DATE	1999	appos	15	SENT_53	[p2l819t2625r978b2684],
18	;	:	O	;	_	0	SENT_53	[p2l819t2625r978b2684],
19	Lane	NNP	O	Lane	dep	15	SENT_53	[p2l1012t2625r1149b2675],
20	et	FW	O	et	nn	21	SENT_53	[p2l1179t2630r1235b2675],
21	al.	FW	O	al.	dep	19	SENT_53	[p2l1262t2622r1341b2683],
22	,	,	O	,	_	0	SENT_53	[p2l1262t2622r1341b2683],
23	2005	CD	DATE	2005	num	24	SENT_53	[p2l1371t2622r1560b2688],
24	)	NN	O	)	appos	21	SENT_53	[p2l1371t2622r1560b2688],
25	,	,	O	,	_	0	SENT_53	[p2l1371t2622r1560b2688],
26	DRD4	NN	O	drd4	nn	28	SENT_53	[p2l1590t2625r1760b2675],
27	(	CD	NUMBER	(	num	28	SENT_53	[p2l1788t2622r1954b2688],
28	Hwu	NNP	PERSON	Hwu	appos	21	SENT_53	[p2l1788t2622r1954b2688],
29	et	FW	O	et	nn	30	SENT_53	[p2l1983t2630r2040b2675],
30	al.	FW	O	al.	dep	28	SENT_53	[p2l2067t2622r2146b2684],
31	,	,	O	,	_	0	SENT_53	[p2l2067t2622r2146b2684],
32	1998	CD	DATE	1998	appos	21	SENT_53	[p2l51t2711r210b2770],
33	;	:	O	;	_	0	SENT_53	[p2l51t2711r210b2770],
34	Cohen	NNP	PERSON	Cohen	dep	15	SENT_53	[p2l243t2708r431b2761],
35	et	FW	O	et	nn	36	SENT_53	[p2l457t2716r514b2761],
36	al.	FW	O	al.	dep	34	SENT_53	[p2l539t2708r618b2769],
37	,	,	O	,	_	0	SENT_53	[p2l539t2708r618b2769],
38	1999	CD	DATE	1999	appos	36	SENT_53	[p2l645t2711r803b2770],
39	;	:	O	;	_	0	SENT_53	[p2l645t2711r803b2770],
40	Zalsman	NNP	O	Zalsman	dep	15	SENT_53	[p2l834t2708r1087b2761],
41	et	FW	O	et	nn	42	SENT_53	[p2l1113t2716r1170b2761],
42	al.	FW	O	al.	dep	40	SENT_53	[p2l1195t2708r1274b2769],
43	,	,	O	,	_	0	SENT_53	[p2l1195t2708r1274b2769],
44	2003	CD	DATE	2003	num	45	SENT_53	[p2l1302t2708r1476b2774],
45	)	NN	O	)	conj_and	13	SENT_53	[p2l1302t2708r1476b2774],
46	and	CC	O	and	_	0	SENT_53	[p2l1503t2708r1612b2761],
47	COMT	NN	O	comt	nn	49	SENT_53	[p2l1641t2711r1823b2761],
48	(	CD	NUMBER	(	num	49	SENT_53	[p2l1848t2708r2146b2774],
49	Bertolino	NN	PERSON	bertolino	conj_and	13	SENT_53	[p2l1848t2708r2146b2774],

1	1492	CD	DATE	1492	_	0	SENT_54	[p2l215t2850r270b2871],
2	N.	NNP	PERSON	N.	nn	3	SENT_54	[p2l643t2851r665b2871],
3	Yasui	NNP	PERSON	Yasui	dep	1	SENT_54	[p2l677t2849r847b2871],
4	.	.	O	.	_	0	SENT_54	[p2l677t2849r847b2871],

1	—	NN	O	—	_	0	SENT_55	[p2l677t2849r847b2871],
2	.	.	O	.	_	0	SENT_55	[p2l677t2849r847b2871],

1	Furukon	NN	PERSON	furukon	_	0	SENT_56	[p2l677t2849r847b2871],
2	'	''	O	'	_	0	SENT_56	[p2l677t2849r847b2871],
3	et	FW	O	et	nn	4	SENT_56	[p2l857t2852r879b2871],
4	al.	FW	O	al.	dep	1	SENT_56	[p2l887t2849r912b2871],
5	/	:	O	/	punct	6	SENT_56	[p2l921t2849r932b2876],
6	Progress	NNP	O	Progress	dep	4	SENT_56	[p2l940t2851r1036b2876],
7	in	IN	O	in	_	0	SENT_56	[p2l1047t2850r1067b2871],
8	Neuro	NNP	O	Neuro	prep_in	4	SENT_56	[p2l1077t2849r1403b2876],
9	.	.	O	.	_	0	SENT_56	[p2l1077t2849r1403b2876],

1	—	NN	O	—	_	0	SENT_57	[p2l1077t2849r1403b2876],
2	.	.	O	.	_	0	SENT_57	[p2l1077t2849r1403b2876],

1	Psychopharmacology	NN	O	psychopharmacology	_	0	SENT_58	[p2l1077t2849r1403b2876],
2	8	CD	NUMBER	8	num	1	SENT_58	[p2l1413t2850r1435b2871],
3	'	''	O	'	_	0	SENT_58	[p2l1413t2850r1435b2871],
4	Biological	JJ	O	biological	amod	5	SENT_58	[p2l1442t2849r1554b2876],
5	Psychiatry	NNP	O	Psychiatry	dep	1	SENT_58	[p2l1563t2849r1682b2876],
6	32	CD	NUMBER	32	num	5	SENT_58	[p2l1692t2850r1721b2871],
7	(	CD	NUMBER	(	num	8	SENT_58	[p2l1731t2849r1808b2876],
8	2008	CD	DATE	2008	dep	1	SENT_58	[p2l1731t2849r1808b2876],
9	)	CD	NUMBER	)	num	10	SENT_58	[p2l1731t2849r1808b2876],
10	1491-1495	CD	DATE	1491-1495	dep	8	SENT_58	[p2l1821t2850r1945b2871],

1	et	FW	O	et	nn	2	SENT_59	[p2l9t2996r66b3043],
2	al.	FW	O	al.	_	0	SENT_59	[p2l83t2988r163b3051],
3	,	,	O	,	_	0	SENT_59	[p2l83t2988r163b3051],
4	2004	CD	DATE	2004	appos	2	SENT_59	[p2l182t2991r354b3051],
5	;	:	O	;	_	0	SENT_59	[p2l182t2991r354b3051],
6	Weickert	NNP	O	Weickert	dep	2	SENT_59	[p2l375t2988r654b3043],
7	et	FW	O	et	nn	8	SENT_59	[p2l671t2996r728b3043],
8	al.	FW	O	al.	dep	6	SENT_59	[p2l744t2988r825b3051],
9	,	,	O	,	_	0	SENT_59	[p2l744t2988r825b3051],
10	2004	CD	DATE	2004	num	11	SENT_59	[p2l844t2988r1022b3056],
11	)	NN	O	)	nsubjpass	13	SENT_59	[p2l844t2988r1022b3056],
12	are	VBP	O	be	auxpass	13	SENT_59	[p2l1040t3004r1134b3043],
13	associated	VBN	O	associate	dep	2	SENT_59	[p2l1152t2988r1465b3043],
14	with	IN	O	with	_	0	SENT_59	[p2l1482t2988r1623b3043],
15	clinical	JJ	O	clinical	amod	16	SENT_59	[p2l1641t2988r1855b3043],
16	response	NN	O	response	prep_with	13	SENT_59	[p2l1874t3004r2145b3057],
17	to	TO	O	to	_	0	SENT_59	[p2l8t3085r67b3132],
18	antipsychotics	NNS	O	antipsychotic	prep_to	13	SENT_59	[p2l100t3077r552b3146],
19	.	.	O	.	_	0	SENT_59	[p2l100t3077r552b3146],

1	Based	VBN	O	base	_	0	SENT_60	[p2l587t3077r761b3132],
2	on	IN	O	on	prepc_based_on	8	SENT_60	[p2l796t3093r871b3132],
3	these	DT	O	these	det	4	SENT_60	[p2l904t3077r1066b3132],
4	ﬁndings	NNS	O	ﬁndings	pobj	8	SENT_60	[p2l1101t3077r1361b3146],
5	,	,	O	,	_	0	SENT_60	[p2l1101t3077r1361b3146],
6	it	PRP	O	it	nsubj	8	SENT_60	[p2l1396t3078r1437b3132],
7	is	VBZ	O	be	cop	8	SENT_60	[p2l1469t3078r1514b3132],
8	possible	JJ	O	possible	_	0	SENT_60	[p2l1548t3077r1795b3146],
9	that	IN	O	that	complm	12	SENT_60	[p2l1828t3077r1951b3132],
10	these	DT	O	these	det	11	SENT_60	[p2l1983t3077r2145b3132],
11	polymorphisms	NNS	O	polymorphism	nsubj	12	SENT_60	[p2l9t3166r488b3235],
12	have	VBP	O	have	ccomp	8	SENT_60	[p2l519t3166r660b3221],
13	some	DT	O	some	det	14	SENT_60	[p2l691t3182r852b3221],
14	association	NN	O	association	dobj	12	SENT_60	[p2l882t3167r1220b3221],
15	with	IN	O	with	_	0	SENT_60	[p2l1246t3166r1388b3221],
16	prolactin	NN	O	prolactin	nn	17	SENT_60	[p2l1418t3166r1690b3235],
17	concentration	NN	O	concentration	prep_with	14	SENT_60	[p2l1721t3167r2145b3221],
18	during	IN	O	during	_	0	SENT_60	[p2l9t3255r211b3324],
19	risperidone	NN	O	risperidone	nn	20	SENT_60	[p2l256t3255r606b3324],
20	treatment	NN	O	treatment	prep_during	12	SENT_60	[p2l652t3264r972b3311],
21	.	.	O	.	_	0	SENT_60	[p2l652t3264r972b3311],

1	Thus	RB	O	thus	advmod	4	SENT_61	[p2l1016t3255r1177b3319],
2	,	,	O	,	_	0	SENT_61	[p2l1016t3255r1177b3319],
3	we	PRP	O	we	nsubj	4	SENT_61	[p2l1222t3271r1312b3310],
4	examined	VBD	O	examine	_	0	SENT_61	[p2l1359t3255r1658b3310],
5	the	DT	O	the	det	6	SENT_61	[p2l1704t3256r1801b3310],
6	effects	NNS	O	effect	nsubj	10	SENT_61	[p2l1847t3255r2043b3310],
7	of	IN	O	of	_	0	SENT_61	[p2l2089t3255r2153b3310],
8	dopamine	NN	O	dopamine	nn	9	SENT_61	[p2l9t3345r575b3413],
9	—	NN	O	—	prep_of	6	SENT_61	[p2l9t3345r575b3413],
10	related	JJ	O	related	ccomp	4	SENT_61	[p2l9t3345r575b3413],
11	polymorphisms	NNS	O	polymorphism	dobj	10	SENT_61	[p2l626t3345r1119b3413],
12	including	VBG	O	include	_	0	SENT_61	[p2l1170t3345r1465b3413],
13	DRD2	NN	O	drd2	prep_including	11	SENT_61	[p2l1514t3348r1688b3399],
14	on	IN	O	on	_	0	SENT_61	[p2l1739t3361r1815b3400],
15	prolactin	NN	O	prolactin	nn	16	SENT_61	[p2l1863t3345r2145b3413],
16	concentration	NN	O	concentration	prep_on	13	SENT_61	[p2l9t3435r433b3489],
17	during	IN	O	during	_	0	SENT_61	[p2l458t3434r660b3502],
18	risperidone	NN	O	risperidone	nn	19	SENT_61	[p2l684t3434r1034b3502],
19	treatment	NN	O	treatment	prep_during	10	SENT_61	[p2l1058t3442r1378b3489],
20	.	.	O	.	_	0	SENT_61	[p2l1058t3442r1378b3489],

1	2	LS	NUMBER	2	_	0	SENT_62	[p2l8t3615r60b3667],
2	.	.	O	.	_	0	SENT_62	[p2l8t3615r60b3667],

1	Methods	NNS	O	method	_	0	SENT_63	[p2l86t3612r366b3667],

1	The	DT	O	the	det	2	SENT_64	[p3l108t68r220b123],
2	subjects	NNS	O	subject	nsubj	7	SENT_64	[p3l240t68r485b136],
3	were	VBD	O	be	cop	7	SENT_64	[p3l503t84r656b123],
4	174	CD	NUMBER	174	num	7	SENT_64	[p3l678t71r776b122],
5	schizophrenic	JJ	O	schizophrenic	amod	7	SENT_64	[p3l796t68r1221b136],
6	Japanese	JJ	MISC	japanese	amod	7	SENT_64	[p3l1232t71r1505b136],
7	inpatients	NNS	O	inpatient	_	0	SENT_64	[p3l1526t69r1830b136],
8	(	VBP	O	(	rcmod	7	SENT_64	[p3l1850t68r1946b136],
9	68	CD	NUMBER	68	num	10	SENT_64	[p3l1850t68r1946b136],
10	males	NNS	O	male	nsubj	14	SENT_64	[p3l1969t68r2145b123],
11	and	CC	O	and	_	0	SENT_64	[p3l8t157r120b212],
12	106	CD	NUMBER	106	num	13	SENT_64	[p3l143t160r248b212],
13	females	NNS	O	female	conj_and	10	SENT_64	[p3l267t157r526b225],
14	)	VBP	O	)	ccomp	8	SENT_64	[p3l267t157r526b225],
15	who	WP	O	who	nsubj	16	SENT_64	[p3l543t157r677b212],
16	fulﬁlled	VBD	O	fulﬁlled	ccomp	14	SENT_64	[p3l697t157r930b212],
17	the	DT	O	the	det	18	SENT_64	[p3l949t157r1046b212],
18	criteria	NNS	O	criterion	dobj	16	SENT_64	[p3l1065t158r1281b212],
19	for	IN	O	for	_	0	SENT_64	[p3l1300t157r1385b212],
20	schizophrenia	NN	O	schizophrenia	prep_for	16	SENT_64	[p3l1403t157r1831b225],
21	according	VBG	O	accord	_	0	SENT_64	[p3l1848t157r2146b225],
22	to	TO	O	to	prepc_according_to	16	SENT_64	[p3l8t253r67b300],
23	the	DT	O	the	det	27	SENT_64	[p3l95t245r191b300],
24	Diagnostic	JJ	MISC	diagnostic	amod	27	SENT_64	[p3l222t246r542b314],
25	and	CC	O	and	_	0	SENT_64	[p3l570t245r681b300],
26	Statistical	JJ	ORGANIZATION	statistical	amod	27	SENT_64	[p3l711t245r1005b300],
27	Manual	NN	ORGANIZATION	manual	pobj	16	SENT_64	[p3l1034t245r1263b300],
28	of	IN	ORGANIZATION	of	_	0	SENT_64	[p3l1292t245r1356b300],
29	Mental	JJ	ORGANIZATION	mental	amod	30	SENT_64	[p3l1378t245r1591b300],
30	Disorders	NNS	ORGANIZATION	disorder	prep_of	27	SENT_64	[p3l1621t245r1926b309],
31	,	,	O	,	_	0	SENT_64	[p3l1621t245r1926b309],
32	fourth	JJ	ORDINAL	fourth	amod	33	SENT_64	[p3l1956t245r2146b300],
33	edition	NN	O	edition	appos	30	SENT_64	[p3l9t334r238b390],
34	.	.	O	.	_	0	SENT_64	[p3l9t334r238b390],

1	Some	DT	O	some	nsubj	5	SENT_65	[p3l265t337r431b389],
2	of	IN	O	of	_	0	SENT_65	[p3l458t334r521b389],
3	the	DT	O	the	det	4	SENT_65	[p3l540t334r637b389],
4	patients	NNS	O	patient	prep_of	1	SENT_65	[p3l664t335r908b403],
5	participated	VBD	O	participate	_	0	SENT_65	[p3l935t334r1303b403],
6	in	IN	O	in	_	0	SENT_65	[p3l1330t335r1386b388],
7	our	PRP$	O	we	poss	9	SENT_65	[p3l1412t350r1516b389],
8	previous	JJ	O	previous	amod	9	SENT_65	[p3l1541t335r1802b403],
9	studies	NNS	O	study	prep_in	5	SENT_65	[p3l1829t334r2044b389],
10	on	IN	O	on	_	0	SENT_65	[p3l2071t350r2145b389],
11	the	DT	O	the	det	12	SENT_65	[p3l8t423r105b478],
12	relationship	NN	O	relationship	prep_on	5	SENT_65	[p3l122t423r488b492],
13	between	IN	O	between	_	0	SENT_65	[p3l504t423r768b478],
14	steady	JJ	O	steady	amod	19	SENT_65	[p3l786t423r1155b492],
15	—	JJ	O	—	amod	19	SENT_65	[p3l786t423r1155b492],
16	state	NN	O	state	nn	19	SENT_65	[p3l786t423r1155b492],
17	plasma	NN	O	plasma	nn	19	SENT_65	[p3l1173t423r1390b492],
18	drug	NN	O	drug	nn	19	SENT_65	[p3l1407t423r1548b492],
19	concentrations	NNS	O	concentration	prep_between	12	SENT_65	[p3l1563t424r2016b478],
20	and	CC	O	and	_	0	SENT_65	[p3l2034t423r2145b478],
21	CYPZD6	NN	O	cypzd6	conj_and	12	SENT_65	[p3l9t515r241b567],
22	or	CC	O	or	_	0	SENT_65	[p3l263t528r326b567],
23	MDR1	NN	O	mdr1	conj_or	21	SENT_65	[p3l348t515r527b567],
24	genotype	NN	O	genotype	nn	26	SENT_65	[p3l557t521r840b581],
25	(	CD	NUMBER	(	num	26	SENT_65	[p3l864t512r1105b581],
26	Mihara	NNP	PERSON	Mihara	dep	21	SENT_65	[p3l864t512r1105b581],
27	et	FW	O	et	nn	28	SENT_65	[p3l1128t521r1186b567],
28	al.	FW	O	al.	dobj	5	SENT_65	[p3l1207t513r1287b576],
29	,	,	O	,	_	0	SENT_65	[p3l1207t513r1287b576],
30	2003	CD	DATE	2003	appos	28	SENT_65	[p3l1313t515r1484b576],
31	;	:	O	;	_	0	SENT_65	[p3l1313t515r1484b576],
32	Yasui	NNP	PERSON	Yasui	dep	28	SENT_65	[p3l1510t512r1961b567],
33	.	.	O	.	_	0	SENT_65	[p3l1510t512r1961b567],

1	—	NN	O	—	_	0	SENT_66	[p3l1510t512r1961b567],
2	.	.	O	.	_	0	SENT_66	[p3l1510t512r1961b567],

1	Furukori	NNP	O	Furukori	_	0	SENT_67	[p3l1510t512r1961b567],
2	et	FW	O	et	nn	3	SENT_67	[p3l1985t521r2042b567],
3	al.	FW	O	al.	dep	1	SENT_67	[p3l2064t513r2144b576],
4	,	,	O	,	_	0	SENT_67	[p3l2064t513r2144b576],
5	2003	CD	DATE	2003	appos	3	SENT_67	[p3l9t605r180b665],
6	;	:	O	;	_	0	SENT_67	[p3l9t605r180b665],
7	Yasui	NNP	PERSON	Yasui	dep	3	SENT_67	[p3l209t602r660b657],
8	.	.	O	.	_	0	SENT_67	[p3l209t602r660b657],

1	—	NN	O	—	_	0	SENT_68	[p3l209t602r660b657],
2	.	.	O	.	_	0	SENT_68	[p3l209t602r660b657],

1	Furukori	NNP	O	Furukori	_	0	SENT_69	[p3l209t602r660b657],
2	et	FW	O	et	nn	3	SENT_69	[p3l687t610r744b657],
3	al.	FW	O	al.	dep	1	SENT_69	[p3l769t602r849b665],
4	,	,	O	,	_	0	SENT_69	[p3l769t602r849b665],
5	2004	CD	DATE	2004	num	6	SENT_69	[p3l877t602r1070b670],
6	)	NN	O	)	appos	3	SENT_69	[p3l877t602r1070b670],
7	.	.	O	.	_	0	SENT_69	[p3l877t602r1070b670],

1	Patients	NNS	O	patient	nsubjpass	34	SENT_70	[p3l1098t603r1340b657],
2	with	IN	O	with	_	0	SENT_70	[p3l1366t602r1507b657],
3	clinically	RB	O	clinically	advmod	4	SENT_70	[p3l1534t602r1804b670],
4	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_70	[p3l1830t602r2147b670],
5	abnormal	JJ	O	abnormal	amod	6	SENT_70	[p3l8t691r300b746],
6	laboratory	NN	O	laboratory	prep_with	1	SENT_70	[p3l318t691r634b759],
7	or	CC	O	or	_	0	SENT_70	[p3l649t706r712b746],
8	electrocardiography	NN	O	electrocardiography	nn	9	SENT_70	[p3l726t691r1341b759],
9	ﬁndings	NNS	O	ﬁndings	prep_with	1	SENT_70	[p3l1356t690r1616b759],
10	,	,	O	,	_	0	SENT_70	[p3l1356t690r1616b759],
11	histories	NNS	O	history	conj_or	9	SENT_70	[p3l1634t691r1893b746],
12	of	IN	O	of	_	0	SENT_70	[p3l1911t690r1975b746],
13	mental	JJ	O	mental	amod	14	SENT_70	[p3l1984t706r2145b746, p3l8t779r83b834],
14	disorder	NN	O	disorder	prep_of	11	SENT_70	[p3l117t779r373b834],
15	other	JJ	O	other	dep	14	SENT_70	[p3l404t779r567b834],
16	than	IN	O	than	_	0	SENT_70	[p3l598t779r736b834],
17	schizophrenia	NN	O	schizophrenia	nn	24	SENT_70	[p3l770t779r1212b848],
18	,	,	O	,	_	0	SENT_70	[p3l770t779r1212b848],
19	epilepsy	NN	O	epilepsy	nn	24	SENT_70	[p3l1247t779r1511b848],
20	,	,	O	,	_	0	SENT_70	[p3l1247t779r1511b848],
21	alcoholism	NN	O	alcoholism	nn	24	SENT_70	[p3l1546t779r1878b834],
22	or	CC	O	or	_	0	SENT_70	[p3l1910t795r1973b834],
23	drug	NN	O	drug	nn	24	SENT_70	[p3l2005t779r2147b848],
24	abuse	NN	O	abuse	prep_than	14	SENT_70	[p3l8t868r198b931],
25	,	,	O	,	_	0	SENT_70	[p3l8t868r198b931],
26	or	CC	O	or	_	0	SENT_70	[p3l232t884r296b923],
27	clinically	RB	O	clinically	advmod	28	SENT_70	[p3l326t868r597b937],
28	signiﬁcant	JJ	O	signiﬁcant	prep_than	14	SENT_70	[p3l629t868r947b937],
29	organic	JJ	O	organic	amod	28	SENT_70	[p3l978t869r1204b937],
30	or	CC	O	or	_	0	SENT_70	[p3l1236t884r1300b923],
31	neurological	JJ	O	neurological	amod	32	SENT_70	[p3l1331t868r1708b937],
32	disease	NN	O	disease	conj_or	9	SENT_70	[p3l1742t868r1962b923],
33	were	VBD	O	be	auxpass	34	SENT_70	[p3l1993t884r2145b923],
34	excluded	VBN	O	exclude	_	0	SENT_70	[p3l9t957r297b1013],
35	.	.	O	.	_	0	SENT_70	[p3l9t957r297b1013],

1	The	DT	O	the	det	2	SENT_71	[p3l339t957r451b1012],
2	patients	NNS	O	patient	nsubjpass	10	SENT_71	[p3l496t958r741b1026],
3	receiving	VBG	O	receive	partmod	2	SENT_71	[p3l787t958r1065b1026],
4	prolactin	NN	O	prolactin	nn	7	SENT_71	[p3l1110t957r1759b1026],
5	—	NN	O	—	nn	7	SENT_71	[p3l1110t957r1759b1026],
6	inﬂuencing	NN	O	inﬂuencing	nn	7	SENT_71	[p3l1110t957r1759b1026],
7	medication	NN	O	medication	dobj	3	SENT_71	[p3l1803t957r2145b1012],
8	were	VBD	O	be	auxpass	10	SENT_71	[p3l7t1062r159b1101],
9	also	RB	O	also	advmod	10	SENT_71	[p3l189t1046r306b1101],
10	excluded	VBN	O	exclude	_	0	SENT_71	[p3l337t1046r625b1102],
11	.	.	O	.	_	0	SENT_71	[p3l337t1046r625b1102],

1	The	DT	O	the	det	5	SENT_72	[p3l653t1046r765b1101],
2	mean1rSD	NN	O	mean1rsd	nn	5	SENT_72	[p3l796t1049r1100b1101],
3	(	NN	O	(	nn	5	SENT_72	[p3l1130t1046r1350b1115],
4	range	NN	O	range	nn	5	SENT_72	[p3l1130t1046r1350b1115],
5	)	NN	O	)	nsubj	16	SENT_72	[p3l1130t1046r1350b1115],
6	of	IN	O	of	_	0	SENT_72	[p3l1380t1046r1444b1101],
7	age	NN	O	age	nn	10	SENT_72	[p3l1465t1062r1582b1115],
8	,	,	O	,	_	0	SENT_72	[p3l1465t1062r1582b1115],
9	body	NN	O	body	prep_of	5	SENT_72	[p3l1612t1046r1764b1115],
10	weight	NN	O	weight	prep_of	5	SENT_72	[p3l1792t1047r2005b1115],
11	and	CC	O	and	_	0	SENT_72	[p3l2034t1046r2145b1101],
12	duration	NN	O	duration	prep_of	5	SENT_72	[p3l9t1136r270b1191],
13	of	IN	O	of	_	0	SENT_72	[p3l292t1136r356b1191],
14	illness	NN	O	illness	prep_of	5	SENT_72	[p3l371t1136r561b1191],
15	were	VBD	O	be	cop	16	SENT_72	[p3l582t1152r734b1191],
16	43.2	CD	NUMBER	43.2	_	0	SENT_72	[p3l755t1139r930b1191],
17	:	:	O	:	_	0	SENT_72	[p3l755t1139r930b1191],
18	18.9	CD	NUMBER	18.9	number	19	SENT_72	[p3l945t1139r1064b1191],
19	(	CD	NUMBER	(	dep	16	SENT_72	[p3l1088t1136r1321b1204],
20	18-75	CD	NUMBER	18-75	num	22	SENT_72	[p3l1088t1136r1321b1204],
21	)	CD	NUMBER	)	num	22	SENT_72	[p3l1088t1136r1321b1204],
22	years	NNS	NUMBER	year	dep	19	SENT_72	[p3l1342t1152r1517b1204],
23	,	,	O	,	_	0	SENT_72	[p3l1342t1152r1517b1204],
24	58.6	CD	NUMBER	58.6	appos	19	SENT_72	[p3l1542t1139r1714b1191],
25	:	:	O	:	_	0	SENT_72	[p3l1542t1139r1714b1191],
26	12.6	CD	NUMBER	12.6	number	27	SENT_72	[p3l1729t1139r1850b1191],
27	(	CD	NUMBER	(	dep	19	SENT_72	[p3l1873t1136r2145b1204],
28	37-105	CD	NUMBER	37-105	num	30	SENT_72	[p3l1873t1136r2145b1204],
29	)	CD	NUMBER	)	num	30	SENT_72	[p3l1873t1136r2145b1204],
30	kg	NN	O	kg	dep	27	SENT_72	[p3l9t1225r80b1293],
31	and	CC	O	and	_	0	SENT_72	[p3l127t1225r240b1280],
32	162	CD	NUMBER	162	conj_and	27	SENT_72	[p3l291t1227r444b1280],
33	:	:	O	:	_	0	SENT_72	[p3l291t1227r444b1280],
34	128	CD	NUMBER	128	number	35	SENT_72	[p3l460t1227r566b1280],
35	(	CD	NUMBER	(	dep	19	SENT_72	[p3l616t1225r863b1293],
36	4-448	CD	NUMBER	4-448	num	38	SENT_72	[p3l616t1225r863b1293],
37	)	CD	NUMBER	)	num	38	SENT_72	[p3l616t1225r863b1293],
38	months	NNS	NUMBER	month	dep	35	SENT_72	[p3l911t1225r1163b1288],
39	,	,	O	,	_	0	SENT_72	[p3l911t1225r1163b1288],
40	respectively	RB	O	respectively	advmod	16	SENT_72	[p3l1212t1225r1601b1293],
41	.	.	O	.	_	0	SENT_72	[p3l1212t1225r1601b1293],

1	The	DT	O	the	det	2	SENT_73	[p3l1647t1225r1760b1280],
2	study	NN	O	study	nsubjpass	4	SENT_73	[p3l1809t1225r1981b1293],
3	was	VBD	O	be	auxpass	4	SENT_73	[p3l2025t1240r2144b1280],
4	approved	VBN	O	approve	_	0	SENT_73	[p3l8t1313r294b1382],
5	by	IN	O	by	_	0	SENT_73	[p3l329t1313r402b1382],
6	the	DT	O	the	det	8	SENT_73	[p3l435t1313r531b1368],
7	Ethics	NNPS	ORGANIZATION	Ethics	nn	8	SENT_73	[p3l567t1313r746b1368],
8	Committee	NNP	ORGANIZATION	Committee	agent	4	SENT_73	[p3l782t1314r1118b1368],
9	of	IN	ORGANIZATION	of	_	0	SENT_73	[p3l1153t1313r1217b1368],
10	Hirosaki	NNP	ORGANIZATION	Hirosaki	nn	12	SENT_73	[p3l1244t1313r1495b1368],
11	University	NNP	ORGANIZATION	University	nn	12	SENT_73	[p3l1530t1314r1844b1382],
12	Hospital	NNP	ORGANIZATION	Hospital	prep_of	8	SENT_73	[p3l1877t1313r2144b1382],
13	,	,	O	,	_	0	SENT_73	[p3l1877t1313r2144b1382],
14	and	CC	O	and	_	0	SENT_73	[p3l8t1402r120b1457],
15	written	VBN	O	write	amod	17	SENT_73	[p3l136t1403r363b1457],
16	informed	JJ	O	informed	amod	17	SENT_73	[p3l381t1402r662b1457],
17	consent	NN	O	consent	nsubjpass	24	SENT_73	[p3l680t1410r919b1457],
18	to	TO	O	to	aux	19	SENT_73	[p3l934t1410r992b1457],
19	participate	VB	O	participate	infmod	17	SENT_73	[p3l1011t1403r1338b1471],
20	in	IN	O	in	_	0	SENT_73	[p3l1357t1403r1412b1456],
21	this	DT	O	this	det	22	SENT_73	[p3l1429t1402r1540b1457],
22	study	NN	O	study	prep_in	19	SENT_73	[p3l1559t1402r1727b1471],
23	was	VBD	O	be	auxpass	24	SENT_73	[p3l1741t1418r1858b1457],
24	obtained	VBN	O	obtain	conj_and	4	SENT_73	[p3l1877t1402r2145b1457],
25	from	IN	O	from	_	0	SENT_73	[p3l9t1491r155b1546],
26	the	DT	O	the	det	27	SENT_73	[p3l175t1491r272b1546],
27	patients	NNS	O	patient	prep_from	24	SENT_73	[p3l296t1492r540b1560],
28	and	CC	O	and	_	0	SENT_73	[p3l564t1491r674b1546],
29	their	PRP$	O	they	poss	30	SENT_73	[p3l697t1492r843b1546],
30	families	NNS	O	family	prep_from	24	SENT_73	[p3l865t1491r1118b1547],
31	.	.	O	.	_	0	SENT_73	[p3l865t1491r1118b1547],

1	The	DT	O	the	det	2	SENT_74	[p3l108t1581r220b1635],
2	subjects	NNS	O	subject	nsubj	4	SENT_74	[p3l240t1580r485b1649],
3	had	VBD	O	have	aux	4	SENT_74	[p3l506t1580r616b1635],
4	received	VBN	O	receive	_	0	SENT_74	[p3l637t1580r892b1635],
5	risperidone	NN	O	risperidone	dobj	4	SENT_74	[p3l913t1580r1263b1649],
6	3	CD	NUMBER	3	num	7	SENT_74	[p3l1281t1583r1314b1635],
7	mg	NN	O	mg	npadvmod	8	SENT_74	[p3l1336t1596r1432b1649],
8	twice	RB	O	twice	advmod	5	SENT_74	[p3l1450t1581r1615b1635],
9	a	DT	DURATION	a	det	10	SENT_74	[p3l1635t1596r1666b1635],
10	day	NN	DURATION	day	pobj	8	SENT_74	[p3l1685t1580r1793b1649],
11	(	CD	NUMBER	(	number	12	SENT_74	[p3l1811t1581r1869b1649],
12	8	CD	TIME	8	num	13	SENT_74	[p3l1811t1581r1869b1649],
13	a.m.	NN	TIME	a.m.	dep	5	SENT_74	[p3l1890t1596r2013b1636],
14	and	CC	O	and	_	0	SENT_74	[p3l2034t1580r2145b1635],
15	8	CD	TIME	8	num	17	SENT_74	[p3l9t1673r41b1725],
16	p.m.	NN	TIME	p.m.	nn	17	SENT_74	[p3l63t1670r216b1738],
17	)	NN	O	)	conj_and	5	SENT_74	[p3l63t1670r216b1738],
18	for	IN	O	for	_	0	SENT_74	[p3l236t1670r321b1725],
19	4	CD	DURATION	4	number	21	SENT_74	[p3l337t1673r374b1724],
20	to	TO	DURATION	to	dep	21	SENT_74	[p3l393t1678r450b1725],
21	79	CD	DURATION	79	num	22	SENT_74	[p3l471t1673r543b1725],
22	weeks	NNS	NUMBER	week	prep_for	4	SENT_74	[p3l561t1670r768b1725],
23	.	.	O	.	_	0	SENT_74	[p3l561t1670r768b1725],

1	The	DT	O	the	det	5	SENT_75	[p3l787t1670r899b1725],
2	elimination	NN	O	elimination	nn	5	SENT_75	[p3l918t1670r1270b1725],
3	half	NN	O	half	nn	5	SENT_75	[p3l1290t1670r1569b1725],
4	—	JJ	O	—	amod	5	SENT_75	[p3l1290t1670r1569b1725],
5	lives	NNS	O	life	nsubjpass	13	SENT_75	[p3l1290t1670r1569b1725],
6	of	IN	O	of	_	0	SENT_75	[p3l1589t1670r1653b1725],
7	risperidone	NN	O	risperidone	prep_of	5	SENT_75	[p3l1665t1670r2014b1738],
8	and	CC	O	and	_	0	SENT_75	[p3l2034t1670r2145b1725],
9	9	CD	NUMBER	9	num	11	SENT_75	[p3l9t1759r678b1827],
10	—	NN	O	—	nn	11	SENT_75	[p3l9t1759r678b1827],
11	hydroxyrisperidone	NN	O	hydroxyrisperidone	prep_of	5	SENT_75	[p3l9t1759r678b1827],
12	were	VBD	O	be	auxpass	13	SENT_75	[p3l704t1774r855b1814],
13	reported	VBN	O	report	_	0	SENT_75	[p3l883t1759r1145b1827],
14	to	TO	O	to	aux	19	SENT_75	[p3l1172t1767r1231b1814],
15	be	VB	O	be	cop	19	SENT_75	[p3l1257t1759r1328b1814],
16	3	CD	NUMBER	3	number	18	SENT_75	[p3l1355t1761r1387b1814],
17	to	TO	O	to	dep	18	SENT_75	[p3l1417t1767r1476b1814],
18	20	CD	NUMBER	20	num	19	SENT_75	[p3l1503t1761r1576b1814],
19	h	NN	O	h	xcomp	13	SENT_75	[p3l1604t1759r1640b1813],
20	and	CC	O	and	_	0	SENT_75	[p3l1667t1759r1778b1814],
21	20	CD	NUMBER	20	number	23	SENT_75	[p3l1806t1761r1879b1814],
22	to	TO	O	to	dep	23	SENT_75	[p3l1906t1767r1964b1814],
23	29	CD	NUMBER	29	num	24	SENT_75	[p3l1992t1761r2065b1814],
24	h	NN	O	h	xcomp	13	SENT_75	[p3l2093t1759r2144b1822],
25	,	,	O	,	_	0	SENT_75	[p3l2093t1759r2144b1822],
26	respectively	RB	O	respectively	advmod	19	SENT_75	[p3l9t1847r386b1916],
27	.	.	O	.	_	0	SENT_75	[p3l9t1847r386b1916],

1	Therefore	RB	O	therefore	advmod	9	SENT_76	[p3l418t1847r729b1910],
2	,	,	O	,	_	0	SENT_76	[p3l418t1847r729b1910],
3	plasma	NN	O	plasma	nn	4	SENT_76	[p3l764t1847r981b1916],
4	concentrations	NNS	O	concentration	nsubj	9	SENT_76	[p3l1014t1848r1468b1902],
5	of	IN	O	of	_	0	SENT_76	[p3l1502t1847r1566b1902],
6	these	DT	O	these	det	7	SENT_76	[p3l1592t1847r1754b1902],
7	compounds	NNS	O	compound	prep_of	4	SENT_76	[p3l1788t1847r2144b1916],
8	already	RB	O	already	advmod	9	SENT_76	[p3l8t1936r234b2005],
9	reached	VBD	O	reach	_	0	SENT_76	[p3l255t1936r494b1991],
10	steady	JJ	O	steady	amod	11	SENT_76	[p3l517t1936r715b2005],
11	state	NN	O	state	dobj	9	SENT_76	[p3l735t1944r879b1991],
12	in	IN	O	in	_	0	SENT_76	[p3l900t1937r957b1990],
13	all	DT	O	all	prep_in	9	SENT_76	[p3l978t1936r1048b1991],
14	of	IN	O	of	_	0	SENT_76	[p3l1070t1936r1134b1991],
15	the	DT	O	the	det	16	SENT_76	[p3l1148t1936r1245b1991],
16	subjects	NNS	O	subject	prep_of	13	SENT_76	[p3l1268t1936r1513b2005],
17	before	IN	O	before	_	0	SENT_76	[p3l1535t1936r1727b1991],
18	initiating	VBG	O	initiate	prepc_before	9	SENT_76	[p3l1750t1937r2028b2005],
19	the	DT	O	the	det	20	SENT_76	[p3l2048t1936r2145b1991],
20	study	NN	O	study	dobj	18	SENT_76	[p3l9t2025r187b2094],
21	.	.	O	.	_	0	SENT_76	[p3l9t2025r187b2094],

1	Blood	NN	O	blood	nn	2	SENT_77	[p3l210t2025r382b2080],
2	samplings	NNS	O	sampling	nsubjpass	10	SENT_77	[p3l405t2025r713b2094],
3	for	IN	O	for	_	0	SENT_77	[p3l735t2025r820b2080],
4	drug	NN	O	drug	nn	5	SENT_77	[p3l839t2025r980b2094],
5	concentrations	NNS	O	concentration	prep_for	2	SENT_77	[p3l1001t2026r1454b2080],
6	and	CC	O	and	_	0	SENT_77	[p3l1476t2025r1587b2080],
7	prolactin	NN	O	prolactin	nn	8	SENT_77	[p3l1609t2025r1881b2094],
8	concentration	NN	O	concentration	conj_and	5	SENT_77	[p3l1903t2041r2144b2080, p3l8t2115r214b2169],
9	were	VBD	O	be	auxpass	10	SENT_77	[p3l228t2130r379b2169],
10	performed	VBN	O	perform	_	0	SENT_77	[p3l398t2114r721b2183],
11	at	IN	O	at	_	0	SENT_77	[p3l739t2123r795b2169],
12	8:00	CD	TIME	8:00	prep_at	10	SENT_77	[p3l811t2117r948b2170],
13	a.m.	RB	TIME	a.m.	advmod	12	SENT_77	[p3l966t2130r1089b2170],
14	just	RB	O	just	advmod	10	SENT_77	[p3l1100t2115r1220b2183],
15	before	IN	O	before	_	0	SENT_77	[p3l1235t2114r1427b2169],
16	taking	VBG	O	take	prepc_before	10	SENT_77	[p3l1445t2115r1636b2183],
17	risperidone	NN	O	risperidone	dobj	16	SENT_77	[p3l1653t2114r2017b2183],
18	.	.	O	.	_	0	SENT_77	[p3l1653t2114r2017b2183],

1	The	DT	O	the	det	2	SENT_78	[p3l2033t2114r2145b2169],
2	drugs	NNS	O	drug	nsubj	7	SENT_78	[p3l9t2204r178b2272],
3	coadministered	VBN	O	coadminister	partmod	2	SENT_78	[p3l208t2204r682b2259],
4	were	VBD	O	be	cop	7	SENT_78	[p3l710t2220r862b2259],
5	ﬂunitrazepam	NN	O	ﬂunitrazepam	nn	7	SENT_78	[p3l892t2204r1322b2272],
6	1-6	CD	NUMBER	1-6	num	7	SENT_78	[p3l1354t2207r1462b2259],
7	mg/day	NN	O	mg/day	_	0	SENT_78	[p3l1493t2204r1722b2272],
8	in	IN	O	in	_	0	SENT_78	[p3l1751t2205r1806b2258],
9	105	CD	NUMBER	105	num	14	SENT_78	[p3l1839t2207r1941b2259],
10	cases	NNS	O	case	nn	14	SENT_78	[p3l1973t2220r2144b2267],
11	,	,	O	,	_	0	SENT_78	[p3l1973t2220r2144b2267],
12	diazepam	NN	O	diazepam	dep	14	SENT_78	[p3l9t2293r305b2361],
13	2-30	CD	NUMBER	2-30	num	14	SENT_78	[p3l324t2295r475b2348],
14	mg/day	NN	O	mg/day	prep_in	7	SENT_78	[p3l495t2292r725b2361],
15	in	IN	O	in	_	0	SENT_78	[p3l743t2293r799b2347],
16	25	CD	NUMBER	25	num	21	SENT_78	[p3l818t2295r889b2348],
17	cases	NNS	O	case	nn	21	SENT_78	[p3l911t2308r1083b2356],
18	,	,	O	,	_	0	SENT_78	[p3l911t2308r1083b2356],
19	lorazepam	NN	O	lorazepam	dep	21	SENT_78	[p3l1103t2293r1424b2361],
20	1-3	CD	NUMBER	1-3	num	21	SENT_78	[p3l1446t2295r1552b2348],
21	mg/day	NN	O	mg/day	prep_in	7	SENT_78	[p3l1575t2292r1805b2361],
22	in	IN	O	in	_	0	SENT_78	[p3l1823t2293r1879b2347],
23	12	CD	NUMBER	12	num	24	SENT_78	[p3l1902t2295r1967b2347],
24	cases	NNS	O	case	num	29	SENT_78	[p3l1988t2308r2144b2348],
25	and	CC	O	and	_	0	SENT_78	[p3l8t2381r120b2436],
26	alprazolam	NN	O	alprazolam	num	29	SENT_78	[p3l144t2381r485b2450],
27	0.8-2	CD	NUMBER	0.8-2	num	26	SENT_78	[p3l508t2384r730b2437],
28	.4	CD	NUMBER	.4	num	29	SENT_78	[p3l508t2384r730b2437],
29	mg/day	NN	O	mg/day	prep_in	7	SENT_78	[p3l754t2381r984b2450],
30	in	IN	O	in	_	0	SENT_78	[p3l1007t2382r1063b2435],
31	25	CD	NUMBER	25	num	32	SENT_78	[p3l1087t2384r1158b2436],
32	cases	NNS	O	case	prep_in	29	SENT_78	[p3l1185t2397r1356b2444],
33	,	,	O	,	_	0	SENT_78	[p3l1185t2397r1356b2444],
34	biperiden	JJ	O	biperiden	amod	36	SENT_78	[p3l1380t2381r1675b2450],
35	4-6	CD	NUMBER	4-6	tmod	34	SENT_78	[p3l1697t2384r1811b2436],
36	mg/day	NN	O	mg/day	appos	29	SENT_78	[p3l1836t2381r2066b2450],
37	in	IN	O	in	_	0	SENT_78	[p3l2089t2382r2145b2435],
38	69	CD	NUMBER	69	num	39	SENT_78	[p3l9t2473r81b2525],
39	cases	NNS	O	case	prep_in	36	SENT_78	[p3l117t2486r288b2533],
40	,	,	O	,	_	0	SENT_78	[p3l117t2486r288b2533],
41	trihexyphenidyl	NN	O	trihexyphenidyl	nn	43	SENT_78	[p3l323t2470r813b2539],
42	4-10	CD	NUMBER	4-10	num	43	SENT_78	[p3l846t2473r995b2525],
43	mg/day	NN	O	mg/day	appos	29	SENT_78	[p3l1030t2470r1261b2539],
44	in	IN	O	in	_	0	SENT_78	[p3l1294t2471r1350b2524],
45	18	CD	NUMBER	18	num	46	SENT_78	[p3l1388t2473r1451b2525],
46	cases	NNS	O	case	prep_in	43	SENT_78	[p3l1489t2486r1660b2533],
47	,	,	O	,	_	0	SENT_78	[p3l1489t2486r1660b2533],
48	sennoside	NN	O	sennoside	nn	50	SENT_78	[p3l1696t2470r2001b2525],
49	1260	CD	DATE	1260	num	50	SENT_78	[p3l2039t2473r2144b2524, p3l9t2562r82b2614],
50	mg/day	NN	O	mg/day	appos	29	SENT_78	[p3l105t2559r335b2628],
51	in	IN	O	in	_	0	SENT_78	[p3l356t2560r412b2614],
52	71	CD	NUMBER	71	num	53	SENT_78	[p3l436t2562r498b2614],
53	cases	NNS	O	case	prep_in	50	SENT_78	[p3l529t2575r700b2615],
54	.	.	O	.	_	0	SENT_78	[p3l529t2575r700b2615],

1	Plasma	NN	O	plasma	nn	2	SENT_79	[p3l111t2648r326b2703],
2	concentrations	NNS	O	concentration	nsubjpass	10	SENT_79	[p3l361t2649r814b2703],
3	of	IN	O	of	_	0	SENT_79	[p3l851t2648r914b2703],
4	risperidone	NN	O	risperidone	prep_of	2	SENT_79	[p3l942t2648r1293b2717],
5	and	CC	O	and	_	0	SENT_79	[p3l1328t2648r1439b2703],
6	9	CD	NUMBER	9	num	8	SENT_79	[p3l1475t2648r2145b2717],
7	—	NN	O	—	nn	8	SENT_79	[p3l1475t2648r2145b2717],
8	hydroxyrisperidone	NN	O	hydroxyrisperidone	conj_and	4	SENT_79	[p3l1475t2648r2145b2717],
9	were	VBD	O	be	auxpass	10	SENT_79	[p3l7t2753r159b2793],
10	measured	VBN	O	measure	_	0	SENT_79	[p3l204t2738r503b2793],
11	using	VBG	O	use	xcomp	10	SENT_79	[p3l549t2739r713b2806],
12	liquid	JJ	O	liquid	amod	17	SENT_79	[p3l758t2738r930b2806],
13	chromatography	NN	O	chromatography	nn	17	SENT_79	[p3l976t2738r1664b2806],
14	—	CD	NUMBER	—	num	17	SENT_79	[p3l976t2738r1664b2806],
15	mass	NN	O	mass	nn	17	SENT_79	[p3l976t2738r1664b2806],
16	spectrometrymass	NN	O	spectrometrymass	nn	17	SENT_79	[p3l1710t2746r2144b2806, p3l9t2842r160b2881],
17	spectrometry	NN	O	spectrometry	nsubj	19	SENT_79	[p3l183t2834r594b2895],
18	(	CD	NUMBER	(	num	19	SENT_79	[p3l614t2826r984b2894],
19	LC	NN	O	lc	xcomp	11	SENT_79	[p3l614t2826r984b2894],
20	.	.	O	.	_	0	SENT_79	[p3l614t2826r984b2894],

1	—	NN	O	—	_	0	SENT_80	[p3l614t2826r984b2894],
2	.	.	O	.	_	0	SENT_80	[p3l614t2826r984b2894],

1	MS	NN	O	m	_	0	SENT_81	[p3l614t2826r984b2894],
2	.	.	O	.	_	0	SENT_81	[p3l614t2826r984b2894],

1	—	NN	O	—	_	0	SENT_82	[p3l614t2826r984b2894],
2	.	.	O	.	_	0	SENT_82	[p3l614t2826r984b2894],

1	MS	NN	O	m	_	0	SENT_83	[p3l614t2826r984b2894],
2	)	NN	O	)	nn	3	SENT_83	[p3l614t2826r984b2894],
3	method	NN	O	method	dep	1	SENT_83	[p3l1007t2826r1258b2882],
4	.	.	O	.	_	0	SENT_83	[p3l1007t2826r1258b2882],

1	Extraction	NN	O	extraction	nn	2	SENT_84	[p3l1281t2827r1593b2881],
2	procedure	NN	O	procedure	nsubj	3	SENT_84	[p3l1614t2826r1925b2895],
3	was	VBD	O	be	ccomp	38	SENT_84	[p3l1944t2842r2062b2881],
4	as	IN	O	as	dep	5	SENT_84	[p3l2085t2842r2144b2881],
5	follows	VBZ	O	follow	advcl	3	SENT_84	[p3l9t2915r247b2971],
6	:	:	O	:	_	0	SENT_84	[p3l9t2915r247b2971],
7	200	CD	NUMBER	200	num	8	SENT_84	[p3l284t2918r398b2970],
8	pl	NN	O	pl	dobj	5	SENT_84	[p3l430t2915r480b2985],
9	of	IN	O	of	_	0	SENT_84	[p3l514t2915r577b2970],
10	0.1	CD	NUMBER	0.1	num	13	SENT_84	[p3l602t2918r678b2971],
11	M	NN	O	m	nn	13	SENT_84	[p3l720t2918r777b2969],
12	phosphate	NN	O	phosphate	nn	13	SENT_84	[p3l811t2915r1130b2984],
13	buffer	NN	O	buffer	prep_of	8	SENT_84	[p3l1163t2915r1347b2970],
14	(	CD	NUMBER	(	num	17	SENT_84	[p3l1378t2915r1488b2984],
15	pH	NN	O	ph	nn	17	SENT_84	[p3l1378t2915r1488b2984],
16	7	CD	NUMBER	7	num	17	SENT_84	[p3l1523t2915r1595b2983],
17	)	NN	O	)	nsubj	5	SENT_84	[p3l1523t2915r1595b2983],
18	,	,	O	,	_	0	SENT_84	[p3l1523t2915r1595b2983],
19	50	CD	NUMBER	50	num	20	SENT_84	[p3l1630t2918r1702b2970],
20	ul	NN	O	ul	nsubjpass	38	SENT_84	[p3l1734t2915r1784b2985],
21	of	IN	O	of	_	0	SENT_84	[p3l1818t2915r1881b2970],
22	internal	JJ	O	internal	amod	24	SENT_84	[p3l1907t2915r2145b2970],
23	standard	JJ	O	standard	amod	24	SENT_84	[p3l9t3004r275b3059],
24	solution	NN	O	solution	prep_of	20	SENT_84	[p3l301t3005r548b3059],
25	(	CD	NUMBER	(	num	26	SENT_84	[p3l571t3005r886b3073],
26	R068808	NN	O	r068808	dep	24	SENT_84	[p3l571t3005r886b3073],
27	:	:	O	:	_	0	SENT_84	[p3l571t3005r886b3073],
28	Jansen	NNP	ORGANIZATION	Jansen	nn	30	SENT_84	[p3l907t3008r1113b3073],
29	Research	NNP	ORGANIZATION	Research	nn	30	SENT_84	[p3l1137t3005r1407b3059],
30	Foundation	NNP	ORGANIZATION	Foundation	dep	24	SENT_84	[p3l1431t3004r1802b3073],
31	)	NN	O	)	dep	30	SENT_84	[p3l1431t3004r1802b3073],
32	and	CC	O	and	_	0	SENT_84	[p3l1826t3004r1937b3059],
33	100	CD	NUMBER	100	num	34	SENT_84	[p3l1965t3007r2071b3059],
34	pl	NN	O	pl	prep_of	20	SENT_84	[p3l2094t3004r2145b3075],
35	of	IN	O	of	_	0	SENT_84	[p3l9t3093r72b3148],
36	methanol	NN	O	methanol	prep_of	34	SENT_84	[p3l85t3093r376b3148],
37	were	VBD	O	be	auxpass	38	SENT_84	[p3l394t3109r545b3148],
38	added	VBN	O	add	_	0	SENT_84	[p3l565t3093r751b3148],
39	to	TO	O	to	_	0	SENT_84	[p3l770t3102r829b3148],
40	200	CD	NUMBER	200	num	41	SENT_84	[p3l848t3096r962b3148],
41	ul	NN	O	ul	prep_to	38	SENT_84	[p3l981t3093r1031b3164],
42	of	IN	O	of	_	0	SENT_84	[p3l1051t3093r1115b3148],
43	plasma	NN	O	plasma	nn	44	SENT_84	[p3l1126t3093r1344b3162],
44	sample	NN	O	sample	prep_of	41	SENT_84	[p3l1364t3093r1595b3162],
45	.	.	O	.	_	0	SENT_84	[p3l1364t3093r1595b3162],

1	Thereafter	RB	O	thereafter	advmod	10	SENT_85	[p3l1612t3093r1941b3157],
2	,	,	O	,	_	0	SENT_85	[p3l1612t3093r1941b3157],
3	400	CD	NUMBER	400	num	4	SENT_85	[p3l1960t3096r2076b3148],
4	pl	NN	O	pl	nsubjpass	10	SENT_85	[p3l2094t3093r2145b3164],
5	of	IN	O	of	_	0	SENT_85	[p3l9t3183r72b3238],
6	0.1	CD	NUMBER	0.1	num	8	SENT_85	[p3l84t3186r160b3238],
7	M	NN	O	m	nn	8	SENT_85	[p3l188t3186r245b3237],
8	Borax	NNP	O	Borax	prep_of	4	SENT_85	[p3l266t3186r439b3238],
9	was	VBD	O	be	auxpass	10	SENT_85	[p3l456t3199r573b3238],
10	added	VBN	O	add	_	0	SENT_85	[p3l593t3183r795b3238],
11	.	.	O	.	_	0	SENT_85	[p3l593t3183r795b3238],

1	The	DT	O	the	det	2	SENT_86	[p3l812t3183r924b3238],
2	mixture	NN	O	mixture	nsubjpass	4	SENT_86	[p3l944t3184r1185b3238],
3	is	VBZ	O	be	auxpass	4	SENT_86	[p3l1205t3184r1250b3238],
4	vortexed	VBN	O	vortex	_	0	SENT_86	[p3l1268t3183r1536b3238],
5	and	CC	O	and	_	0	SENT_86	[p3l1556t3183r1667b3238],
6	poured	VBN	O	pour	conj_and	4	SENT_86	[p3l1687t3183r1903b3251],
7	over	IN	O	over	_	0	SENT_86	[p3l1923t3199r2057b3238],
8	an	DT	O	a	det	10	SENT_86	[p3l2074t3199r2145b3238],
9	Extrelut	NNP	O	Extrelut	nn	10	SENT_86	[p3l9t3272r253b3327],
10	NT	NN	O	nt	prep_over	4	SENT_86	[p3l286t3275r371b3326],
11	1	CD	NUMBER	1	number	12	SENT_86	[p3l406t3275r430b3326],
12	(	CD	NUMBER	(	num	15	SENT_86	[p3l472t3272r710b3340],
13	Merck	NNP	ORGANIZATION	Merck	nn	15	SENT_86	[p3l472t3272r710b3340],
14	)	CD	NUMBER	)	num	15	SENT_86	[p3l472t3272r710b3340],
15	column	NN	O	column	dep	10	SENT_86	[p3l745t3272r989b3335],
16	,	,	O	,	_	0	SENT_86	[p3l745t3272r989b3335],
17	which	WDT	O	which	nsubjpass	19	SENT_86	[p3l1022t3272r1212b3327],
18	is	VBZ	O	be	auxpass	19	SENT_86	[p3l1246t3273r1290b3327],
19	eluted	VBN	O	elute	rcmod	10	SENT_86	[p3l1325t3272r1515b3327],
20	with	IN	O	with	_	0	SENT_86	[p3l1548t3272r1689b3327],
21	7	CD	NUMBER	7	num	22	SENT_86	[p3l1724t3275r1756b3326],
22	ml	NN	O	ml	prep_with	19	SENT_86	[p3l1793t3272r1870b3326],
23	of	IN	O	of	_	0	SENT_86	[p3l1905t3271r1968b3327],
24	ethyl	NN	O	ethyl	nn	25	SENT_86	[p3l1995t3272r2145b3340],
25	acetate	NN	O	acetate	prep_of	22	SENT_86	[p3l8t3368r239b3416],
26	.	.	O	.	_	0	SENT_86	[p3l8t3368r239b3416],

1	The	DT	O	the	det	2	SENT_87	[p3l262t3360r374b3415],
2	eluate	NN	O	eluate	nsubjpass	16	SENT_87	[p3l399t3360r583b3415],
3	was	VBD	O	be	auxpass	4	SENT_87	[p3l606t3376r723b3415],
4	evaporated	VBN	O	evaporate	_	0	SENT_87	[p3l749t3360r1088b3429],
5	under	IN	O	under	_	0	SENT_87	[p3l1114t3360r1296b3415],
6	a	DT	O	a	det	8	SENT_87	[p3l1318t3376r1349b3415],
7	nitrogen	NN	O	nitrogen	nn	8	SENT_87	[p3l1373t3361r1632b3429],
8	stream	NN	O	stream	prep_under	4	SENT_87	[p3l1657t3368r1865b3415],
9	at	IN	O	at	_	0	SENT_87	[p3l1889t3368r1946b3415],
10	65	CD	NUMBER	65	number	11	SENT_87	[p3l1970t3363r2040b3415],
11	°	CD	NUMBER	°	num	12	SENT_87	[p3l2068t3360r2144b3423],
12	C	NN	O	c	prep_at	8	SENT_87	[p3l2068t3360r2144b3423],
13	,	,	O	,	_	0	SENT_87	[p3l2068t3360r2144b3423],
14	and	CC	O	and	_	0	SENT_87	[p3l8t3449r120b3504],
15	was	VBD	O	be	auxpass	16	SENT_87	[p3l142t3465r260b3504],
16	redissolved	VBN	O	redissolve	conj_and	4	SENT_87	[p3l285t3449r630b3504],
17	in	IN	O	in	_	0	SENT_87	[p3l655t3450r711b3503],
18	100	CD	NUMBER	100	num	19	SENT_87	[p3l738t3452r845b3504],
19	ul	NN	O	ul	prep_in	16	SENT_87	[p3l868t3449r918b3519],
20	of	IN	O	of	_	0	SENT_87	[p3l943t3449r1006b3504],
21	methanol	NN	O	methanol	prep_of	19	SENT_87	[p3l1022t3449r1314b3504],
22	which	WDT	O	which	nsubjpass	25	SENT_87	[p3l1337t3449r1526b3504],
23	is	VBZ	O	be	auxpass	25	SENT_87	[p3l1550t3450r1594b3504],
24	again	RB	O	again	advmod	25	SENT_87	[p3l1619t3450r1781b3518],
25	evaporated	VBN	O	evaporate	rcmod	19	SENT_87	[p3l1805t3449r2144b3518],
26	under	IN	O	under	_	0	SENT_87	[p3l9t3538r191b3593],
27	a	DT	O	a	det	29	SENT_87	[p3l218t3554r249b3593],
28	nitrogen	NN	O	nitrogen	nn	29	SENT_87	[p3l280t3539r538b3607],
29	stream	NN	O	stream	prep_under	25	SENT_87	[p3l570t3547r779b3593],
30	at	IN	O	at	_	0	SENT_87	[p3l808t3547r865b3593],
31	65	CD	NUMBER	65	number	32	SENT_87	[p3l895t3541r965b3593],
32	°	CD	NUMBER	°	num	33	SENT_87	[p3l1000t3538r1076b3594],
33	C	NN	O	c	prep_at	29	SENT_87	[p3l1000t3538r1076b3594],
34	,	,	O	,	_	0	SENT_87	[p3l1000t3538r1076b3594],
35	The	DT	O	the	det	36	SENT_87	[p3l1105t3538r1217b3593],
36	residues	NNS	O	residue	nsubjpass	38	SENT_87	[p3l1248t3538r1499b3593],
37	were	VBD	O	be	auxpass	38	SENT_87	[p3l1529t3554r1681b3593],
38	redissolved	VBN	O	redissolve	dep	4	SENT_87	[p3l1713t3538r2057b3593],
39	in	IN	O	in	_	0	SENT_87	[p3l2089t3539r2145b3593],
40	200	CD	NUMBER	200	num	41	SENT_87	[p3l9t3630r123b3682],
41	pl	NN	O	pl	prep_in	38	SENT_87	[p3l146t3627r196b3698],
42	of	IN	O	of	_	0	SENT_87	[p3l221t3627r285b3682],
43	acetonitrile/0	NN	O	acetonitrile/0	nn	47	SENT_87	[p3l301t3627r794b3696],
44	.01	CD	NUMBER	.01	num	47	SENT_87	[p3l301t3627r794b3696],
45	M	NN	O	m	nn	47	SENT_87	[p3l827t3631r884b3682],
46	ammonium	NN	O	ammonium	nn	47	SENT_87	[p3l909t3628r1267b3682],
47	acetate	NN	O	acetate	prep_of	41	SENT_87	[p3l1290t3635r1505b3682],
48	(	CD	NUMBER	(	number	49	SENT_87	[p3l1531t3627r1744b3696],
49	50/50	CD	NUMBER	50/50	dobj	38	SENT_87	[p3l1531t3627r1744b3696],
50	,	,	O	,	_	0	SENT_87	[p3l1531t3627r1744b3696],
51	pH	NN	O	ph	appos	49	SENT_87	[p3l1770t3631r1855b3696],
52	9.0	CD	NUMBER	9.0	num	53	SENT_87	[p3l1880t3628r2008b3696],
53	)	NN	O	)	dep	51	SENT_87	[p3l1880t3628r2008b3696],
54	,	,	O	,	_	0	SENT_87	[p3l1880t3628r2008b3696],
55	and	CC	O	and	_	0	SENT_87	[p3l2034t3627r2145b3682],
56	5	CD	NUMBER	5	num	57	SENT_87	[p3l10t3721r41b3773],
57	ul	NN	O	ul	nsubjpass	59	SENT_87	[p3l64t3718r114b3788],
58	was	VBD	O	be	auxpass	59	SENT_87	[p3l136t3734r253b3773],
59	injected	VBN	O	inject	conj_and	4	SENT_87	[p3l277t3718r520b3786],
60	onto	IN	O	onto	_	0	SENT_87	[p3l543t3726r679b3773],
61	the	DT	O	the	det	62	SENT_87	[p3l701t3718r798b3773],
62	LC	NN	O	lc	prep_onto	59	SENT_87	[p3l821t3721r1141b3773],
63	.	.	O	.	_	0	SENT_87	[p3l821t3721r1141b3773],

1	—	NN	O	—	_	0	SENT_88	[p3l821t3721r1141b3773],
2	.	.	O	.	_	0	SENT_88	[p3l821t3721r1141b3773],

1	MS	NN	O	m	_	0	SENT_89	[p3l821t3721r1141b3773],
2	.	.	O	.	_	0	SENT_89	[p3l821t3721r1141b3773],

1	—	NN	O	—	_	0	SENT_90	[p3l821t3721r1141b3773],
2	.	.	O	.	_	0	SENT_90	[p3l821t3721r1141b3773],

1	MS	NN	O	m	_	0	SENT_91	[p3l821t3721r1141b3773],
2	system	NN	O	system	dep	1	SENT_91	[p3l1165t3726r1391b3786],
3	.	.	O	.	_	0	SENT_91	[p3l1165t3726r1391b3786],

1	The	DT	O	the	det	2	SENT_92	[p3l1412t3718r1524b3773],
2	system	NN	O	system	nsubj	3	SENT_92	[p3l1547t3726r1760b3786],
3	consisted	VBD	O	consist	_	0	SENT_92	[p3l1781t3718r2066b3773],
4	of	IN	O	of	prep	3	SENT_92	[p3l2089t3718r2153b3773],

1	API	NNP	O	API	_	0	SENT_93	[p4l6t18r107b70],
2	3000	CD	NUMBER	3000	num	1	SENT_93	[p4l129t19r285b71],
3	(	CD	NUMBER	(	num	5	SENT_93	[p4l308t16r510b84],
4	Sciex	NNP	O	Sciex	nn	5	SENT_93	[p4l308t16r510b84],
5	)	NN	O	)	dep	1	SENT_93	[p4l308t16r510b84],
6	and	CC	O	and	_	0	SENT_93	[p4l533t16r644b71],
7	a	DT	O	a	det	12	SENT_93	[p4l667t32r698b71],
8	column	NN	O	column	nn	12	SENT_93	[p4l720t16r949b71],
9	(	CD	NUMBER	(	num	12	SENT_93	[p4l971t16r1251b84],
10	Hypersil	NN	O	hypersil	nn	12	SENT_93	[p4l971t16r1251b84],
11	BDS	NN	O	bd	nn	12	SENT_93	[p4l1273t19r1392b71],
12	C18	NN	O	c18	conj_and	5	SENT_93	[p4l1415t19r1522b71],
13	100x4	CD	NUMBER	100x4	num	14	SENT_93	[p4l1549t19r1801b79],
14	.6	CD	NUMBER	.6	dep	1	SENT_93	[p4l1549t19r1801b79],
15	,	,	O	,	_	0	SENT_93	[p4l1549t19r1801b79],
16	3	CD	NUMBER	3	num	18	SENT_93	[p4l1823t19r1856b71],
17	wn	NN	O	wn	nn	18	SENT_93	[p4l1880t16r2013b86],
18	)	NN	O	)	appos	14	SENT_93	[p4l1880t16r2013b86],
19	.	.	O	.	_	0	SENT_93	[p4l1880t16r2013b86],

1	The	DT	O	the	det	3	SENT_94	[p4l2033t16r2145b71],
2	mobile	JJ	O	mobile	amod	3	SENT_94	[p4l9t103r218b158],
3	phase	NN	O	phase	nsubj	7	SENT_94	[p4l259t103r434b172],
4	was	VBD	O	be	cop	7	SENT_94	[p4l471t119r589b158],
5	gradient	NN	O	gradient	nn	7	SENT_94	[p4l628t103r886b172],
6	ammonium	NN	O	ammonium	nn	7	SENT_94	[p4l924t104r1281b158],
7	acetate	NN	O	acetate	_	0	SENT_94	[p4l1319t111r1534b158],
8	(	CD	NUMBER	(	num	10	SENT_94	[p4l1575t103r1717b172],
9	0.01	CD	NUMBER	0.01	num	10	SENT_94	[p4l1575t103r1717b172],
10	M	NN	O	m	dep	7	SENT_94	[p4l1765t107r1838b167],
11	,	,	O	,	_	0	SENT_94	[p4l1765t107r1838b167],
12	pH	NN	O	ph	appos	7	SENT_94	[p4l1878t107r1964b172],
13	9.0	CD	NUMBER	9.0	number	14	SENT_94	[p4l2003t103r2144b171, p4l8t192r371b248],
14	)	CD	NUMBER	)	num	15	SENT_94	[p4l2003t103r2144b171, p4l8t192r371b248],
15	acetonitrile	NN	O	acetonitrile	dep	12	SENT_94	[p4l2003t103r2144b171, p4l8t192r371b248],
16	.	.	O	.	_	0	SENT_94	[p4l2003t103r2144b171, p4l8t192r371b248],

1	Among	IN	O	among	_	0	SENT_95	[p4l387t194r609b261],
2	the	DT	O	the	det	4	SENT_95	[p4l625t192r723b247],
3	fragment	NN	O	fragment	nn	4	SENT_95	[p4l742t192r1021b261],
4	ions	NNS	O	ion	prep_among	39	SENT_95	[p4l1038t193r1162b247],
5	of	IN	O	of	_	0	SENT_95	[p4l1181t192r1244b247],
6	the	DT	O	the	det	7	SENT_95	[p4l1255t192r1352b247],
7	compounds	NNS	O	compound	prep_of	4	SENT_95	[p4l1371t192r1742b261],
8	,	,	O	,	_	0	SENT_95	[p4l1371t192r1742b261],
9	the	DT	O	the	det	10	SENT_95	[p4l1761t192r1858b247],
10	mass	NN	O	mass	nsubjpass	39	SENT_95	[p4l1877t200r2144b247],
11	—	CD	NUMBER	—	number	13	SENT_95	[p4l1877t200r2144b247],
12	to	TO	O	to	dep	13	SENT_95	[p4l1877t200r2144b247],
13	—	CD	NUMBER	—	num	17	SENT_95	[p4l1877t200r2144b247],
14	charge	NN	O	charge	nn	17	SENT_95	[p4l9t281r210b350],
15	ratio	NN	O	ratio	nn	17	SENT_95	[p4l246t282r385b336],
16	(	CD	NUMBER	(	num	17	SENT_95	[p4l420t281r577b350],
17	m/z	NN	O	m/z	dep	10	SENT_95	[p4l420t281r577b350],
18	)	CD	NUMBER	)	number	19	SENT_95	[p4l420t281r577b350],
19	207.0	CD	NUMBER	207.0	dep	10	SENT_95	[p4l612t284r773b337],
20	for	IN	O	for	_	0	SENT_95	[p4l808t281r893b336],
21	risperidone	NN	O	risperidone	prep_for	19	SENT_95	[p4l927t281r1291b350],
22	,	,	O	,	_	0	SENT_95	[p4l927t281r1291b350],
23	m/z	NN	O	m/z	conj_and	10	SENT_95	[p4l1328t281r1437b350],
24	191.0	CD	NUMBER	191.0	num	23	SENT_95	[p4l1473t284r1624b337],
25	for	IN	O	for	_	0	SENT_95	[p4l1660t281r1745b336],
26	9	CD	NUMBER	9	num	28	SENT_95	[p4l1778t281r2144b350, p4l9t370r346b439],
27	—	NN	O	—	nn	28	SENT_95	[p4l1778t281r2144b350, p4l9t370r346b439],
28	hydroxyrisperidone	NN	O	hydroxyrisperidone	prep_for	23	SENT_95	[p4l1778t281r2144b350, p4l9t370r346b439],
29	,	,	O	,	_	0	SENT_95	[p4l1778t281r2144b350, p4l9t370r346b439],
30	and	CC	O	and	_	0	SENT_95	[p4l370t370r481b425],
31	m/z	NN	O	m/z	nsubjpass	39	SENT_95	[p4l506t370r616b439],
32	201.0	CD	NUMBER	201.0	num	31	SENT_95	[p4l637t373r795b426],
33	for	IN	O	for	_	0	SENT_95	[p4l820t370r905b425],
34	the	DT	O	the	det	36	SENT_95	[p4l926t370r1023b425],
35	internal	JJ	O	internal	amod	36	SENT_95	[p4l1048t370r1286b425],
36	standard	NN	O	standard	prep_for	31	SENT_95	[p4l1311t370r1592b434],
37	,	,	O	,	_	0	SENT_95	[p4l1311t370r1592b434],
38	were	VBD	O	be	auxpass	39	SENT_95	[p4l1615t386r1766b425],
39	selected	VBN	O	select	_	0	SENT_95	[p4l1792t370r2037b425],
40	for	IN	O	for	_	0	SENT_95	[p4l2062t370r2147b425],
41	ion	NN	O	ion	nn	42	SENT_95	[p4l9t461r103b515],
42	monitoring	NN	O	monitoring	prep_for	39	SENT_95	[p4l149t461r508b528],
43	.	.	O	.	_	0	SENT_95	[p4l149t461r508b528],

1	The	DT	O	the	det	3	SENT_96	[p4l551t460r663b515],
2	lower	JJR	O	lower	amod	3	SENT_96	[p4l710t460r884b515],
3	limit	NN	O	limit	nsubj	8	SENT_96	[p4l928t460r1071b515],
4	of	IN	O	of	_	0	SENT_96	[p4l1114t460r1178b515],
5	detection	NN	O	detection	prep_of	3	SENT_96	[p4l1216t460r1502b515],
6	was	VBD	O	be	cop	8	SENT_96	[p4l1544t476r1661b515],
7	0.1	CD	NUMBER	0.1	num	8	SENT_96	[p4l1708t463r1784b515],
8	ng/ml	NN	O	ng/ml	dep	38	SENT_96	[p4l1838t460r2016b528],
9	for	IN	O	for	_	0	SENT_96	[p4l2062t460r2147b515],
10	risperidone	NN	O	risperidone	prep_for	8	SENT_96	[p4l9t549r359b617],
11	and	CC	O	and	_	0	SENT_96	[p4l392t549r503b604],
12	9	CD	NUMBER	9	num	14	SENT_96	[p4l537t549r1222b617],
13	—	NN	O	—	nn	14	SENT_96	[p4l537t549r1222b617],
14	hydroxyrisperidone	NN	O	hydroxyrisperidone	prep_for	8	SENT_96	[p4l537t549r1222b617],
15	,	,	O	,	_	0	SENT_96	[p4l537t549r1222b617],
16	and	CC	O	and	_	0	SENT_96	[p4l1255t549r1367b604],
17	the	DT	O	the	det	18	SENT_96	[p4l1401t549r1497b604],
18	values	NNS	O	value	nsubj	33	SENT_96	[p4l1529t549r1721b604],
19	of	IN	O	of	_	0	SENT_96	[p4l1755t549r1819b604],
20	the	DT	O	the	det	21	SENT_96	[p4l1844t549r1941b604],
21	intraassay	NN	O	intraassay	prep_of	18	SENT_96	[p4l1976t550r2144b604, p4l8t653r170b706],
22	and	CC	O	and	_	0	SENT_96	[p4l194t637r305b692],
23	inter	NN	O	inter	nn	26	SENT_96	[p4l333t638r666b706],
24	—	NN	O	—	nn	26	SENT_96	[p4l333t638r666b706],
25	assay	NN	O	assay	nn	26	SENT_96	[p4l333t638r666b706],
26	coefﬁcient	NN	O	coefﬁcient	prep_of	18	SENT_96	[p4l690t637r1009b692],
27	of	IN	O	of	_	0	SENT_96	[p4l1033t637r1097b692],
28	variation	NN	O	variation	prep_of	26	SENT_96	[p4l1114t638r1388b692],
29	were	VBD	O	be	cop	33	SENT_96	[p4l1410t653r1562b692],
30	less	JJR	O	less	mwe	31	SENT_96	[p4l1589t637r1698b692],
31	than	IN	O	than	quantmod	32	SENT_96	[p4l1726t637r1864b692],
32	5	CD	PERCENT	5	num	33	SENT_96	[p4l1891t640r1967b692],
33	%	NN	PERCENT	%	conj_and	8	SENT_96	[p4l1891t640r1967b692],
34	at	IN	O	at	_	0	SENT_96	[p4l1993t645r2050b692],
35	all	PDT	O	all	predet	37	SENT_96	[p4l2075t637r2145b692],
36	the	DT	O	the	det	37	SENT_96	[p4l8t726r105b781],
37	concentrations	NNS	O	concentration	prep_at	33	SENT_96	[p4l145t727r599b781],
38	(	VBP	O	(	_	0	SENT_96	[p4l640t726r902b794],
39	0.1	CD	NUMBER	0.1	num	40	SENT_96	[p4l640t726r902b794],
40	—	CD	NUMBER	—	dobj	38	SENT_96	[p4l640t726r902b794],
41	100	CD	NUMBER	100	num	43	SENT_96	[p4l640t726r902b794],
42	ng/ml	NN	O	ng/ml	nn	43	SENT_96	[p4l942t726r1145b795],
43	)	NN	O	)	nsubj	38	SENT_96	[p4l942t726r1145b795],
44	of	IN	O	of	_	0	SENT_96	[p4l1186t726r1250b781],
45	calibration	NN	O	calibration	nn	46	SENT_96	[p4l1282t726r1608b781],
46	curves	NNS	O	curve	prep_of	43	SENT_96	[p4l1647t742r1843b781],
47	for	IN	O	for	_	0	SENT_96	[p4l1885t726r1969b781],
48	both	DT	O	both	det	49	SENT_96	[p4l2007t726r2145b781],
49	compounds	NNS	O	compound	prep_for	46	SENT_96	[p4l9t816r380b884],
50	.	.	O	.	_	0	SENT_96	[p4l9t816r380b884],

1	Plasma	NN	O	plasma	nn	3	SENT_97	[p4l111t905r326b959],
2	prolactin	NN	O	prolactin	nn	3	SENT_97	[p4l349t905r621b973],
3	concentration	NN	O	concentration	nsubjpass	5	SENT_97	[p4l645t905r1069b959],
4	was	VBD	O	be	auxpass	5	SENT_97	[p4l1089t920r1206b959],
5	determined	VBN	O	determine	_	0	SENT_97	[p4l1230t904r1586b959],
6	using	VBG	O	use	xcomp	5	SENT_97	[p4l1610t905r1775b973],
7	enzymeim	NN	O	enzymeim	nn	13	SENT_97	[p4l1797t905r2144b973],
8	—	NN	O	—	nn	13	SENT_97	[p4l1797t905r2144b973],
9	munoassay	NN	O	munoassay	nn	13	SENT_97	[p4l9t1010r352b1062],
10	(	CD	NUMBER	(	num	13	SENT_97	[p4l385t994r536b1062],
11	IMX	NNP	O	IMX	nn	13	SENT_97	[p4l385t994r536b1062],
12	Prolactin	NN	O	prolactin	nn	13	SENT_97	[p4l569t994r838b1049],
13	Dainapack	NN	O	dainapack	dobj	6	SENT_97	[p4l873t994r1205b1062],
14	,	,	O	,	_	0	SENT_97	[p4l873t994r1205b1062],
15	Dainabot	NN	PERSON	dainabot	appos	13	SENT_97	[p4l1240t994r1529b1057],
16	,	,	O	,	_	0	SENT_97	[p4l1240t994r1529b1057],
17	Osaka	NNP	LOCATION	Osaka	appos	13	SENT_97	[p4l1565t994r1760b1057],
18	,	,	O	,	_	0	SENT_97	[p4l1565t994r1760b1057],
19	Japan	NNP	LOCATION	Japan	appos	13	SENT_97	[p4l1786t994r2001b1062],
20	)	CD	NUMBER	)	num	19	SENT_97	[p4l1786t994r2001b1062],
21	.	.	O	.	_	0	SENT_97	[p4l1786t994r2001b1062],

1	The	DT	O	the	det	3	SENT_98	[p4l2033t994r2145b1049],
2	lowest	JJS	O	lowest	amod	3	SENT_98	[p4l9t1083r211b1138],
3	limit	NN	O	limit	nsubj	8	SENT_98	[p4l235t1083r378b1138],
4	of	IN	O	of	_	0	SENT_98	[p4l401t1082r465b1138],
5	detection	NN	O	detection	prep_of	3	SENT_98	[p4l483t1083r769b1138],
6	was	VBD	O	be	cop	8	SENT_98	[p4l791t1098r908b1138],
7	0.6	CD	NUMBER	0.6	num	8	SENT_98	[p4l934t1085r1023b1138],
8	ng/ml	NN	O	ng/ml	_	0	SENT_98	[p4l1050t1082r1242b1151],
9	,	,	O	,	_	0	SENT_98	[p4l1050t1082r1242b1151],
10	and	CC	O	and	_	0	SENT_98	[p4l1269t1083r1380b1138],
11	inter	NN	O	inter	nn	12	SENT_98	[p4l1407t1083r1740b1151],
12	—	NN	O	—	nsubj	31	SENT_98	[p4l1407t1083r1740b1151],
13	assay	NN	O	assay	nn	14	SENT_98	[p4l1407t1083r1740b1151],
14	CV	NN	O	cv	dep	12	SENT_98	[p4l1764t1085r1847b1138],
15	were	VBD	O	be	cop	31	SENT_98	[p4l1869t1098r2020b1138],
16	3.7	CD	NUMBER	3.7	nn	31	SENT_98	[p4l2045t1085r2144b1146],
17	,	,	O	,	_	0	SENT_98	[p4l2045t1085r2144b1146],
18	3.5	CD	NUMBER	3.5	conj_and	16	SENT_98	[p4l7t1174r95b1227],
19	and	CC	O	and	_	0	SENT_98	[p4l119t1171r230b1226],
20	3.5	CD	PERCENT	3.5	number	21	SENT_98	[p4l252t1174r384b1227],
21	%	NN	PERCENT	%	nn	31	SENT_98	[p4l252t1174r384b1227],
22	at	IN	O	at	_	0	SENT_98	[p4l405t1179r462b1226],
23	the	DT	O	the	det	24	SENT_98	[p4l482t1171r579b1226],
24	concentrations	NNS	O	concentration	prep_at	21	SENT_98	[p4l601t1172r1055b1226],
25	of	IN	O	of	_	0	SENT_98	[p4l1077t1171r1141b1226],
26	8	CD	NUMBER	8	prep_of	24	SENT_98	[p4l1155t1174r1204b1234],
27	,	,	O	,	_	0	SENT_98	[p4l1155t1174r1204b1234],
28	20	CD	NUMBER	20	num	26	SENT_98	[p4l1227t1174r1300b1226],
29	and	CC	O	and	_	0	SENT_98	[p4l1322t1171r1434b1226],
30	40	CD	NUMBER	40	conj_and	26	SENT_98	[p4l1454t1174r1529b1226],
31	ng/ml	NN	O	ng/ml	conj_and	8	SENT_98	[p4l1552t1171r1730b1240],
32	for	IN	O	for	_	0	SENT_98	[p4l1753t1171r1837b1226],
33	prolactin	NN	O	prolactin	prep_for	31	SENT_98	[p4l1858t1171r2144b1240],
34	,	,	O	,	_	0	SENT_98	[p4l1858t1171r2144b1240],
35	respectively	RB	O	respectively	advmod	31	SENT_98	[p4l9t1260r386b1329],
36	.	.	O	.	_	0	SENT_98	[p4l9t1260r386b1329],

1	Genomic	JJ	O	genomic	amod	2	SENT_99	[p4l112t1350r385b1404],
2	DNA	NN	O	dna	nsubjpass	4	SENT_99	[p4l414t1351r552b1404],
3	was	VBD	O	be	auxpass	4	SENT_99	[p4l577t1365r695b1404],
4	extracted	VBN	O	extract	_	0	SENT_99	[p4l727t1349r1011b1404],
5	from	IN	O	from	_	0	SENT_99	[p4l1043t1349r1189b1404],
6	peripheral	JJ	O	peripheral	amod	7	SENT_99	[p4l1219t1349r1534b1418],
7	leukocytes	NNS	O	leukocyte	prep_from	4	SENT_99	[p4l1566t1349r1889b1418],
8	using	VBG	O	use	partmod	7	SENT_99	[p4l1922t1350r2086b1418],
9	a	DT	O	a	det	13	SENT_99	[p4l2116t1365r2147b1404],
10	QIAamp	NN	O	qiaamp	nn	13	SENT_99	[p4l10t1440r256b1507],
11	DNA	NN	O	dna	nn	13	SENT_99	[p4l276t1440r414b1493],
12	Blood	NN	O	blood	nn	13	SENT_99	[p4l432t1438r604b1493],
13	Kit	NN	O	kit	dobj	8	SENT_99	[p4l625t1439r710b1493],
14	(	CD	NUMBER	(	num	17	SENT_99	[p4l729t1438r978b1507],
15	Qiagen	NNP	ORGANIZATION	Qiagen	nn	17	SENT_99	[p4l729t1438r978b1507],
16	,	,	O	,	_	0	SENT_99	[p4l729t1438r978b1507],
17	Tokyo	NNP	LOCATION	Tokyo	tmod	8	SENT_99	[p4l998t1438r1422b1507],
18	,	,	O	,	_	0	SENT_99	[p4l998t1438r1422b1507],
19	]	CD	NUMBER	]	num	21	SENT_99	[p4l998t1438r1422b1507],
20	apan	JJ	O	apan	amod	21	SENT_99	[p4l998t1438r1422b1507],
21	)	NN	O	)	appos	17	SENT_99	[p4l998t1438r1422b1507],
22	.	.	O	.	_	0	SENT_99	[p4l998t1438r1422b1507],

1	Two	CD	NUMBER	two	num	2	SENT_100	[p4l1441t1441r1571b1493],
2	SNPs	NNS	O	snp	nsubjpass	13	SENT_100	[p4l1592t1441r1740b1493],
3	of	IN	O	of	_	0	SENT_100	[p4l1761t1438r1825b1493],
4	Taq1A	NN	O	taq1a	nn	8	SENT_100	[p4l1838t1440r2014b1507],
5	and	CC	O	and	_	0	SENT_100	[p4l2035t1438r2146b1493],
6	—	NN	O	—	nn	8	SENT_100	[p4l10t1530r181b1582],
7	141C	NN	O	141c	nn	8	SENT_100	[p4l10t1530r181b1582],
8	Ins/Del	NN	O	ins/del	prep_of	2	SENT_100	[p4l198t1527r402b1596],
9	in	IN	O	in	_	0	SENT_100	[p4l425t1528r481b1582],
10	the	DT	O	the	det	11	SENT_100	[p4l505t1527r602b1582],
11	DRD2	NN	O	drd2	prep_in	8	SENT_100	[p4l625t1530r792b1582],
12	were	VBD	O	be	auxpass	13	SENT_100	[p4l815t1543r967b1582],
13	determined	VBN	O	determine	dep	18	SENT_100	[p4l992t1527r1348b1582],
14	by	IN	O	by	_	0	SENT_100	[p4l1372t1527r1445b1596],
15	our	PRP$	O	we	poss	17	SENT_100	[p4l1466t1543r1570b1582],
16	previous	JJ	O	previous	amod	17	SENT_100	[p4l1593t1528r1854b1596],
17	methods	NNS	O	method	agent	13	SENT_100	[p4l1880t1527r2146b1582],
18	(	VBP	O	(	_	0	SENT_100	[p4l10t1616r236b1684],
19	Suzuki	NNP	PERSON	Suzuki	dobj	18	SENT_100	[p4l10t1616r236b1684],
20	et	FW	O	et	nn	21	SENT_100	[p4l265t1624r322b1671],
21	al.	FW	O	al.	nsubj	18	SENT_100	[p4l349t1616r429b1680],
22	,	,	O	,	_	0	SENT_100	[p4l349t1616r429b1680],
23	2000	CD	DATE	2000	appos	21	SENT_100	[p4l458t1619r632b1680],
24	;	:	O	;	_	0	SENT_100	[p4l458t1619r632b1680],
25	Suzuki	NNP	PERSON	Suzuki	dep	23	SENT_100	[p4l666t1616r867b1671],
26	et	FW	O	et	nn	27	SENT_100	[p4l896t1624r953b1671],
27	al.	FW	O	al.	dep	25	SENT_100	[p4l980t1616r1060b1680],
28	,	,	O	,	_	0	SENT_100	[p4l980t1616r1060b1680],
29	2001b	JJ	O	2001b	amod	30	SENT_100	[p4l1089t1616r1318b1684],
30	)	NN	O	)	appos	27	SENT_100	[p4l1089t1616r1318b1684],
31	.	.	O	.	_	0	SENT_100	[p4l1089t1616r1318b1684],

1	Ser9Gly	RB	O	ser9gly	advmod	23	SENT_101	[p4l1345t1616r1572b1685],
2	in	IN	O	in	_	0	SENT_101	[p4l1600t1617r1657b1671],
3	DRD3	NN	O	drd3	nn	5	SENT_101	[p4l1682t1619r1849b1671],
4	(	CD	NUMBER	(	num	5	SENT_101	[p4l1881t1616r2146b1685],
5	Lorenzo	NNP	PERSON	Lorenzo	prep_in	23	SENT_101	[p4l1881t1616r2146b1685],
6	et	FW	O	et	nn	7	SENT_101	[p4l10t1714r67b1761],
7	al.	FW	O	al.	dep	5	SENT_101	[p4l97t1706r177b1769],
8	,	,	O	,	_	0	SENT_101	[p4l97t1706r177b1769],
9	2007	CD	DATE	2007	num	10	SENT_101	[p4l209t1706r386b1774],
10	)	NN	O	)	conj_and	5	SENT_101	[p4l209t1706r386b1774],
11	and	CC	O	and	_	0	SENT_101	[p4l417t1706r528b1761],
12	Val158Met	NN	O	val158met	conj_and	5	SENT_101	[p4l561t1706r878b1761],
13	in	IN	O	in	_	0	SENT_101	[p4l907t1707r964b1760],
14	COMT	NNP	O	COMT	nn	16	SENT_101	[p4l995t1708r1176b1761],
15	(	CD	NUMBER	(	num	16	SENT_101	[p4l1200t1706r1558b1774],
16	Hashimoto	NN	PERSON	hashimoto	prep_in	12	SENT_101	[p4l1200t1706r1558b1774],
17	et	FW	O	et	nn	18	SENT_101	[p4l1589t1714r1646b1761],
18	al.	FW	O	al.	dep	12	SENT_101	[p4l1675t1706r1755b1769],
19	,	,	O	,	_	0	SENT_101	[p4l1675t1706r1755b1769],
20	2007	CD	DATE	2007	num	21	SENT_101	[p4l1787t1706r1965b1774],
21	)	NN	O	)	nsubjpass	23	SENT_101	[p4l1787t1706r1965b1774],
22	were	VBD	O	be	auxpass	23	SENT_101	[p4l1994t1721r2147b1761],
23	determined	VBN	O	determine	_	0	SENT_101	[p4l10t1795r366b1850],
24	identiﬁed	VBN	O	identiﬁed	dep	23	SENT_101	[p4l395t1794r687b1850],
25	using	VBG	O	use	xcomp	24	SENT_101	[p4l716t1796r881b1863],
26	PCR	NN	O	pcr	nn	27	SENT_101	[p4l907t1797r1026b1850],
27	methods	NNS	O	method	dobj	25	SENT_101	[p4l1052t1795r1333b1850],
28	.	.	O	.	_	0	SENT_101	[p4l1052t1795r1333b1850],

1	The	DT	O	the	det	3	SENT_102	[p4l1359t1795r1471b1850],
2	VNTR	NN	ORGANIZATION	vntr	nn	3	SENT_102	[p4l1497t1798r1671b1849],
3	polymorphism	NN	O	polymorphism	_	0	SENT_102	[p4l1696t1795r2147b1863],
4	in	IN	O	in	_	0	SENT_102	[p4l10t1884r66b1937],
5	the	DT	O	the	det	7	SENT_102	[p4l91t1883r187b1938],
6	DRD4	NN	O	drd4	nn	7	SENT_102	[p4l210t1886r379b1937],
7	gene	NN	O	gene	prep_in	3	SENT_102	[p4l402t1899r546b1952],
8	was	VBD	O	be	auxpass	9	SENT_102	[p4l569t1899r686b1938],
9	determined	VBN	O	determine	rcmod	3	SENT_102	[p4l711t1883r1067b1938],
10	by	IN	O	by	_	0	SENT_102	[p4l1092t1883r1166b1952],
11	Qian	NNP	PERSON	Qian	agent	9	SENT_102	[p4l1188t1884r1327b1949],
12	et	FW	O	et	nn	14	SENT_102	[p4l1351t1891r1408b1938],
13	al.	FW	O	al.	nn	14	SENT_102	[p4l1432t1883r1496b1939],
14	(	FW	O	(	dobj	9	SENT_102	[p4l1522t1883r1740b1951],
15	2004	CD	DATE	2004	num	16	SENT_102	[p4l1522t1883r1740b1951],
16	)	CD	NUMBER	)	nsubjpass	9	SENT_102	[p4l1522t1883r1740b1951],
17	.	.	O	.	_	0	SENT_102	[p4l1522t1883r1740b1951],

1	The	DT	O	the	det	2	SENT_103	[p4l109t1972r221b2027],
2	comparison	NN	O	comparison	nsubjpass	19	SENT_103	[p4l242t1973r601b2041],
3	of	IN	O	of	_	0	SENT_103	[p4l622t1972r685b2027],
4	several	JJ	O	several	amod	5	SENT_103	[p4l699t1973r911b2027],
5	factors	NNS	O	factor	prep_of	2	SENT_103	[p4l933t1972r1135b2027],
6	including	VBG	O	include	_	0	SENT_103	[p4l1157t1972r1444b2041],
7	the	DT	O	the	det	9	SENT_103	[p4l1463t1972r1560b2027],
8	plasma	NN	O	plasma	nn	9	SENT_103	[p4l1581t1972r1798b2041],
9	concentration	NN	O	concentration	prep_including	5	SENT_103	[p4l1818t1981r2146b2027, p4l9t2062r129b2116],
10	of	IN	O	of	_	0	SENT_103	[p4l150t2061r214b2116],
11	prolactin	NN	O	prolactin	prep_of	9	SENT_103	[p4l227t2061r499b2130],
12	and	CC	O	and	_	0	SENT_103	[p4l520t2061r630b2116],
13	each	DT	O	each	det	15	SENT_103	[p4l652t2062r790b2116],
14	dopamine	NN	O	dopamine	nn	15	SENT_103	[p4l811t2061r1361b2130],
15	—	NN	O	—	prep_including	5	SENT_103	[p4l811t2061r1361b2130],
16	related	JJ	O	related	amod	17	SENT_103	[p4l811t2061r1361b2130],
17	genotype	NN	O	genotype	dep	15	SENT_103	[p4l1381t2070r1665b2130],
18	was	VBD	O	be	auxpass	19	SENT_103	[p4l1683t2077r1801b2116],
19	performed	VBN	O	perform	_	0	SENT_103	[p4l1823t2061r2146b2130],
20	with	IN	O	with	_	0	SENT_103	[p4l8t2151r149b2206],
21	use	NN	O	use	prep_with	19	SENT_103	[p4l173t2167r273b2206],
22	of	IN	O	of	_	0	SENT_103	[p4l297t2151r361b2206],
23	one	CD	NUMBER	one	prep_of	21	SENT_103	[p4l377t2167r644b2219],
24	—	CD	NUMBER	—	num	26	SENT_103	[p4l377t2167r644b2219],
25	way	NN	O	way	nn	26	SENT_103	[p4l377t2167r644b2219],
26	ANOVA	NNP	O	ANOVA	dep	23	SENT_103	[p4l663t2153r905b2206],
27	.	.	O	.	_	0	SENT_103	[p4l663t2153r905b2206],

1	Multiple	JJ	O	multiple	amod	3	SENT_104	[p4l931t2151r1188b2219],
2	regression	NN	O	regression	nn	3	SENT_104	[p4l1213t2152r1528b2219],
3	analyses	NNS	O	analysis	nsubjpass	5	SENT_104	[p4l1551t2151r1806b2219],
4	were	VBD	O	be	auxpass	5	SENT_104	[p4l1829t2167r1982b2206],
5	used	VBN	O	use	_	0	SENT_104	[p4l2005t2151r2146b2206],
6	to	TO	O	to	aux	7	SENT_104	[p4l9t2248r68b2295],
7	detect	VB	O	detect	xcomp	5	SENT_104	[p4l95t2240r283b2295],
8	correlation	NN	O	correlation	dobj	7	SENT_104	[p4l309t2240r642b2295],
9	between	IN	O	between	_	0	SENT_104	[p4l668t2240r932b2295],
10	plasma	NN	O	plasma	nn	11	SENT_104	[p4l958t2240r1176b2308],
11	concentration	NN	O	concentration	prep_between	8	SENT_104	[p4l1202t2240r1626b2295],
12	of	IN	O	of	_	0	SENT_104	[p4l1653t2239r1716b2295],
13	prolactin	NN	O	prolactin	prep_of	11	SENT_104	[p4l1735t2240r2008b2308],
14	and	CC	O	and	_	0	SENT_104	[p4l2035t2240r2146b2295],
15	several	JJ	O	several	amod	16	SENT_104	[p4l11t2328r222b2383],
16	factors	NNS	O	factor	conj_and	11	SENT_104	[p4l258t2328r460b2383],
17	including	VBG	O	include	_	0	SENT_104	[p4l495t2328r782b2397],
18	dopamine	NN	O	dopamine	nn	21	SENT_104	[p4l815t2328r1365b2397],
19	—	NN	O	—	nn	21	SENT_104	[p4l815t2328r1365b2397],
20	related	JJ	O	related	amod	21	SENT_104	[p4l815t2328r1365b2397],
21	polymorphisms	NNS	O	polymorphism	prep_including	16	SENT_104	[p4l1400t2328r1895b2397],
22	,	,	O	,	_	0	SENT_104	[p4l1400t2328r1895b2397],
23	plasma	NN	O	plasma	nn	25	SENT_104	[p4l1930t2328r2147b2397],
24	drug	NN	O	drug	nn	25	SENT_104	[p4l10t2417r152b2486],
25	concentration	NN	O	concentration	prep_including	16	SENT_104	[p4l184t2418r608b2472],
26	and	CC	O	and	_	0	SENT_104	[p4l641t2417r752b2472],
27	age	NN	O	age	prep_including	16	SENT_104	[p4l786t2433r903b2486],
28	.	.	O	.	_	0	SENT_104	[p4l786t2433r903b2486],

1	Gender	NN	O	gender	nn	2	SENT_105	[p4l937t2417r1162b2472],
2	difference	NN	O	difference	nsubjpass	4	SENT_105	[p4l1192t2417r1497b2472],
3	was	VBD	O	be	auxpass	4	SENT_105	[p4l1528t2433r1645b2472],
4	analyzed	VBN	O	analyze	dep	8	SENT_105	[p4l1680t2417r1949b2486],
5	using	VBG	O	use	xcomp	4	SENT_105	[p4l1983t2418r2148b2486],
6	dummy	NN	O	dummy	nn	7	SENT_105	[p4l10t2506r247b2575],
7	variables	NNS	O	variable	dobj	5	SENT_105	[p4l263t2506r535b2561],
8	(	VBP	O	(	_	0	SENT_105	[p4l557t2507r729b2575],
9	male	NN	O	male	dobj	8	SENT_105	[p4l557t2507r729b2575],
10	=	JJ	O	=	amod	11	SENT_105	[p4l741t2529r773b2546],
11	o	NN	O	o	nsubj	8	SENT_105	[p4l786t2509r835b2570],
12	,	,	O	,	_	0	SENT_105	[p4l786t2509r835b2570],
13	female	NN	O	female	appos	11	SENT_105	[p4l857t2506r1061b2561],
14	=	JJ	O	=	amod	16	SENT_105	[p4l1074t2507r1192b2575],
15	1	CD	NUMBER	1	tmod	14	SENT_105	[p4l1074t2507r1192b2575],
16	)	NN	O	)	dep	13	SENT_105	[p4l1074t2507r1192b2575],
17	.	.	O	.	_	0	SENT_105	[p4l1074t2507r1192b2575],

1	The	DT	O	the	dep	113	SENT_106	[p4l1210t2506r1322b2561],
2	number	NN	O	number	dep	113	SENT_106	[p4l1344t2506r1585b2561],
3	of	IN	O	of	dep	113	SENT_106	[p4l1603t2506r1667b2561],
4	mutated	VBN	O	mutate	dep	113	SENT_106	[p4l1680t2506r1935b2561],
5	alleles	NNS	O	allele	dep	113	SENT_106	[p4l1956t2506r2145b2561],
6	were	VBD	O	be	dep	113	SENT_106	[p4l8t2611r161b2650],
7	was	VBD	O	be	dep	113	SENT_106	[p4l185t2611r303b2650],
8	used	VBN	O	use	dep	113	SENT_106	[p4l331t2595r471b2650],
9	as	IN	O	as	dep	113	SENT_106	[p4l499t2611r559b2650],
10	independent	JJ	O	independent	dep	113	SENT_106	[p4l588t2595r979b2664],
11	variables	NNS	O	variable	dep	113	SENT_106	[p4l1003t2595r1275b2650],
12	and	CC	O	and	dep	113	SENT_106	[p4l1302t2595r1413b2650],
13	their	PRP$	O	they	dep	113	SENT_106	[p4l1442t2595r1588b2650],
14	dummy	NN	O	dummy	dep	113	SENT_106	[p4l1613t2596r1849b2664],
15	variables	NNS	O	variable	dep	113	SENT_106	[p4l1873t2595r2145b2650],
16	were	VBD	O	be	dep	113	SENT_106	[p4l8t2701r160b2740],
17	used	VBN	O	use	dep	113	SENT_106	[p4l183t2685r323b2740],
18	for	IN	O	for	dep	113	SENT_106	[p4l346t2685r431b2740],
19	analyses	NNS	O	analysis	dep	113	SENT_106	[p4l450t2685r706b2753],
20	of	IN	O	of	dep	113	SENT_106	[p4l728t2685r791b2740],
21	A1	NN	O	a1	dep	113	SENT_106	[p4l803t2687r877b2739],
22	/	:	O	/	dep	113	SENT_106	[p4l889t2685r983b2753],
23	A1	NN	O	a1	dep	113	SENT_106	[p4l889t2685r983b2753],
24	=	JJ	O	=	dep	113	SENT_106	[p4l1004t2688r1098b2748],
25	o	NN	O	o	dep	113	SENT_106	[p4l1004t2688r1098b2748],
26	,	,	O	,	_	0	SENT_106	[p4l1004t2688r1098b2748],
27	A1	NN	O	a1	dep	113	SENT_106	[p4l1118t2687r1192b2739],
28	/	:	O	/	dep	113	SENT_106	[p4l1204t2685r1305b2753],
29	A2	NN	O	a2	dep	113	SENT_106	[p4l1204t2685r1305b2753],
30	=	JJ	O	=	dep	113	SENT_106	[p4l1320t2688r1391b2739],
31	1	CD	NUMBER	1	dep	113	SENT_106	[p4l1320t2688r1391b2739],
32	and	CC	O	and	dep	113	SENT_106	[p4l1420t2685r1532b2740],
33	A2	NN	O	a2	dep	113	SENT_106	[p4l1552t2687r1631b2739],
34	/	:	O	/	dep	113	SENT_106	[p4l1638t2685r1739b2753],
35	A2	NN	O	a2	dep	113	SENT_106	[p4l1638t2685r1739b2753],
36	=	JJ	O	=	dep	113	SENT_106	[p4l1753t2688r1830b2739],
37	2	CD	NUMBER	2	dep	113	SENT_106	[p4l1753t2688r1830b2739],
38	for	IN	O	for	dep	113	SENT_106	[p4l1854t2685r1939b2740],
39	Taq1A	NN	O	taq1a	dep	113	SENT_106	[p4l1956t2687r2149b2753],
40	in	IN	O	in	dep	113	SENT_106	[p4l10t2774r66b2828],
41	DRD2	NN	O	drd2	dep	113	SENT_106	[p4l104t2776r291b2837],
42	,	,	O	,	_	0	SENT_106	[p4l104t2776r291b2837],
43	Ins/Ins	NN	O	ins/ins	dep	113	SENT_106	[p4l329t2773r637b2842],
44	=	JJ	O	=	dep	113	SENT_106	[p4l329t2773r637b2842],
45	o	NN	O	o	dep	113	SENT_106	[p4l329t2773r637b2842],
46	,	,	O	,	_	0	SENT_106	[p4l329t2773r637b2842],
47	Ins/Del	NN	O	ins/del	dep	113	SENT_106	[p4l676t2773r972b2842],
48	=	JJ	O	=	dep	113	SENT_106	[p4l676t2773r972b2842],
49	1	CD	NUMBER	1	dep	113	SENT_106	[p4l676t2773r972b2842],
50	and	CC	O	and	dep	113	SENT_106	[p4l1017t2774r1128b2829],
51	Del/Del	NN	O	del/del	dep	113	SENT_106	[p4l1167t2773r1481b2842],
52	=	JJ	O	=	dep	113	SENT_106	[p4l1167t2773r1481b2842],
53	2	CD	NUMBER	2	dep	113	SENT_106	[p4l1167t2773r1481b2842],
54	for	IN	O	for	dep	113	SENT_106	[p4l1521t2773r1606b2829],
55	—	CD	NUMBER	—	dep	113	SENT_106	[p4l1638t2776r1811b2829],
56	141C	NN	O	141c	dep	113	SENT_106	[p4l1638t2776r1811b2829],
57	ins/del	NN	O	ins/del	dep	113	SENT_106	[p4l1849t2773r2053b2842],
58	in	IN	O	in	dep	113	SENT_106	[p4l2090t2774r2146b2828],
59	DRD2	NN	O	drd2	dep	113	SENT_106	[p4l10t2865r197b2926],
60	,	,	O	,	_	0	SENT_106	[p4l10t2865r197b2926],
61	Ser/Ser	NN	O	ser/ser	dep	113	SENT_106	[p4l221t2862r543b2931],
62	=	JJ	O	=	dep	113	SENT_106	[p4l221t2862r543b2931],
63	o	NN	O	o	dep	113	SENT_106	[p4l221t2862r543b2931],
64	,	,	O	,	_	0	SENT_106	[p4l221t2862r543b2931],
65	Ser/Gly	NN	O	ser/gly	dep	113	SENT_106	[p4l568t2862r871b2931],
66	=	JJ	O	=	dep	113	SENT_106	[p4l568t2862r871b2931],
67	1	CD	NUMBER	1	dep	113	SENT_106	[p4l568t2862r871b2931],
68	and	CC	O	and	dep	113	SENT_106	[p4l902t2862r1014b2917],
69	Gly/Gly	NN	O	gly/gly	dep	113	SENT_106	[p4l1038t2862r1353b2931],
70	=	JJ	O	=	dep	113	SENT_106	[p4l1038t2862r1353b2931],
71	2	CD	NUMBER	2	dep	113	SENT_106	[p4l1038t2862r1353b2931],
72	for	IN	O	for	dep	113	SENT_106	[p4l1379t2862r1464b2917],
73	Ser9Gly	NN	O	ser9gly	dep	113	SENT_106	[p4l1486t2862r1723b2931],
74	in	IN	O	in	dep	113	SENT_106	[p4l1746t2863r1802b2916],
75	DRD3	NN	O	drd3	dep	113	SENT_106	[p4l1825t2865r2012b2925],
76	,	,	O	,	_	0	SENT_106	[p4l1825t2865r2012b2925],
77	less	JJR	O	less	dep	113	SENT_106	[p4l2036t2862r2145b2917],
78	than	IN	O	than	dep	113	SENT_106	[p4l9t2951r147b3006],
79	7	CD	NUMBER	7	dep	113	SENT_106	[p4l168t2954r200b3005],
80	repeats	NNS	O	repeat	dep	113	SENT_106	[p4l223t2954r536b3020],
81	=	JJ	O	=	dep	113	SENT_106	[p4l223t2954r536b3020],
82	o	NN	O	o	dep	113	SENT_106	[p4l223t2954r536b3020],
83	and	CC	O	and	dep	113	SENT_106	[p4l556t2951r667b3006],
84	more	JJR	O	more	dep	113	SENT_106	[p4l689t2967r846b3006],
85	than	IN	O	than	dep	113	SENT_106	[p4l867t2951r1005b3006],
86	8	CD	NUMBER	8	dep	113	SENT_106	[p4l1025t2954r1057b3006],
87	repeats	NNS	O	repeat	dep	113	SENT_106	[p4l1080t2954r1386b3020],
88	=	JJ	O	=	dep	113	SENT_106	[p4l1080t2954r1386b3020],
89	1	CD	NUMBER	1	dep	113	SENT_106	[p4l1080t2954r1386b3020],
90	for	IN	O	for	dep	113	SENT_106	[p4l1415t2951r1499b3006],
91	48	CD	NUMBER	48	dep	113	SENT_106	[p4l1516t2954r1590b3006],
92	bp	NN	O	bp	dep	113	SENT_106	[p4l1612t2951r1687b3020],
93	VNTR	NN	ORGANIZATION	vntr	dep	113	SENT_106	[p4l1706t2954r1880b3006],
94	in	IN	O	in	dep	113	SENT_106	[p4l1898t2952r1954b3005],
95	DRD4	NN	O	drd4	dep	113	SENT_106	[p4l1975t2954r2147b3005],
96	and	CC	O	and	dep	113	SENT_106	[p4l10t3040r121b3095],
97	Val/Val	NN	O	val/val	dep	113	SENT_106	[p4l145t3040r470b3109],
98	=	JJ	O	=	dep	113	SENT_106	[p4l145t3040r470b3109],
99	o	NN	O	o	dep	113	SENT_106	[p4l145t3040r470b3109],
100	,	,	O	,	_	0	SENT_106	[p4l145t3040r470b3109],
101	Val/Met	NN	O	val/met	dep	113	SENT_106	[p4l495t3040r822b3109],
102	=	JJ	O	=	dep	113	SENT_106	[p4l495t3040r822b3109],
103	1	CD	NUMBER	1	dep	113	SENT_106	[p4l495t3040r822b3109],
104	and	CC	O	and	dep	113	SENT_106	[p4l856t3040r967b3095],
105	Met/Met	NN	O	met/met	dep	113	SENT_106	[p4l994t3040r1349b3109],
106	=	JJ	O	=	dep	113	SENT_106	[p4l994t3040r1349b3109],
107	2	CD	NUMBER	2	dep	113	SENT_106	[p4l994t3040r1349b3109],
108	for	IN	O	for	dep	113	SENT_106	[p4l1377t3040r1462b3095],
109	Val158Met	NN	O	val158met	dep	113	SENT_106	[p4l1483t3040r1818b3095],
110	for	IN	O	for	dep	113	SENT_106	[p4l1843t3040r1927b3095],
111	COMT	NNP	O	COMT	dep	113	SENT_106	[p4l1952t3043r2145b3104],
112	,	,	O	,	_	0	SENT_106	[p4l1952t3043r2145b3104],
113	respectively	RB	O	respectively	_	0	SENT_106	[p4l10t3129r387b3198],
114	.	.	O	.	_	0	SENT_106	[p4l10t3129r387b3198],

1	A	DT	O	a	det	3	SENT_107	[p4l421t3132r466b3184],
2	p	NN	O	p	nn	3	SENT_107	[p4l495t3145r532b3198],
3	value	NN	O	value	nsubjpass	8	SENT_107	[p4l567t3129r729b3184],
4	less	JJR	O	less	amod	3	SENT_107	[p4l765t3129r874b3184],
5	than	IN	O	than	_	0	SENT_107	[p4l910t3129r1048b3184],
6	0.05	CD	NUMBER	0.05	prep_than	4	SENT_107	[p4l1083t3132r1209b3185],
7	was	VBD	O	be	auxpass	8	SENT_107	[p4l1244t3145r1362b3184],
8	regarded	VBN	O	regard	_	0	SENT_107	[p4l1399t3129r1669b3198],
9	as	IN	O	as	_	0	SENT_107	[p4l1706t3145r1765b3184],
10	statistically	RB	O	statistically	advmod	11	SENT_107	[p4l1802t3129r2148b3198],
11	signiﬁcant	JJ	O	signiﬁcant	prep_as	8	SENT_107	[p4l11t3218r341b3287],
12	.	.	O	.	_	0	SENT_107	[p4l11t3218r341b3287],

1	All	DT	O	all	det	2	SENT_108	[p4l360t3219r442b3273],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_108	[p4l463t3219r717b3287],
3	were	VBD	O	be	auxpass	4	SENT_108	[p4l737t3234r889b3274],
4	performed	VBN	O	perform	_	0	SENT_108	[p4l910t3218r1234b3287],
5	using	VBG	O	use	xcomp	4	SENT_108	[p4l1255t3219r1419b3287],
6	SPSS	NNP	ORGANIZATION	SPSS	dobj	5	SENT_108	[p4l1439t3221r1578b3274],
7	13.0	CD	NUMBER	13.0	num	8	SENT_108	[p4l1602t3221r1743b3287],
8	]	NN	O	]	dep	14	SENT_108	[p4l1602t3221r1743b3287],
9	for	IN	O	for	_	0	SENT_108	[p4l1764t3218r1848b3274],
10	windows	NNS	O	window	prep_for	8	SENT_108	[p4l1866t3219r2146b3274],
11	(	CD	NUMBER	(	dep	14	SENT_108	[p4l10t3308r174b3376],
12	SPSS	NNP	ORGANIZATION	SPSS	nn	14	SENT_108	[p4l10t3308r174b3376],
13	Japan	NNP	ORGANIZATION	Japan	nn	14	SENT_108	[p4l191t3311r366b3376],
14	Inc.	NNP	ORGANIZATION	Inc.	dep	5	SENT_108	[p4l391t3311r510b3371],
15	,	,	O	,	_	0	SENT_108	[p4l391t3311r510b3371],
16	Tokyo	NNP	LOCATION	Tokyo	appos	14	SENT_108	[p4l532t3308r728b3376],
17	,	,	O	,	_	0	SENT_108	[p4l532t3308r728b3376],
18	Japan	NNP	LOCATION	Japan	appos	14	SENT_108	[p4l747t3308r960b3376],
19	)	CD	NUMBER	)	num	18	SENT_108	[p4l747t3308r960b3376],
20	.	.	O	.	_	0	SENT_108	[p4l747t3308r960b3376],

1	3	LS	NUMBER	3	_	0	SENT_109	[p4l8t3489r61b3541],
2	.	.	O	.	_	0	SENT_109	[p4l8t3489r61b3541],

1	Results	NNS	O	result	_	0	SENT_110	[p4l87t3486r316b3540],

1	The	DT	O	the	dep	101	SENT_111	[p5l109t68r221b123],
2	patients	NNS	O	patient	dep	101	SENT_111	[p5l244t69r489b137],
3	had	VBD	O	have	dep	101	SENT_111	[p5l512t68r623b123],
4	the	DT	O	the	dep	101	SENT_111	[p5l645t68r742b123],
5	following	VBG	O	follow	dep	101	SENT_111	[p5l766t68r1055b137],
6	genotypes	NNS	O	genotype	dep	101	SENT_111	[p5l1075t76r1407b137],
7	:	:	O	:	_	0	SENT_111	[p5l1075t76r1407b137],
8	A1/A1	NN	O	a1/a1	dep	101	SENT_111	[p5l1428t68r1601b137],
9	(	CD	NUMBER	(	dep	101	SENT_111	[p5l1630t68r1723b136],
10	12	CD	NUMBER	12	dep	101	SENT_111	[p5l1630t68r1723b136],
11	cases	NNS	O	case	dep	101	SENT_111	[p5l1749t68r1944b136],
12	)	RB	O	)	dep	101	SENT_111	[p5l1749t68r1944b136],
13	,	,	O	,	_	0	SENT_111	[p5l1749t68r1944b136],
14	A1/A2	NN	O	a1/a2	dep	101	SENT_111	[p5l1965t68r2146b137],
15	(	CD	NUMBER	(	dep	101	SENT_111	[p5l10t158r133b226],
16	68	CD	NUMBER	68	dep	101	SENT_111	[p5l10t158r133b226],
17	)	NN	O	)	dep	101	SENT_111	[p5l10t158r133b226],
18	and	CC	O	and	dep	101	SENT_111	[p5l163t158r274b213],
19	A2/A2	NN	O	a2/a2	dep	101	SENT_111	[p5l298t157r478b226],
20	(	CD	NUMBER	(	dep	101	SENT_111	[p5l508t158r630b226],
21	94	CD	NUMBER	94	dep	101	SENT_111	[p5l508t158r630b226],
22	)	NN	O	)	dep	101	SENT_111	[p5l508t158r630b226],
23	for	IN	O	for	dep	101	SENT_111	[p5l661t157r746b213],
24	TaqA1	NN	O	taqa1	dep	101	SENT_111	[p5l774t160r959b226],
25	,	,	O	,	_	0	SENT_111	[p5l774t160r959b226],
26	Ins/Ins	NNS	O	ins/ins	dep	101	SENT_111	[p5l988t157r1180b226],
27	(	VBP	O	(	dep	101	SENT_111	[p5l1209t158r1380b226],
28	121	CD	NUMBER	121	dep	101	SENT_111	[p5l1209t158r1380b226],
29	)	CD	NUMBER	)	dep	101	SENT_111	[p5l1209t158r1380b226],
30	,	,	O	,	_	0	SENT_111	[p5l1209t158r1380b226],
31	Ins/Del	NNP	O	Ins/Del	dep	101	SENT_111	[p5l1409t157r1613b226],
32	(	CD	NUMBER	(	dep	101	SENT_111	[p5l1641t158r1763b226],
33	50	CD	NUMBER	50	dep	101	SENT_111	[p5l1641t158r1763b226],
34	)	NN	O	)	dep	101	SENT_111	[p5l1641t158r1763b226],
35	and	CC	O	and	dep	101	SENT_111	[p5l1793t158r1904b213],
36	Del/Del	NN	O	del/del	dep	101	SENT_111	[p5l1932t157r2148b226],
37	(	CD	NUMBER	(	dep	101	SENT_111	[p5l10t247r93b315],
38	3	CD	NUMBER	3	dep	101	SENT_111	[p5l10t247r93b315],
39	)	NN	O	)	dep	101	SENT_111	[p5l10t247r93b315],
40	for	IN	O	for	dep	101	SENT_111	[p5l114t246r199b302],
41	-141	CD	NUMBER	-141	dep	101	SENT_111	[p5l216t249r336b301],
42	C	NN	O	c	dep	101	SENT_111	[p5l348t249r387b302],
43	Ins/Del	NN	O	ins/del	dep	101	SENT_111	[p5l399t246r615b315],
44	,	,	O	,	_	0	SENT_111	[p5l399t246r615b315],
45	Ser/Ser	NN	O	ser/ser	dep	101	SENT_111	[p5l634t246r842b315],
46	(	CD	NUMBER	(	dep	101	SENT_111	[p5l857t247r953b315],
47	95	CD	NUMBER	95	dep	101	SENT_111	[p5l857t247r953b315],
48	cases	NNS	O	case	dep	101	SENT_111	[p5l975t247r1171b315],
49	)	RB	O	)	dep	101	SENT_111	[p5l975t247r1171b315],
50	,	,	O	,	_	0	SENT_111	[p5l975t247r1171b315],
51	Ser/Gly	NNP	O	Ser/Gly	dep	101	SENT_111	[p5l1192t246r1405b315],
52	(	CD	NUMBER	(	dep	101	SENT_111	[p5l1424t247r1542b315],
53	13	CD	NUMBER	13	dep	101	SENT_111	[p5l1424t247r1542b315],
54	)	NN	O	)	dep	101	SENT_111	[p5l1424t247r1542b315],
55	and	CC	O	and	dep	101	SENT_111	[p5l1561t247r1673b302],
56	Gly/Gly	JJ	O	gly/gly	dep	101	SENT_111	[p5l1693t246r1907b315],
57	(	NN	O	(	dep	101	SENT_111	[p5l1926t247r2043b315],
58	16	CD	NUMBER	16	dep	101	SENT_111	[p5l1926t247r2043b315],
59	)	NN	O	)	dep	101	SENT_111	[p5l1926t247r2043b315],
60	for	IN	O	for	dep	101	SENT_111	[p5l2064t246r2148b302],
61	Ser9Gly	NN	O	ser9gly	dep	101	SENT_111	[p5l7t335r245b404],
62	,	,	O	,	_	0	SENT_111	[p5l7t335r245b404],
63	2/2	CD	NUMBER	2/2	dep	101	SENT_111	[p5l275t335r369b404],
64	(	NN	O	(	dep	101	SENT_111	[p5l400t335r498b403],
65	2	CD	NUMBER	2	dep	101	SENT_111	[p5l400t335r498b403],
66	)	NN	O	)	dep	101	SENT_111	[p5l400t335r498b403],
67	,	,	O	,	_	0	SENT_111	[p5l400t335r498b403],
68	2/4	CD	NUMBER	2/4	dep	101	SENT_111	[p5l528t335r625b404],
69	(	CD	NUMBER	(	dep	101	SENT_111	[p5l653t335r776b403],
70	30	CD	NUMBER	30	dep	101	SENT_111	[p5l653t335r776b403],
71	)	NN	O	)	dep	101	SENT_111	[p5l653t335r776b403],
72	and	CC	O	and	dep	101	SENT_111	[p5l805t335r915b390],
73	4/4	CD	NUMBER	4/4	dep	101	SENT_111	[p5l943t335r1042b404],
74	(	NN	O	(	dep	101	SENT_111	[p5l1070t335r1227b403],
75	142	CD	NUMBER	142	dep	101	SENT_111	[p5l1070t335r1227b403],
76	)	NN	O	)	dep	101	SENT_111	[p5l1070t335r1227b403],
77	for	IN	O	for	dep	101	SENT_111	[p5l1256t335r1341b390],
78	48	CD	NUMBER	48	dep	101	SENT_111	[p5l1366t335r1548b404],
79	—	CD	NUMBER	—	dep	101	SENT_111	[p5l1366t335r1548b404],
80	bp	NN	O	bp	dep	101	SENT_111	[p5l1366t335r1548b404],
81	VNTR	NN	O	vntr	dep	101	SENT_111	[p5l1574t338r1760b399],
82	,	,	O	,	_	0	SENT_111	[p5l1574t338r1760b399],
83	and	CC	O	and	dep	101	SENT_111	[p5l1789t335r1900b390],
84	Val/Val	JJ	O	val/val	dep	101	SENT_111	[p5l1927t335r2146b404],
85	(	NN	O	(	dep	101	SENT_111	[p5l10t424r147b492],
86	58	CD	NUMBER	58	dep	101	SENT_111	[p5l10t424r147b492],
87	)	NN	O	)	dep	101	SENT_111	[p5l10t424r147b492],
88	,	,	O	,	_	0	SENT_111	[p5l10t424r147b492],
89	Val/Met	NN	O	val/met	dep	101	SENT_111	[p5l165t424r410b493],
90	(	CD	NUMBER	(	dep	101	SENT_111	[p5l428t424r546b492],
91	74	CD	NUMBER	74	dep	101	SENT_111	[p5l428t424r546b492],
92	)	NN	O	)	dep	101	SENT_111	[p5l428t424r546b492],
93	and	CC	O	and	dep	101	SENT_111	[p5l566t424r677b479],
94	Met/Met	NN	O	met/met	dep	101	SENT_111	[p5l697t424r964b493],
95	(	CD	NUMBER	(	dep	101	SENT_111	[p5l982t424r1104b492],
96	42	CD	NUMBER	42	dep	101	SENT_111	[p5l982t424r1104b492],
97	)	NN	O	)	dep	101	SENT_111	[p5l982t424r1104b492],
98	for	IN	O	for	dep	101	SENT_111	[p5l1124t424r1209b479],
99	COMT	NNP	O	COMT	dep	101	SENT_111	[p5l1227t427r1420b488],
100	,	,	O	,	_	0	SENT_111	[p5l1227t427r1420b488],
101	respectively	RB	O	respectively	_	0	SENT_111	[p5l1442t424r1819b493],
102	.	.	O	.	_	0	SENT_111	[p5l1442t424r1819b493],

1	There	EX	O	there	expl	2	SENT_112	[p5l1837t424r2011b479],
2	was	VBD	O	be	_	0	SENT_112	[p5l2028t440r2145b479],
3	no	DT	O	no	det	4	SENT_112	[p5l10t529r84b568],
4	difference	NN	O	difference	nsubj	2	SENT_112	[p5l108t513r413b568],
5	in	IN	O	in	_	0	SENT_112	[p5l438t514r494b568],
6	age	NN	O	age	prep_in	4	SENT_112	[p5l518t529r620b582],
7	or	CC	O	or	_	0	SENT_112	[p5l644t529r707b568],
8	duration	NN	O	duration	prep_in	4	SENT_112	[p5l729t513r990b568],
9	of	IN	O	of	_	0	SENT_112	[p5l1014t513r1078b568],
10	illness	NN	O	illness	prep_of	4	SENT_112	[p5l1094t513r1283b568],
11	between	IN	O	between	_	0	SENT_112	[p5l1308t513r1572b568],
12	dopamine	NN	O	dopamine	nn	15	SENT_112	[p5l1596t513r2146b582],
13	—	NN	O	—	nn	15	SENT_112	[p5l1596t513r2146b582],
14	related	JJ	O	related	amod	15	SENT_112	[p5l1596t513r2146b582],
15	polymorphisms	NNS	O	polymorphism	prep_between	10	SENT_112	[p5l10t602r504b671],
16	.	.	O	.	_	0	SENT_112	[p5l10t602r504b671],

1	The	DT	O	the	det	2	SENT_113	[p5l109t692r219b747],
2	mean	NN	O	mean	nsubj	15	SENT_113	[p5l247t708r414b747],
3	(	RB	O	(	dep	8	SENT_113	[p5l440t692r608b760],
4	$	$	MONEY	$	num	8	SENT_113	[p5l440t692r608b760],
5	SD	NN	MONEY	sd	dep	4	SENT_113	[p5l440t692r608b760],
6	)	CD	NUMBER	)	number	4	SENT_113	[p5l440t692r608b760],
7	plasma	NN	O	plasma	nn	8	SENT_113	[p5l636t692r850b760],
8	concentration	NN	O	concentration	dep	2	SENT_113	[p5l875t693r1291b747],
9	of	IN	O	of	_	0	SENT_113	[p5l1317t692r1380b747],
10	prolactin	NN	O	prolactin	prep_of	2	SENT_113	[p5l1399t692r1665b760],
11	in	IN	O	in	_	0	SENT_113	[p5l1693t693r1748b746],
12	females	NNS	O	female	prep_in	10	SENT_113	[p5l1775t692r2004b747],
13	was	VBD	O	be	cop	15	SENT_113	[p5l2029t708r2147b747],
14	signiﬁcantly	RB	O	signiﬁcantly	advmod	15	SENT_113	[p5l11t780r375b849],
15	higher	JJR	O	higher	_	0	SENT_113	[p5l392t781r586b849],
16	than	IN	O	than	mark	18	SENT_113	[p5l602t781r738b836],
17	males	NNS	O	male	nsubj	18	SENT_113	[p5l756t781r930b836],
18	(	VBP	O	(	ccomp	15	SENT_113	[p5l948t781r1095b849],
19	54.3	CD	NUMBER	54.3	num	22	SENT_113	[p5l948t781r1095b849],
20	$	$	MONEY	$	amod	22	SENT_113	[p5l1109t783r1270b836],
21	27.2	CD	MONEY	27.2	number	20	SENT_113	[p5l1109t783r1270b836],
22	ng/ml	NN	O	ng/ml	dobj	18	SENT_113	[p5l1290t780r1466b849],
23	versus	CC	O	versus	prep	22	SENT_113	[p5l1481t796r1673b836],
24	126.8	CD	NUMBER	126.8	dep	23	SENT_113	[p5l1695t783r1851b836],
25	$	$	MONEY	$	dep	18	SENT_113	[p5l1864t790r1896b835],
26	70.2	CD	MONEY	70.2	num	25	SENT_113	[p5l1909t783r2031b836],
27	ng	NN	O	ng	dep	25	SENT_113	[p5l2051t780r2146b849],
28	/	:	O	/	punct	25	SENT_113	[p5l2051t780r2146b849],
29	ml	NN	O	ml	dep	25	SENT_113	[p5l10t869r100b932],
30	,	,	O	,	_	0	SENT_113	[p5l10t869r100b932],
31	p	NN	O	p	amod	29	SENT_113	[p5l132t869r429b938],
32	<	JJR	O	<	dep	31	SENT_113	[p5l132t869r429b938],
33	0.001	CD	NUMBER	0.001	num	34	SENT_113	[p5l132t869r429b938],
34	)	NN	O	)	dep	31	SENT_113	[p5l132t869r429b938],
35	.	.	O	.	_	0	SENT_113	[p5l132t869r429b938],

1	No	DT	O	no	det	2	SENT_114	[p5l466t872r548b924],
2	differences	NNS	O	difference	nsubjpass	7	SENT_114	[p5l584t869r911b924],
3	in	IN	O	in	_	0	SENT_114	[p5l947t870r1002b923],
4	prolactin	NN	O	prolactin	nn	5	SENT_114	[p5l1037t869r1303b938],
5	concentration	NN	O	concentration	prep_in	2	SENT_114	[p5l1339t870r1754b924],
6	were	VBD	O	be	auxpass	7	SENT_114	[p5l1786t885r1936b924],
7	found	VBN	O	find	conj_and	7	SENT_114	[p5l1973t869r2146b924],
8	between	IN	O	between	_	0	SENT_114	[p5l9t958r269b1013],
9	patients	NNS	O	patient	prep_between	7	SENT_114	[p5l313t959r554b1027],
10	with	IN	O	with	_	0	SENT_114	[p5l597t958r737b1013],
11	and	CC	O	and	_	0	SENT_114	[p5l781t958r890b1013],
12	without	IN	O	without	_	0	SENT_114	[p5l934t958r1176b1013],
13	anticholinergic	JJ	O	anticholinergic	amod	14	SENT_114	[p5l1219t958r1669b1027],
14	agents	NNS	O	agent	prep_without	7	SENT_114	[p5l1713t966r1907b1027],
15	(	VBP	O	(	_	0	SENT_114	[p5l1952t958r2147b1026],
16	45.6	CD	NUMBER	45.6	dobj	15	SENT_114	[p5l1952t958r2147b1026],
17	$	$	MONEY	$	dep	19	SENT_114	[p5l1952t958r2147b1026],
18	17.0	CD	MONEY	17.0	num	19	SENT_114	[p5l13t1050r123b1103],
19	ng/ml	NN	O	ng/ml	dep	16	SENT_114	[p5l147t1047r322b1116],
20	versus	CC	O	versus	_	0	SENT_114	[p5l343t1063r535b1102],
21	57.8	CD	NUMBER	57.8	num	24	SENT_114	[p5l559t1050r848b1103],
22	$	$	MONEY	$	amod	24	SENT_114	[p5l559t1050r848b1103],
23	37.2	CD	MONEY	37.2	number	22	SENT_114	[p5l559t1050r848b1103],
24	ng/ml	NN	O	ng/ml	dobj	15	SENT_114	[p5l874t1047r1048b1116],
25	for	IN	O	for	_	0	SENT_114	[p5l1072t1047r1156b1102],
26	men	NNS	O	man	prep_for	24	SENT_114	[p5l1178t1063r1310b1102],
27	and	CC	O	and	_	0	SENT_114	[p5l1333t1047r1442b1102],
28	125.3	CD	NUMBER	125.3	num	31	SENT_114	[p5l1470t1050r1808b1103],
29	$	$	MONEY	$	amod	31	SENT_114	[p5l1470t1050r1808b1103],
30	59.9	CD	MONEY	59.9	number	29	SENT_114	[p5l1470t1050r1808b1103],
31	ng/ml	NN	O	ng/ml	conj_and	16	SENT_114	[p5l1832t1047r2007b1116],
32	versus	CC	O	versus	prep	31	SENT_114	[p5l2029t1063r2146b1102, p5l11t1152r102b1191],
33	112.6	CD	NUMBER	112.6	num	36	SENT_114	[p5l129t1139r459b1192],
34	$	$	MONEY	$	amod	36	SENT_114	[p5l129t1139r459b1192],
35	70.9	CD	MONEY	70.9	number	34	SENT_114	[p5l129t1139r459b1192],
36	ng/ml	NN	O	ng/ml	dep	32	SENT_114	[p5l482t1136r657b1205],
37	for	IN	O	for	_	0	SENT_114	[p5l679t1136r763b1191],
38	women	NNS	O	woman	prep_for	36	SENT_114	[p5l781t1136r1046b1205],
39	)	CD	NUMBER	)	nsubj	15	SENT_114	[p5l781t1136r1046b1205],
40	.	.	O	.	_	0	SENT_114	[p5l781t1136r1046b1205],

1	The	DT	O	the	det	2	SENT_115	[p5l109t1226r221b1281],
2	mean	NN	O	mean	nsubjpass	15	SENT_115	[p5l249t1242r418b1281],
3	(	RB	O	(	dep	8	SENT_115	[p5l446t1226r617b1294],
4	$	$	MONEY	$	num	8	SENT_115	[p5l446t1226r617b1294],
5	SD	NN	MONEY	sd	dep	4	SENT_115	[p5l446t1226r617b1294],
6	)	CD	NUMBER	)	number	4	SENT_115	[p5l446t1226r617b1294],
7	plasma	NN	O	plasma	nn	8	SENT_115	[p5l646t1226r864b1294],
8	concentration	NN	O	concentration	dep	2	SENT_115	[p5l891t1227r1315b1281],
9	of	IN	O	of	_	0	SENT_115	[p5l1342t1226r1406b1281],
10	prolactin	NN	O	prolactin	prep_of	2	SENT_115	[p5l1427t1226r1699b1294],
11	in	IN	O	in	_	0	SENT_115	[p5l1727t1227r1784b1280],
12	dopaminerelated	JJ	O	dopaminerelated	amod	13	SENT_115	[p5l1812t1226r2146b1294, p5l10t1314r221b1369],
13	polymorphisms	NNS	O	polymorphism	prep_in	10	SENT_115	[p5l242t1314r722b1383],
14	is	VBZ	O	be	auxpass	15	SENT_115	[p5l744t1315r787b1369],
15	shown	VBN	O	show	_	0	SENT_115	[p5l810t1314r1012b1369],
16	in	IN	O	in	_	0	SENT_115	[p5l1034t1315r1090b1369],
17	Table	NNP	O	Table	prep_in	15	SENT_115	[p5l1106t1314r1266b1369],
18	1	CD	NUMBER	1	num	17	SENT_115	[p5l1291t1317r1331b1370],
19	.	.	O	.	_	0	SENT_115	[p5l1291t1317r1331b1370],

1	There	EX	O	there	expl	2	SENT_116	[p5l1350t1314r1525b1369],
2	were	VBD	O	be	_	0	SENT_116	[p5l1543t1330r1696b1369],
3	no	DT	O	no	det	4	SENT_116	[p5l1717t1330r1790b1369],
4	differences	NNS	O	difference	nsubj	2	SENT_116	[p5l1812t1314r2146b1369],
5	in	IN	O	in	_	0	SENT_116	[p5l10t1404r66b1457],
6	prolactin	NN	O	prolactin	nn	7	SENT_116	[p5l93t1403r364b1472],
7	concentration	NN	O	concentration	prep_in	4	SENT_116	[p5l392t1404r816b1458],
8	between	IN	O	between	_	0	SENT_116	[p5l843t1403r1107b1458],
9	TaqA1	NN	O	taqa1	nn	10	SENT_116	[p5l1129t1405r1311b1472],
10	polymorphisms	NNS	O	polymorphism	prep_between	7	SENT_116	[p5l1346t1403r1825b1472],
11	(	VBP	O	(	rcmod	4	SENT_116	[p5l1853t1403r1913b1471],
12	F	NN	O	f	dobj	11	SENT_116	[p5l1853t1403r1913b1471],
13	=	JJ	O	=	amod	12	SENT_116	[p5l1919t1426r1951b1442],
14	0.368	CD	NUMBER	0.368	tmod	13	SENT_116	[p5l1963t1406r2145b1466],
15	.	.	O	.	_	0	SENT_116	[p5l1963t1406r2145b1466],

1	Table	NNP	O	Table	_	0	SENT_117	[p5l7t1626r143b1670],
2	1	CD	NUMBER	1	num	1	SENT_117	[p5l163t1629r186b1669],
3	Plasma	NN	O	plasma	nn	5	SENT_117	[p5l10t1697r182b1740],
4	prolactin	NN	O	prolactin	nn	5	SENT_117	[p5l205t1697r424b1751],
5	concentrations	NNS	O	concentration	nsubj	6	SENT_117	[p5l447t1697r811b1740],
6	(	VBP	O	(	rcmod	1	SENT_117	[p5l835t1696r1017b1751],
7	ng/ml	JJ	O	ng/ml	amod	8	SENT_117	[p5l835t1696r1017b1751],
8	)	NN	O	)	dobj	6	SENT_117	[p5l835t1696r1017b1751],
9	among	IN	O	among	_	0	SENT_117	[p5l1041t1709r1209b1751],
10	dopamine	NN	O	dopamine	nn	13	SENT_117	[p5l1232t1697r1673b1751],
11	—	NN	O	—	nn	13	SENT_117	[p5l1232t1697r1673b1751],
12	related	JJ	O	related	amod	13	SENT_117	[p5l1232t1697r1673b1751],
13	polymorphisms	NNS	O	polymorphism	prep_among	6	SENT_117	[p5l1697t1697r2082b1751],
14	in	IN	O	in	_	0	SENT_117	[p5l2106t1697r2151b1740],
15	schizophrenic	JJ	O	schizophrenic	amod	16	SENT_117	[p5l10t1768r351b1822],
16	inpatients	NNS	O	inpatient	prep_in	1	SENT_117	[p5l370t1769r614b1822],
17	treated	VBN	O	treat	partmod	16	SENT_117	[p5l634t1768r809b1811],
18	with	IN	O	with	_	0	SENT_117	[p5l827t1768r940b1811],
19	6	CD	NUMBER	6	num	20	SENT_117	[p5l960t1770r987b1811],
20	mg/day	NN	O	mg/day	prep_with	17	SENT_117	[p5l1008t1768r1192b1822],
21	of	IN	O	of	_	0	SENT_117	[p5l1210t1768r1261b1811],
22	risperidone	NN	O	risperidone	prep_of	20	SENT_117	[p5l1275t1768r1555b1822],

1	Total	JJ	O	total	amod	2	SENT_118	[p5l803t1909r923b1952],
2	subjects	NNS	O	subject	_	0	SENT_118	[p5l944t1909r1141b1963],
3	Male	JJ	PERSON	male	amod	6	SENT_118	[p5l1380t1909r1499b1952],
4	Female	JJ	PERSON	female	amod	6	SENT_118	[p5l1871t1909r2045b1952],
5	(	NN	O	(	nn	6	SENT_118	[p5l805t1980r999b2034],
6	n	NN	O	n	dep	2	SENT_118	[p5l805t1980r999b2034],
7	=	JJ	O	=	quantmod	9	SENT_118	[p5l805t1980r999b2034],
8	174	CD	NUMBER	174	number	9	SENT_118	[p5l805t1980r999b2034],
9	)	CD	NUMBER	)	num	19	SENT_118	[p5l805t1980r999b2034],
10	(	NN	O	(	nn	19	SENT_118	[p5l1380t1980r1553b2034],
11	n	NN	O	n	nn	19	SENT_118	[p5l1380t1980r1553b2034],
12	=	JJ	O	=	amod	19	SENT_118	[p5l1380t1980r1553b2034],
13	68	CD	NUMBER	68	number	14	SENT_118	[p5l1380t1980r1553b2034],
14	)	CD	NUMBER	)	num	19	SENT_118	[p5l1380t1980r1553b2034],
15	(	NN	O	(	nn	19	SENT_118	[p5l1871t1980r2071b2034],
16	n	NN	O	n	nn	19	SENT_118	[p5l1871t1980r2071b2034],
17	=	JJ	O	=	amod	19	SENT_118	[p5l1871t1980r2071b2034],
18	106	CD	NUMBER	106	num	19	SENT_118	[p5l1871t1980r2071b2034],
19	)	NN	O	)	dep	6	SENT_118	[p5l1871t1980r2071b2034],

1	Taq	NN	O	taq	nn	2	SENT_119	[p5l7t2124r92b2175],
2	1A	NN	O	1a	_	0	SENT_119	[p5l115t2123r177b2164],
3	in	IN	O	in	_	0	SENT_119	[p5l196t2122r241b2164],
4	DRD2	NN	O	drd2	prep_in	2	SENT_119	[p5l261t2123r397b2164],

1	A1	NN	O	a1	_	0	SENT_120	[p5l61t2194r121b2235],
2	/	:	O	/	punct	13	SENT_120	[p5l130t2191r206b2246],
3	A1	NN	O	a1	dep	7	SENT_120	[p5l130t2191r206b2246],
4	96.0	CD	NUMBER	96.0	dep	3	SENT_120	[p5l834t2194r937b2236],
5	$	$	MONEY	$	dep	7	SENT_120	[p5l947t2199r973b2235],
6	84.1	CD	MONEY	84.1	num	5	SENT_120	[p5l983t2194r1076b2236],
7	52.0	CD	MONEY	52.0	dep	13	SENT_120	[p5l1381t2194r1483b2236],
8	$	$	MONEY	$	dep	7	SENT_120	[p5l1493t2199r1520b2235],
9	50.5	CD	MONEY	50.5	number	8	SENT_120	[p5l1530t2194r1629b2236],
10	127.1	CD	MONEY	127.1	number	8	SENT_120	[p5l1883t2194r1996b2236],
11	$	$	MONEY	$	dep	8	SENT_120	[p5l2013t2199r2039b2235],
12	70.2	CD	MONEY	70.2	num	11	SENT_120	[p5l2049t2194r2149b2236],
13	A1	NN	O	a1	dep	1	SENT_120	[p5l61t2265r121b2306],
14	/	:	O	/	punct	13	SENT_120	[p5l130t2263r211b2317],
15	A2	NN	O	a2	dep	20	SENT_120	[p5l130t2263r211b2317],
16	103.1	CD	NUMBER	103.1	num	15	SENT_120	[p5l813t2265r931b2307],
17	$	$	MONEY	$	dep	15	SENT_120	[p5l947t2265r1076b2307],
18	66.1	CD	MONEY	66.1	num	17	SENT_120	[p5l947t2265r1076b2307],
19	52.6	CD	MONEY	52.6	dep	20	SENT_120	[p5l1381t2265r1630b2307],
20	$	$	MONEY	$	dep	25	SENT_120	[p5l1381t2265r1630b2307],
21	26.8	CD	MONEY	26.8	num	20	SENT_120	[p5l1381t2265r1630b2307],
22	125.9	CD	MONEY	125.9	num	20	SENT_120	[p5l1873t2265r2141b2307],
23	$	$	MONEY	$	dep	20	SENT_120	[p5l1873t2265r2141b2307],
24	66.1	CD	MONEY	66.1	num	23	SENT_120	[p5l1873t2265r2141b2307],
25	A2	NN	O	a2	dep	13	SENT_120	[p5l61t2336r125b2377],
26	/	:	O	/	punct	25	SENT_120	[p5l130t2334r211b2389],
27	A2	NN	O	a2	dep	25	SENT_120	[p5l130t2334r211b2389],
28	94.0	CD	NUMBER	94.0	dep	27	SENT_120	[p5l834t2336r936b2378],
29	$	$	MONEY	$	num	32	SENT_120	[p5l947t2342r973b2377],
30	65.3	CD	MONEY	65.3	number	29	SENT_120	[p5l983t2336r1083b2378],
31	56.0	CD	MONEY	56.0	number	29	SENT_120	[p5l1381t2336r1483b2378],
32	$	$	MONEY	$	dep	28	SENT_120	[p5l1493t2342r1520b2377],
33	22.8	CD	MONEY	22.8	number	32	SENT_120	[p5l1529t2336r1630b2378],
34	128.9	CD	MONEY	128.9	number	32	SENT_120	[p5l1874t2336r2002b2378],
35	$	$	MONEY	$	dep	1	SENT_120	[p5l2013t2342r2039b2377],
36	71.3	CD	MONEY	71.3	num	35	SENT_120	[p5l2049t2336r2143b2378],

1	-141	CD	NUMBER	-141	num	2	SENT_121	[p5l9t2407r109b2448],
2	C	NN	O	c	_	0	SENT_121	[p5l119t2407r148b2448],
3	Ins/Del	NN	O	ins/del	dep	2	SENT_121	[p5l168t2404r338b2459],
4	in	IN	O	in	_	0	SENT_121	[p5l358t2405r403b2448],
5	DRD2	NN	O	drd2	prep_in	3	SENT_121	[p5l423t2407r560b2448],

1	Ins/Ins	NNS	O	ins/ins	dep	11	SENT_122	[p5l64t2476r224b2530],
2	93.3	CD	NUMBER	93.3	num	1	SENT_122	[p5l834t2478r934b2520],
3	$	$	MONEY	$	dep	1	SENT_122	[p5l947t2478r1069b2520],
4	61.1	CD	MONEY	61.1	number	3	SENT_122	[p5l947t2478r1069b2520],
5	52.6	CD	MONEY	52.6	number	3	SENT_122	[p5l1381t2478r1630b2520],
6	$	$	MONEY	$	dep	3	SENT_122	[p5l1381t2478r1630b2520],
7	26.8	CD	MONEY	26.8	num	6	SENT_122	[p5l1381t2478r1630b2520],
8	122.5	CD	MONEY	122.5	num	6	SENT_122	[p5l1874t2478r2000b2520],
9	$	$	MONEY	$	dep	11	SENT_122	[p5l2013t2478r2141b2520],
10	62.1	CD	MONEY	62.1	num	9	SENT_122	[p5l2013t2478r2141b2520],
11	Ins/Del	NN	O	ins/del	dep	21	SENT_122	[p5l64t2547r234b2602],
12	112.4	CD	NUMBER	112.4	num	11	SENT_122	[p5l814t2549r1078b2591],
13	$	$	MONEY	$	num	16	SENT_122	[p5l814t2549r1078b2591],
14	91.5	CD	MONEY	91.5	number	13	SENT_122	[p5l814t2549r1078b2591],
15	59.6	CD	MONEY	59.6	number	13	SENT_122	[p5l1381t2549r1623b2591],
16	$	$	MONEY	$	dep	11	SENT_122	[p5l1381t2549r1623b2591],
17	31.2	CD	MONEY	31.2	number	16	SENT_122	[p5l1381t2549r1623b2591],
18	137.2	CD	MONEY	137.2	number	16	SENT_122	[p5l1881t2549r2149b2591],
19	$	$	MONEY	$	dep	16	SENT_122	[p5l1881t2549r2149b2591],
20	86.2	CD	MONEY	86.2	num	19	SENT_122	[p5l1881t2549r2149b2591],
21	Del/Del	NN	MONEY	del/del	dep	23	SENT_122	[p5l64t2617r244b2672],
22	86.3	CD	MONEY	86.3	num	21	SENT_122	[p5l835t2620r934b2662],
23	$	$	MONEY	$	_	0	SENT_122	[p5l947t2620r1085b2662],
24	39.0	CD	MONEY	39.0	num	23	SENT_122	[p5l947t2620r1085b2662],
25	52.0	CD	MONEY	52.0	number	26	SENT_122	[p5l1381t2620r1483b2662],
26	103.4	CD	MONEY	103.4	dep	23	SENT_122	[p5l1875t2620r2150b2662],
27	$	$	MONEY	$	dep	26	SENT_122	[p5l1875t2620r2150b2662],
28	35.8	CD	MONEY	35.8	num	27	SENT_122	[p5l1875t2620r2150b2662],

1	Ser9Gly	RB	O	ser9gly	_	0	SENT_123	[p5l9t2689r200b2743],
2	in	IN	O	in	dep	1	SENT_123	[p5l219t2690r264b2732],
3	DRD3	NN	O	drd3	pobj	2	SENT_123	[p5l284t2691r419b2733],

1	Ser/Ser	NN	O	ser/ser	dep	13	SENT_124	[p5l64t2760r237b2814],
2	99.1	CD	NUMBER	99.1	num	1	SENT_124	[p5l838t2762r931b2804],
3	$	$	MONEY	$	num	6	SENT_124	[p5l947t2767r973b2803],
4	73.7	CD	MONEY	73.7	number	3	SENT_124	[p5l984t2762r1084b2804],
5	49.8	CD	MONEY	49.8	number	3	SENT_124	[p5l1379t2762r1482b2804],
6	$	$	MONEY	$	dep	1	SENT_124	[p5l1494t2767r1520b2803],
7	26.4	CD	MONEY	26.4	number	6	SENT_124	[p5l1530t2762r1633b2804],
8	130.0	CD	MONEY	130.0	number	6	SENT_124	[p5l1875t2762r2002b2804],
9	$	$	MONEY	$	dep	6	SENT_124	[p5l2013t2767r2039b2803],
10	77.0	CD	MONEY	77.0	num	9	SENT_124	[p5l2049t2762r2146b2804],
11	Ser/Gly	NN	O	ser/gly	dep	13	SENT_124	[p5l64t2831r242b2885],
12	96.7	CD	NUMBER	96.7	num	11	SENT_124	[p5l834t2833r936b2875],
13	$	$	MONEY	$	dep	21	SENT_124	[p5l947t2839r973b2874],
14	58.0	CD	MONEY	58.0	num	13	SENT_124	[p5l984t2833r1085b2875],
15	60.8	CD	MONEY	60.8	num	13	SENT_124	[p5l1381t2833r1481b2875],
16	$	$	MONEY	$	dep	13	SENT_124	[p5l1493t2833r1631b2875],
17	30.0	CD	MONEY	30.0	number	16	SENT_124	[p5l1493t2833r1631b2875],
18	120.3	CD	MONEY	120.3	number	16	SENT_124	[p5l1874t2833r2000b2875],
19	$	$	MONEY	$	dep	16	SENT_124	[p5l2013t2839r2039b2874],
20	60.1	CD	MONEY	60.1	num	19	SENT_124	[p5l2049t2833r2141b2875],
21	Gly/Gly	NN	O	gly/gly	dep	23	SENT_124	[p5l63t2901r246b2956],
22	103.3	CD	NUMBER	103.3	num	21	SENT_124	[p5l809t2904r934b2945],
23	$	$	MONEY	$	_	0	SENT_124	[p5l947t2909r973b2945],
24	67.1	CD	MONEY	67.1	num	23	SENT_124	[p5l983t2904r1070b2945],
25	54.3	CD	MONEY	54.3	num	23	SENT_124	[p5l1381t2904r1481b2945],
26	$	$	MONEY	$	dep	23	SENT_124	[p5l1493t2909r1520b2945],
27	27.7	CD	MONEY	27.7	number	26	SENT_124	[p5l1529t2904r1625b2945],
28	132.7	CD	MONEY	132.7	number	26	SENT_124	[p5l1875t2904r2001b2945],
29	$	$	MONEY	$	dep	26	SENT_124	[p5l2013t2909r2039b2945],
30	68.1	CD	MONEY	68.1	num	29	SENT_124	[p5l2049t2904r2141b2945],

1	48	CD	NUMBER	48	_	0	SENT_125	[p5l8t2973r154b3027],
2	—	CD	NUMBER	—	num	4	SENT_125	[p5l8t2973r154b3027],
3	bp	NN	O	bp	nn	4	SENT_125	[p5l8t2973r154b3027],
4	VNTR	NN	O	vntr	dep	1	SENT_125	[p5l172t2975r312b3016],
5	in	IN	O	in	_	0	SENT_125	[p5l330t2974r375b3016],
6	DRD4	NN	O	drd4	prep_in	4	SENT_125	[p5l395t2975r533b3016],

1	Less	RBR	O	less	advmod	17	SENT_126	[p5l64t3047r162b3088],
2	than	IN	O	than	quantmod	3	SENT_126	[p5l182t3044r293b3088],
3	7	CD	NUMBER	7	dep	14	SENT_126	[p5l313t3047r339b3087],
4	repeats	NNS	O	repeat	npadvmod	14	SENT_126	[p5l360t3050r538b3098],
5	96.4	CD	NUMBER	96.4	num	4	SENT_126	[p5l835t3046r937b3088],
6	$	$	MONEY	$	dep	4	SENT_126	[p5l947t3052r973b3087],
7	70.5	CD	MONEY	70.5	number	6	SENT_126	[p5l984t3046r1084b3088],
8	48.1	CD	MONEY	48.1	number	6	SENT_126	[p5l1379t3046r1474b3088],
9	$	$	MONEY	$	prep	6	SENT_126	[p5l1490t3052r1516b3087],
10	25.4	CD	MONEY	25.4	number	9	SENT_126	[p5l1525t3046r1628b3088],
11	133.9	CD	MONEY	133.9	number	9	SENT_126	[p5l1875t3046r2003b3088],
12	$	$	MONEY	$	dep	9	SENT_126	[p5l2013t3052r2039b3087],
13	71.7	CD	MONEY	71.7	num	12	SENT_126	[p5l2049t3046r2144b3088],
14	More	JJR	O	more	amod	17	SENT_126	[p5l64t3117r191b3158],
15	than	IN	O	than	_	0	SENT_126	[p5l210t3114r321b3158],
16	7	CD	NUMBER	7	prep_than	14	SENT_126	[p5l341t3117r367b3158],
17	repeats	NNS	O	repeat	_	0	SENT_126	[p5l388t3121r566b3169],
18	99.1	CD	NUMBER	99.1	dep	17	SENT_126	[p5l838t3117r931b3158],
19	$	$	MONEY	$	num	22	SENT_126	[p5l947t3122r973b3158],
20	67.1	CD	MONEY	67.1	number	19	SENT_126	[p5l983t3117r1070b3158],
21	55.8	CD	MONEY	55.8	number	19	SENT_126	[p5l1381t3117r1481b3158],
22	$	$	MONEY	$	dep	17	SENT_126	[p5l1493t3122r1520b3158],
23	28.2	CD	MONEY	28.2	number	22	SENT_126	[p5l1529t3117r1629b3158],
24	125.4	CD	MONEY	125.4	number	22	SENT_126	[p5l1874t3117r2003b3158],
25	$	$	MONEY	$	dep	22	SENT_126	[p5l2013t3122r2039b3158],
26	70.2	CD	MONEY	70.2	num	25	SENT_126	[p5l2049t3117r2149b3158],

1	Val158Met	NN	O	val158met	_	0	SENT_127	[p5l7t3187r275b3230],
2	in	IN	O	in	_	0	SENT_127	[p5l294t3188r339b3230],
3	COMT	NNP	O	COMT	prep_in	1	SENT_127	[p5l359t3189r509b3230],

1	Val/Val	JJ	O	val/val	amod	2	SENT_128	[p5l61t3258r237b3312],
2	100.0	CD	NUMBER	100.0	dep	21	SENT_128	[p5l807t3260r937b3302],
3	$	$	MONEY	$	num	6	SENT_128	[p5l947t3266r973b3301],
4	76.6	CD	MONEY	76.6	number	3	SENT_128	[p5l984t3260r1083b3302],
5	43.1	CD	MONEY	43.1	number	3	SENT_128	[p5l1379t3260r1473b3302],
6	$	$	MONEY	$	dep	2	SENT_128	[p5l1489t3260r1616b3302],
7	17.2	CD	MONEY	17.2	number	6	SENT_128	[p5l1489t3260r1616b3302],
8	133.8	CD	MONEY	133.8	number	6	SENT_128	[p5l1875t3260r2002b3302],
9	$	$	MONEY	$	dep	6	SENT_128	[p5l2013t3266r2039b3301],
10	78.2	CD	MONEY	78.2	num	9	SENT_128	[p5l2049t3260r2149b3302],
11	Val/Met	NN	O	val/met	dep	6	SENT_128	[p5l61t3329r258b3383],
12	105.7	CD	NUMBER	105.7	num	11	SENT_128	[p5l809t3331r1084b3373],
13	$	$	MONEY	$	num	16	SENT_128	[p5l809t3331r1084b3373],
14	70.5	CD	MONEY	70.5	number	13	SENT_128	[p5l809t3331r1084b3373],
15	60.5	CD	MONEY	60.5	number	13	SENT_128	[p5l1381t3331r1481b3373],
16	$	$	MONEY	$	dep	11	SENT_128	[p5l1493t3331r1629b3373],
17	33.3	CD	MONEY	33.3	number	16	SENT_128	[p5l1493t3331r1629b3373],
18	131.8	CD	MONEY	131.8	number	16	SENT_128	[p5l1882t3331r2148b3373],
19	$	$	MONEY	$	dep	21	SENT_128	[p5l1882t3331r2148b3373],
20	73.2	CD	MONEY	73.2	num	19	SENT_128	[p5l1882t3331r2148b3373],
21	Met/Met	NN	O	met/met	_	0	SENT_128	[p5l64t3400r277b3455],
22	82.6	CD	NUMBER	82.6	num	21	SENT_128	[p5l835t3402r937b3444],
23	$	$	MONEY	$	num	26	SENT_128	[p5l947t3402r1085b3444],
24	44.3	CD	MONEY	44.3	number	23	SENT_128	[p5l947t3402r1085b3444],
25	54.2	CD	MONEY	54.2	number	23	SENT_128	[p5l1381t3402r1481b3444],
26	$	$	MONEY	$	dep	21	SENT_128	[p5l1493t3408r1520b3443],
27	27.7	CD	MONEY	27.7	number	26	SENT_128	[p5l1529t3402r1625b3444],
28	131.8	CD	MONEY	131.8	number	26	SENT_128	[p5l1882t3402r2001b3444],
29	$	$	MONEY	$	dep	26	SENT_128	[p5l2013t3402r2150b3444],
30	46.8	CD	MONEY	46.8	num	29	SENT_128	[p5l2013t3402r2150b3444],

1	Data	NNS	O	datum	nsubjpass	3	SENT_129	[p5l10t3545r120b3585],
2	are	VBP	O	be	auxpass	3	SENT_129	[p5l139t3554r214b3585],
3	shown	VBN	O	show	_	0	SENT_129	[p5l234t3542r397b3585],
4	as	IN	O	as	_	0	SENT_129	[p5l416t3554r463b3585],
5	mean	JJ	O	mean	prep_as	3	SENT_129	[p5l484t3544r740b3586],
6	$	$	MONEY	$	amod	5	SENT_129	[p5l484t3544r740b3586],
7	SD	NN	MONEY	sd	dep	6	SENT_129	[p5l484t3544r740b3586],
8	.	.	O	.	_	0	SENT_129	[p5l484t3544r740b3586],

1	N.	NNP	PERSON	N.	nn	2	SENT_130	[p5l214t3663r236b3683],
2	Yasui	NNP	PERSON	Yasui	_	0	SENT_130	[p5l248t3661r418b3683],
3	.	.	O	.	_	0	SENT_130	[p5l248t3661r418b3683],

1	—	NN	O	—	_	0	SENT_131	[p5l248t3661r418b3683],
2	.	.	O	.	_	0	SENT_131	[p5l248t3661r418b3683],

1	Furul	NN	O	furul	_	0	SENT_132	[p5l248t3661r418b3683],
2	<	JJR	O	<	amod	3	SENT_132	[p5l248t3661r418b3683],
3	ori	NN	O	orus	dep	1	SENT_132	[p5l248t3661r418b3683],
4	et	FW	O	et	nn	5	SENT_132	[p5l428t3664r450b3683],
5	al.	FW	O	al.	dep	3	SENT_132	[p5l458t3661r483b3683],
6	/	:	O	/	punct	7	SENT_132	[p5l492t3661r503b3688],
7	Progress	NNP	O	Progress	dep	5	SENT_132	[p5l511t3663r607b3688],
8	in	IN	O	in	_	0	SENT_132	[p5l618t3662r638b3683],
9	Neuro	NNP	O	Neuro	prep_in	7	SENT_132	[p5l648t3661r974b3688],
10	.	.	O	.	_	0	SENT_132	[p5l648t3661r974b3688],

1	—	NN	O	—	_	0	SENT_133	[p5l648t3661r974b3688],
2	.	.	O	.	_	0	SENT_133	[p5l648t3661r974b3688],

1	Psychopharmacology	NN	O	psychopharmacology	_	0	SENT_134	[p5l648t3661r974b3688],
2	8	CD	NUMBER	8	num	1	SENT_134	[p5l984t3662r1006b3683],
3	'	''	O	'	_	0	SENT_134	[p5l984t3662r1006b3683],
4	Biological	JJ	O	biological	amod	5	SENT_134	[p5l1013t3661r1124b3688],
5	Psychiatry	NNP	O	Psychiatry	dep	1	SENT_134	[p5l1134t3661r1253b3688],
6	32	CD	NUMBER	32	num	5	SENT_134	[p5l1263t3662r1292b3683],
7	(	CD	NUMBER	(	num	8	SENT_134	[p5l1302t3661r1379b3688],
8	2008	CD	DATE	2008	dep	1	SENT_134	[p5l1302t3661r1379b3688],
9	)	CD	NUMBER	)	num	10	SENT_134	[p5l1302t3661r1379b3688],
10	1491-1495	CD	DATE	1491-1495	dep	8	SENT_134	[p5l1392t3662r1516b3683],

1	df	NN	O	df	dep	274	SENT_135	[p6l11t63r171b132],
2	=	JJ	O	=	dep	274	SENT_135	[p6l11t63r171b132],
3	2	CD	NUMBER	2	dep	274	SENT_135	[p6l11t63r171b132],
4	,	,	O	,	_	0	SENT_135	[p6l11t63r171b132],
5	171	CD	NUMBER	171	dep	274	SENT_135	[p6l198t66r308b126],
6	,	,	O	,	_	0	SENT_135	[p6l198t66r308b126],
7	p	NN	O	p	dep	274	SENT_135	[p6l332t66r591b132],
8	=	JJ	O	=	dep	274	SENT_135	[p6l332t66r591b132],
9	O.	NNP	O	O.	dep	274	SENT_135	[p6l332t66r591b132],
10	693	CD	NUMBER	693	dep	274	SENT_135	[p6l332t66r591b132],
11	for	IN	O	for	dep	274	SENT_135	[p6l622t63r707b118],
12	total	JJ	O	total	dep	274	SENT_135	[p6l732t63r869b118],
13	patients	NNS	O	patient	dep	274	SENT_135	[p6l898t64r1157b132],
14	,	,	O	,	_	0	SENT_135	[p6l898t64r1157b132],
15	F	NN	O	f	dep	274	SENT_135	[p6l1185t66r1221b117],
16	=	JJ	O	=	dep	274	SENT_135	[p6l1228t66r1444b126],
17	0.134	CD	NUMBER	0.134	dep	274	SENT_135	[p6l1228t66r1444b126],
18	,	,	O	,	_	0	SENT_135	[p6l1228t66r1444b126],
19	df	NN	O	df	dep	274	SENT_135	[p6l1473t63r1633b132],
20	=	JJ	O	=	dep	274	SENT_135	[p6l1473t63r1633b132],
21	2	CD	NUMBER	2	dep	274	SENT_135	[p6l1473t63r1633b132],
22	,	,	O	,	_	0	SENT_135	[p6l1473t63r1633b132],
23	65	CD	NUMBER	65	dep	274	SENT_135	[p6l1663t66r1750b126],
24	,	,	O	,	_	0	SENT_135	[p6l1663t66r1750b126],
25	p	NN	O	p	dep	274	SENT_135	[p6l1774t66r2034b132],
26	=	JJ	O	=	dep	274	SENT_135	[p6l1774t66r2034b132],
27	0.875	CD	NUMBER	0.875	dep	274	SENT_135	[p6l1774t66r2034b132],
28	for	IN	O	for	dep	274	SENT_135	[p6l2065t63r2149b118],
29	males	NNS	O	male	dep	274	SENT_135	[p6l11t152r203b215],
30	,	,	O	,	_	0	SENT_135	[p6l11t152r203b215],
31	and	CC	O	and	dep	274	SENT_135	[p6l231t152r342b207],
32	F	NN	O	f	dep	274	SENT_135	[p6l367t155r442b206],
33	=	JJ	O	=	dep	274	SENT_135	[p6l367t155r442b206],
34	0.021	CD	NUMBER	0.021	dep	274	SENT_135	[p6l455t155r627b215],
35	,	,	O	,	_	0	SENT_135	[p6l455t155r627b215],
36	df	NN	O	df	dep	274	SENT_135	[p6l656t152r816b221],
37	=	JJ	O	=	dep	274	SENT_135	[p6l656t152r816b221],
38	2	CD	NUMBER	2	dep	274	SENT_135	[p6l656t152r816b221],
39	,	,	O	,	_	0	SENT_135	[p6l656t152r816b221],
40	103	CD	NUMBER	103	dep	274	SENT_135	[p6l842t155r961b215],
41	,	,	O	,	_	0	SENT_135	[p6l842t155r961b215],
42	p	NN	O	p	dep	274	SENT_135	[p6l985t155r1245b221],
43	=	JJ	O	=	dep	274	SENT_135	[p6l985t155r1245b221],
44	0.979	CD	NUMBER	0.979	dep	274	SENT_135	[p6l985t155r1245b221],
45	for	IN	O	for	dep	274	SENT_135	[p6l1273t152r1358b207],
46	females	NNS	O	female	dep	274	SENT_135	[p6l1383t152r1657b220],
47	)	RB	O	)	dep	274	SENT_135	[p6l1383t152r1657b220],
48	,	,	O	,	_	0	SENT_135	[p6l1383t152r1657b220],
49	between	IN	O	between	dep	274	SENT_135	[p6l1684t152r1948b207],
50	—	CD	NUMBER	—	dep	274	SENT_135	[p6l1976t155r2149b207],
51	141C	CD	NUMBER	141c	dep	274	SENT_135	[p6l1976t155r2149b207],
52	Ins	NNS	O	in	dep	274	SENT_135	[p6l11t245r97b296],
53	/	:	O	/	dep	274	SENT_135	[p6l102t241r121b310],
54	Del	NNP	O	Del	dep	274	SENT_135	[p6l126t241r224b296],
55	polymorphisms	NNS	O	polymorphism	dep	274	SENT_135	[p6l244t241r723b310],
56	(	CD	NUMBER	(	dep	274	SENT_135	[p6l743t241r802b310],
57	F	NN	O	f	dep	274	SENT_135	[p6l743t241r802b310],
58	=	JJ	O	=	dep	274	SENT_135	[p6l808t264r839b281],
59	1.472	CD	NUMBER	1.472	dep	274	SENT_135	[p6l856t244r1024b305],
60	,	,	O	,	_	0	SENT_135	[p6l856t244r1024b305],
61	df	NN	O	df	dep	274	SENT_135	[p6l1044t241r1142b310],
62	=	JJ	O	=	dep	274	SENT_135	[p6l1044t241r1142b310],
63	2	CD	NUMBER	2	dep	274	SENT_135	[p6l1155t244r1204b305],
64	,	,	O	,	_	0	SENT_135	[p6l1155t244r1204b305],
65	171	CD	NUMBER	171	dep	274	SENT_135	[p6l1223t244r1331b305],
66	,	,	O	,	_	0	SENT_135	[p6l1223t244r1331b305],
67	p	NN	O	p	dep	274	SENT_135	[p6l1347t257r1385b310],
68	=	JJ	O	=	dep	274	SENT_135	[p6l1398t264r1430b281],
69	0.232	CD	NUMBER	0.232	dep	274	SENT_135	[p6l1443t244r1607b297],
70	for	IN	O	for	dep	274	SENT_135	[p6l1629t241r1714b296],
71	total	JJ	O	total	dep	274	SENT_135	[p6l1730t241r1867b296],
72	patients	NNS	O	patient	dep	274	SENT_135	[p6l1887t242r2147b310],
73	,	,	O	,	_	0	SENT_135	[p6l1887t242r2147b310],
74	F	NN	O	f	dep	274	SENT_135	[p6l9t334r84b385],
75	=	JJ	O	=	dep	274	SENT_135	[p6l9t334r84b385],
76	0.384	CD	NUMBER	0.384	dep	274	SENT_135	[p6l96t333r277b394],
77	,	,	O	,	_	0	SENT_135	[p6l96t333r277b394],
78	df	NN	O	df	dep	274	SENT_135	[p6l314t330r474b399],
79	=	JJ	O	=	dep	274	SENT_135	[p6l314t330r474b399],
80	2	CD	NUMBER	2	dep	274	SENT_135	[p6l314t330r474b399],
81	,	,	O	,	_	0	SENT_135	[p6l314t330r474b399],
82	65	CD	NUMBER	65	dep	274	SENT_135	[p6l511t333r598b394],
83	,	,	O	,	_	0	SENT_135	[p6l511t333r598b394],
84	p	NN	O	p	dep	274	SENT_135	[p6l630t333r889b399],
85	=	JJ	O	=	dep	274	SENT_135	[p6l630t333r889b399],
86	0.683	CD	NUMBER	0.683	dep	274	SENT_135	[p6l630t333r889b399],
87	for	IN	O	for	dep	274	SENT_135	[p6l928t330r1013b385],
88	males	NNS	O	male	dep	274	SENT_135	[p6l1048t330r1239b394],
89	,	,	O	,	_	0	SENT_135	[p6l1048t330r1239b394],
90	and	CC	O	and	dep	274	SENT_135	[p6l1275t330r1386b385],
91	F	NN	O	f	dep	274	SENT_135	[p6l1420t334r1495b385],
92	=	JJ	O	=	dep	274	SENT_135	[p6l1420t334r1495b385],
93	0.610	CD	NUMBER	0.610	dep	274	SENT_135	[p6l1507t333r1682b394],
94	,	,	O	,	_	0	SENT_135	[p6l1507t333r1682b394],
95	df	NN	O	df	dep	274	SENT_135	[p6l1719t330r1879b399],
96	=	JJ	O	=	dep	274	SENT_135	[p6l1719t330r1879b399],
97	2	CD	NUMBER	2	dep	274	SENT_135	[p6l1719t330r1879b399],
98	,	,	O	,	_	0	SENT_135	[p6l1719t330r1879b399],
99	103	CD	NUMBER	103	dep	274	SENT_135	[p6l1913t333r2033b394],
100	,	,	O	,	_	0	SENT_135	[p6l1913t333r2033b394],
101	p	NN	O	p	dep	274	SENT_135	[p6l2065t346r2147b399],
102	=	JJ	O	=	dep	274	SENT_135	[p6l2065t346r2147b399],
103	0.545	CD	NUMBER	0.545	dep	274	SENT_135	[p6l11t423r175b475],
104	for	IN	O	for	dep	274	SENT_135	[p6l204t420r289b475],
105	females	NNS	O	female	dep	274	SENT_135	[p6l314t420r587b488],
106	)	RB	O	)	dep	274	SENT_135	[p6l314t420r587b488],
107	,	,	O	,	_	0	SENT_135	[p6l314t420r587b488],
108	between	IN	O	between	dep	274	SENT_135	[p6l614t420r878b475],
109	Ser9Gly	NNP	O	Ser9Gly	dep	274	SENT_135	[p6l904t420r1142b488],
110	polymorphisms	NNS	O	polymorphism	dep	274	SENT_135	[p6l1167t420r1646b488],
111	(	CD	NUMBER	(	dep	274	SENT_135	[p6l1673t420r1771b488],
112	F	NN	O	f	dep	274	SENT_135	[p6l1673t420r1771b488],
113	=	JJ	O	=	dep	274	SENT_135	[p6l1673t420r1771b488],
114	0.067	CD	NUMBER	0.067	dep	274	SENT_135	[p6l1783t423r1959b483],
115	,	,	O	,	_	0	SENT_135	[p6l1783t423r1959b483],
116	df	NN	O	df	dep	274	SENT_135	[p6l1986t420r2146b488],
117	=	JJ	O	=	dep	274	SENT_135	[p6l1986t420r2146b488],
118	2	CD	NUMBER	2	dep	274	SENT_135	[p6l1986t420r2146b488],
119	,	,	O	,	_	0	SENT_135	[p6l1986t420r2146b488],
120	171	CD	NUMBER	171	dep	274	SENT_135	[p6l14t512r124b572],
121	,	,	O	,	_	0	SENT_135	[p6l14t512r124b572],
122	p	NN	O	p	dep	274	SENT_135	[p6l146t511r407b577],
123	=	JJ	O	=	dep	274	SENT_135	[p6l146t511r407b577],
124	0.926	CD	NUMBER	0.926	dep	274	SENT_135	[p6l146t511r407b577],
125	for	IN	O	for	dep	274	SENT_135	[p6l434t508r519b564],
126	total	JJ	O	total	dep	274	SENT_135	[p6l542t509r679b564],
127	patients	NNS	O	patient	dep	274	SENT_135	[p6l705t509r965b577],
128	,	,	O	,	_	0	SENT_135	[p6l705t509r965b577],
129	F	NN	O	f	dep	274	SENT_135	[p6l990t512r1065b563],
130	=	JJ	O	=	dep	274	SENT_135	[p6l990t512r1065b563],
131	1.189	CD	NUMBER	1.189	dep	274	SENT_135	[p6l1081t511r1243b572],
132	,	,	O	,	_	0	SENT_135	[p6l1081t511r1243b572],
133	df	NN	O	df	dep	274	SENT_135	[p6l1270t508r1431b577],
134	=	JJ	O	=	dep	274	SENT_135	[p6l1270t508r1431b577],
135	2	CD	NUMBER	2	dep	274	SENT_135	[p6l1270t508r1431b577],
136	,	,	O	,	_	0	SENT_135	[p6l1270t508r1431b577],
137	65	CD	NUMBER	65	dep	274	SENT_135	[p6l1458t511r1545b572],
138	,	,	O	,	_	0	SENT_135	[p6l1458t511r1545b572],
139	p	NN	O	p	dep	274	SENT_135	[p6l1567t511r1811b577],
140	=	JJ	O	=	dep	274	SENT_135	[p6l1567t511r1811b577],
141	O.	NNP	O	O.	dep	274	SENT_135	[p6l1567t511r1811b577],
142	311	CD	NUMBER	311	dep	274	SENT_135	[p6l1567t511r1811b577],
143	for	IN	O	for	dep	274	SENT_135	[p6l1846t508r1931b564],
144	males	NNS	O	male	dep	274	SENT_135	[p6l1955t509r2147b572],
145	,	,	O	,	_	0	SENT_135	[p6l1955t509r2147b572],
146	and	CC	O	and	dep	274	SENT_135	[p6l11t597r122b652],
147	F	NN	O	f	dep	274	SENT_135	[p6l148t600r223b651],
148	=	JJ	O	=	dep	274	SENT_135	[p6l148t600r223b651],
149	0.258	CD	NUMBER	0.258	dep	274	SENT_135	[p6l236t600r418b660],
150	,	,	O	,	_	0	SENT_135	[p6l236t600r418b660],
151	df	NN	O	df	dep	274	SENT_135	[p6l446t597r544b666],
152	=	JJ	O	=	dep	274	SENT_135	[p6l446t597r544b666],
153	2	CD	NUMBER	2	dep	274	SENT_135	[p6l557t600r606b660],
154	,	,	O	,	_	0	SENT_135	[p6l557t600r606b660],
155	103	CD	NUMBER	103	dep	274	SENT_135	[p6l633t600r753b660],
156	,	,	O	,	_	0	SENT_135	[p6l633t600r753b660],
157	p	NN	O	p	dep	274	SENT_135	[p6l776t600r1034b666],
158	=	JJ	O	=	dep	274	SENT_135	[p6l776t600r1034b666],
159	0.773	CD	NUMBER	0.773	dep	274	SENT_135	[p6l776t600r1034b666],
160	for	IN	O	for	dep	274	SENT_135	[p6l1065t597r1150b652],
161	females	NNS	O	female	dep	274	SENT_135	[p6l1176t597r1450b665],
162	)	RB	O	)	dep	274	SENT_135	[p6l1176t597r1450b665],
163	,	,	O	,	_	0	SENT_135	[p6l1176t597r1450b665],
164	between	IN	O	between	dep	274	SENT_135	[p6l1478t597r1742b652],
165	48	CD	NUMBER	48	dep	274	SENT_135	[p6l1768t597r1950b666],
166	—	CD	NUMBER	—	dep	274	SENT_135	[p6l1768t597r1950b666],
167	bp	NN	O	bp	dep	274	SENT_135	[p6l1768t597r1950b666],
168	VNTR	NN	O	vntr	dep	274	SENT_135	[p6l1976t600r2150b652],
169	(	CD	NUMBER	(	dep	274	SENT_135	[p6l11t687r108b755],
170	F	NN	O	f	dep	274	SENT_135	[p6l11t687r108b755],
171	=	JJ	O	=	dep	274	SENT_135	[p6l11t687r108b755],
172	0.043	CD	NUMBER	0.043	dep	274	SENT_135	[p6l121t689r302b750],
173	,	,	O	,	_	0	SENT_135	[p6l121t689r302b750],
174	df	NN	O	df	dep	274	SENT_135	[p6l339t686r437b755],
175	=	JJ	O	=	dep	274	SENT_135	[p6l339t686r437b755],
176	1	CD	NUMBER	1	dep	274	SENT_135	[p6l454t689r493b750],
177	,	,	O	,	_	0	SENT_135	[p6l454t689r493b750],
178	172	CD	NUMBER	172	dep	274	SENT_135	[p6l528t689r644b750],
179	,	,	O	,	_	0	SENT_135	[p6l528t689r644b750],
180	p	NN	O	p	dep	274	SENT_135	[p6l675t689r934b755],
181	=	JJ	O	=	dep	274	SENT_135	[p6l675t689r934b755],
182	0.853	CD	NUMBER	0.853	dep	274	SENT_135	[p6l675t689r934b755],
183	for	IN	O	for	dep	274	SENT_135	[p6l973t686r1058b741],
184	total	JJ	O	total	dep	274	SENT_135	[p6l1091t686r1227b741],
185	patients	NNS	O	patient	dep	274	SENT_135	[p6l1263t687r1523b755],
186	,	,	O	,	_	0	SENT_135	[p6l1263t687r1523b755],
187	F	NN	O	f	dep	274	SENT_135	[p6l1557t690r1594b741],
188	=	JJ	O	=	dep	274	SENT_135	[p6l1600t709r1632b726],
189	0.863	CD	NUMBER	0.863	dep	274	SENT_135	[p6l1644t689r1826b750],
190	,	,	O	,	_	0	SENT_135	[p6l1644t689r1826b750],
191	df	NN	O	df	dep	274	SENT_135	[p6l1862t686r2022b755],
192	=	JJ	O	=	dep	274	SENT_135	[p6l1862t686r2022b755],
193	2	CD	NUMBER	2	dep	274	SENT_135	[p6l1862t686r2022b755],
194	,	,	O	,	_	0	SENT_135	[p6l1862t686r2022b755],
195	65	CD	NUMBER	65	dep	274	SENT_135	[p6l2059t689r2146b750],
196	,	,	O	,	_	0	SENT_135	[p6l2059t689r2146b750],
197	p	NN	O	p	dep	274	SENT_135	[p6l6t778r267b844],
198	=	JJ	O	=	dep	274	SENT_135	[p6l6t778r267b844],
199	0.356	CD	NUMBER	0.356	dep	274	SENT_135	[p6l6t778r267b844],
200	for	IN	O	for	dep	274	SENT_135	[p6l297t775r382b830],
201	males	NNS	O	male	dep	274	SENT_135	[p6l409t775r601b839],
202	,	,	O	,	_	0	SENT_135	[p6l409t775r601b839],
203	and	CC	O	and	dep	274	SENT_135	[p6l630t775r741b830],
204	F	NN	O	f	dep	274	SENT_135	[p6l769t779r806b830],
205	=	JJ	O	=	dep	274	SENT_135	[p6l812t799r844b815],
206	0.218	CD	NUMBER	0.218	dep	274	SENT_135	[p6l857t778r1030b839],
207	,	,	O	,	_	0	SENT_135	[p6l857t778r1030b839],
208	df	NN	O	df	dep	274	SENT_135	[p6l1060t775r1220b844],
209	=	JJ	O	=	dep	274	SENT_135	[p6l1060t775r1220b844],
210	2	CD	NUMBER	2	dep	274	SENT_135	[p6l1060t775r1220b844],
211	,	,	O	,	_	0	SENT_135	[p6l1060t775r1220b844],
212	103	CD	NUMBER	103	dep	274	SENT_135	[p6l1249t778r1368b839],
213	,	,	O	,	_	0	SENT_135	[p6l1249t778r1368b839],
214	p	NN	O	p	dep	274	SENT_135	[p6l1393t778r1654b844],
215	=	JJ	O	=	dep	274	SENT_135	[p6l1393t778r1654b844],
216	0.642	CD	NUMBER	0.642	dep	274	SENT_135	[p6l1393t778r1654b844],
217	for	IN	O	for	dep	274	SENT_135	[p6l1685t775r1770b830],
218	females	NNS	O	female	dep	274	SENT_135	[p6l1798t775r2057b844],
219	)	CD	NUMBER	)	dep	274	SENT_135	[p6l1798t775r2057b844],
220	or	CC	O	or	dep	274	SENT_135	[p6l2086t791r2149b830],
221	between	IN	O	between	dep	274	SENT_135	[p6l10t865r274b920],
222	Val/Met	NNP	O	Val/Met	dep	274	SENT_135	[p6l310t865r555b933],
223	polymorphisms	NNS	O	polymorphism	dep	274	SENT_135	[p6l591t865r1069b933],
224	(	CD	NUMBER	(	dep	274	SENT_135	[p6l1108t865r1168b933],
225	F	NN	O	f	dep	274	SENT_135	[p6l1108t865r1168b933],
226	=	JJ	O	=	dep	274	SENT_135	[p6l1174t888r1206b904],
227	1.643	CD	NUMBER	1.643	dep	274	SENT_135	[p6l1222t868r1395b928],
228	,	,	O	,	_	0	SENT_135	[p6l1222t868r1395b928],
229	df	NN	O	df	dep	274	SENT_135	[p6l1433t865r1593b933],
230	=	JJ	O	=	dep	274	SENT_135	[p6l1433t865r1593b933],
231	2	CD	NUMBER	2	dep	274	SENT_135	[p6l1433t865r1593b933],
232	,	,	O	,	_	0	SENT_135	[p6l1433t865r1593b933],
233	171	CD	NUMBER	171	dep	274	SENT_135	[p6l1631t868r1740b928],
234	,	,	O	,	_	0	SENT_135	[p6l1631t868r1740b928],
235	p	NN	O	p	dep	274	SENT_135	[p6l1773t868r2026b933],
236	=	JJ	O	=	dep	274	SENT_135	[p6l1773t868r2026b933],
237	0.196	CD	NUMBER	0.196	dep	274	SENT_135	[p6l1773t868r2026b933],
238	for	IN	O	for	dep	274	SENT_135	[p6l2065t865r2149b920],
239	total	JJ	O	total	dep	274	SENT_135	[p6l10t954r146b1009],
240	patients	NNS	O	patient	dep	274	SENT_135	[p6l183t955r443b1022],
241	,	,	O	,	_	0	SENT_135	[p6l183t955r443b1022],
242	F	NN	O	f	dep	274	SENT_135	[p6l478t957r515b1008],
243	=	JJ	O	=	dep	274	SENT_135	[p6l521t956r742b1017],
244	2.815	CD	NUMBER	2.815	dep	274	SENT_135	[p6l521t956r742b1017],
245	,	,	O	,	_	0	SENT_135	[p6l521t956r742b1017],
246	df	NN	O	df	dep	274	SENT_135	[p6l779t953r939b1022],
247	=	JJ	O	=	dep	274	SENT_135	[p6l779t953r939b1022],
248	2	CD	NUMBER	2	dep	274	SENT_135	[p6l779t953r939b1022],
249	,	,	O	,	_	0	SENT_135	[p6l779t953r939b1022],
250	65	CD	NUMBER	65	dep	274	SENT_135	[p6l977t956r1064b1017],
251	,	,	O	,	_	0	SENT_135	[p6l977t956r1064b1017],
252	p	NN	O	p	dep	274	SENT_135	[p6l1097t956r1357b1022],
253	=	JJ	O	=	dep	274	SENT_135	[p6l1097t956r1357b1022],
254	0.067	CD	NUMBER	0.067	dep	274	SENT_135	[p6l1097t956r1357b1022],
255	for	IN	O	for	dep	274	SENT_135	[p6l1395t953r1480b1009],
256	males	NNS	O	male	dep	274	SENT_135	[p6l1514t954r1705b1017],
257	,	,	O	,	_	0	SENT_135	[p6l1514t954r1705b1017],
258	and	CC	O	and	dep	274	SENT_135	[p6l1742t954r1853b1009],
259	F	NN	O	f	dep	274	SENT_135	[p6l1887t957r1924b1008],
260	=	JJ	O	=	dep	274	SENT_135	[p6l1931t977r1962b993],
261	1.814	CD	NUMBER	1.814	dep	274	SENT_135	[p6l1979t956r2146b1017],
262	,	,	O	,	_	0	SENT_135	[p6l1979t956r2146b1017],
263	df	NN	O	df	dep	274	SENT_135	[p6l11t1042r171b1111],
264	=	JJ	O	=	dep	274	SENT_135	[p6l11t1042r171b1111],
265	2	CD	NUMBER	2	dep	274	SENT_135	[p6l11t1042r171b1111],
266	,	,	O	,	_	0	SENT_135	[p6l11t1042r171b1111],
267	103	CD	NUMBER	103	dep	274	SENT_135	[p6l209t1045r329b1105],
268	,	,	O	,	_	0	SENT_135	[p6l209t1045r329b1105],
269	p	NN	O	p	dep	274	SENT_135	[p6l363t1045r615b1111],
270	=	JJ	O	=	dep	274	SENT_135	[p6l363t1045r615b1111],
271	0.168	CD	NUMBER	0.168	dep	274	SENT_135	[p6l363t1045r615b1111],
272	for	IN	O	for	dep	274	SENT_135	[p6l656t1042r741b1097],
273	females	NNS	O	female	dep	274	SENT_135	[p6l778t1042r1052b1110],
274	)	CD	NUMBER	)	_	0	SENT_135	[p6l778t1042r1052b1110],
275	.	.	O	.	_	0	SENT_135	[p6l778t1042r1052b1110],

1	The	DT	O	the	det	2	SENT_136	[p6l1089t1042r1201b1097],
2	power	NN	O	power	nsubj	8	SENT_136	[p6l1240t1058r1435b1111],
3	of	IN	O	of	_	0	SENT_136	[p6l1471t1042r1534b1097],
4	detection	NN	O	detection	prep_of	2	SENT_136	[p6l1566t1042r1852b1097],
5	in	IN	O	in	_	0	SENT_136	[p6l1891t1043r1947b1096],
6	these	DT	O	these	det	7	SENT_136	[p6l1985t1042r2147b1097],
7	analyses	NNS	O	analysis	prep_in	4	SENT_136	[p6l11t1131r266b1200],
8	was	VBD	O	be	_	0	SENT_136	[p6l286t1147r403b1186],
9	from	IN	O	from	_	0	SENT_136	[p6l426t1131r572b1186],
10	0.34	CD	NUMBER	0.34	number	12	SENT_136	[p6l592t1134r721b1187],
11	to	TO	NUMBER	to	dep	12	SENT_136	[p6l741t1139r800b1186],
12	0.65	CD	NUMBER	0.65	prep_from	8	SENT_136	[p6l821t1134r964b1194],
13	,	,	O	,	_	0	SENT_136	[p6l821t1134r964b1194],
14	when	WRB	O	when	advmod	17	SENT_136	[p6l985t1131r1158b1186],
15	difference	NN	O	difference	nsubjpass	17	SENT_136	[p6l1179t1131r1484b1186],
16	is	VBZ	O	be	auxpass	17	SENT_136	[p6l1506t1132r1549b1186],
17	assumed	VBN	O	assume	dep	12	SENT_136	[p6l1572t1131r1839b1186],
18	to	TO	O	to	aux	21	SENT_136	[p6l1861t1139r1919b1186],
19	be	VB	O	be	cop	21	SENT_136	[p6l1940t1131r2010b1186],
20	30	CD	PERCENT	30	num	21	SENT_136	[p6l2031t1134r2148b1186],
21	%	NN	PERCENT	%	xcomp	17	SENT_136	[p6l2031t1134r2148b1186],
22	of	IN	O	of	_	0	SENT_136	[p6l11t1220r75b1275],
23	average	JJ	O	average	amod	24	SENT_136	[p6l91t1236r324b1289],
24	levels	NNS	O	level	prep_of	21	SENT_136	[p6l349t1220r535b1276],
25	.	.	O	.	_	0	SENT_136	[p6l349t1220r535b1276],

1	Multiple	JJ	O	multiple	amod	3	SENT_137	[p6l113t1309r363b1378],
2	regression	NN	O	regression	nn	3	SENT_137	[p6l393t1310r698b1378],
3	analyses	NNS	O	analysis	nsubj	18	SENT_137	[p6l726t1309r974b1378],
4	including	VBG	O	include	_	0	SENT_137	[p6l1004t1309r1283b1378],
5	dopamine	NN	O	dopamine	nn	17	SENT_137	[p6l1310t1309r1843b1378],
6	—	NN	O	—	nn	17	SENT_137	[p6l1310t1309r1843b1378],
7	related	JJ	O	related	amod	17	SENT_137	[p6l1310t1309r1843b1378],
8	polymorphisms	NNS	O	polymorphism	nn	17	SENT_137	[p6l1873t1310r2147b1378, p6l11t1399r237b1467],
9	,	,	O	,	_	0	SENT_137	[p6l1873t1310r2147b1378, p6l11t1399r237b1467],
10	gender	NN	O	gender	dep	17	SENT_137	[p6l258t1399r467b1467],
11	difference	NN	O	difference	nn	17	SENT_137	[p6l485t1399r794b1462],
12	,	,	O	,	_	0	SENT_137	[p6l485t1399r794b1462],
13	age	NN	O	age	nn	17	SENT_137	[p6l815t1415r915b1467],
14	and	CC	O	and	_	0	SENT_137	[p6l935t1399r1045b1454],
15	plasma	NN	O	plasma	nn	17	SENT_137	[p6l1066t1399r1278b1467],
16	drug	NN	O	drug	nn	17	SENT_137	[p6l1297t1399r1436b1467],
17	concentrations	NNS	O	concentration	prep_including	3	SENT_137	[p6l1455t1400r1895b1454],
18	showed	VBD	O	show	_	0	SENT_137	[p6l1917t1399r2147b1454],
19	that	IN	O	that	complm	24	SENT_137	[p6l10t1488r130b1543],
20	the	DT	O	the	det	23	SENT_137	[p6l156t1488r250b1543],
21	plasma	NN	O	plasma	nn	23	SENT_137	[p6l279t1488r491b1556],
22	prolactin	NN	O	prolactin	nn	23	SENT_137	[p6l518t1488r782b1556],
23	concentration	NN	O	concentration	nsubj	24	SENT_137	[p6l810t1488r1222b1543],
24	correlated	VBD	O	correlate	ccomp	18	SENT_137	[p6l1249t1488r1548b1543],
25	with	IN	O	with	_	0	SENT_137	[p6l1576t1488r1713b1543],
26	gender	NN	O	gender	nn	29	SENT_137	[p6l1740t1488r1949b1556],
27	(	NN	O	(	nn	29	SENT_137	[p6l1975t1488r2147b1556, p6l11t1576r269b1631],
28	standardized	JJ	O	standardized	amod	29	SENT_137	[p6l1975t1488r2147b1556, p6l11t1576r269b1631],
29	beta	NN	O	beta	prep_with	24	SENT_137	[p6l297t1576r645b1640],
30	=	JJ	O	=	amod	43	SENT_137	[p6l297t1576r645b1640],
31	0.551	CD	NUMBER	0.551	tmod	30	SENT_137	[p6l297t1576r645b1640],
32	,	,	O	,	_	0	SENT_137	[p6l297t1576r645b1640],
33	p	NN	O	p	dep	43	SENT_137	[p6l668t1576r949b1645],
34	<	JJR	O	<	nn	43	SENT_137	[p6l668t1576r949b1645],
35	0.001	CD	NUMBER	0.001	num	36	SENT_137	[p6l668t1576r949b1645],
36	)	NN	O	)	dep	34	SENT_137	[p6l668t1576r949b1645],
37	and	CC	O	and	_	0	SENT_137	[p6l978t1576r1087b1631],
38	negatively	RB	O	negatively	nn	43	SENT_137	[p6l1115t1576r1421b1645],
39	with	IN	O	with	dep	38	SENT_137	[p6l1446t1576r1584b1631],
40	age	NN	O	age	pobj	39	SENT_137	[p6l1611t1592r1711b1645],
41	(	CD	NUMBER	(	num	40	SENT_137	[p6l1739t1576r2147b1644],
42	standardized	JJ	O	standardized	amod	43	SENT_137	[p6l1739t1576r2147b1644],
43	beta	NN	O	beta	dep	24	SENT_137	[p6l10t1665r137b1720],
44	=	SYM	O	=	dep	46	SENT_137	[p6l148t1688r180b1704],
45	-	:	O	-	_	0	SENT_137	[p6l192t1691r224b1697],
46	0.202	CD	NUMBER	0.202	dep	66	SENT_137	[p6l235t1668r410b1729],
47	,	,	O	,	_	0	SENT_137	[p6l235t1668r410b1729],
48	p	NN	O	p	dep	49	SENT_137	[p6l423t1680r507b1734],
49	<	JJR	O	<	nsubj	66	SENT_137	[p6l423t1680r507b1734],
50	0.01	CD	NUMBER	0.01	num	51	SENT_137	[p6l518t1665r678b1733],
51	)	NN	O	)	dep	49	SENT_137	[p6l518t1665r678b1733],
52	,	,	O	,	_	0	SENT_137	[p6l518t1665r678b1733],
53	while	IN	O	while	mark	55	SENT_137	[p6l695t1665r861b1720],
54	there	EX	O	there	expl	55	SENT_137	[p6l878t1665r1032b1720],
55	was	VBD	O	be	dep	49	SENT_137	[p6l1047t1681r1162b1720],
56	no	DT	O	no	det	57	SENT_137	[p6l1181t1681r1253b1720],
57	correlation	NN	O	correlation	nsubj	55	SENT_137	[p6l1271t1665r1593b1720],
58	between	IN	O	between	_	0	SENT_137	[p6l1610t1665r1868b1720],
59	prolactin	NN	O	prolactin	nn	60	SENT_137	[p6l1883t1665r2147b1734],
60	concentration	NN	O	concentration	prep_between	57	SENT_137	[p6l11t1755r423b1809],
61	and	CC	O	and	_	0	SENT_137	[p6l455t1754r563b1809],
62	dopamine	NN	O	dopamine	nn	65	SENT_137	[p6l596t1754r1130b1823],
63	—	NN	O	—	nn	65	SENT_137	[p6l596t1754r1130b1823],
64	related	JJ	O	related	amod	65	SENT_137	[p6l596t1754r1130b1823],
65	polymorphisms	NNS	O	polymorphism	conj_and	60	SENT_137	[p6l1164t1754r1631b1823],
66	(	VBP	O	(	ccomp	24	SENT_137	[p6l1663t1754r1840b1823],
67	Table	NNP	O	Table	nsubj	69	SENT_137	[p6l1663t1754r1840b1823],
68	2	CD	NUMBER	2	num	69	SENT_137	[p6l1873t1755r1944b1823],
69	)	CD	NUMBER	)	xcomp	66	SENT_137	[p6l1873t1755r1944b1823],
70	.	.	O	.	_	0	SENT_137	[p6l1873t1755r1944b1823],

1	These	DT	O	these	det	4	SENT_138	[p6l1975t1754r2147b1809],
2	multiple	JJ	O	multiple	amod	4	SENT_138	[p6l11t1843r261b1912],
3	regression	NN	O	regression	nn	4	SENT_138	[p6l294t1844r599b1912],
4	analyses	NNS	O	analysis	nsubj	8	SENT_138	[p6l631t1843r879b1912],
5	without	IN	O	without	_	0	SENT_138	[p6l910t1843r1150b1898],
6	gender	NN	O	gender	nn	7	SENT_138	[p6l1180t1843r1389b1912],
7	difference	NN	O	difference	prep_without	4	SENT_138	[p6l1418t1843r1713b1898],
8	revealed	VBD	O	reveal	_	0	SENT_138	[p6l1746t1843r1997b1898],
9	that	IN	O	that	complm	13	SENT_138	[p6l2029t1843r2149b1898],
10	plasma	NN	O	plasma	nn	12	SENT_138	[p6l11t1933r223b2001],
11	prolactin	NN	O	prolactin	nn	12	SENT_138	[p6l238t1933r502b2001],
12	concentration	NN	O	concentration	nsubj	13	SENT_138	[p6l518t1934r930b1988],
13	correlated	VBD	O	correlate	ccomp	8	SENT_138	[p6l945t1933r1244b1988],
14	negatively	RB	O	negatively	advmod	13	SENT_138	[p6l1262t1933r1568b2001],
15	with	IN	O	with	_	0	SENT_138	[p6l1580t1933r1717b1988],
16	age	NN	O	age	prep_with	13	SENT_138	[p6l1733t1949r1832b2001],
17	in	IN	O	in	_	0	SENT_138	[p6l1849t1934r1903b1987],
18	females	NNS	O	female	nn	21	SENT_138	[p6l1919t1933r2147b1988],
19	(	CD	NUMBER	(	num	18	SENT_138	[p6l11t2022r418b2090],
20	standardized	JJ	O	standardized	amod	21	SENT_138	[p6l11t2022r418b2090],
21	beta	NN	O	beta	prep_in	13	SENT_138	[p6l445t2022r845b2085],
22	=	JJ	O	=	dep	21	SENT_138	[p6l445t2022r845b2085],
23	.	.	O	.	_	0	SENT_138	[p6l445t2022r845b2085],

1	—	NN	O	—	_	0	SENT_139	[p6l445t2022r845b2085],
2	.	.	O	.	_	0	SENT_139	[p6l445t2022r845b2085],

1	0.295	CD	NUMBER	0.295	_	0	SENT_140	[p6l445t2022r845b2085],
2	,	,	O	,	_	0	SENT_140	[p6l445t2022r845b2085],
3	p	NN	O	p	appos	1	SENT_140	[p6l867t2022r1124b2090],
4	<	JJR	O	<	dep	3	SENT_140	[p6l867t2022r1124b2090],
5	0.05	CD	NUMBER	0.05	num	6	SENT_140	[p6l867t2022r1124b2090],
6	)	NN	O	)	dep	4	SENT_140	[p6l867t2022r1124b2090],
7	,	,	O	,	_	0	SENT_140	[p6l867t2022r1124b2090],
8	but	CC	O	but	dep	10	SENT_140	[p6l1151t2022r1251b2077],
9	not	RB	O	not	neg	10	SENT_140	[p6l1276t2030r1374b2077],
10	in	IN	O	in	dep	4	SENT_140	[p6l1400t2022r1454b2076],
11	males	NNS	O	male	pobj	10	SENT_140	[p6l1481t2022r1667b2077],
12	.	.	O	.	_	0	SENT_140	[p6l1481t2022r1667b2077],

1	Signiﬁcant	NN	O	signiﬁcant	nn	2	SENT_141	[p6l1694t2021r2010b2090],
2	correlation	NN	O	correlation	nsubjpass	12	SENT_141	[p6l2033t2037r2147b2077, p6l11t2110r239b2165],
3	between	IN	O	between	_	0	SENT_141	[p6l266t2110r524b2165],
4	COMT	NNP	O	COMT	nn	5	SENT_141	[p6l551t2113r734b2165],
5	polymorphism	NN	O	polymorphism	prep_between	2	SENT_141	[p6l759t2110r1198b2179],
6	and	CC	O	and	_	0	SENT_141	[p6l1225t2110r1334b2165],
7	prolactin	NN	O	prolactin	nn	8	SENT_141	[p6l1362t2110r1626b2179],
8	concentration	NN	O	concentration	prep_between	2	SENT_141	[p6l1653t2111r2065b2165],
9	in	IN	O	in	_	0	SENT_141	[p6l2093t2111r2147b2164],
10	females	NNS	O	female	prep_in	5	SENT_141	[p6l11t2199r238b2254],
11	was	VBD	O	be	auxpass	12	SENT_141	[p6l259t2215r376b2254],
12	found	VBN	O	find	_	0	SENT_141	[p6l398t2199r571b2254],
13	in	IN	O	in	_	0	SENT_141	[p6l593t2200r648b2253],
14	simple	JJ	O	simple	amod	17	SENT_141	[p6l671t2199r867b2268],
15	regression	NN	O	regression	nn	17	SENT_141	[p6l890t2200r1195b2268],
16	(	NN	O	(	nn	17	SENT_141	[p6l1217t2199r1515b2268],
17	p	NN	O	p	prep_in	12	SENT_141	[p6l1217t2199r1515b2268],
18	=	JJ	O	=	amod	20	SENT_141	[p6l1217t2199r1515b2268],
19	0.032	CD	NUMBER	0.032	tmod	18	SENT_141	[p6l1217t2199r1515b2268],
20	)	NN	O	)	dep	17	SENT_141	[p6l1217t2199r1515b2268],
21	and	CC	O	and	_	0	SENT_141	[p6l1536t2199r1645b2254],
22	multiple	JJ	O	multiple	amod	25	SENT_141	[p6l1668t2199r1918b2268],
23	regression	NN	O	regression	nn	25	SENT_141	[p6l1941t2215r2147b2268, p6l12t2289r132b2343],
24	(	NN	O	(	nn	25	SENT_141	[p6l153t2289r209b2357],
25	p	NN	O	p	prep_in	12	SENT_141	[p6l153t2289r209b2357],
26	=	JJ	O	=	amod	28	SENT_141	[p6l221t2312r253b2328],
27	0.047	CD	NUMBER	0.047	tmod	26	SENT_141	[p6l265t2289r462b2357],
28	)	NN	O	)	dep	25	SENT_141	[p6l265t2289r462b2357],
29	.	.	O	.	_	0	SENT_141	[p6l265t2289r462b2357],

1	4	LS	NUMBER	4	_	0	SENT_142	[p6l8t2470r62b2521],
2	.	.	O	.	_	0	SENT_142	[p6l8t2470r62b2521],

1	Discussion	NN	O	discussion	_	0	SENT_143	[p6l88t2467r431b2521],

1	Recently	RB	DATE	recently	advmod	6	SENT_144	[p6l113t2644r378b2713],
2	,	,	O	,	_	0	SENT_144	[p6l113t2644r378b2713],
3	it	PRP	O	it	nsubj	6	SENT_144	[p6l423t2645r465b2699],
4	is	VBZ	O	be	cop	6	SENT_144	[p6l507t2645r550b2699],
5	increasingly	RB	O	increasingly	advmod	6	SENT_144	[p6l595t2644r956b2713],
6	evident	JJ	O	evident	_	0	SENT_144	[p6l996t2644r1223b2699],
7	that	IN	O	that	complm	12	SENT_144	[p6l1263t2644r1385b2699],
8	DRD2	NN	O	drd2	nn	11	SENT_144	[p6l1427t2647r1594b2698],
9	receptor	NN	O	receptor	nn	11	SENT_144	[p6l1641t2652r1891b2713],
10	genetic	JJ	O	genetic	amod	11	SENT_144	[p6l1932t2645r2148b2713],
11	variations	NNS	O	variation	nsubj	12	SENT_144	[p6l9t2734r305b2788],
12	have	VBP	O	have	ccomp	6	SENT_144	[p6l326t2733r464b2788],
13	a	DT	O	a	det	15	SENT_144	[p6l485t2749r516b2788],
14	pivotal	JJ	O	pivotal	amod	15	SENT_144	[p6l537t2733r739b2802],
15	role	NN	O	role	dobj	12	SENT_144	[p6l760t2733r873b2788],
16	in	IN	O	in	_	0	SENT_144	[p6l895t2734r950b2787],
17	pharmacodynamics	NNS	O	pharmacodynamic	prep_in	15	SENT_144	[p6l970t2733r1559b2802],
18	of	IN	O	of	_	0	SENT_144	[p6l1580t2733r1643b2788],
19	numerous	JJ	O	numerous	amod	20	SENT_144	[p6l1656t2749r1959b2788],
20	drugs	NNS	O	drug	prep_of	17	SENT_144	[p6l1981t2733r2147b2802],
21	with	IN	O	with	_	0	SENT_144	[p6l9t2822r148b2877],
22	therapeutic	JJ	O	therapeutic	amod	23	SENT_144	[p6l174t2822r519b2891],
23	implications	NNS	O	implication	prep_with	20	SENT_144	[p6l544t2822r926b2891],
24	.	.	O	.	_	0	SENT_144	[p6l544t2822r926b2891],

1	Numerous	JJ	O	numerous	dep	148	SENT_145	[p6l954t2826r1265b2877],
2	studies	NNS	O	study	dep	148	SENT_145	[p6l1292t2822r1502b2877],
3	as	RB	O	as	dep	148	SENT_145	[p6l1529t2838r1588b2877],
4	well	RB	O	well	dep	148	SENT_145	[p6l1613t2822r1740b2877],
5	as	IN	O	as	dep	148	SENT_145	[p6l1767t2838r1826b2877],
6	ours	PRP	O	ours	dep	148	SENT_145	[p6l1853t2838r1981b2877],
7	have	VBP	O	have	dep	148	SENT_145	[p6l2009t2822r2147b2877],
8	revealed	VBN	O	reveal	dep	148	SENT_145	[p6l11t2911r263b2966],
9	that	IN	O	that	dep	148	SENT_145	[p6l294t2912r416b2966],
10	the	DT	O	the	dep	148	SENT_145	[p6l444t2911r540b2966],
11	DRD2	NN	O	drd2	dep	148	SENT_145	[p6l571t2914r739b2966],
12	receptor	NN	O	receptor	dep	148	SENT_145	[p6l771t2920r1021b2980],
13	polymorphisms	NNS	O	polymorphism	dep	148	SENT_145	[p6l1051t2911r1521b2980],
14	are	VBP	O	be	dep	148	SENT_145	[p6l1551t2927r1642b2966],
15	associated	VBN	O	associate	dep	148	SENT_145	[p6l1673t2911r1980b2966],
16	with	IN	O	with	dep	148	SENT_145	[p6l2009t2911r2147b2966],
17	therapeutic	JJ	O	therapeutic	dep	148	SENT_145	[p6l10t3001r355b3069],
18	response	NN	O	response	dep	148	SENT_145	[p6l370t3017r636b3069],
19	to	TO	O	to	dep	148	SENT_145	[p6l652t3009r709b3056],
20	antipsychotics	NNS	O	antipsychotic	dep	148	SENT_145	[p6l726t3001r1152b3069],
21	(	VBP	O	(	dep	148	SENT_145	[p6l1169t3001r1414b3069],
22	Alenius	NNP	O	Alenius	dep	148	SENT_145	[p6l1169t3001r1414b3069],
23	et	FW	O	et	dep	148	SENT_145	[p6l1431t3009r1487b3056],
24	al.	FW	O	al.	dep	148	SENT_145	[p6l1502t3001r1580b3064],
25	,	,	O	,	_	0	SENT_145	[p6l1502t3001r1580b3064],
26	in	IN	O	in	dep	148	SENT_145	[p6l1598t3002r1654b3055],
27	press	NN	O	press	dep	148	SENT_145	[p6l1668t3017r1840b3069],
28	;	:	O	;	_	0	SENT_145	[p6l1668t3017r1840b3069],
29	Kim	NNP	PERSON	Kim	dep	148	SENT_145	[p6l1861t3002r1981b3055],
30	et	FW	O	et	dep	148	SENT_145	[p6l1997t3009r2054b3056],
31	al.	FW	O	al.	dep	148	SENT_145	[p6l2069t3001r2147b3064],
32	,	,	O	,	_	0	SENT_145	[p6l2069t3001r2147b3064],
33	2008	CD	DATE	2008	dep	148	SENT_145	[p6l11t3093r179b3153],
34	;	:	O	;	_	0	SENT_145	[p6l11t3093r179b3153],
35	Vijayan	NNP	PERSON	Vijayan	dep	148	SENT_145	[p6l220t3091r441b3158],
36	et	FW	O	et	dep	148	SENT_145	[p6l479t3098r535b3145],
37	al.	FW	O	al.	dep	148	SENT_145	[p6l572t3090r650b3153],
38	,	,	O	,	_	0	SENT_145	[p6l572t3090r650b3153],
39	2007	CD	DATE	2007	dep	148	SENT_145	[p6l688t3092r856b3153],
40	;	:	O	;	_	0	SENT_145	[p6l688t3092r856b3153],
41	Zhang	NNP	PERSON	Zhang	dep	148	SENT_145	[p6l898t3090r1085b3158],
42	et	FW	O	et	dep	148	SENT_145	[p6l1120t3098r1177b3145],
43	al.	FW	O	al.	dep	148	SENT_145	[p6l1213t3090r1292b3153],
44	,	,	O	,	_	0	SENT_145	[p6l1213t3090r1292b3153],
45	2003	CD	DATE	2003	dep	148	SENT_145	[p6l1330t3090r1504b3158],
46	)	NN	O	)	dep	148	SENT_145	[p6l1330t3090r1504b3158],
47	and	CC	O	and	dep	148	SENT_145	[p6l1543t3090r1652b3145],
48	extrapyramidal	JJ	O	extrapyramidal	dep	148	SENT_145	[p6l1691t3090r2148b3158],
49	symptoms	NNS	O	symptom	dep	148	SENT_145	[p6l12t3186r322b3247],
50	(	VBP	O	(	dep	148	SENT_145	[p6l352t3178r561b3246],
51	Gunes	NNP	O	Gunes	dep	148	SENT_145	[p6l352t3178r561b3246],
52	et	FW	O	et	dep	148	SENT_145	[p6l590t3186r648b3233],
53	al.	FW	O	al.	dep	148	SENT_145	[p6l674t3178r751b3241],
54	,	,	O	,	_	0	SENT_145	[p6l674t3178r751b3241],
55	2007	CD	DATE	2007	dep	148	SENT_145	[p6l781t3181r950b3241],
56	;	:	O	;	_	0	SENT_145	[p6l781t3181r950b3241],
57	Guzey	NNP	O	Guzey	dep	148	SENT_145	[p6l983t3181r1169b3247],
58	et	FW	O	et	dep	148	SENT_145	[p6l1195t3186r1251b3233],
59	al.	FW	O	al.	dep	148	SENT_145	[p6l1278t3178r1355b3241],
60	,	,	O	,	_	0	SENT_145	[p6l1278t3178r1355b3241],
61	2007	CD	DATE	2007	dep	148	SENT_145	[p6l1385t3181r1553b3241],
62	;	:	O	;	_	0	SENT_145	[p6l1385t3181r1553b3241],
63	Hedenmalm	NNP	O	Hedenmalm	dep	148	SENT_145	[p6l1587t3178r1957b3233],
64	et	FW	O	et	dep	148	SENT_145	[p6l1985t3186r2042b3233],
65	al.	FW	O	al.	dep	148	SENT_145	[p6l2069t3178r2147b3241],
66	,	,	O	,	_	0	SENT_145	[p6l2069t3178r2147b3241],
67	2006	CD	DATE	2006	dep	148	SENT_145	[p6l11t3269r180b3328],
68	;	:	O	;	_	0	SENT_145	[p6l11t3269r180b3328],
69	lnada	NN	O	lnada	dep	148	SENT_145	[p6l209t3266r372b3320],
70	et	FW	O	et	dep	148	SENT_145	[p6l396t3274r452b3320],
71	al.	FW	O	al.	dep	148	SENT_145	[p6l474t3266r552b3328],
72	,	,	O	,	_	0	SENT_145	[p6l474t3266r552b3328],
73	1992	CD	DATE	1992	dep	148	SENT_145	[p6l575t3269r735b3328],
74	;	:	O	;	_	0	SENT_145	[p6l575t3269r735b3328],
75	Kaiser	NNP	PERSON	Kaiser	dep	148	SENT_145	[p6l763t3267r947b3320],
76	et	FW	O	et	dep	148	SENT_145	[p6l968t3274r1024b3320],
77	al.	FW	O	al.	dep	148	SENT_145	[p6l1046t3266r1124b3328],
78	,	,	O	,	_	0	SENT_145	[p6l1046t3266r1124b3328],
79	2002	CD	DATE	2002	dep	148	SENT_145	[p6l1148t3269r1317b3328],
80	;	:	O	;	_	0	SENT_145	[p6l1148t3269r1317b3328],
81	Nakazono	NNP	O	Nakazono	dep	148	SENT_145	[p6l1346t3266r1642b3320],
82	et	FW	O	et	dep	148	SENT_145	[p6l1665t3274r1721b3320],
83	al.	FW	O	al.	dep	148	SENT_145	[p6l1743t3266r1822b3328],
84	,	,	O	,	_	0	SENT_145	[p6l1743t3266r1822b3328],
85	2005	CD	DATE	2005	dep	148	SENT_145	[p6l1846t3269r2014b3328],
86	;	:	O	;	_	0	SENT_145	[p6l1846t3269r2014b3328],
87	Wu	NNP	O	Wu	dep	148	SENT_145	[p6l2040t3269r2148b3320],
88	et	FW	O	et	dep	148	SENT_145	[p6l11t3363r67b3409],
89	al.	FW	O	al.	dep	148	SENT_145	[p6l89t3354r167b3418],
90	,	,	O	,	_	0	SENT_145	[p6l89t3354r167b3418],
91	2006	CD	DATE	2006	dep	148	SENT_145	[p6l191t3354r366b3423],
92	)	CD	NUMBER	)	dep	148	SENT_145	[p6l191t3354r366b3423],
93	including	VBG	O	include	dep	148	SENT_145	[p6l390t3354r671b3423],
94	tardive	JJ	O	tardive	dep	148	SENT_145	[p6l692t3354r900b3409],
95	dyskinesia	NN	O	dyskinesium	dep	148	SENT_145	[p6l924t3354r1236b3423],
96	(	CD	NUMBER	(	dep	148	SENT_145	[p6l1259t3354r1474b3423],
97	Chong	NNP	PERSON	Chong	dep	148	SENT_145	[p6l1259t3354r1474b3423],
98	et	FW	O	et	dep	148	SENT_145	[p6l1495t3363r1552b3409],
99	al.	FW	O	al.	dep	148	SENT_145	[p6l1573t3354r1651b3418],
100	,	,	O	,	_	0	SENT_145	[p6l1573t3354r1651b3418],
101	2003	CD	DATE	2003	dep	148	SENT_145	[p6l1675t3357r1843b3418],
102	;	:	O	;	_	0	SENT_145	[p6l1675t3357r1843b3418],
103	Mo	NNP	DURATION	Mo	dep	148	SENT_145	[p6l1872t3358r1968b3409],
104	et	FW	O	et	dep	148	SENT_145	[p6l1991t3363r2047b3409],
105	al.	FW	O	al.	dep	148	SENT_145	[p6l2069t3354r2147b3418],
106	,	,	O	,	_	0	SENT_145	[p6l2069t3354r2147b3418],
107	2007	CD	DATE	2007	dep	148	SENT_145	[p6l11t3446r179b3507],
108	;	:	O	;	_	0	SENT_145	[p6l11t3446r179b3507],
109	Segman	NNP	O	Segman	dep	148	SENT_145	[p6l221t3446r457b3512],
110	et	FW	O	et	dep	148	SENT_145	[p6l494t3452r550b3498],
111	al.	FW	O	al.	dep	148	SENT_145	[p6l585t3444r663b3507],
112	,	,	O	,	_	0	SENT_145	[p6l585t3444r663b3507],
113	2003	CD	DATE	2003	dep	148	SENT_145	[p6l701t3446r869b3507],
114	;	:	O	;	_	0	SENT_145	[p6l701t3446r869b3507],
115	Zai	NNP	PERSON	Zai	dep	148	SENT_145	[p6l909t3444r997b3498],
116	et	FW	O	et	dep	148	SENT_145	[p6l1034t3452r1091b3498],
117	al.	FW	O	al.	dep	148	SENT_145	[p6l1125t3444r1204b3507],
118	,	,	O	,	_	0	SENT_145	[p6l1125t3444r1204b3507],
119	2007	CD	DATE	2007	dep	148	SENT_145	[p6l1241t3444r1429b3512],
120	)	NN	O	)	dep	148	SENT_145	[p6l1241t3444r1429b3512],
121	,	,	O	,	_	0	SENT_145	[p6l1241t3444r1429b3512],
122	neuroleptic	JJ	O	neuroleptic	dep	148	SENT_145	[p6l1467t3444r1808b3512],
123	malignant	JJ	O	malignant	dep	148	SENT_145	[p6l1844t3443r2149b3512],
124	syndromes	NNS	O	syndrome	dep	148	SENT_145	[p7l12t17r339b85],
125	(	VBP	O	(	dep	148	SENT_145	[p7l375t17r620b85],
126	Kishida	NNP	PERSON	Kishida	dep	148	SENT_145	[p7l375t17r620b85],
127	et	FW	O	et	dep	148	SENT_145	[p7l654t25r711b72],
128	al.	FW	O	al.	dep	148	SENT_145	[p7l743t17r822b80],
129	,	,	O	,	_	0	SENT_145	[p7l743t17r822b80],
130	2003	CD	DATE	2003	dep	148	SENT_145	[p7l857t17r1032b85],
131	)	NN	O	)	dep	148	SENT_145	[p7l857t17r1032b85],
132	and	CC	O	and	dep	148	SENT_145	[p7l1067t17r1176b72],
133	pathogenesis	NN	O	pathogenesis	dep	148	SENT_145	[p7l1212t17r1603b85],
134	of	IN	O	of	dep	148	SENT_145	[p7l1639t17r1702b72],
135	schizophrenia	NN	O	schizophrenia	dep	148	SENT_145	[p7l1729t17r2148b85],
136	(	CD	NUMBER	(	dep	148	SENT_145	[p7l11t105r214b173],
137	Himei	NNP	O	Himei	dep	148	SENT_145	[p7l11t105r214b173],
138	et	FW	O	et	dep	148	SENT_145	[p7l248t113r305b160],
139	al.	FW	O	al.	dep	148	SENT_145	[p7l336t105r415b169],
140	,	,	O	,	_	0	SENT_145	[p7l336t105r415b169],
141	2002	CD	DATE	2002	dep	148	SENT_145	[p7l448t108r617b169],
142	;	:	O	;	_	0	SENT_145	[p7l448t108r617b169],
143	Virgos	NNP	O	Virgos	dep	148	SENT_145	[p7l653t106r842b174],
144	et	FW	O	et	dep	148	SENT_145	[p7l876t113r933b160],
145	al.	FW	O	al.	dep	148	SENT_145	[p7l964t105r1043b169],
146	,	,	O	,	_	0	SENT_145	[p7l964t105r1043b169],
147	2001	CD	DATE	2001	dep	148	SENT_145	[p7l1076t105r1263b174],
148	)	NN	O	)	_	0	SENT_145	[p7l1076t105r1263b174],
149	.	.	O	.	_	0	SENT_145	[p7l1076t105r1263b174],

1	In	IN	O	in	_	0	SENT_146	[p7l1298t109r1353b160],
2	addirionaddition	NN	O	addirionaddition	prep_in	7	SENT_146	[p7l1386t105r1905b169],
3	,	,	O	,	_	0	SENT_146	[p7l1386t105r1905b169],
4	several	JJ	O	several	amod	5	SENT_146	[p7l1940t105r2148b160],
5	studies	NNS	O	study	nsubj	7	SENT_146	[p7l12t194r221b249],
6	have	VBP	O	have	aux	7	SENT_146	[p7l244t194r382b249],
7	focused	VBN	O	focus	_	0	SENT_146	[p7l405t194r632b249],
8	on	IN	O	on	_	0	SENT_146	[p7l655t210r729b249],
9	the	DT	O	the	det	10	SENT_146	[p7l751t194r846b249],
10	relationships	NNS	O	relationship	prep_on	7	SENT_146	[p7l869t194r1255b263],
11	between	IN	O	between	_	0	SENT_146	[p7l1277t194r1536b249],
12	D2	NN	O	d2	nn	15	SENT_146	[p7l1558t197r1637b248],
13	receptor	NN	O	receptor	nn	15	SENT_146	[p7l1663t202r1913b263],
14	genetic	JJ	O	genetic	amod	15	SENT_146	[p7l1932t195r2148b263],
15	variations	NNS	O	variation	prep_between	10	SENT_146	[p7l9t284r305b338],
16	and	CC	O	and	_	0	SENT_146	[p7l338t283r447b338],
17	therapeutic	JJ	O	therapeutic	amod	18	SENT_146	[p7l481t283r825b352],
18	response	NN	O	response	conj_and	10	SENT_146	[p7l858t299r1124b352],
19	to	TO	O	to	_	0	SENT_146	[p7l1157t292r1214b338],
20	risperidone	NN	O	risperidone	prep_to	18	SENT_146	[p7l1248t283r1591b352],
21	treatment	NN	O	treatment	nn	23	SENT_146	[p7l1624t292r1926b338],
22	(	CD	NUMBER	(	num	23	SENT_146	[p7l1956t283r2147b352],
23	Lencz	NNP	O	Lencz	dobj	7	SENT_146	[p7l1956t283r2147b352],
24	et	FW	O	et	nn	25	SENT_146	[p7l11t381r67b427],
25	al.	FW	O	al.	dep	23	SENT_146	[p7l91t372r168b436],
26	,	,	O	,	_	0	SENT_146	[p7l91t372r168b436],
27	2006	CD	DATE	2006	appos	23	SENT_146	[p7l194t375r363b436],
28	;	:	O	;	_	0	SENT_146	[p7l194t375r363b436],
29	Xing	NNP	O	Xing	dep	27	SENT_146	[p7l391t373r531b441],
30	et	FW	O	et	nn	31	SENT_146	[p7l553t381r609b427],
31	al.	FW	O	al.	nsubj	38	SENT_146	[p7l632t373r710b436],
32	,	,	O	,	_	0	SENT_146	[p7l632t373r710b436],
33	2007	CD	DATE	2007	num	34	SENT_146	[p7l735t373r909b441],
34	)	NN	O	)	nsubj	38	SENT_146	[p7l735t373r909b441],
35	and	CC	O	and	_	0	SENT_146	[p7l934t372r1044b427],
36	extrapyramidal	JJ	O	extrapyramidal	amod	37	SENT_146	[p7l1069t372r1526b441],
37	symptoms	NNS	O	symptom	nsubj	38	SENT_146	[p7l1551t381r1863b441],
38	(	VBP	O	(	rcmod	29	SENT_146	[p7l1887t372r1982b441],
39	de	IN	O	de	amod	40	SENT_146	[p7l1887t372r1982b441],
40	Leon	NNP	O	Leon	dobj	38	SENT_146	[p7l2007t376r2147b427],
41	et	FW	O	et	nn	42	SENT_146	[p7l11t470r67b517],
42	al.	FW	O	al.	dep	40	SENT_146	[p7l95t462r172b525],
43	,	,	O	,	_	0	SENT_146	[p7l95t462r172b525],
44	2005	CD	DATE	2005	appos	40	SENT_146	[p7l203t465r371b525],
45	;	:	O	;	_	0	SENT_146	[p7l203t465r371b525],
46	Dolzan	NNP	O	Dolzan	dep	40	SENT_146	[p7l405t462r611b517],
47	et	FW	O	et	nn	48	SENT_146	[p7l640t470r697b517],
48	al.	FW	O	al.	dep	46	SENT_146	[p7l724t462r802b525],
49	,	,	O	,	_	0	SENT_146	[p7l724t462r802b525],
50	2007	CD	DATE	2007	num	51	SENT_146	[p7l832t462r1020b530],
51	)	NN	O	)	appos	48	SENT_146	[p7l832t462r1020b530],
52	.	.	O	.	_	0	SENT_146	[p7l832t462r1020b530],

1	However	RB	O	however	advmod	4	SENT_147	[p7l1051t465r1330b525],
2	,	,	O	,	_	0	SENT_147	[p7l1051t465r1330b525],
3	there	EX	O	there	expl	4	SENT_147	[p7l1360t462r1516b517],
4	was	VBD	O	be	_	0	SENT_147	[p7l1542t478r1659b517],
5	no	DT	O	no	det	6	SENT_147	[p7l1688t478r1762b517],
6	information	NN	O	information	nsubj	4	SENT_147	[p7l1792t462r2147b517],

1	Table	NNP	O	Table	_	0	SENT_148	[p7l8t684r144b727],
2	2	CD	NUMBER	2	num	5	SENT_148	[p7l162t686r191b727],
3	Partial	JJ	O	partial	amod	5	SENT_148	[p7l11t755r171b799],
4	correlation	NN	O	correlation	nn	5	SENT_148	[p7l211t755r487b799],
5	coefﬁcients	NNS	O	coefﬁcients	dep	1	SENT_148	[p7l527t755r813b799],
6	and	CC	O	and	_	0	SENT_148	[p7l853t755r944b799],
7	multiple	JJ	O	multiple	amod	9	SENT_148	[p7l984t755r1196b809],
8	correlation	NN	O	correlation	nn	9	SENT_148	[p7l1236t755r1512b799],
9	coefﬁcient	NN	O	coefﬁcient	dep	1	SENT_148	[p7l1552t755r1815b799],
10	in	IN	O	in	_	0	SENT_148	[p7l1853t756r1899b798],
11	multiple	JJ	O	multiple	amod	13	SENT_148	[p7l1940t755r2151b809],
12	regression	NN	O	regression	nn	13	SENT_148	[p7l11t826r263b880],
13	analyses	NNS	O	analysis	prep_in	9	SENT_148	[p7l291t825r496b880],
14	in	IN	O	in	_	0	SENT_148	[p7l526t826r570b869],
15	total	JJ	O	total	amod	20	SENT_148	[p7l599t825r720b876],
16	,	,	O	,	_	0	SENT_148	[p7l599t825r720b876],
17	male	JJ	O	male	amod	20	SENT_148	[p7l750t825r868b869],
18	and	CC	O	and	_	0	SENT_148	[p7l896t825r986b869],
19	female	JJ	O	female	conj_and	15	SENT_148	[p7l1015t825r1179b869],
20	subjects	NNS	O	subject	prep_in	13	SENT_148	[p7l1208t826r1405b880],
21	between	IN	O	between	_	0	SENT_148	[p7l1434t826r1646b869],
22	prolactin	NN	O	prolactin	nn	23	SENT_148	[p7l1673t825r1891b880],
23	level	NN	O	level	prep_between	9	SENT_148	[p7l1920t825r2034b869],
24	and	CC	O	and	_	0	SENT_148	[p7l2063t826r2151b869],
25	various	JJ	O	various	amod	26	SENT_148	[p7l9t899r187b941],
26	factors	NNS	O	factor	conj_and	5	SENT_148	[p7l208t898r370b941],

1	Factors	NNS	O	factor	_	0	SENT_149	[p7l11t1039r181b1080],
2	Total	JJ	O	total	amod	3	SENT_149	[p7l1056t1037r1176b1080],
3	subjects	NNS	O	subject	dep	1	SENT_149	[p7l1198t1037r1394b1091],
4	Male	JJ	PERSON	male	amod	20	SENT_149	[p7l1575t1037r1694b1080],
5	Female	JJ	PERSON	female	amod	20	SENT_149	[p7l1928t1037r2101b1080],
6	(	NN	O	(	nn	20	SENT_149	[p7l1058t1107r1252b1162],
7	n	NN	O	n	nn	20	SENT_149	[p7l1058t1107r1252b1162],
8	=	JJ	O	=	amod	20	SENT_149	[p7l1058t1107r1252b1162],
9	174	CD	NUMBER	174	number	10	SENT_149	[p7l1058t1107r1252b1162],
10	)	CD	NUMBER	)	num	20	SENT_149	[p7l1058t1107r1252b1162],
11	(	NN	O	(	nn	20	SENT_149	[p7l1575t1108r1748b1162],
12	n	NN	O	n	nn	20	SENT_149	[p7l1575t1108r1748b1162],
13	=	JJ	O	=	amod	20	SENT_149	[p7l1575t1108r1748b1162],
14	68	CD	NUMBER	68	number	15	SENT_149	[p7l1575t1108r1748b1162],
15	)	CD	NUMBER	)	num	20	SENT_149	[p7l1575t1108r1748b1162],
16	(	NN	O	(	nn	20	SENT_149	[p7l1928t1107r2128b1162],
17	n	NN	O	n	nn	20	SENT_149	[p7l1928t1107r2128b1162],
18	=	JJ	O	=	amod	20	SENT_149	[p7l1928t1107r2128b1162],
19	106	CD	NUMBER	106	num	20	SENT_149	[p7l1928t1107r2128b1162],
20	)	NN	O	)	dep	3	SENT_149	[p7l1928t1107r2128b1162],

1	Age	NNP	O	Age	_	0	SENT_150	[p7l8t1249r100b1301],
2	-0.202	CD	NUMBER	-0.202	num	1	SENT_150	[p7l1058t1247r1281b1291],
3	**	CD	NUMBER	**	number	4	SENT_150	[p7l1058t1247r1281b1291],
4	-0.215	CD	NUMBER	-0.215	dep	1	SENT_150	[p7l1575t1249r1736b1291],
5	-0.295	CD	NUMBER	-0.295	num	6	SENT_150	[p7l1928t1247r2151b1291],
6	**	CD	NUMBER	**	dep	4	SENT_150	[p7l1928t1247r2151b1291],
7	Plasma	NN	O	plasma	nn	12	SENT_150	[p7l11t1318r183b1362],
8	drug	NN	O	drug	nn	12	SENT_150	[p7l202t1318r316b1372],
9	concentration	NN	O	concentration	nn	12	SENT_150	[p7l334t1319r676b1362],
10	(	CD	NUMBER	(	num	12	SENT_150	[p7l695t1318r877b1372],
11	ng/ml	NN	O	ng/ml	nn	12	SENT_150	[p7l695t1318r877b1372],
12	)	NN	O	)	dep	1	SENT_150	[p7l695t1318r877b1372],

1	Risperidone	NNP	O	Risperidone	_	0	SENT_151	[p7l65t1389r357b1443],
2	-	:	O	-	_	0	SENT_151	[p7l1058t1409r1084b1414],
3	0.107	CD	NUMBER	0.107	number	4	SENT_151	[p7l1093t1391r1218b1433],
4	0.116	CD	NUMBER	0.116	dep	1	SENT_151	[p7l1609t1391r1731b1433],
5	-0.166	CD	NUMBER	-0.166	num	7	SENT_151	[p7l1928t1391r2090b1433],
6	Active	JJ	O	active	amod	7	SENT_151	[p7l62t1461r214b1504],
7	moiety	NN	O	moiety	dep	4	SENT_151	[p7l234t1461r406b1514],
8	0.068	CD	NUMBER	0.068	number	9	SENT_151	[p7l1093t1462r1226b1504],
9	0.066	CD	NUMBER	0.066	dep	4	SENT_151	[p7l1609t1462r1745b1504],
10	0.088	CD	NUMBER	0.088	dep	9	SENT_151	[p7l1962t1462r2095b1504],

1	DRD-related	JJ	O	drd-related	amod	2	SENT_152	[p7l11t1530r312b1574],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_152	[p7l333t1530r717b1585],

1	Taq	NN	ORGANIZATION	taq	nn	2	SENT_153	[p7l62t1605r148b1656],
2	IA	NN	ORGANIZATION	ia	_	0	SENT_153	[p7l168t1604r218b1645],
3	in	IN	O	in	_	0	SENT_153	[p7l236t1603r281b1645],
4	DRD2	NN	O	drd2	prep_in	2	SENT_153	[p7l302t1604r438b1645],
5	-	:	O	-	_	0	SENT_153	[p7l1058t1622r1084b1627],
6	0.032	CD	NUMBER	0.032	number	7	SENT_153	[p7l1093t1604r1225b1646],
7	-0.009	CD	NUMBER	-0.009	dep	4	SENT_153	[p7l1575t1604r1745b1646],
8	0.011	CD	NUMBER	0.011	number	9	SENT_153	[p7l1962t1604r2083b1646],
9	-141	CD	NUMBER	-141	num	11	SENT_153	[p7l65t1675r164b1716],
10	C	NN	O	c	nn	11	SENT_153	[p7l174t1675r204b1717],
11	Ins/Del	NN	O	ins/del	dep	17	SENT_153	[p7l223t1673r393b1727],
12	in	IN	O	in	_	0	SENT_153	[p7l414t1674r459b1716],
13	DRD2	NN	O	drd2	prep_in	11	SENT_153	[p7l479t1675r615b1716],
14	0.051	CD	NUMBER	0.051	dep	17	SENT_153	[p7l1093t1675r1217b1717],
15	0.099	CD	NUMBER	0.099	number	16	SENT_153	[p7l1609t1675r1743b1717],
16	0.072	CD	NUMBER	0.072	num	17	SENT_153	[p7l1962t1675r2093b1717],
17	Ser9Gly	NN	O	ser9gly	dep	25	SENT_153	[p7l65t1743r255b1798],
18	in	IN	O	in	_	0	SENT_153	[p7l274t1744r319b1787],
19	DRD3	NN	O	drd3	prep_in	17	SENT_153	[p7l339t1746r474b1787],
20	0.026	CD	NUMBER	0.026	num	19	SENT_153	[p7l1093t1746r1227b1787],
21	0.054	CD	NUMBER	0.054	number	22	SENT_153	[p7l1609t1746r1744b1787],
22	0.001	CD	NUMBER	0.001	num	25	SENT_153	[p7l1962t1746r2091b1787],
23	48-bp	JJ	O	48-bp	amod	25	SENT_153	[p7l63t1815r209b1869],
24	VNT	NN	O	vnt	nn	25	SENT_153	[p7l227t1817r333b1858],
25	R	NN	O	r	dep	4	SENT_153	[p7l335t1818r367b1858],
26	in	IN	O	in	_	0	SENT_153	[p7l385t1816r430b1858],
27	DRD4	NN	O	drd4	prep_in	25	SENT_153	[p7l450t1817r588b1858],
28	-	:	O	-	_	0	SENT_153	[p7l1058t1835r1084b1840],
29	0.034	CD	NUMBER	0.034	number	30	SENT_153	[p7l1093t1817r1227b1859],
30	0.094	CD	NUMBER	0.094	dep	27	SENT_153	[p7l1609t1817r1744b1859],
31	-0.065	CD	NUMBER	-0.065	num	32	SENT_153	[p7l1928t1817r2095b1859],
32	Val158Met	NN	O	val158met	dep	30	SENT_153	[p7l62t1887r331b1931],
33	in	IN	O	in	_	0	SENT_153	[p7l350t1888r395b1930],
34	COMT	NNP	ORGANIZATION	COMT	prep_in	4	SENT_153	[p7l414t1889r564b1931],
35	-	:	O	-	_	0	SENT_153	[p7l1058t1907r1084b1912],
36	0.098	CD	NUMBER	0.098	number	37	SENT_153	[p7l1093t1889r1225b1931],
37	0.217	CD	NUMBER	0.217	dep	2	SENT_153	[p7l1609t1889r1735b1931],
38	-0.209	CD	NUMBER	-0.209	num	39	SENT_153	[p7l1928t1887r2123b1931],
39	*	NN	O	*	dep	37	SENT_153	[p7l1928t1887r2123b1931],

1	Gender	NN	O	gender	_	0	SENT_154	[p7l10t1959r190b2003],
2	0.551	CD	NUMBER	0.551	num	1	SENT_154	[p7l1093t1961r1217b2003],
3	***	CD	NUMBER	***	num	6	SENT_154	[p7l1227t1959r1306b1985],
4	Multiple	JJ	O	multiple	amod	6	SENT_154	[p7l11t2030r217b2085],
5	correlation	NN	O	correlation	nn	6	SENT_154	[p7l238t2030r506b2074],
6	coefﬁcient	NN	O	coefﬁcient	dep	1	SENT_154	[p7l525t2030r780b2074],
7	0.571	CD	NUMBER	0.571	number	8	SENT_154	[p7l1093t2032r1217b2074],
8	***	CD	NUMBER	***	num	10	SENT_154	[p7l1227t2031r1306b2056],
9	0.365	CD	NUMBER	0.365	number	10	SENT_154	[p7l1609t2032r1741b2074],
10	0.357	CD	NUMBER	0.357	dep	6	SENT_154	[p7l1962t2032r2093b2074],

1	*	NN	O	*	nn	2	SENT_155	[p7l11t2169r226b2223],
2	p	NN	O	p	_	0	SENT_155	[p7l11t2169r226b2223],
3	<	JJR	O	<	dep	2	SENT_155	[p7l11t2169r226b2223],
4	0.05	CD	NUMBER	0.05	dep	3	SENT_155	[p7l11t2169r226b2223],
5	,	,	O	,	_	0	SENT_155	[p7l11t2169r226b2223],
6	**	CD	NUMBER	**	num	7	SENT_155	[p7l247t2169r484b2223],
7	p	NN	O	p	npadvmod	8	SENT_155	[p7l247t2169r484b2223],
8	<	JJR	O	<	amod	3	SENT_155	[p7l247t2169r484b2223],
9	0.01	CD	NUMBER	0.01	dep	2	SENT_155	[p7l247t2169r484b2223],
10	,	,	O	,	_	0	SENT_155	[p7l247t2169r484b2223],
11	***	CD	NUMBER	***	num	12	SENT_155	[p7l505t2169r802b2223],
12	p	NN	O	p	appos	9	SENT_155	[p7l505t2169r802b2223],
13	<	JJR	O	<	dep	2	SENT_155	[p7l505t2169r802b2223],
14	0.001	CD	NUMBER	0.001	dep	13	SENT_155	[p7l505t2169r802b2223],
15	.	.	O	.	_	0	SENT_155	[p7l505t2169r802b2223],

1	about	IN	O	about	_	0	SENT_156	[p7l8t2246r179b2301],
2	association	NN	O	association	pobj	1	SENT_156	[p7l198t2247r528b2301],
3	between	IN	O	between	_	0	SENT_156	[p7l548t2246r808b2301],
4	prolactin	NN	O	prolactin	nn	5	SENT_156	[p7l828t2246r1094b2315],
5	response	NN	O	response	prep_between	2	SENT_156	[p7l1115t2262r1381b2315],
6	to	TO	O	to	_	0	SENT_156	[p7l1401t2254r1458b2301],
7	risperidone	NN	O	risperidone	nn	11	SENT_156	[p7l1481t2246r1823b2315],
8	and	CC	O	and	_	0	SENT_156	[p7l1844t2246r1953b2301],
9	DRD2	NN	O	drd2	nn	11	SENT_156	[p7l1975t2249r2143b2300],
10	gene	NN	O	gene	nn	11	SENT_156	[p7l7t2351r149b2404],
11	variation	NN	O	variation	prep_to	5	SENT_156	[p7l169t2336r450b2391],
12	.	.	O	.	_	0	SENT_156	[p7l169t2336r450b2391],

1	The	DT	O	the	det	2	SENT_157	[p7l107t2425r217b2479],
2	results	NNS	O	result	nsubj	6	SENT_157	[p7l240t2425r437b2479],
3	of	IN	O	of	_	0	SENT_157	[p7l459t2424r522b2479],
4	our	PRP$	O	we	poss	5	SENT_157	[p7l536t2440r639b2479],
5	study	NN	O	study	prep_of	2	SENT_157	[p7l659t2424r824b2493],
6	showed	VBD	O	show	_	0	SENT_157	[p7l844t2424r1075b2479],
7	no	DT	O	no	det	8	SENT_157	[p7l1098t2440r1172b2479],
8	differences	NNS	O	difference	dobj	6	SENT_157	[p7l1194t2424r1520b2479],
9	in	IN	O	in	_	0	SENT_157	[p7l1543t2425r1598b2479],
10	prolactin	NN	O	prolactin	nn	11	SENT_157	[p7l1619t2424r1886b2493],
11	concentration	NN	O	concentration	prep_in	6	SENT_157	[p7l1907t2440r2144b2479, p7l8t2514r209b2568],
12	between	IN	O	between	_	0	SENT_157	[p7l240t2513r499b2568],
13	DRD2	NN	O	drd2	nn	14	SENT_157	[p7l532t2516r700b2568],
14	genotypes	NNS	O	genotype	prep_between	11	SENT_157	[p7l731t2521r1052b2582],
15	,	,	O	,	_	0	SENT_157	[p7l731t2521r1052b2582],
16	although	IN	O	although	mark	20	SENT_157	[p7l1085t2513r1353b2582],
17	our	PRP$	O	we	poss	19	SENT_157	[p7l1383t2529r1486b2568],
18	previous	JJ	O	previous	amod	19	SENT_157	[p7l1516t2514r1773b2582],
19	studies	NNS	O	study	nsubj	20	SENT_157	[p7l1805t2513r2015b2568],
20	demonstrated	VBD	O	demonstrate	advcl	6	SENT_157	[p7l2047t2513r2144b2568, p7l9t2603r353b2658],
21	that	IN	O	that	complm	25	SENT_157	[p7l373t2603r494b2658],
22	Taq1A	NN	O	taq1a	nn	23	SENT_157	[p7l509t2605r698b2671],
23	polymorphism	NN	O	polymorphism	nsubjpass	25	SENT_157	[p7l717t2603r1160b2671],
24	was	VBD	O	be	auxpass	25	SENT_157	[p7l1175t2618r1292b2658],
25	associated	VBN	O	associate	ccomp	20	SENT_157	[p7l1312t2603r1618b2658],
26	with	IN	O	with	_	0	SENT_157	[p7l1637t2603r1776b2658],
27	a	DT	O	a	det	28	SENT_157	[p7l1796t2618r1827b2658],
28	difference	NN	O	difference	prep_with	25	SENT_157	[p7l1847t2602r2145b2658],
29	in	IN	O	in	_	0	SENT_157	[p7l9t2692r64b2746],
30	acute	JJ	O	acute	amod	32	SENT_157	[p7l91t2700r250b2747],
31	prolactin	NN	O	prolactin	nn	32	SENT_157	[p7l278t2692r544b2760],
32	response	NN	O	response	prep_in	28	SENT_157	[p7l572t2707r837b2760],
33	to	TO	O	to	_	0	SENT_157	[p7l865t2700r922b2747],
34	selective	JJ	O	selective	amod	36	SENT_157	[p7l951t2692r1207b2747],
35	dopamine	NN	O	dopamine	nn	36	SENT_157	[p7l1235t2692r1536b2760],
36	antagonists	NNS	O	antagonist	prep_to	25	SENT_157	[p7l1564t2693r1920b2760],
37	,	,	O	,	_	0	SENT_157	[p7l1564t2693r1920b2760],
38	nemo	NN	O	nemo	nn	39	SENT_157	[p7l1948t2707r2144b2747],
39	—	NN	O	—	prep_to	25	SENT_157	[p7l1948t2707r2144b2747],
40	napride	NN	O	napride	nn	42	SENT_157	[p7l9t2780r238b2849],
41	(	CD	NUMBER	(	num	42	SENT_157	[p7l258t2780r493b2848],
42	Mihara	NNP	PERSON	Mihara	dep	39	SENT_157	[p7l258t2780r493b2848],
43	et	FW	O	et	nn	44	SENT_157	[p7l512t2788r569b2835],
44	al.	FW	O	al.	dep	39	SENT_157	[p7l587t2780r664b2843],
45	,	,	O	,	_	0	SENT_157	[p7l587t2780r664b2843],
46	2001	CD	DATE	2001	num	47	SENT_157	[p7l685t2780r858b2848],
47	)	NN	O	)	conj_and	36	SENT_157	[p7l685t2780r858b2848],
48	and	CC	O	and	_	0	SENT_157	[p7l878t2780r987b2835],
49	bromperidol	NN	O	bromperidol	nn	51	SENT_157	[p7l1007t2780r1382b2849],
50	(	CD	NUMBER	(	num	51	SENT_157	[p7l1402t2780r1637b2848],
51	Mihara	NNP	PERSON	Mihara	prep_to	25	SENT_157	[p7l1402t2780r1637b2848],
52	et	FW	O	et	nn	53	SENT_157	[p7l1657t2788r1713b2835],
53	al.	FW	O	al.	dep	51	SENT_157	[p7l1731t2780r1809b2843],
54	,	,	O	,	_	0	SENT_157	[p7l1731t2780r1809b2843],
55	2001	CD	DATE	2001	num	56	SENT_157	[p7l1830t2780r2016b2848],
56	)	NN	O	)	appos	53	SENT_157	[p7l1830t2780r2016b2848],
57	.	.	O	.	_	0	SENT_157	[p7l1830t2780r2016b2848],

1	The	DT	O	the	det	2	SENT_158	[p7l2034t2780r2144b2835],
2	discrepancy	NN	O	discrepancy	nsubjpass	5	SENT_158	[p7l8t2869r366b2938],
3	may	MD	O	may	aux	5	SENT_158	[p7l387t2885r516b2938],
4	be	VB	O	be	auxpass	5	SENT_158	[p7l537t2869r607b2924],
5	explained	VBN	O	explain	dep	17	SENT_158	[p7l630t2869r921b2938],
6	by	IN	O	by	_	0	SENT_158	[p7l944t2869r1016b2938],
7	a	DT	O	a	det	8	SENT_158	[p7l1037t2885r1067b2924],
8	difference	NN	O	difference	agent	5	SENT_158	[p7l1091t2869r1388b2924],
9	in	IN	O	in	_	0	SENT_158	[p7l1413t2870r1468b2924],
10	the	DT	O	the	det	11	SENT_158	[p7l1490t2869r1586b2924],
11	duration	NN	O	duration	prep_in	8	SENT_158	[p7l1609t2869r1866b2924],
12	of	IN	O	of	_	0	SENT_158	[p7l1889t2869r1952b2924],
13	medication	NN	O	medication	prep_of	11	SENT_158	[p7l1968t2869r2144b2924, p7l8t2959r190b3013],
14	because	IN	O	because	_	0	SENT_158	[p7l212t2958r449b3013],
15	prolactin	NN	O	prolactin	nn	16	SENT_158	[p7l472t2958r739b3027],
16	response	NN	O	response	prep_because	5	SENT_158	[p7l762t2974r1027b3027],
17	tends	VBZ	O	tend	_	0	SENT_158	[p7l1050t2958r1214b3013],
18	to	TO	O	to	aux	21	SENT_158	[p7l1236t2967r1293b3013],
19	be	VB	O	be	cop	21	SENT_158	[p7l1315t2958r1386b3013],
20	more	RBR	O	more	advmod	21	SENT_158	[p7l1409t2974r1564b3013],
21	pronounced	JJ	O	pronounced	xcomp	17	SENT_158	[p7l1587t2958r1947b3027],
22	in	IN	O	in	_	0	SENT_158	[p7l1972t2959r2026b3013],
23	the	DT	O	the	det	25	SENT_158	[p7l2049t2959r2144b3013],
24	acute	JJ	O	acute	amod	25	SENT_158	[p7l8t3056r166b3103],
25	phase	NN	O	phase	prep_in	21	SENT_158	[p7l183t3048r356b3116],
26	than	IN	O	than	dep	21	SENT_158	[p7l372t3048r508b3103],
27	in	IN	O	in	_	0	SENT_158	[p7l525t3049r580b3102],
28	chronic	JJ	O	chronic	amod	29	SENT_158	[p7l596t3048r819b3103],
29	phase	NN	O	phase	prep_in	21	SENT_158	[p7l835t3048r1007b3116],
30	(	CD	NUMBER	(	num	31	SENT_158	[p7l1024t3048r1362b3116],
31	Sawamura	NNP	O	Sawamura	dep	29	SENT_158	[p7l1024t3048r1362b3116],
32	et	FW	O	et	nn	33	SENT_158	[p7l1378t3056r1436b3103],
33	al.	FW	O	al.	nsubj	17	SENT_158	[p7l1450t3048r1528b3111],
34	,	,	O	,	_	0	SENT_158	[p7l1450t3048r1528b3111],
35	2006	CD	DATE	2006	num	36	SENT_158	[p7l1545t3048r1735b3116],
36	)	NN	O	)	appos	33	SENT_158	[p7l1545t3048r1735b3116],
37	.	.	O	.	_	0	SENT_158	[p7l1545t3048r1735b3116],

1	In	IN	O	in	_	0	SENT_159	[p7l1753t3051r1809b3102],
2	addition	NN	O	addition	prep_in	7	SENT_159	[p7l1825t3048r2089b3111],
3	,	,	O	,	_	0	SENT_159	[p7l1825t3048r2089b3111],
4	it	PRP	O	it	nsubj	7	SENT_159	[p7l2106t3049r2146b3103],
5	may	MD	O	may	aux	7	SENT_159	[p7l9t3152r136b3205],
6	be	VB	O	be	cop	7	SENT_159	[p7l156t3137r226b3192],
7	due	JJ	O	due	_	0	SENT_159	[p7l248t3137r357b3192],
8	to	TO	O	to	_	0	SENT_159	[p7l379t3145r436b3192],
9	pharmacological	JJ	O	pharmacological	amod	10	SENT_159	[p7l459t3137r954b3205],
10	complexity	NN	O	complexity	prep_to	7	SENT_159	[p7l977t3137r1311b3205],
11	of	IN	O	of	_	0	SENT_159	[p7l1331t3136r1394b3192],
12	risperidone	NN	O	risperidone	prep_of	10	SENT_159	[p7l1408t3137r1764b3205],
13	,	,	O	,	_	0	SENT_159	[p7l1408t3137r1764b3205],
14	which	WDT	O	which	nsubj	15	SENT_159	[p7l1785t3137r1972b3192],
15	has	VBZ	O	have	rcmod	12	SENT_159	[p7l1993t3137r2092b3192],
16	a	DT	O	a	det	19	SENT_159	[p7l2114t3152r2145b3192],
17	potent	JJ	O	potent	amod	19	SENT_159	[p7l8t3233r204b3294],
18	serotonin	NN	O	serotonin	nn	19	SENT_159	[p7l228t3226r510b3280],
19	5HT2	NN	O	5ht2	dobj	15	SENT_159	[p7l535t3228r682b3291],
20	and	CC	O	and	_	0	SENT_159	[p7l707t3225r816b3280],
21	a	DT	O	a	det	23	SENT_159	[p7l841t3241r872b3280],
22	milder	JJR	O	milder	amod	23	SENT_159	[p7l897t3225r1094b3280],
23	dopamine	NN	O	dopamine	conj_and	19	SENT_159	[p7l1116t3225r1418b3294],
24	D2	NN	O	d2	dep	28	SENT_159	[p7l1443t3229r1514b3291],
25	antagonistic	JJ	O	antagonistic	amod	26	SENT_159	[p7l1539t3226r1903b3294],
26	activity	NN	O	activity	dep	24	SENT_159	[p7l1926t3226r2146b3294],
27	(	CD	NUMBER	(	dep	28	SENT_159	[p7l8t3314r252b3382],
28	Schotte	NNP	PERSON	Schotte	dep	19	SENT_159	[p7l8t3314r252b3382],
29	et	FW	O	et	nn	30	SENT_159	[p7l284t3322r341b3369],
30	al.	FW	O	al.	dep	28	SENT_159	[p7l371t3314r449b3377],
31	,	,	O	,	_	0	SENT_159	[p7l371t3314r449b3377],
32	1995	CD	DATE	1995	num	33	SENT_159	[p7l481t3314r660b3382],
33	)	NN	O	)	appos	30	SENT_159	[p7l481t3314r660b3382],
34	.	.	O	.	_	0	SENT_159	[p7l481t3314r660b3382],

1	Dopamine	NN	O	dopamine	nsubjpass	4	SENT_160	[p7l692t3315r1002b3383],
2	is	VBZ	O	be	auxpass	4	SENT_160	[p7l1034t3315r1077b3369],
3	well	RB	O	well	advmod	4	SENT_160	[p7l1108t3314r1234b3369],
4	known	VBN	O	know	_	0	SENT_160	[p7l1268t3314r1475b3369],
5	to	TO	O	to	aux	6	SENT_160	[p7l1506t3322r1563b3369],
6	block	VB	O	block	xcomp	4	SENT_160	[p7l1594t3314r1755b3369],
7	secretion	NN	O	secretion	dobj	6	SENT_160	[p7l1786t3315r2058b3369],
8	of	IN	O	of	_	0	SENT_160	[p7l2089t3314r2153b3369],
9	prolactin	NN	O	prolactin	prep_of	7	SENT_160	[p7l8t3403r289b3472],
10	,	,	O	,	_	0	SENT_160	[p7l8t3403r289b3472],
11	and	CC	O	and	_	0	SENT_160	[p7l319t3403r429b3458],
12	dopamine	NN	O	dopamine	nn	13	SENT_160	[p7l459t3403r761b3472],
13	antagonists	NNS	O	antagonist	nsubj	14	SENT_160	[p7l791t3404r1132b3472],
14	elevate	VBP	O	elevate	conj_and	4	SENT_160	[p7l1163t3403r1373b3458],
15	prolactin	NN	O	prolactin	nn	16	SENT_160	[p7l1405t3404r1671b3472],
16	concentrations	NNS	O	concentration	nsubj	17	SENT_160	[p7l1701t3404r2144b3458],
17	(	VBP	O	(	ccomp	14	SENT_160	[p7l8t3493r220b3561],
18	Rubin	NNP	PERSON	Rubin	dobj	17	SENT_160	[p7l8t3493r220b3561],
19	,	,	O	,	_	0	SENT_160	[p7l8t3493r220b3561],
20	1987	CD	DATE	1987	num	21	SENT_160	[p7l245t3492r425b3561],
21	)	NN	O	)	appos	18	SENT_160	[p7l245t3492r425b3561],
22	.	.	O	.	_	0	SENT_160	[p7l245t3492r425b3561],

1	Contrary	JJ	O	contrary	_	0	SENT_161	[p7l452t3495r714b3561],
2	to	TO	O	to	_	0	SENT_161	[p7l739t3501r795b3547],
3	dopamine	NN	O	dopamine	prep_contrary_to	7	SENT_161	[p7l822t3493r1138b3561],
4	,	,	O	,	_	0	SENT_161	[p7l822t3493r1138b3561],
5	serotonin	NN	O	serotonin	nsubjpass	7	SENT_161	[p7l1167t3493r1449b3547],
6	is	VBZ	O	be	auxpass	7	SENT_161	[p7l1476t3493r1520b3547],
7	known	VBN	O	know	_	0	SENT_161	[p7l1547t3493r1755b3547],
8	to	TO	O	to	aux	9	SENT_161	[p7l1780t3501r1837b3547],
9	stimulate	VB	O	stimulate	xcomp	7	SENT_161	[p7l1866t3492r2144b3547],
10	prolactin	NN	O	prolactin	nn	11	SENT_161	[p7l8t3582r274b3650],
11	secretion	NN	O	secretion	dobj	9	SENT_161	[p7l306t3583r592b3645],
12	,	,	O	,	_	0	SENT_161	[p7l306t3583r592b3645],
13	and	CC	O	and	_	0	SENT_161	[p7l623t3582r732b3637],
14	its	PRP$	O	its	poss	15	SENT_161	[p7l764t3583r832b3637],
15	antagonists	NNS	O	antagonist	nsubj	16	SENT_161	[p7l862t3583r1205b3650],
16	decrease	VBP	O	decrease	conj_and	7	SENT_161	[p7l1236t3582r1495b3637],
17	prolactin	NN	O	prolactin	nn	18	SENT_161	[p7l1526t3582r1793b3650],
18	concentrations	NNS	O	concentration	dobj	16	SENT_161	[p7l1823t3590r2145b3637, p8l7t17r154b72],

1	(	NN	O	(	nn	2	SENT_162	[p8l182t17r393b85],
2	Rubin	NNP	PERSON	Rubin	_	0	SENT_162	[p8l182t17r393b85],
3	,	,	O	,	_	0	SENT_162	[p8l182t17r393b85],
4	1987	CD	DATE	1987	num	5	SENT_162	[p8l421t17r600b85],
5	)	NN	O	)	appos	2	SENT_162	[p8l421t17r600b85],
6	.	.	O	.	_	0	SENT_162	[p8l421t17r600b85],

1	Thus	RB	O	thus	advmod	6	SENT_163	[p8l627t17r785b80],
2	,	,	O	,	_	0	SENT_163	[p8l627t17r785b80],
3	prolactin	NN	O	prolactin	nn	4	SENT_163	[p8l814t17r1082b85],
4	secretion	NN	O	secretion	nsubjpass	6	SENT_163	[p8l1110t17r1381b72],
5	is	VBZ	O	be	auxpass	6	SENT_163	[p8l1410t17r1453b72],
6	regulated	VBN	O	regulate	_	0	SENT_163	[p8l1483t17r1764b85],
7	by	IN	O	by	_	0	SENT_163	[p8l1792t17r1865b85],
8	not	RB	O	not	neg	11	SENT_163	[p8l1892t25r1990b72],
9	only	RB	O	only	advmod	11	SENT_163	[p8l2017t17r2146b85],
10	dopamine	NN	O	dopamine	nn	11	SENT_163	[p8l8t105r309b174],
11	blockade	NN	O	blockade	agent	6	SENT_163	[p8l340t105r607b160],
12	but	CC	O	but	_	0	SENT_163	[p8l638t105r739b160],
13	also	RB	O	also	_	0	SENT_163	[p8l768t105r884b160],
14	serotonin	NN	O	serotonin	nn	15	SENT_163	[p8l917t106r1198b160],
15	blockade	NN	O	blockade	agent	6	SENT_163	[p8l1229t105r1509b161],
16	.	.	O	.	_	0	SENT_163	[p8l1229t105r1509b161],

1	It	PRP	O	it	nsubj	2	SENT_164	[p8l1542t108r1585b160],
2	appears	VBZ	O	appear	_	0	SENT_164	[p8l1614t121r1846b174],
3	that	IN	O	that	complm	6	SENT_164	[p8l1879t105r1999b160],
4	it	PRP	O	it	nsubjpass	6	SENT_164	[p8l2029t106r2071b160],
5	is	VBZ	O	be	auxpass	6	SENT_164	[p8l2101t106r2144b160],
6	difﬁcult	VBN	O	difﬁcult	ccomp	2	SENT_164	[p8l8t194r240b249],
7	to	TO	O	to	aux	8	SENT_164	[p8l274t202r331b249],
8	predict	VB	O	predict	xcomp	6	SENT_164	[p8l368t194r579b263],
9	prolactin	NN	O	prolactin	nn	10	SENT_164	[p8l614t194r881b263],
10	concentration	NN	O	concentration	dobj	8	SENT_164	[p8l916t195r1331b249],
11	during	IN	O	during	_	0	SENT_164	[p8l1367t194r1566b263],
12	risperidone	NN	O	risperidone	nn	13	SENT_164	[p8l1601t194r1943b263],
13	treatments	NNS	O	treatment	prep_during	8	SENT_164	[p8l1979t202r2144b249, p8l9t292r192b338],
14	using	VBG	O	use	partmod	13	SENT_164	[p8l216t284r377b352],
15	only	RB	O	only	advmod	17	SENT_164	[p8l396t283r526b352],
16	DRD2	NN	O	drd2	nn	17	SENT_164	[p8l547t286r714b338],
17	variants	NNS	O	variant	dobj	14	SENT_164	[p8l736t284r975b338],
18	including	VBG	O	include	_	0	SENT_164	[p8l998t283r1279b352],
19	Taq1A	NN	O	taq1a	nn	20	SENT_164	[p8l1297t286r1486b352],
20	polymorphisms	NNS	O	polymorphism	prep_including	17	SENT_164	[p8l1505t283r1990b352],
21	.	.	O	.	_	0	SENT_164	[p8l1505t283r1990b352],

1	Another	DT	O	another	det	2	SENT_165	[p8l107t372r359b427],
2	study	NN	O	study	nsubj	3	SENT_165	[p8l383t372r552b441],
3	reported	VBD	O	report	_	0	SENT_165	[p8l575t372r837b441],
4	that	IN	O	that	complm	23	SENT_165	[p8l863t372r986b427],
5	patients	NNS	O	patient	nsubj	23	SENT_165	[p8l1010t373r1255b441],
6	with	IN	O	with	_	0	SENT_165	[p8l1279t372r1420b427],
7	the	DT	O	the	det	10	SENT_165	[p8l1444t372r1541b427],
8	DRD2	NN	O	drd2	nn	10	SENT_165	[p8l1567t375r1737b427],
9	A1	NN	O	a1	nn	10	SENT_165	[p8l1762t375r1835b427],
10	allele	NN	O	allele	prep_with	5	SENT_165	[p8l1847t372r2007b427],
11	had	VBD	O	have	aux	23	SENT_165	[p8l2034t372r2144b427],
12	prolactin	NN	O	prolactin	nn	13	SENT_165	[p8l8t462r280b530],
13	levels	NNS	O	level	dobj	23	SENT_165	[p8l306t462r476b517],
14	twice	RB	O	twice	advmod	23	SENT_165	[p8l501t463r666b517],
15	those	DT	O	those	pobj	14	SENT_165	[p8l691t462r856b517],
16	of	IN	O	of	_	0	SENT_165	[p8l881t462r944b517],
17	patients	NNS	O	patient	prep_of	15	SENT_165	[p8l962t463r1207b530],
18	without	IN	O	without	_	0	SENT_165	[p8l1230t462r1476b517],
19	this	DT	O	this	det	20	SENT_165	[p8l1498t462r1609b517],
20	allele	NN	O	allele	prep_without	14	SENT_165	[p8l1634t462r1794b517],
21	in	IN	O	in	_	0	SENT_165	[p8l1819t463r1876b516],
22	patients	NNS	O	patient	prep_in	20	SENT_165	[p8l1899t463r2144b530],
23	treated	VBN	O	treat	ccomp	3	SENT_165	[p8l7t551r224b606],
24	with	IN	O	with	_	0	SENT_165	[p8l245t551r386b606],
25	clozapine	NN	O	clozapine	nn	27	SENT_165	[p8l407t551r696b619],
26	(	CD	NUMBER	(	num	27	SENT_165	[p8l718t551r932b619],
27	Young	NNP	O	Young	prep_with	23	SENT_165	[p8l718t551r932b619],
28	et	FW	O	et	nn	29	SENT_165	[p8l952t559r1010b606],
29	al.	FW	O	al.	dep	27	SENT_165	[p8l1029t551r1110b614],
30	,	,	O	,	_	0	SENT_165	[p8l1029t551r1110b614],
31	2004	CD	DATE	2004	num	32	SENT_165	[p8l1133t551r1325b619],
32	)	NN	O	)	appos	27	SENT_165	[p8l1133t551r1325b619],
33	.	.	O	.	_	0	SENT_165	[p8l1133t551r1325b619],

1	However	RB	O	however	advmod	5	SENT_166	[p8l1349t554r1633b614],
2	,	,	O	,	_	0	SENT_166	[p8l1349t554r1633b614],
3	this	DT	O	this	det	4	SENT_166	[p8l1655t551r1766b606],
4	study	NN	O	study	nsubj	5	SENT_166	[p8l1789t551r1958b619],
5	failed	VBD	O	fail	_	0	SENT_166	[p8l1978t550r2144b606],
6	to	TO	O	to	aux	7	SENT_166	[p8l7t647r66b694],
7	ﬁnd	VB	O	ﬁnd	xcomp	5	SENT_166	[p8l98t639r216b694],
8	the	DT	O	the	det	9	SENT_166	[p8l248t639r345b694],
9	difference	NN	O	difference	dobj	7	SENT_166	[p8l377t639r682b694],
10	in	IN	O	in	_	0	SENT_166	[p8l715t640r771b693],
11	prolactin	NN	O	prolactin	nn	12	SENT_166	[p8l802t639r1074b708],
12	concentration	NN	O	concentration	prep_in	9	SENT_166	[p8l1107t640r1531b694],
13	in	IN	O	in	_	0	SENT_166	[p8l1563t640r1619b693],
14	patients	NNS	O	patient	prep_in	7	SENT_166	[p8l1650t640r1895b708],
15	treated	VBN	O	treat	partmod	14	SENT_166	[p8l1927t639r2144b694],
16	with	IN	O	with	_	0	SENT_166	[p8l6t728r147b783],
17	risperidone	NN	O	risperidone	prep_with	15	SENT_166	[p8l173t728r536b797],
18	,	,	O	,	_	0	SENT_166	[p8l173t728r536b797],
19	which	WDT	O	which	nsubj	20	SENT_166	[p8l561t728r750b783],
20	is	VBZ	O	be	rcmod	17	SENT_166	[p8l775t729r819b783],
21	in	IN	O	in	_	0	SENT_166	[p8l845t729r901b782],
22	accordance	NN	O	accordance	_	0	SENT_166	[p8l925t728r1267b783],
23	with	IN	O	with	_	0	SENT_166	[p8l1289t728r1431b783],
24	the	DT	O	the	det	26	SENT_166	[p8l1454t728r1551b783],
25	present	JJ	DATE	present	amod	26	SENT_166	[p8l1577t736r1807b797],
26	study	NN	O	study	prep_in_accordance_with	20	SENT_166	[p8l1831t728r2009b797],
27	.	.	O	.	_	0	SENT_166	[p8l1831t728r2009b797],

1	The	DT	O	the	det	2	SENT_167	[p8l2032t728r2144b783],
2	study	NN	O	study	nsubj	10	SENT_167	[p8l9t817r177b886],
3	by	IN	O	by	_	0	SENT_167	[p8l192t817r266b886],
4	Wu	NNP	PERSON	Wu	prep_by	2	SENT_167	[p8l279t821r387b872],
5	et	FW	O	et	nn	6	SENT_167	[p8l405t826r462b872],
6	al.	FW	O	al.	dep	4	SENT_167	[p8l479t817r559b881],
7	,	,	O	,	_	0	SENT_167	[p8l479t817r559b881],
8	2005	CD	DATE	2005	num	9	SENT_167	[p8l578t818r755b886],
9	)	NN	O	)	appos	4	SENT_167	[p8l578t818r755b886],
10	conﬁrmed	VBD	O	conﬁrmed	_	0	SENT_167	[p8l773t817r1087b872],
11	the	DT	O	the	det	12	SENT_167	[p8l1105t817r1201b872],
12	association	NN	O	association	dobj	10	SENT_167	[p8l1219t818r1558b872],
13	with	IN	O	with	prep	10	SENT_167	[p8l1571t817r1712b872],
14	the	DT	O	the	det	17	SENT_167	[p8l1729t817r1826b872],
15	-141	CD	NUMBER	-141	num	17	SENT_167	[p8l1845t820r1968b872],
16	C	NN	O	c	nn	17	SENT_167	[p8l1981t820r2018b872],
17	Ins	NNS	O	in	pobj	13	SENT_167	[p8l2035t817r2144b886],
18	/	:	O	/	punct	20	SENT_167	[p8l2035t817r2144b886],
19	Del	NNP	O	Del	nn	20	SENT_167	[p8l8t906r106b961],
20	polymorphism	NN	O	polymorphism	dep	17	SENT_167	[p8l132t906r597b975],
21	,	,	O	,	_	0	SENT_167	[p8l132t906r597b975],
22	but	CC	O	but	_	0	SENT_167	[p8l621t906r723b961],
23	not	RB	O	not	prep	10	SENT_167	[p8l747t915r846b961],
24	with	IN	O	with	dep	13	SENT_167	[p8l868t906r1009b961],
25	the	DT	O	the	det	28	SENT_167	[p8l1033t906r1130b961],
26	Taql	NNP	MISC	Taql	nn	28	SENT_167	[p8l1152t910r1278b975],
27	A	NNP	O	A	nn	28	SENT_167	[p8l1301t909r1346b961],
28	polymorphism	NN	O	polymorphism	pobj	24	SENT_167	[p8l1369t906r1833b975],
29	.	.	O	.	_	0	SENT_167	[p8l1369t906r1833b975],

1	Other	JJ	O	other	amod	5	SENT_168	[p8l110t996r285b1051],
2	dopamine	NN	O	dopamine	nn	5	SENT_168	[p8l308t996r858b1064],
3	—	NN	O	—	nn	5	SENT_168	[p8l308t996r858b1064],
4	related	JJ	O	related	amod	5	SENT_168	[p8l308t996r858b1064],
5	polymorphisms	NNS	O	polymorphism	nsubj	8	SENT_168	[p8l885t996r1364b1064],
6	did	VBD	O	do	aux	8	SENT_168	[p8l1392t996r1487b1051],
7	not	RB	O	not	neg	8	SENT_168	[p8l1514t1004r1614b1051],
8	show	VB	O	show	_	0	SENT_168	[p8l1640t996r1802b1051],
9	any	DT	O	any	det	10	SENT_168	[p8l1825t1012r1933b1064],
10	difference	NN	O	difference	dobj	8	SENT_168	[p8l1958t996r2144b1051, p8l8t1100r147b1140],
11	in	IN	O	in	_	0	SENT_168	[p8l172t1085r227b1139],
12	plasma	NN	O	plasma	nn	14	SENT_168	[p8l250t1085r468b1153],
13	prolactin	NN	O	prolactin	nn	14	SENT_168	[p8l491t1085r763b1153],
14	concentration	NN	O	concentration	prep_in	8	SENT_168	[p8l788t1086r1212b1140],
15	in	IN	O	in	_	0	SENT_168	[p8l1236t1085r1292b1139],
16	ANOVA	NNP	ORGANIZATION	ANOVA	prep_in	14	SENT_168	[p8l1313t1087r1542b1140],
17	or	CC	O	or	_	0	SENT_168	[p8l1564t1100r1627b1140],
18	multiple	JJ	O	multiple	amod	20	SENT_168	[p8l1649t1085r1907b1153],
19	regression	NN	O	regression	nn	20	SENT_168	[p8l1931t1100r2144b1153, p8l9t1174r132b1228],
20	analyses	NNS	O	analysis	prep_in	14	SENT_168	[p8l162t1173r432b1242],
21	.	.	O	.	_	0	SENT_168	[p8l162t1173r432b1242],

1	Therefore	RB	O	therefore	advmod	5	SENT_169	[p8l461t1173r772b1236],
2	,	,	O	,	_	0	SENT_169	[p8l461t1173r772b1236],
3	it	PRP	O	it	nsubj	5	SENT_169	[p8l803t1174r844b1228],
4	is	VBZ	O	be	cop	5	SENT_169	[p8l874t1174r917b1228],
5	unlikely	JJ	O	unlikely	_	0	SENT_169	[p8l948t1173r1194b1242],
6	that	IN	O	that	complm	13	SENT_169	[p8l1223t1173r1346b1228],
7	DRD3	NN	O	drd3	nsubjpass	13	SENT_169	[p8l1374t1176r1562b1236],
8	,	,	O	,	_	0	SENT_169	[p8l1374t1176r1562b1236],
9	DRD4	NN	O	drd4	nsubjpass	13	SENT_169	[p8l1592t1176r1765b1227],
10	or	CC	O	or	_	0	SENT_169	[p8l1795t1189r1858b1228],
11	COMT	NN	O	comt	nsubjpass	13	SENT_169	[p8l1886t1176r2072b1228],
12	is	VBZ	O	be	auxpass	13	SENT_169	[p8l2100t1174r2144b1228],
13	associated	VBN	O	associate	ccomp	5	SENT_169	[p8l8t1262r320b1317],
14	with	IN	O	with	_	0	SENT_169	[p8l358t1262r498b1317],
15	prolactin	NN	O	prolactin	nn	16	SENT_169	[p8l537t1262r809b1331],
16	response	NN	O	response	prep_with	13	SENT_169	[p8l848t1278r1119b1331],
17	to	TO	O	to	_	0	SENT_169	[p8l1157t1270r1216b1317],
18	risperidone	NN	O	risperidone	prep_to	13	SENT_169	[p8l1254t1262r1619b1331],
19	.	.	O	.	_	0	SENT_169	[p8l1254t1262r1619b1331],

1	However	RB	O	however	advmod	8	SENT_170	[p8l1658t1265r1943b1325],
2	,	,	O	,	_	0	SENT_170	[p8l1658t1265r1943b1325],
3	these	DT	O	these	det	4	SENT_170	[p8l1982t1262r2144b1317],
4	results	NNS	O	result	nsubj	8	SENT_170	[p8l9t1351r209b1406],
5	do	VBP	O	do	aux	8	SENT_170	[p8l233t1351r306b1406],
6	not	RB	O	not	neg	8	SENT_170	[p8l330t1360r430b1406],
7	necessarily	RB	O	necessarily	advmod	8	SENT_170	[p8l452t1351r790b1420],
8	mean	VB	O	mean	_	0	SENT_170	[p8l811t1367r980b1406],
9	the	DT	O	the	det	10	SENT_170	[p8l1002t1352r1099b1406],
10	lack	NN	O	lack	dobj	8	SENT_170	[p8l1123t1351r1242b1406],
11	of	IN	O	of	_	0	SENT_170	[p8l1264t1351r1327b1406],
12	association	NN	O	association	prep_of	10	SENT_170	[p8l1342t1352r1680b1406],
13	between	IN	O	between	_	0	SENT_170	[p8l1702t1351r1967b1406],
14	polymorphisms	NNS	O	polymorphism	prep_between	12	SENT_170	[p8l1988t1351r2144b1420, p8l9t1440r354b1509],
15	of	IN	O	of	_	0	SENT_170	[p8l384t1440r447b1495],
16	DRD3	NN	O	drd3	prep_of	14	SENT_170	[p8l470t1443r657b1504],
17	,	,	O	,	_	0	SENT_170	[p8l470t1443r657b1504],
18	DRD4	NN	O	drd4	prep_of	14	SENT_170	[p8l689t1443r862b1495],
19	or	CC	O	or	_	0	SENT_170	[p8l891t1456r954b1495],
20	COMT	NN	O	comt	prep_of	14	SENT_170	[p8l982t1443r1168b1495],
21	and	CC	O	and	_	0	SENT_170	[p8l1192t1440r1303b1495],
22	clinical	JJ	O	clinical	amod	23	SENT_170	[p8l1335t1440r1548b1495],
23	response	NN	O	response	prep_between	12	SENT_170	[p8l1579t1456r1850b1509],
24	to	TO	O	to	_	0	SENT_170	[p8l1880t1449r1938b1495],
25	risperidone	NN	O	risperidone	prep_to	23	SENT_170	[p8l1970t1441r2144b1509, p8l9t1530r220b1585],
26	.	.	O	.	_	0	SENT_170	[p8l1970t1441r2144b1509, p8l9t1530r220b1585],

1	The	DT	O	the	det	2	SENT_171	[p8l246t1530r358b1585],
2	study	NN	O	study	nsubj	14	SENT_171	[p8l387t1530r555b1598],
3	by	IN	O	by	_	0	SENT_171	[p8l581t1530r653b1598],
4	Zalsman	NNP	PERSON	Zalsman	prep_by	2	SENT_171	[p8l678t1530r935b1585],
5	et	FW	O	et	nn	7	SENT_171	[p8l963t1538r1020b1585],
6	al.	FW	O	al.	nn	7	SENT_171	[p8l1047t1530r1111b1585],
7	(	FW	O	(	dep	4	SENT_171	[p8l1140t1530r1342b1598],
8	2003	CD	DATE	2003	num	9	SENT_171	[p8l1140t1530r1342b1598],
9	)	CD	NUMBER	)	dep	7	SENT_171	[p8l1140t1530r1342b1598],
10	actually	RB	O	actually	advmod	11	SENT_171	[p8l1370t1530r1609b1598],
11	yielded	VBD	O	yield	partmod	9	SENT_171	[p8l1633t1530r1858b1598],
12	negative	JJ	O	negative	amod	13	SENT_171	[p8l1887t1531r2145b1598],
13	association	NN	O	association	dobj	11	SENT_171	[p8l8t1619r346b1674],
14	results	VBZ	O	result	_	0	SENT_171	[p8l387t1619r587b1674],
15	(	CD	NUMBER	(	num	16	SENT_171	[p8l630t1619r911b1687],
16	Zalsman	NNP	O	Zalsman	dobj	14	SENT_171	[p8l630t1619r911b1687],
17	et	FW	O	et	nn	18	SENT_171	[p8l951t1627r1008b1674],
18	al.	FW	O	al.	tmod	14	SENT_171	[p8l1048t1619r1128b1682],
19	,	,	O	,	_	0	SENT_171	[p8l1048t1619r1128b1682],
20	2003	CD	DATE	2003	num	21	SENT_171	[p8l1170t1619r1367b1687],
21	)	CD	NUMBER	)	appos	18	SENT_171	[p8l1170t1619r1367b1687],
22	:	:	O	:	_	0	SENT_171	[p8l1170t1619r1367b1687],
23	a	DT	O	a	det	24	SENT_171	[p8l1412t1634r1443b1674],
24	trend	NN	O	trend	dep	31	SENT_171	[p8l1484t1619r1647b1674],
25	of	IN	O	of	_	0	SENT_171	[p8l1689t1618r1753b1674],
26	signiﬁcance	NN	O	signiﬁcance	nn	28	SENT_171	[p8l1786t1618r2144b1687],
27	(	NN	O	(	nn	28	SENT_171	[p8l8t1707r263b1776],
28	p	NN	O	p	prep_of	24	SENT_171	[p8l8t1707r263b1776],
29	=	JJ	O	=	dep	31	SENT_171	[p8l8t1707r263b1776],
30	0.11	CD	NUMBER	0.11	num	31	SENT_171	[p8l8t1707r263b1776],
31	)	NN	O	)	dep	39	SENT_171	[p8l8t1707r263b1776],
32	in	IN	O	in	_	0	SENT_171	[p8l284t1708r341b1761],
33	such	JJ	O	such	amod	36	SENT_171	[p8l362t1707r500b1762],
34	a	DT	O	a	det	36	SENT_171	[p8l520t1723r551b1762],
35	small	JJ	O	small	amod	36	SENT_171	[p8l573t1707r733b1762],
36	sample	NN	O	sample	prep_in	31	SENT_171	[p8l755t1707r971b1776],
37	size	NN	O	size	nn	39	SENT_171	[p8l993t1708r1106b1762],
38	(	NN	O	(	nn	39	SENT_171	[p8l1127t1707r1185b1775],
39	n	NN	O	n	dep	14	SENT_171	[p8l1127t1707r1185b1775],
40	=	JJ	O	=	amod	42	SENT_171	[p8l1199t1707r1340b1775],
41	24	CD	NUMBER	24	num	42	SENT_171	[p8l1199t1707r1340b1775],
42	)	NN	O	)	nsubjpass	46	SENT_171	[p8l1199t1707r1340b1775],
43	can	MD	O	can	aux	46	SENT_171	[p8l1361t1715r1569b1762],
44	not	RB	O	not	neg	46	SENT_171	[p8l1361t1715r1569b1762],
45	be	VB	O	be	auxpass	46	SENT_171	[p8l1587t1707r1658b1762],
46	considered	VBN	O	consider	rcmod	39	SENT_171	[p8l1679t1707r2012b1762],
47	as	IN	O	as	_	0	SENT_171	[p8l2033t1723r2093b1762],
48	a	DT	O	a	det	51	SENT_171	[p8l2114t1723r2145b1762],
49	positive	JJ	O	positive	amod	51	SENT_171	[p8l8t1797r246b1865],
50	association	NN	O	association	nn	51	SENT_171	[p8l268t1797r606b1851],
51	ﬁnding	NN	O	ﬁnding	prep_as	46	SENT_171	[p8l627t1796r857b1865],
52	.	.	O	.	_	0	SENT_171	[p8l627t1796r857b1865],

1	On	IN	O	on	_	0	SENT_172	[p8l880t1799r964b1851],
2	the	DT	O	the	det	4	SENT_172	[p8l984t1796r1081b1851],
3	other	JJ	O	other	amod	4	SENT_172	[p8l1103t1796r1266b1851],
4	hand	NN	O	hand	prep_on	17	SENT_172	[p8l1285t1796r1452b1859],
5	,	,	O	,	_	0	SENT_172	[p8l1285t1796r1452b1859],
6	signiﬁcant	NN	O	signiﬁcant	nn	7	SENT_172	[p8l1474t1796r1792b1865],
7	correlation	NN	O	correlation	nsubjpass	17	SENT_172	[p8l1811t1796r2145b1851],
8	between	IN	O	between	_	0	SENT_172	[p8l7t1885r272b1940],
9	COMT	NNP	O	COMT	nn	10	SENT_172	[p8l291t1888r477b1940],
10	polymorphism	NN	O	polymorphism	prep_between	7	SENT_172	[p8l495t1885r946b1954],
11	and	CC	O	and	_	0	SENT_172	[p8l965t1885r1076b1940],
12	prolactin	NN	O	prolactin	nn	13	SENT_172	[p8l1097t1886r1369b1954],
13	concentration	NN	O	concentration	conj_and	10	SENT_172	[p8l1389t1886r1814b1940],
14	in	IN	O	in	_	0	SENT_172	[p8l1834t1886r1890b1940],
15	females	NNS	O	female	prep_in	10	SENT_172	[p8l1910t1885r2144b1940],
16	was	VBD	O	be	auxpass	17	SENT_172	[p8l6t1990r124b2029],
17	found	VBN	O	find	_	0	SENT_172	[p8l159t1974r336b2029],
18	in	IN	O	in	_	0	SENT_172	[p8l371t1975r428b2029],
19	simple	JJ	O	simple	amod	22	SENT_172	[p8l463t1974r665b2043],
20	regression	NN	O	regression	nn	22	SENT_172	[p8l700t1975r1015b2043],
21	(	NN	O	(	nn	22	SENT_172	[p8l1050t1974r1356b2043],
22	p	NN	O	p	prep_in	17	SENT_172	[p8l1050t1974r1356b2043],
23	=	JJ	O	=	amod	25	SENT_172	[p8l1050t1974r1356b2043],
24	0.032	CD	NUMBER	0.032	tmod	23	SENT_172	[p8l1050t1974r1356b2043],
25	)	NN	O	)	dep	22	SENT_172	[p8l1050t1974r1356b2043],
26	and	CC	O	and	_	0	SENT_172	[p8l1390t1974r1501b2029],
27	multiple	JJ	O	multiple	amod	30	SENT_172	[p8l1538t1975r1795b2043],
28	regression	NN	O	regression	nn	30	SENT_172	[p8l1830t1975r2145b2043],
29	(	NN	O	(	nn	30	SENT_172	[p8l8t2064r327b2132],
30	p	NN	O	p	conj_and	22	SENT_172	[p8l8t2064r327b2132],
31	=	JJ	O	=	amod	33	SENT_172	[p8l8t2064r327b2132],
32	0.047	CD	NUMBER	0.047	tmod	31	SENT_172	[p8l8t2064r327b2132],
33	)	NN	O	)	dep	30	SENT_172	[p8l8t2064r327b2132],
34	,	,	O	,	_	0	SENT_172	[p8l8t2064r327b2132],
35	although	IN	O	although	mark	42	SENT_172	[p8l350t2064r622b2132],
36	no	DT	O	no	det	37	SENT_172	[p8l644t2080r718b2119],
37	difference	NN	O	difference	nsubjpass	42	SENT_172	[p8l741t2064r1045b2119],
38	between	IN	O	between	_	0	SENT_172	[p8l1067t2064r1330b2119],
39	COMT	NNP	ORGANIZATION	COMT	nn	40	SENT_172	[p8l1353t2067r1538b2119],
40	polymorphism	NN	O	polymorphism	prep_between	37	SENT_172	[p8l1558t2064r2009b2132],
41	was	VBD	O	be	auxpass	42	SENT_172	[p8l2026t2080r2144b2119],
42	found	VBN	O	find	advcl	17	SENT_172	[p8l8t2152r184b2207],
43	using	VBG	O	use	xcomp	42	SENT_172	[p8l204t2153r368b2221],
44	ANOVA	NNP	O	ANOVA	nn	47	SENT_172	[p8l383t2155r613b2207],
45	analysis	NN	O	analysis	nn	47	SENT_172	[p8l629t2152r868b2221],
46	(	NN	O	(	nn	47	SENT_172	[p8l888t2152r945b2221],
47	p	NN	O	p	dobj	43	SENT_172	[p8l888t2152r945b2221],
48	=	JJ	O	=	amod	47	SENT_172	[p8l959t2175r990b2192],
49	0.168	CD	NUMBER	0.168	num	50	SENT_172	[p8l1003t2152r1200b2220],
50	)	NN	O	)	dep	48	SENT_172	[p8l1003t2152r1200b2220],
51	.	.	O	.	_	0	SENT_172	[p8l1003t2152r1200b2220],

1	Further	JJ	O	further	amod	2	SENT_173	[p8l1220t2152r1447b2207],
2	studies	NNS	O	study	nsubjpass	4	SENT_173	[p8l1465t2152r1679b2207],
3	are	VBP	O	be	auxpass	4	SENT_173	[p8l1698t2168r1791b2207],
4	required	VBN	O	require	_	0	SENT_173	[p8l1810t2152r2067b2221],
5	to	TO	O	to	aux	6	SENT_173	[p8l2086t2160r2144b2207],
6	conﬁrm	VB	O	conﬁrm	xcomp	4	SENT_173	[p8l8t2241r247b2296],
7	the	DT	O	the	det	9	SENT_173	[p8l270t2241r367b2296],
8	possible	JJ	O	possible	amod	9	SENT_173	[p8l392t2241r639b2310],
9	association	NN	O	association	dobj	6	SENT_173	[p8l663t2242r1016b2297],
10	.	.	O	.	_	0	SENT_173	[p8l663t2242r1016b2297],

1	Plasma	NN	O	plasma	nn	3	SENT_174	[p8l110t2330r322b2385],
2	prolactin	NN	O	prolactin	nn	3	SENT_174	[p8l349t2330r615b2399],
3	concentration	NN	O	concentration	nsubj	14	SENT_174	[p8l643t2331r1058b2385],
4	during	IN	O	during	_	0	SENT_174	[p8l1085t2331r1285b2399],
5	treatment	NN	O	treatment	prep_during	3	SENT_174	[p8l1311t2339r1612b2385],
6	with	IN	O	with	_	0	SENT_174	[p8l1636t2331r1774b2385],
7	risperidone	NN	O	risperidone	nn	9	SENT_174	[p8l1803t2330r2145b2399],
8	6	CD	NUMBER	6	num	9	SENT_174	[p8l8t2422r42b2474],
9	mg/day	NN	O	mg/day	prep_with	5	SENT_174	[p8l65t2419r292b2488],
10	in	IN	O	in	_	0	SENT_174	[p8l314t2420r369b2474],
11	females	NNS	O	female	prep_in	9	SENT_174	[p8l392t2419r621b2474],
12	was	VBD	O	be	cop	14	SENT_174	[p8l642t2435r758b2474],
13	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_174	[p8l783t2419r1147b2488],
14	higher	JJR	O	higher	_	0	SENT_174	[p8l1168t2419r1363b2488],
15	than	IN	O	than	_	0	SENT_174	[p8l1383t2420r1519b2474],
16	that	DT	O	that	prep_than	14	SENT_174	[p8l1541t2419r1662b2474],
17	in	IN	O	in	_	0	SENT_174	[p8l1683t2420r1738b2474],
18	males	NNS	O	male	prep_in	16	SENT_174	[p8l1761t2420r1934b2474],
19	in	IN	O	in	_	0	SENT_174	[p8l1958t2420r2014b2474],
20	this	DT	O	this	det	21	SENT_174	[p8l2035t2419r2144b2474],
21	study	NN	O	study	prep_in	18	SENT_174	[p8l9t2509r183b2577],
22	.	.	O	.	_	0	SENT_174	[p8l9t2509r183b2577],

1	These	DT	O	these	det	2	SENT_175	[p8l213t2509r387b2564],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_175	[p8l419t2509r659b2577],
3	are	VBP	O	be	_	0	SENT_175	[p8l691t2525r782b2564],
4	in	IN	O	in	_	0	SENT_175	[p8l814t2510r869b2563],
5	line	NN	O	line	prep_in	3	SENT_175	[p8l901t2509r1010b2564],
6	with	IN	O	with	_	0	SENT_175	[p8l1039t2509r1178b2564],
7	previous	JJ	O	previous	amod	8	SENT_175	[p8l1209t2510r1466b2577],
8	studies	NNS	O	study	prep_with	3	SENT_175	[p8l1499t2509r1708b2564],
9	showing	VBG	O	show	partmod	8	SENT_175	[p8l1741t2509r1996b2577],
10	that	IN	O	that	complm	47	SENT_175	[p8l2025t2509r2147b2564],
11	higher	JJR	O	higher	amod	13	SENT_175	[p8l8t2598r203b2666],
12	prolactin	NN	O	prolactin	nn	13	SENT_175	[p8l217t2598r483b2666],
13	concentration	NN	O	concentration	dep	47	SENT_175	[p8l499t2598r915b2653],
14	in	IN	O	in	_	0	SENT_175	[p8l931t2598r987b2652],
15	females	NNS	O	female	prep_in	13	SENT_175	[p8l1002t2597r1230b2653],
16	with	IN	O	with	_	0	SENT_175	[p8l1245t2598r1384b2653],
17	chlorpromazine	NN	O	chlorpromazine	nn	19	SENT_175	[p8l1400t2598r1875b2666],
18	(	CD	NUMBER	(	num	19	SENT_175	[p8l1891t2598r2146b2666],
19	Meltzer	NNP	PERSON	Meltzer	prep_with	15	SENT_175	[p8l1891t2598r2146b2666],
20	et	FW	O	et	nn	21	SENT_175	[p8l8t2694r64b2741],
21	al.	FW	O	al.	dep	19	SENT_175	[p8l86t2686r164b2749],
22	,	,	O	,	_	0	SENT_175	[p8l86t2686r164b2749],
23	1983	CD	DATE	1983	appos	13	SENT_175	[p8l187t2689r346b2749],
24	;	:	O	;	_	0	SENT_175	[p8l187t2689r346b2749],
25	Harnryd	NNP	O	Harnryd	dep	23	SENT_175	[p8l374t2686r622b2755],
26	et	FW	O	et	nn	27	SENT_175	[p8l646t2694r702b2741],
27	al.	FW	O	al.	dep	25	SENT_175	[p8l724t2686r802b2750],
28	,	,	O	,	_	0	SENT_175	[p8l724t2686r802b2750],
29	1984	CD	DATE	1984	num	30	SENT_175	[p8l824t2686r1004b2754],
30	)	NN	O	)	appos	13	SENT_175	[p8l824t2686r1004b2754],
31	,	,	O	,	_	0	SENT_175	[p8l824t2686r1004b2754],
32	sulpiride	NN	O	sulpiride	nn	34	SENT_175	[p8l1028t2686r1290b2755],
33	(	CD	NUMBER	(	num	34	SENT_175	[p8l1313t2686r1585b2754],
34	Harnryd	NNP	O	Harnryd	appos	13	SENT_175	[p8l1313t2686r1585b2754],
35	et	FW	O	et	nn	36	SENT_175	[p8l1609t2694r1666b2741],
36	al.	FW	O	al.	dep	34	SENT_175	[p8l1687t2686r1765b2749],
37	,	,	O	,	_	0	SENT_175	[p8l1687t2686r1765b2749],
38	1984	CD	DATE	1984	num	39	SENT_175	[p8l1787t2686r1967b2754],
39	)	NN	O	)	appos	13	SENT_175	[p8l1787t2686r1967b2754],
40	,	,	O	,	_	0	SENT_175	[p8l1787t2686r1967b2754],
41	haloperidol	NN	O	haloperidol	nn	43	SENT_175	[p8l1991t2686r2144b2741, p8l8t2775r220b2844],
42	(	CD	NUMBER	(	num	43	SENT_175	[p8l239t2775r564b2843],
43	Linkowski	NNP	PERSON	Linkowski	appos	13	SENT_175	[p8l239t2775r564b2843],
44	et	FW	O	et	nn	45	SENT_175	[p8l584t2783r640b2830],
45	al.	FW	O	al.	dep	43	SENT_175	[p8l657t2775r736b2838],
46	,	,	O	,	_	0	SENT_175	[p8l657t2775r736b2838],
47	1984	CD	DATE	1984	dep	9	SENT_175	[p8l753t2778r912b2838],
48	;	:	O	;	_	0	SENT_175	[p8l753t2778r912b2838],
49	Yasui	NNP	PERSON	Yasui	dep	47	SENT_175	[p8l933t2775r1373b2830],
50	.	.	O	.	_	0	SENT_175	[p8l933t2775r1373b2830],

1	—	NN	O	—	_	0	SENT_176	[p8l933t2775r1373b2830],
2	.	.	O	.	_	0	SENT_176	[p8l933t2775r1373b2830],

1	Furukori	NNP	O	Furukori	_	0	SENT_177	[p8l933t2775r1373b2830],
2	et	FW	O	et	nn	3	SENT_177	[p8l1392t2783r1450b2830],
3	al.	FW	O	al.	dep	1	SENT_177	[p8l1466t2775r1544b2839],
4	,	,	O	,	_	0	SENT_177	[p8l1466t2775r1544b2839],
5	2001	CD	DATE	2001	num	6	SENT_177	[p8l1563t2775r1750b2843],
6	)	NN	O	)	appos	3	SENT_177	[p8l1563t2775r1750b2843],
7	,	,	O	,	_	0	SENT_177	[p8l1563t2775r1750b2843],
8	bromperidol	NN	O	bromperidol	nn	10	SENT_177	[p8l1769t2775r2144b2844],
9	(	CD	NUMBER	(	num	10	SENT_177	[p8l8t2865r185b2933],
10	Yasui	NNP	PERSON	Yasui	appos	3	SENT_177	[p8l8t2865r185b2933],
11	et	FW	O	et	nn	12	SENT_177	[p8l217t2873r274b2919],
12	al.	FW	O	al.	dep	1	SENT_177	[p8l303t2864r381b2928],
13	,	,	O	,	_	0	SENT_177	[p8l303t2864r381b2928],
14	1998	CD	DATE	1998	num	15	SENT_177	[p8l411t2865r589b2933],
15	)	NN	O	)	appos	12	SENT_177	[p8l411t2865r589b2933],
16	,	,	O	,	_	0	SENT_177	[p8l411t2865r589b2933],
17	nemonaprode	NN	O	nemonaprode	nn	18	SENT_177	[p8l622t2864r1043b2933],
18	(	NN	O	(	appos	1	SENT_177	[p8l1073t2864r1257b2933],
19	Otani	NNP	ORGANIZATION	Otani	dep	18	SENT_177	[p8l1073t2864r1257b2933],
20	et	FW	O	et	nn	21	SENT_177	[p8l1289t2873r1345b2919],
21	al.	FW	O	al.	dep	1	SENT_177	[p8l1374t2865r1452b2928],
22	,	,	O	,	_	0	SENT_177	[p8l1374t2865r1452b2928],
23	1997	CD	DATE	1997	num	24	SENT_177	[p8l1483t2864r1646b2933],
24	)	NN	O	)	conj_and	21	SENT_177	[p8l1483t2864r1646b2933],
25	and	CC	O	and	_	0	SENT_177	[p8l1677t2864r1787b2919],
26	olanzapine	NN	O	olanzapine	nn	28	SENT_177	[p8l1818t2864r2145b2933],
27	(	CD	NUMBER	(	num	28	SENT_177	[p8l8t2954r353b3022],
28	Sawamura	NNP	O	Sawamura	dep	1	SENT_177	[p8l8t2954r353b3022],
29	et	FW	O	et	nn	30	SENT_177	[p8l399t2962r456b3008],
30	al.	FW	O	al.	dep	1	SENT_177	[p8l500t2953r581b3017],
31	,	,	O	,	_	0	SENT_177	[p8l500t2953r581b3017],
32	2006	CD	DATE	2006	num	33	SENT_177	[p8l628t2953r822b3022],
33	)	NN	O	)	appos	30	SENT_177	[p8l628t2953r822b3022],
34	.	.	O	.	_	0	SENT_177	[p8l628t2953r822b3022],

1	Although	IN	O	although	mark	4	SENT_178	[p8l866t2953r1151b3022],
2	several	JJ	O	several	amod	3	SENT_178	[p8l1199t2953r1411b3008],
3	studies	NNS	O	study	nsubj	4	SENT_178	[p8l1459t2953r1672b3008],
4	suggested	VBD	O	suggest	advcl	37	SENT_178	[p8l1721t2953r2023b3022],
5	no	DT	O	no	det	6	SENT_178	[p8l2070t2969r2144b3008],
6	association	NN	O	association	dobj	4	SENT_178	[p8l8t3044r338b3098],
7	between	IN	O	between	_	0	SENT_178	[p8l358t3043r617b3098],
8	plasma	NN	O	plasma	nn	9	SENT_178	[p8l637t3043r851b3111],
9	concentration	NN	O	concentration	prep_between	4	SENT_178	[p8l871t3044r1286b3098],
10	of	IN	O	of	_	0	SENT_178	[p8l1307t3043r1369b3098],
11	prolactin	NN	O	prolactin	prep_of	9	SENT_178	[p8l1383t3043r1649b3111],
12	during	IN	O	during	_	0	SENT_178	[p8l1670t3043r1869b3111],
13	zotepine	NN	O	zotepine	nn	15	SENT_178	[p8l1888t3044r2145b3111],
14	(	CD	NUMBER	(	num	15	SENT_178	[p8l8t3132r192b3200],
15	Otani	NNP	ORGANIZATION	Otani	prep_during	4	SENT_178	[p8l8t3132r192b3200],
16	et	FW	O	et	nn	17	SENT_178	[p8l209t3140r265b3187],
17	al.	FW	O	al.	dep	15	SENT_178	[p8l279t3132r357b3195],
18	,	,	O	,	_	0	SENT_178	[p8l279t3132r357b3195],
19	1993	CD	DATE	1993	num	20	SENT_178	[p8l372t3132r537b3200],
20	)	NN	O	)	prep_during	4	SENT_178	[p8l372t3132r537b3200],
21	and	CC	O	and	_	0	SENT_178	[p8l553t3132r663b3187],
22	nemonapride	NN	O	nemonapride	nn	24	SENT_178	[p8l680t3132r1083b3200],
23	(	NN	O	(	nn	24	SENT_178	[p8l1099t3132r1283b3200],
24	Otani	NNP	ORGANIZATION	Otani	conj_and	20	SENT_178	[p8l1099t3132r1283b3200],
25	et	FW	O	et	nn	26	SENT_178	[p8l1299t3140r1356b3187],
26	al.	FW	O	al.	dep	20	SENT_178	[p8l1370t3132r1448b3195],
27	,	,	O	,	_	0	SENT_178	[p8l1370t3132r1448b3195],
28	1997	CD	DATE	1997	num	29	SENT_178	[p8l1463t3132r1641b3200],
29	)	NN	O	)	conj_and	15	SENT_178	[p8l1463t3132r1641b3200],
30	,	,	O	,	_	0	SENT_178	[p8l1463t3132r1641b3200],
31	and	CC	O	and	_	0	SENT_178	[p8l1657t3132r1766b3187],
32	age	NN	O	age	conj_and	15	SENT_178	[p8l1783t3147r1898b3200],
33	,	,	O	,	_	0	SENT_178	[p8l1783t3147r1898b3200],
34	age	NN	O	age	nsubjpass	37	SENT_178	[p8l1914t3147r2014b3200],
35	was	VBD	O	be	auxpass	37	SENT_178	[p8l2028t3147r2145b3187],
36	negatively	RB	O	negatively	advmod	37	SENT_178	[p8l9t3220r317b3289],
37	correlated	VBN	O	correlate	_	0	SENT_178	[p8l341t3220r642b3275],
38	with	IN	O	with	_	0	SENT_178	[p8l669t3220r808b3275],
39	plasma	NN	O	plasma	nn	41	SENT_178	[p8l834t3220r1048b3289],
40	prolactin	NN	O	prolactin	nn	41	SENT_178	[p8l1074t3220r1341b3289],
41	concentration	NN	O	concentration	prep_with	37	SENT_178	[p8l1368t3221r1783b3275],
42	in	IN	O	in	_	0	SENT_178	[p8l1810t3221r1865b3274],
43	multiple	JJ	O	multiple	amod	45	SENT_178	[p8l1893t3220r2144b3289],
44	regression	NN	O	regression	nn	45	SENT_178	[p8l9t3310r316b3378],
45	analyses	NNS	O	analysis	prep_in	41	SENT_178	[p8l345t3309r609b3378],
46	.	.	O	.	_	0	SENT_178	[p8l345t3309r609b3378],

1	These	DT	O	these	det	2	SENT_179	[p8l636t3309r811b3364],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_179	[p8l840t3309r1079b3378],
3	suggest	VBP	O	suggest	_	0	SENT_179	[p8l1110t3317r1335b3378],
4	that	IN	O	that	complm	8	SENT_179	[p8l1361t3309r1483b3364],
5	prolactin	NN	O	prolactin	nn	6	SENT_179	[p8l1509t3309r1776b3378],
6	response	NN	O	response	nsubjpass	8	SENT_179	[p8l1805t3325r2071b3378],
7	is	VBZ	O	be	auxpass	8	SENT_179	[p8l2101t3310r2144b3364],
8	associated	VBN	O	associate	ccomp	3	SENT_179	[p8l8t3398r314b3453],
9	with	IN	O	with	_	0	SENT_179	[p8l328t3398r468b3453],
10	estrogen	NN	O	estrogen	nn	11	SENT_179	[p8l482t3407r739b3467],
11	activity	NN	O	activity	prep_with	8	SENT_179	[p8l754t3399r975b3467],
12	because	IN	O	because	mark	15	SENT_179	[p8l988t3398r1225b3453],
13	estrogen	NN	O	estrogen	nsubj	15	SENT_179	[p8l1240t3407r1497b3467],
14	is	VBZ	O	be	cop	15	SENT_179	[p8l1513t3399r1557b3453],
15	one	CD	NUMBER	one	advcl	8	SENT_179	[p8l1573t3414r1681b3453],
16	of	IN	O	of	_	0	SENT_179	[p8l1697t3398r1759b3453],
17	the	DT	O	the	det	20	SENT_179	[p8l1767t3398r1863b3453],
18	prolactin	NN	O	prolactin	nn	20	SENT_179	[p8l1878t3398r2144b3467],
19	inhibitory	JJ	O	inhibitory	amod	20	SENT_179	[p8l9t3487r305b3556],
20	factors	NNS	O	factor	prep_of	15	SENT_179	[p8l325t3487r538b3543],
21	.	.	O	.	_	0	SENT_179	[p8l325t3487r538b3543],

1	No	DT	O	no	det	2	SENT_180	[p8l110t3580r190b3632],
2	correlations	NNS	O	correlation	nsubjpass	4	SENT_180	[p8l213t3577r560b3632],
3	were	VBD	O	be	auxpass	4	SENT_180	[p8l581t3593r729b3632],
4	found	VBN	O	find	_	0	SENT_180	[p8l752t3577r922b3632],
5	between	IN	O	between	_	0	SENT_180	[p8l944t3577r1200b3632],
6	plasma	NN	O	plasma	nn	8	SENT_180	[p8l1221t3577r1431b3645],
7	prolactin	NN	O	prolactin	nn	8	SENT_180	[p8l1453t3577r1714b3645],
8	concentration	NN	O	concentration	prep_between	4	SENT_180	[p8l1736t3578r2144b3632],
9	and	CC	O	and	_	0	SENT_180	[p9l8t17r116b72],
10	plasma	NN	O	plasma	nn	11	SENT_180	[p9l132t17r342b85],
11	concentrations	NNS	O	concentration	prep_between	4	SENT_180	[p9l356t18r792b72],
12	of	IN	O	of	_	0	SENT_180	[p9l807t17r870b72],
13	risperidone	NN	O	risperidone	nn	16	SENT_180	[p9l877t17r1213b85],
14	and	CC	O	and	_	0	SENT_180	[p9l1228t17r1336b72],
15	active	JJ	O	active	nn	16	SENT_180	[p9l1351t18r1521b72],
16	moiety	NN	O	moiety	prep_of	11	SENT_180	[p9l1537t18r1752b85],
17	.	.	O	.	_	0	SENT_180	[p9l1537t18r1752b85],

1	Our	PRP$	O	we	poss	3	SENT_181	[p9l1768t20r1879b72],
2	previous	JJ	O	previous	amod	3	SENT_181	[p9l1892t18r2144b85],
3	studies	NNS	O	study	nsubj	4	SENT_181	[p9l9t105r214b160],
4	showed	VBD	O	show	dep	21	SENT_181	[p9l237t105r464b160],
5	positive	JJ	O	positive	amod	6	SENT_181	[p9l486t106r714b174],
6	correlation	NN	O	correlation	dobj	4	SENT_181	[p9l735t105r1054b160],
7	between	IN	O	between	_	0	SENT_181	[p9l1074t105r1330b160],
8	plasma	NN	O	plasma	nn	10	SENT_181	[p9l1349t105r1560b174],
9	drug	NN	O	drug	nn	10	SENT_181	[p9l1580t105r1717b174],
10	concentration	NN	O	concentration	prep_between	4	SENT_181	[p9l1736t106r2144b160],
11	and	CC	O	and	_	0	SENT_181	[p9l8t194r116b249],
12	prolactin	NN	O	prolactin	nn	13	SENT_181	[p9l144t194r405b263],
13	concentration	NN	O	concentration	conj_and	10	SENT_181	[p9l431t195r839b249],
14	during	IN	O	during	_	0	SENT_181	[p9l866t194r1062b263],
15	bromperidol	NN	O	bromperidol	nn	18	SENT_181	[p9l1087t194r1456b263],
16	and	CC	O	and	_	0	SENT_181	[p9l1483t194r1591b249],
17	haloperidol	NN	O	haloperidol	nn	18	SENT_181	[p9l1620t194r1955b263],
18	treatments	NNS	O	treatment	prep_during	10	SENT_181	[p9l1981t202r2144b249, p9l9t292r190b338],
19	in	IN	O	in	_	0	SENT_181	[p9l228t284r283b338],
20	males	NNS	O	male	prep_in	4	SENT_181	[p9l319t284r489b338],
21	(	VBP	O	(	_	0	SENT_181	[p9l526t283r700b352],
22	Yasui	NNP	PERSON	Yasui	dobj	21	SENT_181	[p9l526t283r700b352],
23	et	FW	O	et	nn	24	SENT_181	[p9l736t292r792b338],
24	al.	FW	O	al.	nsubj	21	SENT_181	[p9l827t283r903b347],
25	,	,	O	,	_	0	SENT_181	[p9l827t283r903b347],
26	1998	CD	DATE	1998	appos	24	SENT_181	[p9l938t286r1094b347],
27	;	:	O	;	_	0	SENT_181	[p9l938t286r1094b347],
28	Yasui	NNP	PERSON	Yasui	dep	26	SENT_181	[p9l1133t283r1565b338],
29	.	.	O	.	_	0	SENT_181	[p9l1133t283r1565b338],

1	—	NN	O	—	_	0	SENT_182	[p9l1133t283r1565b338],
2	.	.	O	.	_	0	SENT_182	[p9l1133t283r1565b338],

1	Furukori	NNP	O	Furukori	_	0	SENT_183	[p9l1133t283r1565b338],
2	et	FW	O	et	nn	3	SENT_183	[p9l1602t292r1657b338],
3	al.	FW	O	al.	dep	1	SENT_183	[p9l1692t284r1768b347],
4	,	,	O	,	_	0	SENT_183	[p9l1692t284r1768b347],
5	2001	CD	DATE	2001	num	6	SENT_183	[p9l1805t284r1988b352],
6	)	NN	O	)	appos	3	SENT_183	[p9l1805t284r1988b352],
7	.	.	O	.	_	0	SENT_183	[p9l1805t284r1988b352],

1	This	DT	O	this	det	2	SENT_184	[p9l2022t283r2144b338],
2	discrepancy	NN	O	discrepancy	nsubjpass	6	SENT_184	[p9l8t372r360b441],
3	may	MD	O	may	aux	6	SENT_184	[p9l386t388r513b441],
4	be	VB	O	be	auxpass	6	SENT_184	[p9l537t373r606b427],
5	also	RB	O	also	advmod	6	SENT_184	[p9l633t373r747b427],
6	explained	VBN	O	explain	_	0	SENT_184	[p9l774t372r1060b441],
7	by	IN	O	by	_	0	SENT_184	[p9l1087t372r1159b441],
8	the	DT	O	the	det	10	SENT_184	[p9l1184t372r1278b427],
9	relative	JJ	O	relative	amod	10	SENT_184	[p9l1306t372r1523b427],
10	complexity	NN	O	complexity	agent	6	SENT_184	[p9l1550t372r1881b441],
11	in	IN	O	in	_	0	SENT_184	[p9l1907t373r1962b427],
12	pharmacological	JJ	O	pharmacological	amod	13	SENT_184	[p9l1987t373r2143b441, p9l9t462r356b530],
13	proﬁle	NN	O	proﬁle	prep_in	10	SENT_184	[p9l385t462r575b530],
14	of	IN	O	of	_	0	SENT_184	[p9l603t462r665b517],
15	risperidone	NN	O	risperidone	nn	18	SENT_184	[p9l685t462r1021b530],
16	and	CC	O	and	_	0	SENT_184	[p9l1049t462r1157b517],
17	active	JJ	O	active	nn	18	SENT_184	[p9l1186t463r1355b517],
18	metabolite	NN	O	metabolite	prep_of	13	SENT_184	[p9l1384t462r1712b525],
19	,	,	O	,	_	0	SENT_184	[p9l1384t462r1712b525],
20	9	CD	NUMBER	9	num	21	SENT_184	[p9l1741t462r2144b530],
21	—	NN	O	—	appos	18	SENT_184	[p9l1741t462r2144b530],
22	hydroxyris	NN	O	hydroxyri	nn	24	SENT_184	[p9l1741t462r2144b530],
23	—	NN	O	—	nn	24	SENT_184	[p9l1741t462r2144b530],
24	peridone	NN	O	peridone	dep	21	SENT_184	[p9l8t551r285b619],
25	.	.	O	.	_	0	SENT_184	[p9l8t551r285b619],

1	Risperidone	NNP	O	Risperidone	nsubj	5	SENT_185	[p9l310t551r659b619],
2	and	CC	O	and	_	0	SENT_185	[p9l682t551r790b606],
3	the	DT	O	the	det	4	SENT_185	[p9l813t551r908b606],
4	metabolite	NN	O	metabolite	conj_and	1	SENT_185	[p9l931t551r1246b606],
5	have	VBP	O	have	dep	20	SENT_185	[p9l1270t551r1406b606],
6	a	DT	O	a	det	9	SENT_185	[p9l1429t566r1460b606],
7	potent	JJ	O	potent	amod	9	SENT_185	[p9l1483t559r1675b619],
8	serotonin	NN	O	serotonin	nn	9	SENT_185	[p9l1698t551r1975b606],
9	5HT2	NN	O	5ht2	dobj	5	SENT_185	[p9l1998t554r2144b617],
10	and	CC	O	and	_	0	SENT_185	[p9l8t639r116b694],
11	a	DT	O	a	det	14	SENT_185	[p9l140t655r171b694],
12	milder	JJR	O	milder	amod	14	SENT_185	[p9l195t639r390b694],
13	dopamine	NN	O	dopamine	nn	14	SENT_185	[p9l411t639r708b708],
14	D2	NN	O	d2	conj_and	9	SENT_185	[p9l732t643r803b705],
15	antagonistic	JJ	O	antagonistic	amod	16	SENT_185	[p9l827t640r1184b708],
16	activity	NN	O	activity	dep	14	SENT_185	[p9l1207t640r1423b708],
17	than	IN	O	than	_	0	SENT_185	[p9l1445t639r1578b694],
18	conventional	JJ	O	conventional	amod	19	SENT_185	[p9l1602t639r1982b694],
19	antipsychotics	NNS	O	antipsychotic	prep_than	5	SENT_185	[p9l2006t640r2144b694, p9l8t728r312b797],
20	(	VBP	O	(	_	0	SENT_185	[p9l335t728r575b796],
21	Schotte	NNP	PERSON	Schotte	dobj	20	SENT_185	[p9l335t728r575b796],
22	et	FW	O	et	nn	23	SENT_185	[p9l597t736r653b783],
23	al.	FW	O	al.	nsubj	20	SENT_185	[p9l674t728r750b791],
24	,	,	O	,	_	0	SENT_185	[p9l674t728r750b791],
25	1995	CD	DATE	1995	num	26	SENT_185	[p9l771t728r948b796],
26	)	NN	O	)	appos	23	SENT_185	[p9l771t728r948b796],
27	.	.	O	.	_	0	SENT_185	[p9l771t728r948b796],

1	Because	IN	O	because	mark	5	SENT_186	[p9l971t731r1205b783],
2	prolactin	NN	O	prolactin	nn	3	SENT_186	[p9l1228t728r1489b797],
3	secretion	NN	O	secretion	nsubjpass	5	SENT_186	[p9l1511t729r1778b783],
4	is	VBZ	O	be	auxpass	5	SENT_186	[p9l1801t729r1843b783],
5	regulated	VBN	O	regulate	_	0	SENT_186	[p9l1867t728r2144b797],

1	1494	CD	DATE	1494	_	0	SENT_187	[p9l215t873r272b894],
2	N.	NNP	PERSON	N.	nn	3	SENT_187	[p9l643t874r665b894],
3	Yasui	NNP	PERSON	Yasui	dep	1	SENT_187	[p9l677t872r847b894],
4	.	.	O	.	_	0	SENT_187	[p9l677t872r847b894],

1	—	NN	O	—	_	0	SENT_188	[p9l677t872r847b894],
2	.	.	O	.	_	0	SENT_188	[p9l677t872r847b894],

1	Furukon	NN	PERSON	furukon	_	0	SENT_189	[p9l677t872r847b894],
2	'	''	O	'	_	0	SENT_189	[p9l677t872r847b894],
3	et	FW	O	et	nn	4	SENT_189	[p9l857t875r879b894],
4	al.	FW	O	al.	dep	1	SENT_189	[p9l887t872r912b894],
5	/	:	O	/	punct	6	SENT_189	[p9l921t872r932b899],
6	Progress	NNP	O	Progress	dep	4	SENT_189	[p9l940t874r1036b899],
7	in	IN	O	in	_	0	SENT_189	[p9l1046t873r1067b894],
8	Neuro	NNP	O	Neuro	prep_in	4	SENT_189	[p9l1077t872r1403b899],
9	.	.	O	.	_	0	SENT_189	[p9l1077t872r1403b899],

1	—	NN	O	—	_	0	SENT_190	[p9l1077t872r1403b899],
2	.	.	O	.	_	0	SENT_190	[p9l1077t872r1403b899],

1	Psychopharmacology	NN	O	psychopharmacology	_	0	SENT_191	[p9l1077t872r1403b899],
2	8	CD	NUMBER	8	num	1	SENT_191	[p9l1413t873r1435b894],
3	'	''	O	'	_	0	SENT_191	[p9l1413t873r1435b894],
4	Biological	JJ	O	biological	amod	5	SENT_191	[p9l1442t872r1554b899],
5	Psychiatry	NNP	O	Psychiatry	dep	1	SENT_191	[p9l1563t872r1682b899],
6	32	CD	NUMBER	32	num	5	SENT_191	[p9l1692t873r1721b894],
7	(	CD	NUMBER	(	num	8	SENT_191	[p9l1731t872r1808b899],
8	2008	CD	DATE	2008	dep	1	SENT_191	[p9l1731t872r1808b899],
9	)	CD	NUMBER	)	num	10	SENT_191	[p9l1731t872r1808b899],
10	1491-1495	CD	DATE	1491-1495	dep	8	SENT_191	[p9l1821t873r1945b894],

1	by	IN	O	by	_	0	SENT_192	[p9l9t1011r81b1080],
2	not	RB	O	not	neg	5	SENT_192	[p9l95t1019r192b1066],
3	only	RB	O	only	advmod	5	SENT_192	[p9l205t1011r333b1080],
4	dopamine	NN	O	dopamine	nn	5	SENT_192	[p9l347t1011r644b1080],
5	blockade	NN	O	blockade	prep_by	19	SENT_192	[p9l659t1011r921b1066],
6	but	CC	O	but	_	0	SENT_192	[p9l935t1011r1035b1066],
7	also	RB	O	also	_	0	SENT_192	[p9l1048t1011r1161b1066],
8	serotonin	NN	O	serotonin	conj_and	5	SENT_192	[p9l1178t1012r1456b1066],
9	blockade	NN	O	blockade	nn	11	SENT_192	[p9l1470t1011r1732b1066],
10	(	CD	NUMBER	(	num	11	SENT_192	[p9l1748t1011r1954b1079],
11	Rubin	NNP	PERSON	Rubin	dep	8	SENT_192	[p9l1748t1011r1954b1079],
12	,	,	O	,	_	0	SENT_192	[p9l1748t1011r1954b1079],
13	1987	CD	DATE	1987	num	14	SENT_192	[p9l1969t1011r2145b1079],
14	)	NN	O	)	appos	11	SENT_192	[p9l1969t1011r2145b1079],
15	,	,	O	,	_	0	SENT_192	[p9l1969t1011r2145b1079],
16	it	PRP	O	it	nsubj	19	SENT_192	[p9l10t1101r50b1155],
17	is	VBZ	O	be	cop	19	SENT_192	[p9l77t1101r119b1155],
18	not	RB	O	not	neg	19	SENT_192	[p9l148t1108r246b1155],
19	likely	JJ	O	likely	_	0	SENT_192	[p9l272t1100r430b1169],
20	that	IN	O	that	complm	24	SENT_192	[p9l456t1100r574b1155],
21	plasma	NN	O	plasma	nn	23	SENT_192	[p9l601t1100r811b1169],
22	drug	NN	O	drug	nn	23	SENT_192	[p9l838t1100r976b1169],
23	concentration	NN	O	concentration	nsubj	24	SENT_192	[p9l1003t1101r1411b1155],
24	correlated	VBD	O	correlate	ccomp	19	SENT_192	[p9l1438t1100r1735b1155],
25	directly	RB	O	directly	advmod	24	SENT_192	[p9l1763t1100r1985b1169],
26	with	IN	O	with	_	0	SENT_192	[p9l2009t1100r2146b1155],
27	prolactin	NN	O	prolactin	nn	28	SENT_192	[p9l10t1189r271b1258],
28	concentration	NN	O	concentration	prep_with	24	SENT_192	[p9l292t1190r713b1245],
29	.	.	O	.	_	0	SENT_192	[p9l292t1190r713b1245],

1	There	EX	O	there	expl	2	SENT_193	[p9l109t1278r282b1333],
2	is	VBZ	O	be	_	0	SENT_193	[p9l325t1279r368b1333],
3	some	DT	O	some	det	4	SENT_193	[p9l412t1294r572b1333],
4	evidence	NN	O	evidence	nsubj	2	SENT_193	[p9l614t1278r884b1333],
5	that	IN	O	that	complm	9	SENT_193	[p9l925t1278r1048b1333],
6	cholinergic	JJ	O	cholinergic	amod	7	SENT_193	[p9l1088t1278r1427b1347],
7	tone	NN	O	tone	nsubj	9	SENT_193	[p9l1467t1286r1601b1333],
8	might	MD	O	might	aux	9	SENT_193	[p9l1644t1278r1825b1347],
9	inﬂuence	VB	O	inﬂuence	ccomp	2	SENT_193	[p9l1865t1278r2146b1333],
10	prolactin	NN	O	prolactin	nn	11	SENT_193	[p9l10t1368r282b1436],
11	release	NN	O	release	dobj	9	SENT_193	[p9l316t1368r527b1423],
12	(	CD	NUMBER	(	num	11	SENT_193	[p9l561t1368r703b1436],
13	Chu	NNP	O	Chu	dep	9	SENT_193	[p9l561t1368r703b1436],
14	et	FW	O	et	nn	15	SENT_193	[p9l736t1376r793b1423],
15	al.	FW	O	al.	dep	13	SENT_193	[p9l824t1368r904b1431],
16	,	,	O	,	_	0	SENT_193	[p9l824t1368r904b1431],
17	2001	CD	DATE	2001	appos	15	SENT_193	[p9l938t1371r1108b1431],
18	;	:	O	;	_	0	SENT_193	[p9l938t1371r1108b1431],
19	Lima	NNP	LOCATION	Lima	dep	15	SENT_193	[p9l1146t1369r1292b1423],
20	et	FW	O	et	nn	21	SENT_193	[p9l1325t1376r1382b1423],
21	al.	FW	O	al.	dep	19	SENT_193	[p9l1413t1368r1493b1431],
22	,	,	O	,	_	0	SENT_193	[p9l1413t1368r1493b1431],
23	2001	CD	DATE	2001	num	24	SENT_193	[p9l1527t1368r1718b1436],
24	)	NN	O	)	appos	21	SENT_193	[p9l1527t1368r1718b1436],
25	.	.	O	.	_	0	SENT_193	[p9l1527t1368r1718b1436],

1	However	RB	O	however	advmod	6	SENT_194	[p9l1752t1371r2037b1431],
2	,	,	O	,	_	0	SENT_194	[p9l1752t1371r2037b1431],
3	no	DT	O	no	det	4	SENT_194	[p9l2072t1384r2146b1423],
4	difference	NN	O	difference	nsubjpass	6	SENT_194	[p9l10t1456r314b1512],
5	was	VBD	O	be	auxpass	6	SENT_194	[p9l346t1472r463b1512],
6	found	VBN	O	find	conj_and	6	SENT_194	[p9l498t1456r674b1512],
7	in	IN	O	in	_	0	SENT_194	[p9l709t1457r765b1511],
8	plasma	NN	O	plasma	nn	10	SENT_194	[p9l797t1457r1015b1525],
9	prolactin	NN	O	prolactin	nn	10	SENT_194	[p9l1048t1457r1320b1525],
10	concentration	NN	O	concentration	prep_in	6	SENT_194	[p9l1354t1457r1779b1512],
11	in	IN	O	in	_	0	SENT_194	[p9l1812t1457r1869b1511],
12	patients	NNS	O	patient	prep_in	10	SENT_194	[p9l1901t1457r2146b1525],
13	with	IN	O	with	_	0	SENT_194	[p9l8t1545r149b1600],
14	and	CC	O	and	_	0	SENT_194	[p9l177t1545r288b1600],
15	without	IN	O	without	_	0	SENT_194	[p9l316t1545r562b1600],
16	anticholinergic	JJ	O	anticholinergic	amod	17	SENT_194	[p9l588t1545r1048b1614],
17	agents	NNS	O	agent	prep_without	6	SENT_194	[p9l1074t1553r1286b1614],
18	.	.	O	.	_	0	SENT_194	[p9l1074t1553r1286b1614],

1	It	PRP	O	it	nsubj	3	SENT_195	[p9l1316t1548r1359b1600],
2	is	VBZ	O	be	cop	3	SENT_195	[p9l1386t1546r1430b1600],
3	possible	JJ	O	possible	_	0	SENT_195	[p9l1460t1545r1706b1614],
4	that	IN	O	that	complm	14	SENT_195	[p9l1734t1545r1857b1600],
5	substantially	RB	O	substantially	advmod	7	SENT_195	[p9l1885t1545r2145b1600, p9l9t1634r162b1703],
6	elevated	JJ	O	elevated	amod	7	SENT_195	[p9l196t1634r451b1689],
7	prolactin	NN	O	prolactin	nsubj	14	SENT_195	[p9l490t1634r762b1703],
8	during	IN	O	during	_	0	SENT_195	[p9l800t1634r1002b1703],
9	risperidone	NN	O	risperidone	nn	10	SENT_195	[p9l1039t1634r1389b1703],
10	treatment	NN	O	treatment	prep_during	7	SENT_195	[p9l1425t1642r1733b1689],
11	might	MD	O	might	aux	14	SENT_195	[p9l1769t1634r1951b1703],
12	mask	NN	O	mask	nn	14	SENT_195	[p9l1987t1634r2148b1689],
13	signiﬁcant	JJ	O	signiﬁcant	amod	14	SENT_195	[p9l10t1723r328b1792],
14	alterations	NNS	O	alteration	ccomp	3	SENT_195	[p9l350t1723r674b1778],
15	in	IN	O	in	_	0	SENT_195	[p9l700t1724r755b1778],
16	the	DT	O	the	det	18	SENT_195	[p9l780t1723r877b1778],
17	anticholinergic	JJ	O	anticholinergic	amod	18	SENT_195	[p9l901t1723r1361b1792],
18	effects	NNS	O	effect	prep_in	14	SENT_195	[p9l1384t1723r1595b1779],
19	.	.	O	.	_	0	SENT_195	[p9l1384t1723r1595b1779],

1	It	PRP	O	it	nsubjpass	4	SENT_196	[p9l112t1816r154b1868],
2	should	MD	O	should	aux	4	SENT_196	[p9l180t1813r380b1868],
3	be	VB	O	be	auxpass	4	SENT_196	[p9l407t1813r477b1868],
4	noted	VBN	O	note	_	0	SENT_196	[p9l504t1813r674b1868],
5	that	IN	O	that	complm	16	SENT_196	[p9l702t1813r823b1868],
6	the	DT	O	the	det	7	SENT_196	[p9l847t1813r943b1868],
7	incidence	NN	O	incidence	nsubjpass	16	SENT_196	[p9l971t1813r1255b1868],
8	of	IN	O	of	_	0	SENT_196	[p9l1283t1813r1347b1868],
9	side	JJ	O	side	amod	10	SENT_196	[p9l1367t1813r1483b1868],
10	effects	NNS	O	effect	prep_of	7	SENT_196	[p9l1511t1813r1702b1868],
11	related	VBN	O	relate	partmod	10	SENT_196	[p9l1731t1813r1937b1868],
12	to	TO	O	to	_	0	SENT_196	[p9l1965t1821r2022b1868],
13	hyperprolactinemia	NN	O	hyperprolactinemia	prep_to	11	SENT_196	[p9l2050t1813r2145b1881, p9l10t1902r526b1970],
14	was	VBD	O	be	auxpass	16	SENT_196	[p9l538t1917r655b1957],
15	not	RB	O	not	neg	16	SENT_196	[p9l671t1910r770b1957],
16	evaluated	VBN	O	evaluate	ccomp	4	SENT_196	[p9l784t1902r1072b1957],
17	in	IN	O	in	_	0	SENT_196	[p9l1089t1902r1145b1956],
18	the	DT	O	the	det	20	SENT_196	[p9l1160t1902r1256b1957],
19	present	JJ	DATE	present	amod	20	SENT_196	[p9l1272t1910r1497b1970],
20	study	NN	O	study	prep_in	16	SENT_196	[p9l1512t1902r1686b1970],
21	.	.	O	.	_	0	SENT_196	[p9l1512t1902r1686b1970],

1	In	IN	O	in	_	0	SENT_197	[p9l1704t1905r1760b1956],
2	large	JJ	O	large	amod	4	SENT_197	[p9l1776t1902r1921b1970],
3	clinical	JJ	O	clinical	amod	4	SENT_197	[p9l1938t1902r2146b1957],
4	trials	NNS	O	trial	prep_in	17	SENT_197	[p9l9t1990r172b2053],
5	,	,	O	,	_	0	SENT_197	[p9l9t1990r172b2053],
6	risperidone	NN	O	risperidone	nn	7	SENT_197	[p9l193t1990r872b2059],
7	—	NN	O	—	nsubjpass	17	SENT_197	[p9l193t1990r872b2059],
8	associated	VBN	O	associate	partmod	7	SENT_197	[p9l193t1990r872b2059],
9	increase	NN	O	increase	dobj	8	SENT_197	[p9l892t1991r1137b2045],
10	in	IN	O	in	_	0	SENT_197	[p9l1157t1991r1212b2044],
11	serum	NN	O	serum	nn	13	SENT_197	[p9l1233t2006r1421b2045],
12	prolactin	NN	O	prolactin	nn	13	SENT_197	[p9l1440t1990r1706b2059],
13	levels	NNS	O	level	prep_in	9	SENT_197	[p9l1726t1990r1893b2045],
14	was	VBD	O	be	auxpass	17	SENT_197	[p9l1912t2006r2029b2045],
15	not	RB	O	not	neg	17	SENT_197	[p9l2049t1998r2148b2045],
16	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_197	[p9l10t2079r375b2148],
17	correlated	VBD	O	correlate	dep	28	SENT_197	[p9l399t2079r700b2134],
18	to	TO	O	to	_	0	SENT_197	[p9l728t2087r785b2134],
19	the	DT	O	the	det	20	SENT_197	[p9l811t2079r907b2134],
20	emergence	NN	O	emergence	prep_to	17	SENT_197	[p9l935t2095r1263b2148],
21	of	IN	O	of	_	0	SENT_197	[p9l1291t2079r1354b2134],
22	possible	JJ	O	possible	amod	24	SENT_197	[p9l1374t2079r1615b2148],
23	prolactin	NN	O	prolactin	nn	24	SENT_197	[p9l1642t2079r2146b2148],
24	—	NN	O	—	prep_of	20	SENT_197	[p9l1642t2079r2146b2148],
25	related	JJ	O	related	amod	27	SENT_197	[p9l1642t2079r2146b2148],
26	side	JJ	O	side	amod	27	SENT_197	[p9l10t2168r128b2223],
27	effects	NNS	O	effect	nsubj	28	SENT_197	[p9l149t2168r340b2223],
28	(	VBP	O	(	_	0	SENT_197	[p9l362t2168r675b2237],
29	Kleinberg	NNP	PERSON	Kleinberg	nsubj	31	SENT_197	[p9l362t2168r675b2237],
30	et	FW	O	et	nn	31	SENT_197	[p9l695t2177r752b2223],
31	al.	FW	O	al.	xcomp	28	SENT_197	[p9l771t2169r849b2232],
32	,	,	O	,	_	0	SENT_197	[p9l771t2169r849b2232],
33	1999	CD	DATE	1999	num	34	SENT_197	[p9l870t2168r1049b2237],
34	)	NN	O	)	appos	31	SENT_197	[p9l870t2168r1049b2237],
35	.	.	O	.	_	0	SENT_197	[p9l870t2168r1049b2237],

1	This	DT	DATE	this	nsubj	3	SENT_198	[p9l1068t2168r1191b2223],
2	may	MD	DATE	may	aux	3	SENT_198	[p9l1214t2184r1343b2237],
3	result	VB	O	result	_	0	SENT_198	[p9l1363t2168r1532b2223],
4	from	IN	O	from	_	0	SENT_198	[p9l1553t2168r1695b2223],
5	a	DT	O	a	det	7	SENT_198	[p9l1716t2184r1747b2223],
6	considerable	JJ	O	considerable	amod	7	SENT_198	[p9l1768t2168r2146b2223],
7	number	NN	O	number	nsubj	10	SENT_198	[p9l10t2257r249b2312],
8	of	IN	O	of	_	0	SENT_198	[p9l279t2257r342b2312],
9	patients	NNS	O	patient	prep_of	7	SENT_198	[p9l367t2258r607b2326],
10	having	VBG	O	have	prepc_from	3	SENT_198	[p9l641t2257r843b2326],
11	no	DT	O	no	det	13	SENT_198	[p9l874t2273r948b2312],
12	adverse	JJ	O	adverse	amod	13	SENT_198	[p9l981t2257r1210b2312],
13	effects	NNS	O	effect	dobj	10	SENT_198	[p9l1244t2257r1435b2312],
14	despite	IN	O	despite	_	0	SENT_198	[p9l1469t2257r1684b2326],
15	having	VBG	O	have	prepc_despite	10	SENT_198	[p9l1718t2257r1919b2326],
16	a	DT	O	a	det	19	SENT_198	[p9l1950t2273r1981b2312],
17	high	JJ	O	high	amod	19	SENT_198	[p9l2015t2257r2146b2326],
18	prolactin	NN	O	prolactin	nn	19	SENT_198	[p9l10t2347r276b2415],
19	level	NN	O	level	dobj	15	SENT_198	[p9l305t2347r457b2402],
20	.	.	O	.	_	0	SENT_198	[p9l305t2347r457b2402],

1	Nevertheless	RB	O	nevertheless	advmod	10	SENT_199	[p9l488t2347r886b2410],
2	,	,	O	,	_	0	SENT_199	[p9l488t2347r886b2410],
3	prolactin	NN	O	prolactin	nn	4	SENT_199	[p9l917t2347r1184b2415],
4	monitoring	NN	O	monitoring	nsubjpass	10	SENT_199	[p9l1212t2348r1550b2415],
5	during	IN	O	during	_	0	SENT_199	[p9l1578t2347r1777b2415],
6	risperidone	NN	O	risperidone	nn	7	SENT_199	[p9l1804t2347r2147b2415],
7	treatment	NN	O	treatment	prep_during	4	SENT_199	[p9l9t2444r311b2491],
8	should	MD	O	should	aux	10	SENT_199	[p9l341t2436r540b2491],
9	be	VB	O	be	auxpass	10	SENT_199	[p9l571t2436r641b2491],
10	conducted	VBN	O	conduct	_	0	SENT_199	[p9l672t2436r983b2491],
11	especially	RB	O	especially	advmod	10	SENT_199	[p9l1016t2436r1309b2504],
12	in	IN	O	in	_	0	SENT_199	[p9l1338t2436r1395b2490],
13	premenopausal	JJ	O	premenopausal	amod	14	SENT_199	[p9l1424t2436r1888b2504],
14	women	NNS	O	woman	prep_in	10	SENT_199	[p9l1918t2451r2146b2491],
15	who	WP	O	who	nsubj	17	SENT_199	[p9l8t2524r141b2579],
16	possibly	RB	O	possibly	advmod	17	SENT_199	[p9l182t2524r425b2593],
17	suffer	VBP	O	suffer	rcmod	14	SENT_199	[p9l464t2524r634b2579],
18	from	IN	O	from	_	0	SENT_199	[p9l672t2524r815b2579],
19	potential	JJ	O	potential	amod	21	SENT_199	[p9l854t2524r1121b2593],
20	adverse	JJ	O	adverse	amod	21	SENT_199	[p9l1160t2524r1391b2579],
21	effects	NNS	O	effect	prep_from	17	SENT_199	[p9l1431t2524r1621b2579],
22	associated	VBN	O	associate	partmod	21	SENT_199	[p9l1662t2524r1969b2579],
23	with	IN	O	with	_	0	SENT_199	[p9l2008t2524r2146b2579],
24	hyperprolactinemia	NN	O	hyperprolactinemia	prep_with	22	SENT_199	[p9l10t2613r614b2682],
25	.	.	O	.	_	0	SENT_199	[p9l10t2613r614b2682],

1	In	IN	O	in	_	0	SENT_200	[p9l112t2706r169b2757],
2	conclusion	NN	O	conclusion	prep_in	6	SENT_200	[p9l200t2702r542b2766],
3	,	,	O	,	_	0	SENT_200	[p9l200t2702r542b2766],
4	these	DT	O	these	det	5	SENT_200	[p9l575t2702r737b2757],
5	ﬁndings	NNS	O	ﬁndings	nsubj	6	SENT_200	[p9l769t2702r1014b2771],
6	suggest	VBP	O	suggest	_	0	SENT_200	[p9l1047t2710r1276b2771],
7	that	IN	O	that	complm	15	SENT_200	[p9l1306t2702r1429b2757],
8	plasma	NN	O	plasma	nn	10	SENT_200	[p9l1459t2702r1676b2771],
9	prolactin	NN	O	prolactin	nn	10	SENT_200	[p9l1708t2702r1980b2771],
10	concentrations	NNS	O	concentration	nsubj	15	SENT_200	[p9l2012t2718r2146b2757, p9l10t2792r352b2846],
11	in	IN	O	in	_	0	SENT_200	[p9l375t2792r431b2846],
12	females	NNS	O	female	prep_in	10	SENT_200	[p9l454t2791r687b2846],
13	are	VBP	O	be	cop	15	SENT_200	[p9l709t2807r802b2846],
14	much	RB	O	much	advmod	15	SENT_200	[p9l825t2791r996b2846],
15	higher	JJR	O	higher	ccomp	6	SENT_200	[p9l1018t2791r1217b2860],
16	than	IN	O	than	mark	34	SENT_200	[p9l1236t2791r1374b2846],
17	in	IN	O	in	dep	30	SENT_200	[p9l1396t2792r1452b2846],
18	males	NNS	O	male	pobj	17	SENT_200	[p9l1474t2791r1666b2855],
19	,	,	O	,	_	0	SENT_200	[p9l1474t2791r1666b2855],
20	but	CC	O	but	_	0	SENT_200	[p9l1688t2791r1791b2846],
21	the	DT	O	the	det	24	SENT_200	[p9l1810t2791r1907b2846],
22	plasma	NN	O	plasma	nn	24	SENT_200	[p9l1930t2791r2147b2860],
23	drug	NN	O	drug	nn	24	SENT_200	[p9l10t2881r151b2949],
24	concentrations	NNS	O	concentration	conj_but	17	SENT_200	[p9l184t2882r638b2936],
25	or	CC	O	or	_	0	SENT_200	[p9l672t2897r736b2936],
26	the	DT	O	the	det	28	SENT_200	[p9l767t2881r865b2936],
27	dopamine	NN	O	dopamine	nn	28	SENT_200	[p9l899t2881r1449b2949],
28	—	NN	O	—	conj_but	17	SENT_200	[p9l899t2881r1449b2949],
29	related	JJ	O	related	amod	30	SENT_200	[p9l899t2881r1449b2949],
30	variants	NNS	O	variant	nsubjpass	34	SENT_200	[p9l1482t2882r1726b2936],
31	are	VBP	O	be	auxpass	34	SENT_200	[p9l1761t2897r1853b2936],
32	not	RB	O	not	neg	34	SENT_200	[p9l1888t2889r1988b2936],
33	predominantly	RB	O	predominantly	advmod	34	SENT_200	[p9l2021t2897r2146b2949, p9l10t2970r365b3038],
34	associated	VBN	O	associate	ccomp	15	SENT_200	[p9l386t2970r699b3025],
35	with	IN	O	with	_	0	SENT_200	[p9l722t2970r863b3025],
36	plasma	NN	O	plasma	nn	37	SENT_200	[p9l888t2970r1105b3038],
37	concentration	NN	O	concentration	prep_with	34	SENT_200	[p9l1129t2970r1553b3025],
38	of	IN	O	of	_	0	SENT_200	[p9l1578t2969r1641b3025],
39	prolactin	NN	O	prolactin	prep_of	37	SENT_200	[p9l1658t2970r1945b3038],
40	.	.	O	.	_	0	SENT_200	[p9l1658t2970r1945b3038],

1	Acknowledgement	NN	O	acknowledgement	_	0	SENT_201	[p9l6t3148r613b3217],

1	All	DT	O	all	det	2	SENT_202	[p9l109t3326r190b3381],
2	authors	NNS	O	author	nsubj	3	SENT_202	[p9l224t3326r450b3381],
3	indicate	VBP	O	indicate	_	0	SENT_202	[p9l486t3326r722b3381],
4	there	EX	O	there	expl	5	SENT_202	[p9l757t3326r912b3381],
5	is	VBZ	O	be	ccomp	3	SENT_202	[p9l948t3327r991b3381],
6	no	DT	O	no	det	7	SENT_202	[p9l1027t3342r1101b3381],
7	duality	NN	O	duality	nsubj	5	SENT_202	[p9l1135t3326r1345b3395],
8	of	IN	O	of	_	0	SENT_202	[p9l1376t3326r1439b3381],
9	interest	NN	O	interest	prep_of	7	SENT_202	[p9l1466t3327r1695b3381],
10	that	WDT	O	that	nsubjpass	13	SENT_202	[p9l1726t3326r1846b3381],
11	could	MD	O	could	aux	13	SENT_202	[p9l1880t3326r2042b3381],
12	be	VB	O	be	auxpass	13	SENT_202	[p9l2076t3326r2146b3381],
13	perceived	VBN	O	perceive	rcmod	7	SENT_202	[p9l10t3416r299b3484],
14	to	TO	O	to	_	0	SENT_202	[p9l314t3424r371b3471],
15	bias	NN	O	bias	prep_to	13	SENT_202	[p9l386t3416r503b3471],
16	this	DT	O	this	det	17	SENT_202	[p9l518t3416r626b3471],
17	work	NN	O	work	dep	15	SENT_202	[p9l640t3416r810b3471],
18	.	.	O	.	_	0	SENT_202	[p9l640t3416r810b3471],

1	This	DT	O	this	det	2	SENT_203	[p9l823t3416r947b3471],
2	study	NN	O	study	nsubjpass	4	SENT_203	[p9l963t3416r1128b3484],
3	was	VBD	O	be	auxpass	4	SENT_203	[p9l1140t3432r1257b3471],
4	supported	VBN	O	support	_	0	SENT_203	[p9l1273t3416r1576b3484],
5	by	IN	O	by	_	0	SENT_203	[p9l1592t3416r1664b3484],
6	a	DT	O	a	det	7	SENT_203	[p9l1676t3432r1707b3471],
7	grant	NN	O	grant	agent	4	SENT_203	[p9l1720t3424r1881b3484],
8	from	IN	O	from	_	0	SENT_203	[p9l1894t3416r2036b3471],
9	the	DT	O	the	det	12	SENT_203	[p9l2050t3416r2147b3471],
10	Hirosaki	NNP	ORGANIZATION	Hirosaki	nn	12	SENT_203	[p9l10t3504r256b3558],
11	Research	NNP	ORGANIZATION	Research	nn	12	SENT_203	[p9l287t3504r553b3558],
12	Institute	NNP	ORGANIZATION	Institute	prep_from	7	SENT_203	[p9l583t3504r831b3558],
13	for	IN	ORGANIZATION	for	_	0	SENT_203	[p9l863t3503r947b3558],
14	Neurosciences	NNP	ORGANIZATION	Neurosciences	prep_for	4	SENT_203	[p9l975t3504r1418b3566],
15	,	,	O	,	_	0	SENT_203	[p9l975t3504r1418b3566],
16	a	DT	O	a	det	17	SENT_203	[p9l1450t3519r1481b3558],
17	Grant	NNP	O	Grant	appos	14	SENT_203	[p9l1511t3506r1679b3558],
18	from	IN	O	from	_	0	SENT_203	[p9l1708t3503r1851b3558],
19	Research	NNP	O	Research	prep_from	17	SENT_203	[p9l1882t3504r2147b3558],

1	Group	NN	O	group	dep	14	SENT_204	[p10l10t22r195b88],
2	For	IN	O	for	_	0	SENT_204	[p10l227t22r321b74],
3	Schizophrenia	NNP	O	Schizophrenia	prep_for	1	SENT_204	[p10l352t19r790b88],
4	,	,	O	,	_	0	SENT_204	[p10l352t19r790b88],
5	Japan	NNP	LOCATION	Japan	prep_for	1	SENT_204	[p10l814t22r999b88],
6	,	,	O	,	_	0	SENT_204	[p10l814t22r999b88],
7	Health	NNP	ORGANIZATION	Health	prep_for	1	SENT_204	[p10l1032t19r1229b74],
8	and	CC	ORGANIZATION	and	_	0	SENT_204	[p10l1261t19r1371b74],
9	Labor	NNP	ORGANIZATION	Labor	prep_for	1	SENT_204	[p10l1404t19r1570b74],
10	Sciences	NNP	ORGANIZATION	Sciences	nn	14	SENT_204	[p10l1599t20r1848b74],
11	Research	NNP	ORGANIZATION	Research	nn	14	SENT_204	[p10l1882t19r2147b74],
12	Grants	NNPS	ORGANIZATION	Grants	nn	14	SENT_204	[p10l10t111r206b163],
13	(	NNP	O	(	nn	14	SENT_204	[p10l230t108r520b176],
14	Research	NNP	O	Research	_	0	SENT_204	[p10l230t108r520b176],
15	on	IN	O	on	_	0	SENT_204	[p10l543t124r618b163],
16	Psychiatric	NNP	MISC	Psychiatric	prep_on	14	SENT_204	[p10l642t108r966b177],
17	and	CC	O	and	_	0	SENT_204	[p10l988t108r1098b163],
18	Neurological	JJ	ORGANIZATION	neurological	amod	19	SENT_204	[p10l1123t108r1500b177],
19	Diseases	NNS	ORGANIZATION	disease	conj_and	14	SENT_204	[p10l1525t109r1776b163],
20	and	CC	ORGANIZATION	and	_	0	SENT_204	[p10l1802t108r1911b163],
21	Mental	NNP	ORGANIZATION	Mental	nn	22	SENT_204	[p10l1937t108r2146b163],
22	Health	NNP	ORGANIZATION	Health	conj_and	14	SENT_204	[p10l10t197r231b266],
23	)	CD	NUMBER	)	number	24	SENT_204	[p10l10t197r231b266],
24	(	CD	NUMBER	(	dep	14	SENT_204	[p10l250t197r810b266],
25	H18	NN	O	h18	dep	24	SENT_204	[p10l250t197r810b266],
26	.	.	O	.	_	0	SENT_204	[p10l250t197r810b266],

1	—	NN	O	—	_	0	SENT_205	[p10l250t197r810b266],
2	.	.	O	.	_	0	SENT_205	[p10l250t197r810b266],

1	l	NN	O	l	_	0	SENT_206	[p10l250t197r810b266],
2	<	JJR	O	<	amod	3	SENT_206	[p10l250t197r810b266],
3	ol	NN	O	ol	dep	4	SENT_206	[p10l250t197r810b266],
4	<	JJR	O	<	dep	1	SENT_206	[p10l250t197r810b266],
5	oro	CD	NUMBER	oro	dep	4	SENT_206	[p10l250t197r810b266],
6	.	.	O	.	_	0	SENT_206	[p10l250t197r810b266],

1	—	NN	O	—	_	0	SENT_207	[p10l250t197r810b266],
2	.	.	O	.	_	0	SENT_207	[p10l250t197r810b266],

1	OO2	NN	O	oo2	nn	2	SENT_208	[p10l250t197r810b266],
2	)	NN	O	)	_	0	SENT_208	[p10l250t197r810b266],
3	,	,	O	,	_	0	SENT_208	[p10l250t197r810b266],
4	Grant	NNP	PERSON	Grant	appos	2	SENT_208	[p10l832t197r1242b252],
5	.	.	O	.	_	0	SENT_208	[p10l832t197r1242b252],

1	—	NN	O	—	_	0	SENT_209	[p10l832t197r1242b252],
2	.	.	O	.	_	0	SENT_209	[p10l832t197r1242b252],

1	in	IN	O	in	_	0	SENT_210	[p10l832t197r1242b252],
2	.	.	O	.	_	0	SENT_210	[p10l832t197r1242b252],

1	—	NN	O	—	_	0	SENT_211	[p10l832t197r1242b252],
2	.	.	O	.	_	0	SENT_211	[p10l832t197r1242b252],

1	Aids	NNS	MISC	aid	nsubj	16	SENT_212	[p10l832t197r1242b252],
2	from	IN	O	from	_	0	SENT_212	[p10l1262t197r1405b252],
3	the	DT	O	the	det	5	SENT_212	[p10l1423t197r1519b252],
4	Japanese	NNP	ORGANIZATION	Japanese	nn	5	SENT_212	[p10l1531t201r1800b266],
5	Ministry	NNP	ORGANIZATION	Ministry	prep_from	1	SENT_212	[p10l1820t198r2074b266],
6	of	IN	ORGANIZATION	of	_	0	SENT_212	[p10l2091t197r2154b252],
7	Education	NNP	ORGANIZATION	Education	prep_of	5	SENT_212	[p10l10t286r322b350],
8	,	,	O	,	_	0	SENT_212	[p10l10t286r322b350],
9	Culture	NNP	O	Culture	prep_of	5	SENT_212	[p10l347t286r579b350],
10	,	,	O	,	_	0	SENT_212	[p10l347t286r579b350],
11	Sports	NNP	O	Sports	prep_of	5	SENT_212	[p10l604t289r805b355],
12	,	,	O	,	_	0	SENT_212	[p10l604t289r805b355],
13	Science	NNP	O	Science	prep_of	5	SENT_212	[p10l831t287r1052b341],
14	and	CC	O	and	_	0	SENT_212	[p10l1076t286r1185b341],
15	Technology	NNP	O	Technology	prep_of	5	SENT_212	[p10l1207t286r1554b355],
16	(	CD	NUMBER	(	_	0	SENT_212	[p10l1576t286r1958b355],
17	#	#	MONEY	#	number	18	SENT_212	[p10l1576t286r1958b355],
18	18591270	CD	MONEY	18591270	num	19	SENT_212	[p10l1576t286r1958b355],
19	)	NN	O	)	dobj	16	SENT_212	[p10l1576t286r1958b355],
20	and	CC	O	and	_	0	SENT_212	[p10l1981t286r2091b341],
21	a	DT	O	a	det	22	SENT_212	[p10l2116t302r2147b341],
22	Grant	NNP	O	Grant	dobj	16	SENT_212	[p10l10t379r178b431],
23	for	IN	O	for	_	0	SENT_212	[p10l213t376r297b431],
24	Priority	NNP	O	Priority	nn	26	SENT_212	[p10l329t377r554b444],
25	Research	NNP	O	Research	nn	26	SENT_212	[p10l588t376r853b431],
26	Designated	NNP	O	Designated	prep_for	22	SENT_212	[p10l888t376r1220b444],
27	by	IN	O	by	_	0	SENT_212	[p10l1256t376r1328b444],
28	the	DT	O	the	det	29	SENT_212	[p10l1361t376r1456b431],
29	president	NN	O	president	prep_by	16	SENT_212	[p10l1492t376r1777b444],
30	of	IN	O	of	_	0	SENT_212	[p10l1809t376r1873b431],
31	Hirosaki	NNP	ORGANIZATION	Hirosaki	nn	32	SENT_212	[p10l1900t376r2146b431],
32	University	NNP	ORGANIZATION	University	prep_of	29	SENT_212	[p10l9t465r326b533],
33	.	.	O	.	_	0	SENT_212	[p10l9t465r326b533],

1	References	NNS	O	reference	_	0	SENT_213	[p10l9t630r356b685],

1	Alenius	NNP	PERSON	Alenius	nn	23	SENT_214	[p10l7t754r202b804],
2	,	,	O	,	_	0	SENT_214	[p10l7t754r202b804],
3	M.	NNP	O	M.	appos	23	SENT_214	[p10l223t756r294b804],
4	,	,	O	,	_	0	SENT_214	[p10l223t756r294b804],
5	Wadelius	NNP	PERSON	Wadelius	appos	23	SENT_214	[p10l313t754r553b804],
6	,	,	O	,	_	0	SENT_214	[p10l313t754r553b804],
7	M.	NNP	O	M.	appos	23	SENT_214	[p10l575t756r646b804],
8	,	,	O	,	_	0	SENT_214	[p10l575t756r646b804],
9	Dahl	NNP	PERSON	Dahl	appos	23	SENT_214	[p10l666t754r789b804],
10	,	,	O	,	_	0	SENT_214	[p10l666t754r789b804],
11	M.L.	NNP	LOCATION	M.L.	appos	23	SENT_214	[p10l810t756r920b804],
12	,	,	O	,	_	0	SENT_214	[p10l810t756r920b804],
13	Hartvig	NNP	PERSON	Hartvig	appos	23	SENT_214	[p10l942t754r1134b808],
14	,	,	O	,	_	0	SENT_214	[p10l942t754r1134b808],
15	P.	NNP	O	P.	appos	23	SENT_214	[p10l1155t756r1202b804],
16	,	,	O	,	_	0	SENT_214	[p10l1155t756r1202b804],
17	Lindstrom	NNP	PERSON	Lindstrom	appos	23	SENT_214	[p10l1223t754r1484b804],
18	,	,	O	,	_	0	SENT_214	[p10l1223t754r1484b804],
19	L.	NNP	O	L.	appos	23	SENT_214	[p10l1505t756r1552b804],
20	,	,	O	,	_	0	SENT_214	[p10l1505t756r1552b804],
21	Hammarlund-Udenaes	NNP	PERSON	Hammarlund-Udenaes	appos	23	SENT_214	[p10l1574t754r2146b804],
22	,	,	O	,	_	0	SENT_214	[p10l1574t754r2146b804],
23	M.	NNP	O	M.	_	0	SENT_214	[p10l111t823r182b870],
24	,	,	O	,	_	0	SENT_214	[p10l111t823r182b870],
25	(	CD	NUMBER	(	dep	23	SENT_214	[p10l210t820r275b874],
26	in	IN	O	in	_	0	SENT_214	[p10l210t820r275b874],
27	press	NN	O	press	nn	28	SENT_214	[p10l301t820r459b874],
28	)	NN	O	)	prep_in	25	SENT_214	[p10l301t820r459b874],
29	.	.	O	.	_	0	SENT_214	[p10l301t820r459b874],

1	Gene	NNP	PERSON	Gene	_	0	SENT_215	[p10l487t822r610b863],
2	polymorphism	NN	O	polymorphism	nn	3	SENT_215	[p10l637t820r999b874],
3	inﬂuencing	NN	O	inﬂuencing	dep	1	SENT_215	[p10l1026t820r1302b874],
4	treatment	NN	O	treatment	nn	5	SENT_215	[p10l1328t826r1575b863],
5	response	NN	O	response	dep	3	SENT_215	[p10l1600t832r1818b874],
6	in	IN	O	in	prep	5	SENT_215	[p10l1845t821r1890b863],
7	psychotic	JJ	O	psychotic	amod	8	SENT_215	[p10l1916t820r2148b874],
8	patients	NNS	O	patient	dep	6	SENT_215	[p10l111t886r307b940],
9	in	IN	O	in	_	0	SENT_215	[p10l328t886r374b929],
10	a	DT	O	a	det	12	SENT_215	[p10l393t898r418b929],
11	naturalistic	JJ	O	naturalistic	amod	12	SENT_215	[p10l437t886r713b929],
12	setting	NN	O	setting	prep_in	8	SENT_215	[p10l733t886r944b940],
13	.	.	O	.	_	0	SENT_215	[p10l733t886r944b940],
14	]	SYM	O	]	dep	5	SENT_215	[p10l733t886r944b940],

1	Psychiatr	NNP	O	Psychiatr	nn	2	SENT_216	[p10l964t886r1188b940],
2	Res	NNP	O	Res	_	0	SENT_216	[p10l1207t888r1300b929],
3	.	.	O	.	_	0	SENT_216	[p10l1207t888r1300b929],

1	Bertolino	NNP	PERSON	Bertolino	nn	2	SENT_217	[p10l9t952r233b996],
2	A	NNP	O	A	_	0	SENT_217	[p10l247t954r294b1002],
3	,	,	O	,	_	0	SENT_217	[p10l247t954r294b1002],
4	Caforio	NNP	O	Caforio	nn	5	SENT_217	[p10l311t952r483b996],
5	G	NNP	O	G	appos	2	SENT_217	[p10l500t954r546b1002],
6	,	,	O	,	_	0	SENT_217	[p10l500t954r546b1002],
7	Blasi	NNP	PERSON	Blasi	nn	8	SENT_217	[p10l564t952r675b996],
8	G	NNP	PERSON	G	appos	5	SENT_217	[p10l692t954r738b1002],
9	,	,	O	,	_	0	SENT_217	[p10l692t954r738b1002],
10	De	NNP	PERSON	De	nn	12	SENT_217	[p10l755t955r818b996],
11	Candia	NNP	PERSON	Candia	nn	12	SENT_217	[p10l835t952r1000b996],
12	M	NN	O	m	appos	5	SENT_217	[p10l1016t955r1074b1002],
13	,	,	O	,	_	0	SENT_217	[p10l1016t955r1074b1002],
14	Latorre	NNP	PERSON	Latorre	nn	15	SENT_217	[p10l1092t955r1264b996],
15	V	NNP	PERSON	V	appos	5	SENT_217	[p10l1278t955r1324b1002],
16	,	,	O	,	_	0	SENT_217	[p10l1278t955r1324b1002],
17	Petruzzella	NNP	O	Petruzzella	nn	18	SENT_217	[p10l1341t952r1612b996],
18	V	NNP	O	V	appos	5	SENT_217	[p10l1626t955r1672b1002],
19	,	,	O	,	_	0	SENT_217	[p10l1626t955r1672b1002],
20	et	FW	O	et	nn	21	SENT_217	[p10l1689t958r1735b996],
21	al.	FW	O	al.	appos	5	SENT_217	[p10l1750t952r1801b996],
22	.	.	O	.	_	0	SENT_217	[p10l1750t952r1801b996],

1	Interaction	NN	O	interaction	nsubj	6	SENT_218	[p10l1818t953r2086b996],
2	of	IN	O	of	_	0	SENT_218	[p10l2102t952r2153b996],
3	COMT	NNP	O	COMT	prep_of	1	SENT_218	[p10l111t1020r261b1062],
4	(	CD	NUMBER	(	num	3	SENT_218	[p10l274t1018r386b1072],
5	Val	NN	O	val	nn	6	SENT_218	[p10l274t1018r386b1072],
6	(	NN	O	(	_	0	SENT_218	[p10l274t1018r386b1072],
7	108	CD	NUMBER	108	dobj	6	SENT_218	[p10l396t1018r497b1073],
8	/	:	O	/	punct	13	SENT_218	[p10l396t1018r497b1073],
9	158	CD	NUMBER	158	number	10	SENT_218	[p10l504t1018r726b1072],
10	)	CD	NUMBER	)	num	13	SENT_218	[p10l504t1018r726b1072],
11	Met	NNP	O	Met	nn	13	SENT_218	[p10l504t1018r726b1072],
12	)	CD	NUMBER	)	num	13	SENT_218	[p10l504t1018r726b1072],
13	genotype	NN	O	genotype	dep	7	SENT_218	[p10l741t1025r969b1073],
14	and	CC	O	and	_	0	SENT_218	[p10l984t1018r1073b1062],
15	olanzapine	NN	O	olanzapine	nn	16	SENT_218	[p10l1090t1018r1356b1073],
16	treatment	NN	O	treatment	conj_and	13	SENT_218	[p10l1372t1025r1619b1062],
17	on	IN	O	on	_	0	SENT_218	[p10l1632t1031r1693b1062],
18	prefrontal	JJ	O	prefrontal	amod	20	SENT_218	[p10l1707t1018r1951b1073],
19	cortical	JJ	O	cortical	amod	20	SENT_218	[p10l1967t1018r2146b1062],
20	function	NN	O	function	prep_on	13	SENT_218	[p10l111t1084r315b1127],
21	in	IN	O	in	_	0	SENT_218	[p10l335t1085r380b1127],
22	patients	NNS	O	patient	prep_in	7	SENT_218	[p10l399t1085r595b1138],
23	with	IN	O	with	_	0	SENT_218	[p10l615t1084r728b1127],
24	schizophrenia	NN	O	schizophrenia	prep_with	6	SENT_218	[p10l748t1084r1102b1138],
25	.	.	O	.	_	0	SENT_218	[p10l748t1084r1102b1138],

1	Am	VBP	O	be	dep	2	SENT_219	[p10l1120t1086r1238b1138],
2	]	CD	NUMBER	]	_	0	SENT_219	[p10l1120t1086r1238b1138],
3	Psychitry	JJ	O	psychitry	amod	2	SENT_219	[p10l1257t1084r1484b1138],
4	2004	CD	DATE	2004	tmod	3	SENT_219	[p10l1502t1086r2007b1134],
5	;	:	O	;	_	0	SENT_219	[p10l1502t1086r2007b1134],
6	161:1798	CD	NUMBER	161:1798	num	7	SENT_219	[p10l1502t1086r2007b1134],
7	—	NN	O	—	dep	2	SENT_219	[p10l1502t1086r2007b1134],
8	805	CD	NUMBER	805	rcmod	7	SENT_219	[p10l1502t1086r2007b1134],
9	.	.	O	.	_	0	SENT_219	[p10l1502t1086r2007b1134],

1	Caracci	NNP	O	Caracci	nn	7	SENT_220	[p10l9t1151r182b1194],
2	G	NNP	O	G	nn	7	SENT_220	[p10l202t1152r249b1200],
3	,	,	O	,	_	0	SENT_220	[p10l202t1152r249b1200],
4	Ananthamoorthy	NNP	O	Ananthamoorthy	appos	7	SENT_220	[p10l268t1150r692b1204],
5	R.	NNP	O	R.	nn	7	SENT_220	[p10l711t1153r752b1194],
6	Prolactin	NN	O	prolactin	nn	7	SENT_220	[p10l774t1150r992b1194],
7	levels	NNS	O	level	_	0	SENT_220	[p10l1012t1150r1149b1194],
8	in	IN	O	in	advmod	11	SENT_220	[p10l1170t1151r1215b1193],
9	premenopausal	JJ	O	premenopausal	amod	10	SENT_220	[p10l1235t1150r1615b1204],
10	women	NNS	O	woman	pobj	8	SENT_220	[p10l1634t1163r1820b1194],
11	treated	VBN	O	treat	partmod	7	SENT_220	[p10l1840t1150r2014b1194],
12	with	IN	O	with	_	0	SENT_220	[p10l2033t1150r2147b1194],
13	risperidone	NN	O	risperidone	prep_with	11	SENT_220	[p10l111t1216r391b1270],
14	compared	VBN	O	compare	_	0	SENT_220	[p10l407t1216r652b1270],
15	with	IN	O	with	prepc_compared_with	11	SENT_220	[p10l666t1216r779b1259],
16	those	DT	O	those	pobj	11	SENT_220	[p10l793t1216r925b1259],
17	of	IN	O	of	_	0	SENT_220	[p10l941t1216r992b1259],
18	women	NNS	O	woman	prep_of	16	SENT_220	[p10l999t1228r1185b1259],
19	treated	VBN	O	treat	partmod	18	SENT_220	[p10l1199t1216r1374b1259],
20	with	IN	O	with	_	0	SENT_220	[p10l1388t1216r1501b1259],
21	typical	JJ	O	typical	amod	22	SENT_220	[p10l1515t1216r1678b1270],
22	neuroleptics	NNS	O	neuroleptic	prep_with	19	SENT_220	[p10l1694t1216r2038b1270],
23	.	.	O	.	_	0	SENT_220	[p10l1694t1216r2038b1270],
24	]	SYM	O	]	dep	7	SENT_220	[p10l1694t1216r2038b1270],

1	Clin	NNP	O	Clin	nn	2	SENT_221	[p10l2053t1216r2147b1259],
2	Psychopharmacol	NNP	O	Psychopharmacol	_	0	SENT_221	[p10l111t1282r543b1336],
3	1999	CD	DATE	1999	num	2	SENT_221	[p10l566t1284r696b1332],
4	;	:	O	;	_	0	SENT_221	[p10l566t1284r696b1332],
5	19	CD	NUMBER	19	num	7	SENT_221	[p10l706t1284r774b1326],
6	:	:	O	:	_	0	SENT_221	[p10l706t1284r774b1326],
7	194-6	CD	NUMBER	194-6	dep	2	SENT_221	[p10l784t1284r942b1326],
8	.	.	O	.	_	0	SENT_221	[p10l784t1284r942b1326],

1	Chong	NNP	ORGANIZATION	Chong	nn	2	SENT_222	[p10l9t1347r165b1402],
2	SA	NNP	ORGANIZATION	SA	_	0	SENT_222	[p10l180t1349r252b1398],
3	,	,	O	,	_	0	SENT_222	[p10l180t1349r252b1398],
4	Tan	NNP	O	Tan	nn	5	SENT_222	[p10l266t1350r352b1391],
5	EC	NNP	ORGANIZATION	EC	appos	2	SENT_222	[p10l368t1350r438b1398],
6	,	,	O	,	_	0	SENT_222	[p10l368t1350r438b1398],
7	Tan	NNP	O	Tan	nn	8	SENT_222	[p10l453t1350r539b1391],
8	CH	NN	O	ch	appos	2	SENT_222	[p10l555t1350r635b1398],
9	,	,	O	,	_	0	SENT_222	[p10l555t1350r635b1398],
10	Mythily	NNP	O	Mythily	nn	12	SENT_222	[p10l652t1347r843b1402],
11	Chan	NNP	O	Chan	nn	12	SENT_222	[p10l857t1348r979b1391],
12	YH	NNP	O	YH	appos	2	SENT_222	[p10l992t1350r1076b1391],
13	.	.	O	.	_	0	SENT_222	[p10l992t1350r1076b1391],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_223	[p10l1093t1348r1476b1402],
2	of	IN	O	of	_	0	SENT_223	[p10l1492t1347r1543b1391],
3	dopamine	NN	O	dopamine	nn	4	SENT_223	[p10l1552t1347r1798b1402],
4	receptors	NNS	O	receptor	prep_of	1	SENT_223	[p10l1814t1354r2042b1402],
5	and	CC	O	and	_	0	SENT_223	[p10l2057t1347r2146b1391],
6	tardive	JJ	O	tardive	amod	7	SENT_223	[p10l110t1414r281b1458],
7	dyskinesia	NN	O	dyskinesium	prep_of	1	SENT_223	[p10l301t1414r557b1468],
8	among	IN	O	among	_	0	SENT_223	[p10l576t1427r744b1468],
9	Chinese	JJ	MISC	chinese	amod	10	SENT_223	[p10l762t1414r953b1458],
10	patients	NNS	O	patient	prep_among	1	SENT_223	[p10l972t1415r1168b1468],
11	with	IN	O	with	_	0	SENT_223	[p10l1188t1414r1301b1458],
12	schizophrenia	NN	O	schizophrenia	prep_with	1	SENT_223	[p10l1320t1414r1674b1468],
13	.	.	O	.	_	0	SENT_223	[p10l1320t1414r1674b1468],

1	Am	VBP	O	be	dep	2	SENT_224	[p10l1692t1416r1809b1468],
2	]	CD	NUMBER	]	_	0	SENT_224	[p10l1692t1416r1809b1468],
3	Med	NNP	O	Med	nn	7	SENT_224	[p10l1828t1414r1935b1458],
4	Genet	NNP	PERSON	Genet	nn	7	SENT_224	[p10l1955t1416r2100b1458],
5	B	NNP	PERSON	B	nn	7	SENT_224	[p10l2118t1417r2146b1457],
6	Neuropsychiatr	NNP	PERSON	Neuropsychiatr	nn	7	SENT_224	[p10l111t1480r489b1534],
7	Genet	NNP	PERSON	Genet	dep	2	SENT_224	[p10l508t1482r653b1524],
8	2003	CD	DATE	2003	dep	7	SENT_224	[p10l671t1482r968b1530],
9	;	:	O	;	_	0	SENT_224	[p10l671t1482r968b1530],
10	116:51	CD	NUMBER	116:51	num	11	SENT_224	[p10l671t1482r968b1530],
11	-4	CD	NUMBER	-4	dep	8	SENT_224	[p10l979t1482r1049b1524],
12	.	.	O	.	_	0	SENT_224	[p10l979t1482r1049b1524],

1	Chu	NNP	O	Chu	nn	2	SENT_225	[p10l9t1546r103b1589],
2	YC	NNP	O	YC	_	0	SENT_225	[p10l119t1548r193b1596],
3	,	,	O	,	_	0	SENT_225	[p10l119t1548r193b1596],
4	Tsou	NNP	O	Tsou	nn	5	SENT_225	[p10l210t1548r324b1589],
5	MY	NNP	O	MY	appos	2	SENT_225	[p10l343t1548r430b1596],
6	,	,	O	,	_	0	SENT_225	[p10l343t1548r430b1596],
7	Pan	NNP	O	Pan	nn	10	SENT_225	[p10l450t1548r537b1589],
8	]	NNP	O	]	nn	10	SENT_225	[p10l548t1548r607b1600],
9	T.	NNP	O	T.	nn	10	SENT_225	[p10l548t1548r607b1600],
10	Prostaglandins	NNP	O	Prostaglandins	nsubj	12	SENT_225	[p10l626t1546r987b1600],
11	may	MD	O	may	aux	12	SENT_225	[p10l1006t1558r1111b1600],
12	participate	VB	O	participate	dep	2	SENT_225	[p10l1128t1546r1391b1600],
13	in	IN	O	in	_	0	SENT_225	[p10l1410t1546r1455b1589],
14	opioidergic	JJ	O	opioidergic	amod	17	SENT_225	[p10l1473t1546r1749b1600],
15	and	CC	O	and	_	0	SENT_225	[p10l1767t1546r1856b1589],
16	cholinergic	JJ	O	cholinergic	conj_and	14	SENT_225	[p10l1875t1546r2147b1600],
17	control	NN	O	control	prep_in	12	SENT_225	[p10l111t1612r284b1655],
18	of	IN	O	of	_	0	SENT_225	[p10l321t1612r372b1655],
19	the	DT	O	the	det	21	SENT_225	[p10l403t1612r481b1655],
20	diurnal	JJ	O	diurnal	amod	21	SENT_225	[p10l518t1612r693b1655],
21	changes	NNS	O	change	prep_of	17	SENT_225	[p10l730t1612r927b1666],
22	of	IN	O	of	_	0	SENT_225	[p10l964t1612r1015b1655],
23	tuberoinfundibular	JJ	O	tuberoinfundibular	amod	26	SENT_225	[p10l1046t1612r1517b1655],
24	dopaminergic	JJ	O	dopaminergic	amod	26	SENT_225	[p10l1551t1612r1891b1666],
25	neuronal	JJ	O	neuronal	amod	26	SENT_225	[p10l1928t1612r2147b1655],
26	activity	NN	O	activity	prep_of	21	SENT_225	[p10l111t1678r293b1732],
27	and	CC	O	and	_	0	SENT_225	[p10l313t1677r401b1721],
28	serum	NN	O	serum	nn	30	SENT_225	[p10l426t1690r579b1721],
29	prolactin	NN	O	prolactin	nn	30	SENT_225	[p10l602t1677r821b1732],
30	level	NN	O	level	prep_of	21	SENT_225	[p10l843t1677r957b1721],
31	in	IN	O	in	_	0	SENT_225	[p10l980t1678r1025b1721],
32	ovariectomized	VBN	O	ovariectomize	prepc_in	12	SENT_225	[p10l1048t1678r1437b1728],
33	,	,	O	,	_	0	SENT_225	[p10l1048t1678r1437b1728],
34	estrogen-treated	JJ	O	estrogen-treated	amod	35	SENT_225	[p10l1461t1677r1871b1732],
35	rats	NNS	O	rat	appos	2	SENT_225	[p10l1895t1684r1996b1721],
36	.	.	O	.	_	0	SENT_225	[p10l1895t1684r1996b1721],

1	Brain	NN	O	brain	nn	3	SENT_226	[p10l2020t1678r2147b1721],
2	Res	NNP	O	Res	nn	3	SENT_226	[p10l111t1747r191b1788],
3	Bull	NNP	O	Bull	_	0	SENT_226	[p10l212t1744r304b1788],
4	2001	CD	DATE	2001	num	3	SENT_226	[p10l324t1746r439b1788],
5	;	:	O	;	_	0	SENT_226	[p10l453t1746r600b1794],
6	56:61	CD	NUMBER	56:61	number	7	SENT_226	[p10l453t1746r600b1794],
7	-5	CD	NUMBER	-5	dep	3	SENT_226	[p10l610t1747r680b1788],
8	.	.	O	.	_	0	SENT_226	[p10l610t1747r680b1788],

1	Cohen	NNP	PERSON	Cohen	nn	2	SENT_227	[p10l9t1810r163b1854],
2	BM	NN	O	bm	_	0	SENT_227	[p10l187t1813r278b1860],
3	,	,	O	,	_	0	SENT_227	[p10l187t1813r278b1860],
4	Ennulat	NN	O	ennulat	nn	6	SENT_227	[p10l303t1810r493b1854],
5	D	NN	O	d	nn	6	SENT_227	[p10l516t1813r578b1865],
6	]	NN	O	]	appos	2	SENT_227	[p10l516t1813r578b1865],
7	,	,	O	,	_	0	SENT_227	[p10l516t1813r578b1865],
8	Centorrino	NN	O	centorrino	nn	9	SENT_227	[p10l603t1811r867b1854],
9	F	NN	O	f	appos	6	SENT_227	[p10l891t1813r924b1860],
10	,	,	O	,	_	0	SENT_227	[p10l891t1813r924b1860],
11	Matthysse	NNP	O	Matthysse	nn	12	SENT_227	[p10l949t1810r1199b1865],
12	S	NNP	O	S	appos	6	SENT_227	[p10l1224t1812r1260b1860],
13	,	,	O	,	_	0	SENT_227	[p10l1224t1812r1260b1860],
14	Konieczna	NNP	PERSON	Konieczna	nn	15	SENT_227	[p10l1285t1811r1536b1854],
15	H	NNP	PERSON	H	appos	6	SENT_227	[p10l1561t1813r1609b1860],
16	,	,	O	,	_	0	SENT_227	[p10l1561t1813r1609b1860],
17	Chu	NNP	O	Chu	nn	18	SENT_227	[p10l1634t1810r1728b1854],
18	HM	NNS	O	hm	appos	6	SENT_227	[p10l1753t1813r1851b1861],
19	,	,	O	,	_	0	SENT_227	[p10l1753t1813r1851b1861],
20	et	FW	O	et	nn	21	SENT_227	[p10l1876t1817r1922b1854],
21	al.	FW	O	al.	appos	6	SENT_227	[p10l1945t1810r1997b1854],
22	.	.	O	.	_	0	SENT_227	[p10l1945t1810r1997b1854],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_228	[p10l2023t1810r2146b1865, p10l111t1876r388b1930],
2	of	IN	O	of	_	0	SENT_228	[p10l417t1876r469b1919],
3	the	DT	O	the	det	6	SENT_228	[p10l491t1876r569b1919],
4	dopamine	NN	O	dopamine	nn	6	SENT_228	[p10l598t1876r844b1930],
5	D4	NN	O	d4	nn	6	SENT_228	[p10l874t1878r940b1919],
6	receptor	NN	O	receptor	prep_of	1	SENT_228	[p10l969t1882r1175b1930],
7	and	CC	O	and	_	0	SENT_228	[p10l1201t1876r1290b1919],
8	response	NN	O	response	prep_of	1	SENT_228	[p10l1320t1888r1537b1930],
9	to	TO	O	to	_	0	SENT_228	[p10l1566t1882r1613b1919],
10	antipsychotic	JJ	O	antipsychotic	amod	11	SENT_228	[p10l1641t1876r1970b1930],
11	drugs	NNS	O	drug	prep_to	1	SENT_228	[p10l1997t1876r2146b1930],
12	.	.	O	.	_	0	SENT_228	[p10l1997t1876r2146b1930],

1	Psychopharmacology	NNP	O	Psychopharmacology	_	0	SENT_229	[p10l111t1942r634b1996],
2	1999	CD	DATE	1999	num	1	SENT_229	[p10l656t1944r786b1992],
3	;	:	O	;	_	0	SENT_229	[p10l656t1944r786b1992],
4	141	CD	NUMBER	141	number	5	SENT_229	[p10l796t1944r871b1985],
5	16-10	CD	NUMBER	16-10	dep	1	SENT_229	[p10l884t1944r1029b1986],
6	.	.	O	.	_	0	SENT_229	[p10l884t1944r1029b1986],

1	David	NNP	PERSON	David	nn	2	SENT_230	[p10l9t2008r148b2051],
2	SR	NN	PERSON	sr	_	0	SENT_230	[p10l177t2010r246b2058],
3	,	,	O	,	_	0	SENT_230	[p10l177t2010r246b2058],
4	Taylor	NNP	PERSON	Taylor	nn	5	SENT_230	[p10l272t2008r425b2062],
5	CC	NN	O	cc	appos	2	SENT_230	[p10l451t2010r524b2058],
6	,	,	O	,	_	0	SENT_230	[p10l451t2010r524b2058],
7	Kinon	NN	PERSON	kinon	nn	9	SENT_230	[p10l552t2008r696b2051],
8	B	NN	O	b	nn	9	SENT_230	[p10l724t2010r781b2062],
9	]	NN	O	]	appos	2	SENT_230	[p10l724t2010r781b2062],
10	,	,	O	,	_	0	SENT_230	[p10l724t2010r781b2062],
11	Breier	NNP	PERSON	Breier	nn	14	SENT_230	[p10l810t2008r956b2051],
12	A.	NNP	O	A.	nn	14	SENT_230	[p10l980t2010r1026b2052],
13	The	NNP	O	The	nn	14	SENT_230	[p10l1053t2008r1142b2051],
14	effects	NNS	O	effect	appos	2	SENT_230	[p10l1170t2007r1327b2051],
15	of	IN	O	of	_	0	SENT_230	[p10l1356t2008r1406b2051],
16	olanzapine	NN	O	olanzapine	prep_of	14	SENT_230	[p10l1428t2008r1707b2062],
17	,	,	O	,	_	0	SENT_230	[p10l1428t2008r1707b2062],
18	risperidone	NN	O	risperidone	prep_of	14	SENT_230	[p10l1736t2008r2028b2062],
19	,	,	O	,	_	0	SENT_230	[p10l1736t2008r2028b2062],
20	and	CC	O	and	_	0	SENT_230	[p10l2057t2008r2146b2051],
21	haloperidol	NN	O	haloperidol	prep_of	14	SENT_230	[p10l111t2074r392b2129],
22	on	IN	O	on	_	0	SENT_230	[p10l417t2087r478b2118],
23	plasma	NN	O	plasma	nn	25	SENT_230	[p10l502t2074r676b2129],
24	prolactin	NN	O	prolactin	nn	25	SENT_230	[p10l702t2074r921b2129],
25	levels	NNS	O	level	prep_on	16	SENT_230	[p10l946t2074r1083b2118],
26	in	IN	O	in	_	0	SENT_230	[p10l1109t2075r1154b2117],
27	patients	NNS	O	patient	prep_in	25	SENT_230	[p10l1178t2075r1374b2129],
28	with	IN	O	with	_	0	SENT_230	[p10l1400t2074r1513b2118],
29	schizophrenia	NN	O	schizophrenia	prep_with	27	SENT_230	[p10l1539t2074r1893b2129],
30	.	.	O	.	_	0	SENT_230	[p10l1539t2074r1893b2129],

1	Clin	NNP	O	Clin	nn	2	SENT_231	[p10l1919t2074r2013b2118],
2	Ther	NNP	O	Ther	_	0	SENT_231	[p10l2034t2074r2148b2118],
3	2000	CD	DATE	2000	num	2	SENT_231	[p10l111t2142r562b2190],
4	;	:	O	;	_	0	SENT_231	[p10l111t2142r562b2190],
5	22:1085	CD	NUMBER	22:1085	number	6	SENT_231	[p10l111t2142r562b2190],
6	—	CD	NUMBER	—	dep	2	SENT_231	[p10l111t2142r562b2190],
7	96	CD	NUMBER	96	dep	6	SENT_231	[p10l111t2142r562b2190],
8	.	.	O	.	_	0	SENT_231	[p10l111t2142r562b2190],

1	de	IN	O	de	_	0	SENT_232	[p10l9t2206r66b2250],
2	Leon	NNP	O	Leon	nn	3	SENT_232	[p10l85t2209r242b2260],
3	]	NNP	O	]	dep	1	SENT_232	[p10l85t2209r242b2260],
4	,	,	O	,	_	0	SENT_232	[p10l85t2209r242b2260],
5	Susce	NNP	O	Susce	nn	6	SENT_232	[p10l261t2208r395b2250],
6	MT	NNP	O	MT	appos	3	SENT_232	[p10l414t2209r499b2256],
7	,	,	O	,	_	0	SENT_232	[p10l414t2209r499b2256],
8	Pan	NNP	O	Pan	nn	9	SENT_232	[p10l518t2209r606b2250],
9	RM	NN	O	rm	appos	3	SENT_232	[p10l624t2209r715b2256],
10	,	,	O	,	_	0	SENT_232	[p10l624t2209r715b2256],
11	Koch	NNP	LOCATION	Koch	nn	12	SENT_232	[p10l734t2206r855b2250],
12	WH	NNP	LOCATION	WH	appos	3	SENT_232	[p10l870t2209r977b2256],
13	,	,	O	,	_	0	SENT_232	[p10l870t2209r977b2256],
14	Wedlund	NNP	PERSON	Wedlund	nn	16	SENT_232	[p10l993t2206r1220b2250],
15	P	NN	O	p	nn	16	SENT_232	[p10l1239t2209r1293b2260],
16	]	NN	O	]	appos	3	SENT_232	[p10l1239t2209r1293b2260],
17	.	.	O	.	_	0	SENT_232	[p10l1239t2209r1293b2260],

1	Polymorphic	JJ	MISC	polymorphic	amod	2	SENT_233	[p10l1312t2206r1625b2260],
2	variations	NNS	O	variation	_	0	SENT_233	[p10l1640t2207r1882b2250],
3	in	IN	O	in	_	0	SENT_233	[p10l1902t2207r1947b2249],
4	GSTM1	NN	O	gstm1	prep_in	2	SENT_233	[p10l1965t2208r2146b2256],
5	,	,	O	,	_	0	SENT_233	[p10l1965t2208r2146b2256],
6	GSTT1	NN	O	gstt1	prep_in	2	SENT_233	[p10l111t2274r272b2322],
7	,	,	O	,	_	0	SENT_233	[p10l111t2274r272b2322],
8	PgP	NN	O	pgp	conj_and	4	SENT_233	[p10l307t2275r401b2326],
9	,	,	O	,	_	0	SENT_233	[p10l307t2275r401b2326],
10	CYP2D6	NN	O	cyp2d6	conj_and	4	SENT_233	[p10l437t2274r642b2322],
11	,	,	O	,	_	0	SENT_233	[p10l437t2274r642b2322],
12	CYP3A5	NN	O	cyp3a5	conj_and	4	SENT_233	[p10l677t2274r880b2322],
13	,	,	O	,	_	0	SENT_233	[p10l677t2274r880b2322],
14	and	CC	O	and	_	0	SENT_233	[p10l915t2272r1004b2316],
15	dopamine	NN	O	dopamine	conj_and	4	SENT_233	[p10l1039t2272r1285b2326],
16	D2	NN	O	d2	nn	19	SENT_233	[p10l1320t2274r1384b2315],
17	and	CC	O	and	_	0	SENT_233	[p10l1420t2272r1509b2316],
18	D3	NN	O	d3	nn	19	SENT_233	[p10l1544t2274r1608b2316],
19	receptors	NNS	O	receptor	dep	4	SENT_233	[p10l1645t2278r1872b2326],
20	and	CC	O	and	_	0	SENT_233	[p10l1907t2272r1996b2316],
21	their	PRP$	O	they	poss	22	SENT_233	[p10l2030t2272r2148b2316],
22	association	NN	O	association	conj_and	4	SENT_233	[p10l111t2338r382b2381],
23	with	IN	O	with	_	0	SENT_233	[p10l394t2338r507b2381],
24	tardive	JJ	O	tardive	amod	25	SENT_233	[p10l522t2338r693b2381],
25	dyskinesia	NN	O	dyskinesium	prep_with	22	SENT_233	[p10l708t2338r964b2392],
26	in	IN	O	in	prep	25	SENT_233	[p10l979t2338r1024b2381],
27	severe	JJ	O	severe	amod	29	SENT_233	[p10l1040t2350r1196b2381],
28	mental	JJ	O	mental	amod	29	SENT_233	[p10l1210t2338r1381b2381],
29	illness	NN	O	illness	dep	26	SENT_233	[p10l1397t2338r1590b2392],
30	.	.	O	.	_	0	SENT_233	[p10l1397t2338r1590b2392],
31	]	SYM	O	]	dep	22	SENT_233	[p10l1397t2338r1590b2392],

1	Clin	NNP	O	Clin	nn	2	SENT_234	[p10l1605t2338r1699b2381],
2	Psychopharmacol	NNP	O	Psychopharmacol	_	0	SENT_234	[p10l1714t2338r2146b2392],
3	2005	CD	DATE	2005	num	2	SENT_234	[p10l111t2406r534b2454],
4	;	:	O	;	_	0	SENT_234	[p10l111t2406r534b2454],
5	25:448	CD	NUMBER	25:448	number	6	SENT_234	[p10l111t2406r534b2454],
6	—	CD	NUMBER	—	dep	2	SENT_234	[p10l111t2406r534b2454],
7	56	CD	NUMBER	56	dep	6	SENT_234	[p10l111t2406r534b2454],
8	.	.	O	.	_	0	SENT_234	[p10l111t2406r534b2454],

1	Dickson	NNP	PERSON	Dickson	nn	2	SENT_235	[p10l9t2469r203b2513],
2	RA	NN	O	ra	_	0	SENT_235	[p10l218t2471r296b2520],
3	,	,	O	,	_	0	SENT_235	[p10l218t2471r296b2520],
4	Dalby	NNP	PERSON	Dalby	nn	6	SENT_235	[p10l312t2469r517b2524],
5	]	CD	NUMBER	]	num	6	SENT_235	[p10l312t2469r517b2524],
6	T	NN	O	t	appos	2	SENT_235	[p10l312t2469r517b2524],
7	,	,	O	,	_	0	SENT_235	[p10l312t2469r517b2524],
8	Williams	NNP	PERSON	Williams	nn	9	SENT_235	[p10l531t2469r750b2513],
9	R	NNP	O	R	appos	2	SENT_235	[p10l766t2472r808b2520],
10	,	,	O	,	_	0	SENT_235	[p10l766t2472r808b2520],
11	Edwards	NNP	PERSON	Edwards	nn	12	SENT_235	[p10l824t2469r1034b2513],
12	AL.	NNP	O	AL.	appos	2	SENT_235	[p10l1047t2471r1120b2513],
13	.	.	O	.	_	0	SENT_235	[p10l1047t2471r1120b2513],

1	Risperidone-induced	JJ	O	risperidone-induced	amod	3	SENT_236	[p10l1136t2469r1648b2524],
2	prolactin	NN	O	prolactin	nn	3	SENT_236	[p10l1665t2469r1884b2524],
3	elevations	NNS	O	elevation	_	0	SENT_236	[p10l1899t2469r2145b2513],
4	in	IN	O	in	_	0	SENT_236	[p10l111t2537r157b2579],
5	premenopausal	JJ	O	premenopausal	amod	6	SENT_236	[p10l175t2536r555b2590],
6	women	NNS	O	woman	prep_in	3	SENT_236	[p10l574t2549r759b2580],
7	with	IN	O	with	_	0	SENT_236	[p10l776t2536r889b2580],
8	schizophrenia	NN	O	schizophrenia	prep_with	3	SENT_236	[p10l909t2536r1264b2590],
9	.	.	O	.	_	0	SENT_236	[p10l909t2536r1264b2590],

1	Am	VBP	O	be	dep	3	SENT_237	[p10l1282t2538r1399b2590],
2	]	CD	NUMBER	]	num	3	SENT_237	[p10l1282t2538r1399b2590],
3	Psychiatry	NNP	O	Psychiatry	_	0	SENT_237	[p10l1419t2536r1673b2590],
4	1995	CD	DATE	1995	num	3	SENT_237	[p10l1693t2538r2126b2586],
5	;	:	O	;	_	0	SENT_237	[p10l1693t2538r2126b2586],
6	152:1102	CD	NUMBER	152:1102	dep	3	SENT_237	[p10l1693t2538r2126b2586],
7	—	CD	NUMBER	—	num	8	SENT_237	[p10l1693t2538r2126b2586],
8	3	CD	NUMBER	3	dep	6	SENT_237	[p10l1693t2538r2126b2586],
9	.	.	O	.	_	0	SENT_237	[p10l1693t2538r2126b2586],

1	Dolzan	NNP	MISC	Dolzan	nn	2	SENT_238	[p10l9t2602r178b2646],
2	V	NNP	O	V	_	0	SENT_238	[p10l193t2605r239b2652],
3	,	,	O	,	_	0	SENT_238	[p10l193t2605r239b2652],
4	Plesnicar	NNP	O	Plesnicar	nn	5	SENT_238	[p10l258t2602r478b2646],
5	BK	NNP	O	BK	appos	2	SENT_238	[p10l494t2605r569b2652],
6	,	,	O	,	_	0	SENT_238	[p10l494t2605r569b2652],
7	Serretti	NNP	O	Serretti	nn	8	SENT_238	[p10l587t2603r768b2646],
8	A	NNP	O	A	appos	5	SENT_238	[p10l783t2604r830b2652],
9	,	,	O	,	_	0	SENT_238	[p10l783t2604r830b2652],
10	Mandelli	NNP	ORGANIZATION	Mandelli	nn	11	SENT_238	[p10l848t2602r1063b2646],
11	L	NNP	ORGANIZATION	L	appos	5	SENT_238	[p10l1081t2605r1115b2653],
12	,	,	O	,	_	0	SENT_238	[p10l1081t2605r1115b2653],
13	Zalar	NNP	O	Zalar	nn	14	SENT_238	[p10l1132t2602r1255b2646],
14	B	NNP	O	B	appos	5	SENT_238	[p10l1271t2605r1311b2652],
15	,	,	O	,	_	0	SENT_238	[p10l1271t2605r1311b2652],
16	Koprivsek	NNP	O	Koprivsek	appos	5	SENT_238	[p10l1330t2602r1574b2657],
17	]	CD	NUMBER	]	num	16	SENT_238	[p10l1582t2605r1613b2657],
18	,	,	O	,	_	0	SENT_238	[p10l1582t2605r1613b2657],
19	et	FW	O	et	nn	20	SENT_238	[p10l1631t2609r1677b2646],
20	al.	FW	O	al.	appos	5	SENT_238	[p10l1693t2602r1745b2646],
21	.	.	O	.	_	0	SENT_238	[p10l1693t2602r1745b2646],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_239	[p10l1763t2602r2146b2657],
2	in	IN	O	in	_	0	SENT_239	[p10l111t2669r156b2711],
3	dopamine	NN	O	dopamine	nn	5	SENT_239	[p10l180t2668r426b2722],
4	receptor	NN	O	receptor	nn	5	SENT_239	[p10l450t2674r656b2722],
5	DRD1	NN	O	drd1	prep_in	1	SENT_239	[p10l678t2670r809b2711],
6	and	CC	O	and	_	0	SENT_239	[p10l840t2668r928b2711],
7	DRD2	NN	O	drd2	nn	8	SENT_239	[p10l953t2670r1089b2711],
8	genes	NNS	O	gene	conj_and	5	SENT_239	[p10l1114t2680r1253b2722],
9	and	CC	O	and	_	0	SENT_239	[p10l1277t2668r1366b2711],
10	psychopathological	JJ	O	psychopathological	amod	13	SENT_239	[p10l1390t2668r1864b2722],
11	and	CC	O	and	_	0	SENT_239	[p10l1888t2668r1977b2711],
12	extrapyramidal	JJ	O	extrapyramidal	conj_and	10	SENT_239	[p10l2001t2674r2146b2711, p10l111t2734r359b2788],
13	symptoms	NNS	O	symptom	conj_and	5	SENT_239	[p10l379t2740r633b2788],
14	in	IN	O	in	_	0	SENT_239	[p10l654t2735r699b2777],
15	patients	NNS	O	patient	prep_in	13	SENT_239	[p10l717t2735r914b2788],
16	on	IN	O	on	_	0	SENT_239	[p10l934t2747r995b2778],
17	long	JJ	O	long	amod	21	SENT_239	[p10l1015t2734r1262b2788],
18	—	JJ	O	—	amod	21	SENT_239	[p10l1015t2734r1262b2788],
19	term	NN	O	term	nn	21	SENT_239	[p10l1015t2734r1262b2788],
20	antipsychotic	JJ	O	antipsychotic	amod	21	SENT_239	[p10l1281t2734r1609b2788],
21	treatment	NN	O	treatment	prep_on	1	SENT_239	[p10l1627t2740r1884b2778],
22	.	.	O	.	_	0	SENT_239	[p10l1627t2740r1884b2778],

1	Am	VBP	O	be	dep	2	SENT_240	[p10l1902t2736r2020b2788],
2	]	CD	NUMBER	]	_	0	SENT_240	[p10l1902t2736r2020b2788],
3	Med	NNP	O	Med	nn	7	SENT_240	[p10l2039t2734r2146b2778],
4	Genet	NNP	PERSON	Genet	nn	7	SENT_240	[p10l111t2802r256b2843],
5	B	NNP	PERSON	B	nn	7	SENT_240	[p10l275t2802r303b2843],
6	Neuropsychiatr	NNP	PERSON	Neuropsychiatr	nn	7	SENT_240	[p10l324t2800r702b2854],
7	Genet	NNP	PERSON	Genet	dep	2	SENT_240	[p10l720t2802r865b2843],
8	2007	CD	DATE	2007	dep	7	SENT_240	[p10l884t2802r1330b2850],
9	;	:	O	;	_	0	SENT_240	[p10l884t2802r1330b2850],
10	144:809	CD	NUMBER	144:809	dep	8	SENT_240	[p10l884t2802r1330b2850],
11	—	CD	NUMBER	—	num	12	SENT_240	[p10l884t2802r1330b2850],
12	15	CD	NUMBER	15	dep	10	SENT_240	[p10l884t2802r1330b2850],
13	.	.	O	.	_	0	SENT_240	[p10l884t2802r1330b2850],

1	Gunes	NNP	MISC	Gunes	nn	2	SENT_241	[p10l9t2868r160b2910],
2	A	NNP	MISC	A	_	0	SENT_241	[p10l189t2868r236b2916],
3	,	,	O	,	_	0	SENT_241	[p10l189t2868r236b2916],
4	Scordo	NNP	O	Scordo	nn	5	SENT_241	[p10l267t2866r432b2910],
5	MG	NN	O	mg	appos	2	SENT_241	[p10l463t2868r560b2916],
6	,	,	O	,	_	0	SENT_241	[p10l463t2868r560b2916],
7	]	NN	O	]	nn	9	SENT_241	[p10l584t2869r779b2921],
8	aanson	NN	O	aanson	nn	9	SENT_241	[p10l584t2869r779b2921],
9	P	NN	O	p	appos	2	SENT_241	[p10l810t2869r844b2917],
10	,	,	O	,	_	0	SENT_241	[p10l810t2869r844b2917],
11	Dahl	NNP	PERSON	Dahl	nn	12	SENT_241	[p10l875t2866r986b2910],
12	ML	NNP	O	ML	appos	2	SENT_241	[p10l1017t2869r1102b2910],
13	.	.	O	.	_	0	SENT_241	[p10l1017t2869r1102b2910],

1	Serotonin	NN	O	serotonin	nn	4	SENT_242	[p10l1134t2867r1370b2910],
2	and	CC	O	and	_	0	SENT_242	[p10l1401t2866r1489b2910],
3	dopamine	NN	O	dopamine	conj_and	1	SENT_242	[p10l1520t2866r1766b2921],
4	receptor	NN	O	receptor	_	0	SENT_242	[p10l1797t2873r2003b2921],
5	gene	NN	O	gene	nn	6	SENT_242	[p10l2030t2879r2147b2921],
6	polymorphisms	NNS	O	polymorphism	dep	4	SENT_242	[p10l111t2932r496b2987],
7	and	CC	O	and	_	0	SENT_242	[p10l512t2932r601b2976],
8	the	DT	O	the	det	9	SENT_242	[p10l616t2932r694b2976],
9	risk	NN	O	risk	dep	4	SENT_242	[p10l710t2932r800b2976],
10	of	IN	O	of	_	0	SENT_242	[p10l814t2932r865b2976],
11	extrapyramidal	JJ	O	extrapyramidal	amod	13	SENT_242	[p10l875t2932r1249b2987],
12	side	JJ	O	side	amod	13	SENT_242	[p10l1265t2932r1361b2976],
13	effects	NNS	O	effect	prep_of	4	SENT_242	[p10l1377t2932r1533b2976],
14	in	IN	O	in	_	0	SENT_242	[p10l1550t2933r1595b2975],
15	perphenazine-treated	JJ	O	perphenazine-treated	amod	17	SENT_242	[p10l1610t2932r2146b2987],
16	schizophrenic	JJ	O	schizophrenic	amod	17	SENT_242	[p10l111t2998r453b3052],
17	patients	NNS	O	patient	prep_in	13	SENT_242	[p10l472t2999r680b3052],
18	.	.	O	.	_	0	SENT_242	[p10l472t2999r680b3052],

1	Psychopharmacology	NNP	O	Psychopharmacology	_	0	SENT_243	[p10l702t2998r1225b3052],
2	2007	CD	DATE	2007	num	1	SENT_243	[p10l1243t3000r1690b3048],
3	;	:	O	;	_	0	SENT_243	[p10l1243t3000r1690b3048],
4	190:479	CD	NUMBER	190:479	number	5	SENT_243	[p10l1243t3000r1690b3048],
5	—	CD	NUMBER	—	dep	1	SENT_243	[p10l1243t3000r1690b3048],
6	84	CD	NUMBER	84	dep	5	SENT_243	[p10l1243t3000r1690b3048],
7	.	.	O	.	_	0	SENT_243	[p10l1243t3000r1690b3048],

1	Guzey	NN	O	guzey	nn	2	SENT_244	[p10l9t3066r164b3118],
2	C	NN	O	c	_	0	SENT_244	[p10l200t3066r242b3114],
3	,	,	O	,	_	0	SENT_244	[p10l200t3066r242b3114],
4	Scordo	NNP	O	Scordo	nn	5	SENT_244	[p10l281t3064r449b3108],
5	MG	NN	O	mg	appos	2	SENT_244	[p10l489t3066r586b3114],
6	,	,	O	,	_	0	SENT_244	[p10l489t3066r586b3114],
7	Spina	NNP	ORGANIZATION	Spina	nn	8	SENT_244	[p10l625t3065r762b3118],
8	E	NNP	ORGANIZATION	E	appos	2	SENT_244	[p10l800t3067r839b3114],
9	,	,	O	,	_	0	SENT_244	[p10l800t3067r839b3114],
10	Landsem	NNP	O	Landsem	nn	11	SENT_244	[p10l879t3064r1101b3108],
11	VM	NNP	O	VM	appos	2	SENT_244	[p10l1137t3067r1234b3114],
12	,	,	O	,	_	0	SENT_244	[p10l1137t3067r1234b3114],
13	Spigset	NNP	O	Spigset	nn	14	SENT_244	[p10l1274t3065r1453b3118],
14	O.	NNP	MISC	O.	appos	2	SENT_244	[p10l1490t3066r1538b3108],
15	Antipsychotic-induced	JJ	MISC	antipsychotic-induced	amod	17	SENT_244	[p10l1575t3064r2146b3118],
16	extrapyramidal	JJ	O	extrapyramidal	amod	17	SENT_244	[p10l111t3130r475b3184],
17	symptoms	NNS	O	symptom	dep	14	SENT_244	[p10l500t3136r749b3184],
18	in	IN	O	in	_	0	SENT_244	[p10l773t3130r818b3173],
19	patients	NNS	O	patient	prep_in	2	SENT_244	[p10l840t3130r1031b3184],
20	with	IN	O	with	_	0	SENT_244	[p10l1054t3130r1165b3173],
21	schizophrenia	NN	O	schizophrenia	prep_with	19	SENT_244	[p10l1189t3130r1537b3184],
22	:	:	O	:	_	0	SENT_244	[p10l1189t3130r1537b3184],
23	associations	NNS	O	association	dep	2	SENT_244	[p10l1565t3130r1851b3173],
24	with	IN	O	with	_	0	SENT_244	[p10l1873t3130r1984b3173],
25	dopamine	NN	O	dopamine	nn	28	SENT_244	[p10l2008t3130r2146b3184, p10l110t3196r230b3239],
26	and	CC	O	and	_	0	SENT_244	[p10l252t3196r340b3239],
27	serotonin	NN	O	serotonin	nn	28	SENT_244	[p10l363t3196r588b3239],
28	receptor	NN	O	receptor	prep_with	23	SENT_244	[p10l610t3202r811b3250],
29	and	CC	O	and	_	0	SENT_244	[p10l830t3196r918b3239],
30	transporter	NN	O	transporter	nn	31	SENT_244	[p10l939t3202r1212b3250],
31	polymorphisms	NNS	O	polymorphism	conj_and	28	SENT_244	[p10l1232t3196r1618b3250],
32	.	.	O	.	_	0	SENT_244	[p10l1232t3196r1618b3250],

1	Eur	NNP	O	Eur	nn	4	SENT_245	[p10l1641t3198r1756b3250],
2	]	NNP	O	]	nn	4	SENT_245	[p10l1641t3198r1756b3250],
3	Clin	NNP	O	Clin	nn	4	SENT_245	[p10l1778t3196r1870b3239],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_245	[p10l1892t3196r2145b3239],
5	2007	CD	DATE	2007	num	4	SENT_245	[p10l109t3264r512b3312],
6	;	:	O	;	_	0	SENT_245	[p10l109t3264r512b3312],
7	63:233	CD	NUMBER	63:233	number	8	SENT_245	[p10l109t3264r512b3312],
8	—	CD	NUMBER	—	dep	4	SENT_245	[p10l109t3264r512b3312],
9	41	CD	NUMBER	41	dep	8	SENT_245	[p10l109t3264r512b3312],
10	.	.	O	.	_	0	SENT_245	[p10l109t3264r512b3312],

1	Harnryd	NN	O	harnryd	nn	2	SENT_246	[p10l8t3327r210b3382],
2	C	NN	O	c	_	0	SENT_246	[p10l227t3330r268b3378],
3	,	,	O	,	_	0	SENT_246	[p10l227t3330r268b3378],
4	Bjerkenstedt	NN	PERSON	bjerkenstedt	nn	5	SENT_246	[p10l286t3327r597b3382],
5	L	NN	PERSON	l	appos	2	SENT_246	[p10l612t3330r647b3378],
6	,	,	O	,	_	0	SENT_246	[p10l612t3330r647b3378],
7	Gullberg	NN	PERSON	gullberg	nn	8	SENT_246	[p10l665t3327r875b3382],
8	B	NN	O	b	appos	5	SENT_246	[p10l891t3330r931b3378],
9	,	,	O	,	_	0	SENT_246	[p10l891t3330r931b3378],
10	Oxenstierna	NNP	O	Oxenstierna	nn	11	SENT_246	[p10l949t3328r1245b3371],
11	G	NNP	O	G	appos	5	SENT_246	[p10l1262t3330r1308b3378],
12	,	,	O	,	_	0	SENT_246	[p10l1262t3330r1308b3378],
13	Sedvall	NNP	O	Sedvall	nn	14	SENT_246	[p10l1325t3327r1498b3371],
14	G	NNP	O	G	appos	5	SENT_246	[p10l1515t3330r1561b3378],
15	,	,	O	,	_	0	SENT_246	[p10l1515t3330r1561b3378],
16	Wiesel	NNP	O	Wiesel	nn	17	SENT_246	[p10l1577t3327r1744b3371],
17	FA	NNP	O	FA	appos	5	SENT_246	[p10l1762t3329r1831b3371],
18	.	.	O	.	_	0	SENT_246	[p10l1762t3329r1831b3371],

1	Time	NNP	O	Time	nn	2	SENT_247	[p10l1846t3328r1969b3371],
2	course	NN	O	course	_	0	SENT_247	[p10l1986t3340r2144b3371],
3	for	IN	O	for	_	0	SENT_247	[p10l110t3394r177b3438],
4	effects	NNS	O	effect	prep_for	2	SENT_247	[p10l190t3394r347b3438],
5	of	IN	O	of	_	0	SENT_247	[p10l362t3394r413b3438],
6	sulpiride	NN	O	sulpiride	prep_of	4	SENT_247	[p10l422t3394r636b3448],
7	and	CC	O	and	_	0	SENT_247	[p10l651t3394r740b3438],
8	chlorpromazine	NN	O	chlorpromazine	prep_of	4	SENT_247	[p10l755t3394r1144b3448],
9	on	IN	O	on	_	0	SENT_247	[p10l1159t3407r1220b3438],
10	monoamine	NN	O	monoamine	nn	11	SENT_247	[p10l1234t3395r1528b3438],
11	metabolite	NN	O	metabolite	prep_on	2	SENT_247	[p10l1544t3394r1807b3438],
12	and	CC	O	and	_	0	SENT_247	[p10l1822t3394r1911b3438],
13	prolactin	NN	O	prolactin	nn	14	SENT_247	[p10l1926t3394r2145b3448],
14	levels	NNS	O	level	prep_on	2	SENT_247	[p10l109t3460r247b3504],
15	in	IN	O	in	_	0	SENT_247	[p10l277t3461r322b3503],
16	cerebrospinal	JJ	O	cerebrospinal	amod	17	SENT_247	[p10l353t3460r684b3515],
17	ﬂuid	NN	O	ﬂuid	prep_in	2	SENT_247	[p10l715t3460r824b3504],
18	from	IN	O	from	_	0	SENT_247	[p10l856t3460r972b3504],
19	schizophrenic	JJ	O	schizophrenic	amod	20	SENT_247	[p10l1002t3460r1344b3515],
20	patients	NNS	O	patient	prep_from	17	SENT_247	[p10l1373t3461r1582b3515],
21	.	.	O	.	_	0	SENT_247	[p10l1373t3461r1582b3515],

1	Acta	NNP	O	Acta	nn	4	SENT_248	[p10l1611t3462r1719b3504],
2	Psychiatr	NNP	O	Psychiatr	nn	4	SENT_248	[p10l1748t3460r1972b3515],
3	Scand	NNP	O	Scand	nn	4	SENT_248	[p10l2001t3460r2144b3504],
4	Suppl	NNP	O	Suppl	_	0	SENT_248	[p10l109t3526r246b3580],
5	1984	CD	DATE	1984	num	4	SENT_248	[p10l269t3528r675b3576],
6	;	:	O	;	_	0	SENT_248	[p10l269t3528r675b3576],
7	311:75	CD	NUMBER	311:75	number	8	SENT_248	[p10l269t3528r675b3576],
8	—	CD	NUMBER	—	dep	4	SENT_248	[p10l269t3528r675b3576],
9	92	CD	NUMBER	92	dep	8	SENT_248	[p10l269t3528r675b3576],
10	.	.	O	.	_	0	SENT_248	[p10l269t3528r675b3576],

1	Hashimoto	NN	PERSON	hashimoto	nn	2	SENT_249	[p10l8t3592r274b3635],
2	R	NN	PERSON	r	_	0	SENT_249	[p10l290t3595r332b3642],
3	,	,	O	,	_	0	SENT_249	[p10l290t3595r332b3642],
4	Noguchi	NNP	PERSON	Noguchi	nn	5	SENT_249	[p10l349t3592r551b3646],
5	H	NNP	PERSON	H	appos	2	SENT_249	[p10l568t3595r615b3642],
6	,	,	O	,	_	0	SENT_249	[p10l568t3595r615b3642],
7	Hori	NNP	PERSON	Hori	nn	8	SENT_249	[p10l633t3593r737b3635],
8	H	NNP	O	H	appos	2	SENT_249	[p10l754t3595r802b3642],
9	,	,	O	,	_	0	SENT_249	[p10l754t3595r802b3642],
10	Ohi	NNP	PERSON	Ohi	nsubj	12	SENT_249	[p10l819t3592r902b3635],
11	I	PRP	O	I	dep	10	SENT_249	[p10l919t3595r962b3642],
12	(	VBP	O	(	dep	2	SENT_249	[p10l919t3595r962b3642],
13	,	,	O	,	_	0	SENT_249	[p10l919t3595r962b3642],
14	Yasuda	NNP	ORGANIZATION	Yasuda	nn	15	SENT_249	[p10l977t3592r1150b3635],
15	Y	NN	O	y	appos	2	SENT_249	[p10l1163t3595r1203b3642],
16	,	,	O	,	_	0	SENT_249	[p10l1163t3595r1203b3642],
17	Takeda	NNP	PERSON	Takeda	nn	18	SENT_249	[p10l1218t3592r1390b3635],
18	M	NNP	PERSON	M	appos	2	SENT_249	[p10l1406t3594r1465b3642],
19	,	,	O	,	_	0	SENT_249	[p10l1406t3594r1465b3642],
20	et	FW	O	et	nn	21	SENT_249	[p10l1481t3598r1528b3635],
21	al.	FW	O	al.	appos	2	SENT_249	[p10l1542t3592r1594b3636],
22	.	.	O	.	_	0	SENT_249	[p10l1542t3592r1594b3636],

1	A	DT	O	a	det	3	SENT_250	[p10l1609t3594r1645b3635],
2	possible	JJ	O	possible	amod	3	SENT_250	[p10l1659t3592r1857b3646],
3	association	NN	O	association	_	0	SENT_250	[p10l1874t3592r2144b3635],
4	between	IN	O	between	_	0	SENT_250	[p10l109t3657r321b3701],
5	the	DT	O	the	det	7	SENT_250	[p10l339t3657r417b3701],
6	Val158Met	NN	O	val158met	nn	7	SENT_250	[p10l435t3658r703b3701],
7	polymorphism	NN	O	polymorphism	prep_between	3	SENT_250	[p10l721t3657r1083b3712],
8	of	IN	O	of	_	0	SENT_250	[p10l1102t3657r1153b3701],
9	the	DT	O	the	det	12	SENT_250	[p10l1166t3657r1244b3701],
10	catechol-O-methyl	NN	O	catechol-o-methyl	nn	12	SENT_250	[p10l1264t3657r1721b3712],
11	transferase	NN	O	transferase	nn	12	SENT_250	[p10l1740t3657r2010b3701],
12	gene	NN	O	gene	prep_of	7	SENT_250	[p10l2029t3670r2145b3712],
13	and	CC	O	and	_	0	SENT_250	[p10l109t3724r198b3768],
14	the	DT	O	the	det	16	SENT_250	[p10l217t3724r295b3768],
15	personality	NN	O	personality	nn	16	SENT_250	[p10l314t3724r590b3778],
16	trait	NN	O	trait	conj_and	7	SENT_250	[p10l608t3725r711b3768],
17	of	IN	O	of	_	0	SENT_250	[p10l728t3724r779b3768],
18	harm	NN	O	harm	nn	19	SENT_250	[p10l792t3724r922b3768],
19	avoidance	NN	O	avoidance	prep_of	16	SENT_250	[p10l940t3724r1185b3768],
20	in	IN	O	in	_	0	SENT_250	[p10l1205t3725r1250b3767],
21	Japanese	JJ	MISC	japanese	amod	23	SENT_250	[p10l1262t3727r1482b3778],
22	healthy	JJ	O	healthy	amod	23	SENT_250	[p10l1502t3724r1685b3778],
23	subjects	NNS	O	subject	prep_in	3	SENT_250	[p10l1703t3724r1911b3778],
24	.	.	O	.	_	0	SENT_250	[p10l1703t3724r1911b3778],

1	Neurosci	NNP	PERSON	Neurosci	_	0	SENT_251	[p10l1932t3725r2144b3768],

1	Lett	NNP	PERSON	Lett	_	0	SENT_252	[p11l109t15r202b56],
2	2007	CD	DATE	2007	num	1	SENT_252	[p11l220t14r636b63],
3	;	:	O	;	_	0	SENT_252	[p11l220t14r636b63],
4	428:17	CD	NUMBER	428:17	number	5	SENT_252	[p11l220t14r636b63],
5	—	CD	NUMBER	—	dep	1	SENT_252	[p11l220t14r636b63],
6	20	CD	NUMBER	20	dep	5	SENT_252	[p11l220t14r636b63],
7	.	.	O	.	_	0	SENT_252	[p11l220t14r636b63],

1	Hedenmalm	NN	O	hedenmalm	nn	2	SENT_253	[p11l8t78r309b121],
2	K	NN	O	k	nsubj	14	SENT_253	[p11l333t81r377b128],
3	,	,	O	,	_	0	SENT_253	[p11l333t81r377b128],
4	Guzey	NN	O	guzey	nn	5	SENT_253	[p11l401t80r553b132],
5	C	NN	O	c	appos	2	SENT_253	[p11l576t80r616b128],
6	,	,	O	,	_	0	SENT_253	[p11l576t80r616b128],
7	Dahl	NNP	PERSON	Dahl	nn	8	SENT_253	[p11l641t78r752b121],
8	ML	NNP	O	ML	appos	2	SENT_253	[p11l776t81r861b128],
9	,	,	O	,	_	0	SENT_253	[p11l776t81r861b128],
10	Yue	NNP	O	Yue	nn	11	SENT_253	[p11l884t81r974b121],
11	QY	NNP	O	QY	appos	2	SENT_253	[p11l999t80r1075b130],
12	,	,	O	,	_	0	SENT_253	[p11l999t80r1075b130],
13	Spigset	NNP	PERSON	Spigset	appos	2	SENT_253	[p11l1100t79r1275b132],
14	o.	VBD	O	o.	_	0	SENT_253	[p11l1298t80r1345b122],
15	Risk	NN	O	risk	nn	16	SENT_253	[p11l1370t78r1470b121],
16	factors	NNS	O	factor	dobj	14	SENT_253	[p11l1493t78r1656b121],
17	for	IN	O	for	_	0	SENT_253	[p11l1680t78r1749b121],
18	extrapyramidal	JJ	O	extrapyramidal	amod	19	SENT_253	[p11l1770t78r2145b132],
19	symptoms	NNS	O	symptom	prep_for	14	SENT_253	[p11l110t150r363b198],
20	during	IN	O	during	_	0	SENT_253	[p11l379t144r542b198],
21	treatment	NN	O	treatment	prep_during	14	SENT_253	[p11l556t150r803b188],
22	with	IN	O	with	_	0	SENT_253	[p11l816t144r929b188],
23	selective	JJ	O	selective	amod	26	SENT_253	[p11l945t144r1155b188],
24	serotonin	NN	O	serotonin	nn	26	SENT_253	[p11l1171t145r1403b188],
25	reuptake	NN	O	reuptake	nn	26	SENT_253	[p11l1418t144r1634b198],
26	inhibitors	NNS	O	inhibitor	prep_with	21	SENT_253	[p11l1650t144r1899b194],
27	,	,	O	,	_	0	SENT_253	[p11l1650t144r1899b194],
28	including	VBG	O	include	partmod	14	SENT_253	[p11l1915t144r2145b198],
29	cytochrome	NN	O	cytochrome	nn	31	SENT_253	[p11l109t210r399b264],
30	P-450	NN	MISC	p-450	nn	31	SENT_253	[p11l418t212r560b253],
31	enzyme	NN	O	enzyme	dobj	28	SENT_253	[p11l579t222r783b264],
32	,	,	O	,	_	0	SENT_253	[p11l579t222r783b264],
33	and	CC	O	and	_	0	SENT_253	[p11l802t210r891b253],
34	serotonin	NN	O	serotonin	dobj	28	SENT_253	[p11l912t210r1143b253],
35	and	CC	O	and	_	0	SENT_253	[p11l1162t210r1251b253],
36	dopamine	NN	O	dopamine	nn	37	SENT_253	[p11l1271t210r1517b264],
37	transporter	NN	O	transporter	dobj	28	SENT_253	[p11l1536t216r1815b264],
38	and	CC	O	and	_	0	SENT_253	[p11l1832t210r1921b253],
39	receptor	NN	O	receptor	nn	40	SENT_253	[p11l1941t216r2147b264],
40	polymorphisms	NNS	O	polymorphism	conj_and	37	SENT_253	[p11l109t276r539b331],
41	.	.	O	.	_	0	SENT_253	[p11l109t276r539b331],
42	]	SYM	O	]	dep	31	SENT_253	[p11l109t276r539b331],

1	Clin	NNP	O	Clin	nn	2	SENT_254	[p11l559t276r653b320],
2	Psychopharmacol	NNP	O	Psychopharmacol	_	0	SENT_254	[p11l673t276r1105b331],
3	2006	CD	DATE	2006	num	2	SENT_254	[p11l1125t278r1508b326],
4	;	:	O	;	_	0	SENT_254	[p11l1125t278r1508b326],
5	26:192	CD	NUMBER	26:192	num	6	SENT_254	[p11l1125t278r1508b326],
6	—	NN	O	—	dep	2	SENT_254	[p11l1125t278r1508b326],
7	7	CD	NUMBER	7	dep	6	SENT_254	[p11l1125t278r1508b326],
8	.	.	O	.	_	0	SENT_254	[p11l1125t278r1508b326],

1	Himei	NNP	MISC	Himei	nn	2	SENT_255	[p11l8t342r153b385],
2	A	NNP	O	A	_	0	SENT_255	[p11l188t343r235b392],
3	,	,	O	,	_	0	SENT_255	[p11l188t343r235b392],
4	Koh	NNP	PERSON	Koh	nn	5	SENT_255	[p11l273t341r367b385],
5	J	NNP	PERSON	J	appos	2	SENT_255	[p11l397t344r428b396],
6	,	,	O	,	_	0	SENT_255	[p11l397t344r428b396],
7	Sakai	NNP	LOCATION	Sakai	nn	8	SENT_255	[p11l466t341r591b385],
8	J	NNP	O	J	appos	2	SENT_255	[p11l623t344r654b396],
9	,	,	O	,	_	0	SENT_255	[p11l623t344r654b396],
10	Inada	NNP	PERSON	Inada	nn	11	SENT_255	[p11l691t341r825b385],
11	Y	NN	PERSON	y	appos	2	SENT_255	[p11l859t344r899b392],
12	,	,	O	,	_	0	SENT_255	[p11l859t344r899b392],
13	Akabame	NNP	O	Akabame	nn	14	SENT_255	[p11l934t341r1163b385],
14	K	NNP	O	K	appos	2	SENT_255	[p11l1201t344r1244b392],
15	,	,	O	,	_	0	SENT_255	[p11l1201t344r1244b392],
16	Yoneda	NNP	PERSON	Yoneda	nn	19	SENT_255	[p11l1280t341r1460b385],
17	H.	NNP	O	H.	nn	19	SENT_255	[p11l1497t344r1545b385],
18	The	NNP	O	The	nn	19	SENT_255	[p11l1581t341r1670b385],
19	inﬂuence	NN	O	inﬂuence	appos	2	SENT_255	[p11l1708t341r1933b385],
20	on	IN	O	on	_	0	SENT_255	[p11l1970t354r2030b385],
21	the	DT	O	the	det	23	SENT_255	[p11l2066t341r2144b385],
22	schizophrenic	JJ	O	schizophrenic	amod	23	SENT_255	[p11l110t408r451b462],
23	symptoms	NNS	O	symptom	prep_on	19	SENT_255	[p11l477t414r730b462],
24	by	IN	O	by	_	0	SENT_255	[p11l756t408r815b462],
25	the	DT	O	the	det	26	SENT_255	[p11l839t408r917b452],
26	DRD2Ser/Cys311	NN	O	drd2ser/cys311	prep_by	23	SENT_255	[p11l942t408r1343b462],
27	and	CC	O	and	_	0	SENT_255	[p11l1374t408r1463b452],
28	-141	CD	NUMBER	-141	num	31	SENT_255	[p11l1490t410r1629b452],
29	C	NN	O	c	nn	31	SENT_255	[p11l1490t410r1629b452],
30	Ins/Del	JJ	O	ins/del	amod	31	SENT_255	[p11l1654t408r1824b462],
31	polymorphisms	NNS	O	polymorphism	appos	2	SENT_255	[p11l1851t408r2145b462, p11l110t475r230b518],
32	.	.	O	.	_	0	SENT_255	[p11l1851t408r2145b462, p11l110t475r230b518],

1	Psychiatry	NNP	O	Psychiatry	nn	3	SENT_256	[p11l252t474r505b529],
2	Clin	NNP	O	Clin	nn	3	SENT_256	[p11l524t474r617b518],
3	Neurosci	NNP	O	Neurosci	_	0	SENT_256	[p11l637t475r850b518],
4	2002	CD	DATE	2002	num	3	SENT_256	[p11l870t476r1287b524],
5	;	:	O	;	_	0	SENT_256	[p11l870t476r1287b524],
6	56:97	CD	NUMBER	56:97	num	7	SENT_256	[p11l870t476r1287b524],
7	—	NN	O	—	dep	3	SENT_256	[p11l870t476r1287b524],
8	102	CD	NUMBER	102	dep	7	SENT_256	[p11l870t476r1287b524],
9	.	.	O	.	_	0	SENT_256	[p11l870t476r1287b524],

1	Hwu	NNP	PERSON	Hwu	nn	2	SENT_257	[p11l8t543r123b583],
2	HG	NNP	O	HG	_	0	SENT_257	[p11l143t542r229b590],
3	,	,	O	,	_	0	SENT_257	[p11l143t542r229b590],
4	Hong	NNP	O	Hong	nn	6	SENT_257	[p11l250t543r381b594],
5	C	NNP	O	C	nn	6	SENT_257	[p11l400t542r457b594],
6	]	NN	O	]	appos	2	SENT_257	[p11l400t542r457b594],
7	,	,	O	,	_	0	SENT_257	[p11l400t542r457b594],
8	Lee	NNP	PERSON	Lee	nn	9	SENT_257	[p11l478t543r557b583],
9	YL	NNP	PERSON	YL	appos	2	SENT_257	[p11l576t543r646b590],
10	,	,	O	,	_	0	SENT_257	[p11l576t543r646b590],
11	Lee	NNP	PERSON	Lee	nn	12	SENT_257	[p11l668t543r747b583],
12	PC	NNP	O	PC	appos	2	SENT_257	[p11l767t542r838b590],
13	,	,	O	,	_	0	SENT_257	[p11l767t542r838b590],
14	Lee	NNP	PERSON	Lee	nn	15	SENT_257	[p11l859t543r939b583],
15	SF	NNP	O	SF	appos	2	SENT_257	[p11l960t542r1020b584],
16	.	.	O	.	_	0	SENT_257	[p11l960t542r1020b584],

1	Dopamine	NN	O	dopamine	nn	3	SENT_258	[p11l1041t541r1293b594],
2	D4	NN	O	d4	nn	3	SENT_258	[p11l1314t542r1380b583],
3	receptor	NN	O	receptor	_	0	SENT_258	[p11l1401t546r1606b594],
4	gene	NN	O	gene	nn	5	SENT_258	[p11l1623t552r1739b594],
5	polymorphisms	NNS	O	polymorphism	dep	3	SENT_258	[p11l1760t540r2144b594],
6	and	CC	O	and	_	0	SENT_258	[p11l109t605r198b649],
7	neuroleptic	JJ	O	neuroleptic	amod	8	SENT_258	[p11l219t605r498b660],
8	response	NN	O	response	dep	3	SENT_258	[p11l518t618r736b660],
9	in	IN	O	in	_	0	SENT_258	[p11l756t606r800b649],
10	schizophrenia	NN	O	schizophrenia	prep_in	3	SENT_258	[p11l821t605r1176b660],
11	.	.	O	.	_	0	SENT_258	[p11l821t605r1176b660],

1	Biol	NNP	O	Biol	nn	2	SENT_259	[p11l1196t606r1287b649],
2	Psychiatry	NNP	O	Psychiatry	_	0	SENT_259	[p11l1307t605r1561b660],
3	1998	CD	DATE	1998	num	2	SENT_259	[p11l1582t608r1962b656],
4	;	:	O	;	_	0	SENT_259	[p11l1582t608r1962b656],
5	44:483	CD	NUMBER	44:483	num	6	SENT_259	[p11l1582t608r1962b656],
6	—	NN	O	—	dep	2	SENT_259	[p11l1582t608r1962b656],
7	7	CD	NUMBER	7	dep	6	SENT_259	[p11l1582t608r1962b656],
8	.	.	O	.	_	0	SENT_259	[p11l1582t608r1962b656],

1	Inada	NNP	PERSON	Inada	_	0	SENT_260	[p11l8t671r141b715],
2	T	NN	O	t	dep	1	SENT_260	[p11l154t674r191b722],
3	,	,	O	,	_	0	SENT_260	[p11l154t674r191b722],
4	Arinami	FW	ORGANIZATION	arinami	dep	1	SENT_260	[p11l206t672r404b715],
5	T	NN	ORGANIZATION	t	dep	1	SENT_260	[p11l418t674r455b722],
6	,	,	O	,	_	0	SENT_260	[p11l418t674r455b722],
7	Yagi	NNP	ORGANIZATION	Yagi	nn	9	SENT_260	[p11l470t672r571b726],
8	G.	NNP	ORGANIZATION	G.	nn	9	SENT_260	[p11l587t674r633b715],
9	Association	NNP	ORGANIZATION	Association	appos	5	SENT_260	[p11l648t672r928b715],
10	between	IN	O	between	_	0	SENT_260	[p11l944t671r1156b715],
11	a	DT	O	a	det	12	SENT_260	[p11l1171t684r1196b715],
12	polymorphism	NN	O	polymorphism	prep_between	9	SENT_260	[p11l1211t671r1573b726],
13	in	IN	O	in	_	0	SENT_260	[p11l1589t672r1634b715],
14	the	DT	O	the	det	16	SENT_260	[p11l1649t671r1727b715],
15	promoter	NN	O	promoter	nn	16	SENT_260	[p11l1743t678r1976b726],
16	region	NN	O	region	prep_in	12	SENT_260	[p11l1990t672r2145b726],
17	of	IN	O	of	_	0	SENT_260	[p11l109t738r160b782],
18	the	DT	O	the	det	22	SENT_260	[p11l191t738r268b782],
19	dopamine	NN	O	dopamine	nn	22	SENT_260	[p11l307t738r552b792],
20	D2	NN	O	d2	nn	22	SENT_260	[p11l590t740r655b781],
21	receptor	NN	O	receptor	nn	22	SENT_260	[p11l694t744r900b792],
22	gene	NN	O	gene	prep_of	16	SENT_260	[p11l934t751r1050b792],
23	and	CC	O	and	_	0	SENT_260	[p11l1087t738r1176b782],
24	schizophrenia	NN	O	schizophrenia	conj_and	1	SENT_260	[p11l1214t738r1558b792],
25	in	IN	O	in	_	0	SENT_260	[p11l1595t739r1640b781],
26	Japanese	JJ	MISC	japanese	amod	27	SENT_260	[p11l1670t741r1890b792],
27	subjects	NNS	O	subject	prep_in	24	SENT_260	[p11l1929t738r2141b792],
28	:	:	O	:	_	0	SENT_260	[p11l1929t738r2141b792],
29	replication	NN	O	replication	dep	1	SENT_260	[p11l109t804r372b859],
30	and	CC	O	and	_	0	SENT_260	[p11l398t804r487b848],
31	evaluation	NN	O	evaluation	dep	1	SENT_260	[p11l513t804r769b848],
32	for	IN	O	for	_	0	SENT_260	[p11l796t804r864b848],
33	antipsychotic-related	JJ	O	antipsychotic-related	amod	34	SENT_260	[p11l888t804r1410b859],
34	features	NNS	O	feature	prep_for	29	SENT_260	[p11l1436t804r1644b848],
35	.	.	O	.	_	0	SENT_260	[p11l1436t804r1644b848],

1	Int	NN	O	int	_	0	SENT_261	[p11l1671t807r1775b859],
2	]	CD	NUMBER	]	num	1	SENT_261	[p11l1671t807r1775b859],
3	Neuropsychopharmacol	NNP	O	Neuropsychopharmacol	dep	1	SENT_261	[p11l1801t804r2144b859, p11l109t870r370b924],
4	1992	CD	DATE	1992	num	3	SENT_261	[p11l393t872r740b920],
5	;	:	O	;	_	0	SENT_261	[p11l393t872r740b920],
6	2:181	CD	NUMBER	2:181	number	7	SENT_261	[p11l393t872r740b920],
7	—	CD	NUMBER	—	dep	1	SENT_261	[p11l393t872r740b920],
8	6	CD	NUMBER	6	dep	7	SENT_261	[p11l393t872r740b920],
9	.	.	O	.	_	0	SENT_261	[p11l393t872r740b920],

1	Kaiser	NNP	PERSON	Kaiser	nn	2	SENT_262	[p11l8t937r158b980],
2	R	NNP	PERSON	R	_	0	SENT_262	[p11l189t939r230b986],
3	,	,	O	,	_	0	SENT_262	[p11l189t939r230b986],
4	Tremblay	NNP	O	Tremblay	nn	5	SENT_262	[p11l261t936r494b990],
5	PB	NN	O	pb	appos	2	SENT_262	[p11l524t939r595b986],
6	,	,	O	,	_	0	SENT_262	[p11l524t939r595b986],
7	Klufmoller	NN	O	klufmoller	nn	8	SENT_262	[p11l628t936r889b980],
8	F	NN	O	f	appos	2	SENT_262	[p11l920t939r953b986],
9	,	,	O	,	_	0	SENT_262	[p11l920t939r953b986],
10	Roots	NNS	O	root	appos	2	SENT_262	[p11l986t939r1118b980],
11	I	PRP	O	I	dep	10	SENT_262	[p11l1151t939r1175b986],
12	,	,	O	,	_	0	SENT_262	[p11l1151t939r1175b986],
13	Brockmoller	NNP	O	Brockmoller	nn	15	SENT_262	[p11l1208t936r1508b980],
14	J.	NNP	O	J.	nn	15	SENT_262	[p11l1533t939r1564b990],
15	Relationship	NN	O	relationship	appos	2	SENT_262	[p11l1597t936r1900b990],
16	between	IN	O	between	_	0	SENT_262	[p11l1933t936r2145b980],
17	adverse	JJ	O	adverse	amod	18	SENT_262	[p11l109t1002r297b1045],
18	effects	NNS	O	effect	prep_between	15	SENT_262	[p11l320t1001r476b1045],
19	of	IN	O	of	_	0	SENT_262	[p11l499t1001r550b1045],
20	antipsychotic	JJ	O	antipsychotic	amod	21	SENT_262	[p11l567t1002r895b1056],
21	treatment	NN	O	treatment	prep_of	18	SENT_262	[p11l916t1008r1163b1045],
22	and	CC	O	and	_	0	SENT_262	[p11l1183t1002r1272b1045],
23	dopamine	NN	O	dopamine	nn	24	SENT_262	[p11l1295t1002r1541b1056],
24	D	NN	O	d	prep_of	18	SENT_262	[p11l1564t1002r1669b1056],
25	(	CD	NUMBER	(	num	29	SENT_262	[p11l1564t1002r1669b1056],
26	2	CD	NUMBER	2	num	29	SENT_262	[p11l1564t1002r1669b1056],
27	)	NN	O	)	nn	29	SENT_262	[p11l1564t1002r1669b1056],
28	receptor	NN	O	receptor	nn	29	SENT_262	[p11l1693t1008r1898b1056],
29	polymorphisms	NNS	O	polymorphism	dep	2	SENT_262	[p11l1919t1002r2144b1056, p11l109t1068r283b1123],
30	in	IN	O	in	_	0	SENT_262	[p11l305t1069r350b1111],
31	patients	NNS	O	patient	prep_in	29	SENT_262	[p11l368t1069r564b1123],
32	with	IN	O	with	_	0	SENT_262	[p11l584t1068r697b1112],
33	schizophrenia	NN	O	schizophrenia	prep_with	31	SENT_262	[p11l717t1068r1071b1123],
34	.	.	O	.	_	0	SENT_262	[p11l717t1068r1071b1123],

1	Mol	NNP	O	Mol	nn	2	SENT_263	[p11l1092t1068r1185b1112],
2	Psychiatry	NNP	O	Psychiatry	_	0	SENT_263	[p11l1205t1068r1459b1123],
3	2002	CD	DATE	2002	num	2	SENT_263	[p11l1477t1070r1895b1118],
4	;	:	O	;	_	0	SENT_263	[p11l1477t1070r1895b1118],
5	7:695	CD	NUMBER	7:695	num	6	SENT_263	[p11l1477t1070r1895b1118],
6	—	NN	O	—	dep	2	SENT_263	[p11l1477t1070r1895b1118],
7	705	CD	NUMBER	705	dep	6	SENT_263	[p11l1477t1070r1895b1118],
8	.	.	O	.	_	0	SENT_263	[p11l1477t1070r1895b1118],

1	Kim	NNP	PERSON	Kim	nn	2	SENT_264	[p11l8t1134r105b1177],
2	YK	NNP	O	YK	_	0	SENT_264	[p11l126t1136r204b1184],
3	,	,	O	,	_	0	SENT_264	[p11l126t1136r204b1184],
4	Kim	NNP	PERSON	Kim	nn	5	SENT_264	[p11l229t1134r327b1177],
5	L	NNP	PERSON	L	conj_and	2	SENT_264	[p11l350t1136r385b1184],
6	,	,	O	,	_	0	SENT_264	[p11l350t1136r385b1184],
7	Lee	NNP	PERSON	Lee	nn	9	SENT_264	[p11l408t1136r487b1177],
8	MS.	NNP	PERSON	MS.	nn	9	SENT_264	[p11l512t1136r599b1177],
9	Risperidone	NNP	PERSON	Risperidone	conj_and	2	SENT_264	[p11l623t1133r914b1188],
10	and	CC	O	and	_	0	SENT_264	[p11l938t1133r1027b1177],
11	associated	VBN	O	associate	amod	12	SENT_264	[p11l1051t1133r1302b1177],
12	amenorrhea	NN	O	amenorrhea	conj_and	2	SENT_264	[p11l1326t1133r1639b1177],
13	:	:	O	:	_	0	SENT_264	[p11l1326t1133r1639b1177],
14	a	DT	O	a	det	15	SENT_264	[p11l1666t1146r1691b1177],
15	report	NN	O	report	dep	2	SENT_264	[p11l1714t1140r1867b1188],
16	of	IN	O	of	_	0	SENT_264	[p11l1888t1133r1938b1177],
17	5	CD	NUMBER	5	num	18	SENT_264	[p11l1956t1136r1981b1177],
18	cases	NNS	O	case	prep_of	15	SENT_264	[p11l2007t1146r2144b1177],
19	.	.	O	.	_	0	SENT_264	[p11l2007t1146r2144b1177],

1	J	NNP	O	J	nn	3	SENT_265	[p11l103t1203r123b1254],
2	Clin	NNP	O	Clin	nn	3	SENT_265	[p11l142t1200r235b1244],
3	Psychiatry	NNP	O	Psychiatry	_	0	SENT_265	[p11l255t1200r509b1254],
4	1999	CD	DATE	1999	num	3	SENT_265	[p11l530t1202r903b1250],
5	;	:	O	;	_	0	SENT_265	[p11l530t1202r903b1250],
6	60:315	CD	NUMBER	60:315	num	7	SENT_265	[p11l530t1202r903b1250],
7	—	NN	O	—	dep	3	SENT_265	[p11l530t1202r903b1250],
8	7	CD	NUMBER	7	dep	7	SENT_265	[p11l530t1202r903b1250],
9	.	.	O	.	_	0	SENT_265	[p11l530t1202r903b1250],

1	Kim	NNP	PERSON	Kim	nn	2	SENT_266	[p11l8t1267r105b1309],
2	E	NNP	PERSON	E	_	0	SENT_266	[p11l130t1269r168b1316],
3	,	,	O	,	_	0	SENT_266	[p11l130t1269r168b1316],
4	Kwon	NNP	PERSON	Kwon	nn	5	SENT_266	[p11l194t1269r336b1310],
5	JS	NNP	O	JS	appos	2	SENT_266	[p11l354t1268r413b1321],
6	,	,	O	,	_	0	SENT_266	[p11l354t1268r413b1321],
7	Shin	NNP	PERSON	Shin	nn	8	SENT_266	[p11l439t1266r546b1310],
8	YW	NNP	PERSON	YW	appos	5	SENT_266	[p11l568t1269r666b1316],
9	,	,	O	,	_	0	SENT_266	[p11l568t1269r666b1316],
10	Lee	NNP	PERSON	Lee	nn	11	SENT_266	[p11l692t1269r771b1310],
11	JS	NNP	O	JS	appos	5	SENT_266	[p11l790t1268r849b1321],
12	,	,	O	,	_	0	SENT_266	[p11l790t1268r849b1321],
13	Kang	NNP	PERSON	Kang	nn	15	SENT_266	[p11l875t1269r998b1321],
14	W	NNP	O	W	nn	15	SENT_266	[p11l1019t1269r1103b1321],
15	]	NN	O	]	appos	5	SENT_266	[p11l1019t1269r1103b1321],
16	,	,	O	,	_	0	SENT_266	[p11l1019t1269r1103b1321],
17	Jo	NNP	PERSON	Jo	nn	19	SENT_266	[p11l1122t1269r1172b1321],
18	H	NNP	PERSON	H	nn	19	SENT_266	[p11l1197t1269r1262b1321],
19	]	NN	O	]	appos	5	SENT_266	[p11l1197t1269r1262b1321],
20	,	,	O	,	_	0	SENT_266	[p11l1197t1269r1262b1321],
21	et	FW	O	et	nn	22	SENT_266	[p11l1288t1273r1334b1310],
22	al.	FW	O	al.	appos	5	SENT_266	[p11l1358t1266r1409b1310],
23	.	.	O	.	_	0	SENT_266	[p11l1358t1266r1409b1310],

1	Taq1A	NN	O	taq1a	nn	2	SENT_267	[p11l1433t1268r1587b1321],
2	polymorphism	NN	O	polymorphism	nsubj	9	SENT_267	[p11l1610t1266r1973b1321],
3	in	IN	O	in	_	0	SENT_267	[p11l1997t1267r2042b1309],
4	the	DT	O	the	det	8	SENT_267	[p11l2066t1266r2144b1310],
5	dopamine	NN	O	dopamine	nn	8	SENT_267	[p11l109t1332r355b1386],
6	D2	NN	O	d2	nn	8	SENT_267	[p11l380t1334r444b1375],
7	receptor	NN	O	receptor	nn	8	SENT_267	[p11l470t1338r675b1386],
8	gene	NN	O	gene	prep_in	2	SENT_267	[p11l696t1344r812b1386],
9	predicts	VBZ	O	predict	_	0	SENT_267	[p11l836t1332r1032b1386],
10	brain	NN	O	brain	nn	12	SENT_267	[p11l1055t1332r1182b1375],
11	metabolic	JJ	O	metabolic	amod	12	SENT_267	[p11l1205t1332r1447b1375],
12	response	NN	O	response	dobj	9	SENT_267	[p11l1470t1344r1689b1386],
13	to	TO	O	to	_	0	SENT_267	[p11l1712t1338r1758b1375],
14	aripiprazole	NN	O	aripiprazole	prep_to	12	SENT_267	[p11l1782t1332r2075b1386],
15	in	IN	O	in	_	0	SENT_267	[p11l2100t1332r2145b1375],
16	healthy	JJ	O	healthy	amod	18	SENT_267	[p11l109t1398r293b1452],
17	male	JJ	O	male	amod	18	SENT_267	[p11l311t1397r429b1441],
18	volunteers	NNS	O	volunteer	prep_in	14	SENT_267	[p11l448t1397r719b1441],
19	.	.	O	.	_	0	SENT_267	[p11l448t1397r719b1441],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_268	[p11l741t1397r1124b1452],
2	Genomics	NNP	O	Genomics	_	0	SENT_268	[p11l1142t1398r1383b1441],
3	2008	CD	DATE	2008	num	2	SENT_268	[p11l1403t1400r1752b1448],
4	;	:	O	;	_	0	SENT_268	[p11l1403t1400r1752b1448],
5	18:91	CD	NUMBER	18:91	num	6	SENT_268	[p11l1403t1400r1752b1448],
6	—	NN	O	—	dep	2	SENT_268	[p11l1403t1400r1752b1448],
7	7	CD	NUMBER	7	dep	6	SENT_268	[p11l1403t1400r1752b1448],
8	.	.	O	.	_	0	SENT_268	[p11l1403t1400r1752b1448],

1	Kishida	NNP	PERSON	Kishida	nn	2	SENT_269	[p11l8t1464r182b1507],
2	l	NN	O	l	_	0	SENT_269	[p11l204t1466r229b1514],
3	,	,	O	,	_	0	SENT_269	[p11l204t1466r229b1514],
4	Kawanishi	NNP	ORGANIZATION	Kawanishi	nn	5	SENT_269	[p11l251t1464r495b1507],
5	C	NNP	ORGANIZATION	C	appos	2	SENT_269	[p11l518t1466r559b1514],
6	,	,	O	,	_	0	SENT_269	[p11l518t1466r559b1514],
7	Furuno	NNP	ORGANIZATION	Furuno	nn	8	SENT_269	[p11l581t1466r750b1507],
8	T	NN	ORGANIZATION	t	appos	5	SENT_269	[p11l767t1466r803b1514],
9	,	,	O	,	_	0	SENT_269	[p11l767t1466r803b1514],
10	Matsumura	NNP	ORGANIZATION	Matsumura	nn	11	SENT_269	[p11l827t1466r1101b1507],
11	T	NN	ORGANIZATION	t	appos	5	SENT_269	[p11l1121t1466r1157b1514],
12	,	,	O	,	_	0	SENT_269	[p11l1121t1466r1157b1514],
13	Hasegawa	NN	PERSON	hasegawa	nn	14	SENT_269	[p11l1182t1466r1420b1518],
14	H	NN	PERSON	h	appos	5	SENT_269	[p11l1443t1466r1491b1514],
15	,	,	O	,	_	0	SENT_269	[p11l1443t1466r1491b1514],
16	Sugiyama	NNP	PERSON	Sugiyama	nn	17	SENT_269	[p11l1513t1464r1743b1518],
17	N	NNP	O	N	appos	5	SENT_269	[p11l1765t1466r1812b1514],
18	,	,	O	,	_	0	SENT_269	[p11l1765t1466r1812b1514],
19	et	FW	O	et	nn	20	SENT_269	[p11l1836t1470r1881b1507],
20	al.	FW	O	al.	appos	5	SENT_269	[p11l1902t1464r1953b1508],
21	.	.	O	.	_	0	SENT_269	[p11l1902t1464r1953b1508],

1	Lack	NN	O	lack	_	0	SENT_270	[p11l1976t1464r2080b1507],
2	of	IN	O	of	_	0	SENT_270	[p11l2101t1463r2152b1507],
3	association	NN	O	association	nn	5	SENT_270	[p11l109t1531r370b1574],
4	inJapanese	NN	O	injapanese	nn	5	SENT_270	[p11l382t1531r645b1585],
5	patients	NNS	O	patient	prep_of	1	SENT_270	[p11l658t1531r846b1585],
6	between	IN	O	between	_	0	SENT_270	[p11l859t1530r1065b1574],
7	neuroleptic	JJ	O	neuroleptic	amod	9	SENT_270	[p11l1077t1530r1348b1585],
8	malignant	JJ	O	malignant	amod	9	SENT_270	[p11l1358t1530r1601b1585],
9	syndrome	NN	O	syndrome	prep_between	1	SENT_270	[p11l1611t1530r1848b1585],
10	and	CC	O	and	_	0	SENT_270	[p11l1861t1530r1949b1574],
11	the	DT	O	the	det	14	SENT_270	[p11l1960t1530r2037b1574],
12	Taql	NNP	MISC	Taql	nn	14	SENT_270	[p11l2046t1533r2145b1585],
13	A	NNP	O	A	nn	14	SENT_270	[p11l107t1597r143b1639],
14	polymorphism	NN	O	polymorphism	prep_between	1	SENT_270	[p11l159t1595r509b1650],
15	of	IN	O	of	_	0	SENT_270	[p11l526t1595r576b1639],
16	the	DT	O	the	det	20	SENT_270	[p11l587t1595r663b1639],
17	dopamine	NN	O	dopamine	nn	20	SENT_270	[p11l680t1595r919b1650],
18	D2	NN	O	d2	nn	20	SENT_270	[p11l937t1598r1000b1639],
19	receptor	NN	O	receptor	nn	20	SENT_270	[p11l1019t1602r1218b1650],
20	gene	NN	O	gene	prep_of	1	SENT_270	[p11l1232t1608r1355b1650],
21	.	.	O	.	_	0	SENT_270	[p11l1232t1608r1355b1650],

1	Psychiatr	NNP	O	Psychiatr	nn	2	SENT_271	[p11l1374t1595r1590b1650],
2	Genet	NNP	O	Genet	_	0	SENT_271	[p11l1606t1598r1747b1639],
3	2003	CD	DATE	2003	num	2	SENT_271	[p11l1762t1598r2101b1646],
4	;	:	O	;	_	0	SENT_271	[p11l1762t1598r2101b1646],
5	13:55	CD	TIME	13:55	num	6	SENT_271	[p11l1762t1598r2101b1646],
6	—	NN	O	—	dep	2	SENT_271	[p11l1762t1598r2101b1646],
7	7	CD	NUMBER	7	dep	6	SENT_271	[p11l1762t1598r2101b1646],
8	.	.	O	.	_	0	SENT_271	[p11l1762t1598r2101b1646],

1	Kleinberg	NNP	ORGANIZATION	Kleinberg	nn	2	SENT_272	[p11l8t1662r244b1716],
2	DL	NNP	ORGANIZATION	DL	nsubj	23	SENT_272	[p11l256t1665r329b1712],
3	,	,	O	,	_	0	SENT_272	[p11l256t1665r329b1712],
4	DavisJM	NNP	O	DavisJM	nsubj	23	SENT_272	[p11l343t1663r562b1716],
5	,	,	O	,	_	0	SENT_272	[p11l343t1663r562b1716],
6	de	FW	PERSON	de	nn	8	SENT_272	[p11l575t1662r632b1706],
7	Coster	FW	PERSON	coster	nn	8	SENT_272	[p11l645t1664r800b1706],
8	R	NN	PERSON	r	conj_and	2	SENT_272	[p11l811t1665r853b1712],
9	,	,	O	,	_	0	SENT_272	[p11l811t1665r853b1712],
10	Van	NNP	PERSON	Van	nn	12	SENT_272	[p11l864t1665r960b1706],
11	Baelen	NNP	PERSON	Baelen	nn	12	SENT_272	[p11l973t1662r1134b1706],
12	B	NNP	PERSON	B	conj_and	2	SENT_272	[p11l1147t1665r1187b1712],
13	,	,	O	,	_	0	SENT_272	[p11l1147t1665r1187b1712],
14	Brecher	NNP	PERSON	Brecher	nn	17	SENT_272	[p11l1201t1662r1391b1706],
15	M.	NNP	O	M.	nn	17	SENT_272	[p11l1402t1665r1460b1706],
16	Prolactin	NN	O	prolactin	nn	17	SENT_272	[p11l1474t1662r1691b1706],
17	levels	NNS	O	level	conj_and	2	SENT_272	[p11l1704t1662r1841b1706],
18	and	CC	O	and	_	0	SENT_272	[p11l1854t1662r1943b1706],
19	adverse	JJ	O	adverse	amod	20	SENT_272	[p11l1956t1662r2145b1706],
20	events	NNS	O	event	nsubj	23	SENT_272	[p11l109t1734r268b1772],
21	in	IN	O	in	_	0	SENT_272	[p11l284t1729r329b1771],
22	patients	NNS	O	patient	prep_in	20	SENT_272	[p11l344t1729r540b1782],
23	treated	VBN	O	treat	_	0	SENT_272	[p11l556t1728r730b1772],
24	with	IN	O	with	_	0	SENT_272	[p11l745t1728r858b1772],
25	risperidone	NN	O	risperidone	prep_with	23	SENT_272	[p11l874t1728r1196b1782],
26	.	.	O	.	_	0	SENT_272	[p11l874t1728r1196b1782],

1	J	NNP	O	J	nn	3	SENT_273	[p11l874t1728r1196b1782],
2	Clin	NNP	O	Clin	nn	3	SENT_273	[p11l1212t1728r1306b1772],
3	Psychopharmacol	NNP	O	Psychopharmacol	_	0	SENT_273	[p11l1322t1728r1754b1782],
4	1999	CD	DATE	1999	num	3	SENT_273	[p11l1773t1730r2144b1778],
5	;	:	O	;	_	0	SENT_273	[p11l1773t1730r2144b1778],
6	19:57	CD	TIME	19:57	number	7	SENT_273	[p11l1773t1730r2144b1778],
7	—	CD	NUMBER	—	dep	3	SENT_273	[p11l1773t1730r2144b1778],
8	61	CD	NUMBER	61	dep	7	SENT_273	[p11l1773t1730r2144b1778],
9	.	.	O	.	_	0	SENT_273	[p11l1773t1730r2144b1778],

1	Lane	NNP	O	Lane	nn	2	SENT_274	[p11l8t1796r119b1837],
2	HY	NNP	O	HY	_	0	SENT_274	[p11l133t1796r211b1844],
3	,	,	O	,	_	0	SENT_274	[p11l133t1796r211b1844],
4	Hsu	NNP	PERSON	Hsu	nn	5	SENT_274	[p11l226t1796r318b1837],
5	SK	NNP	O	SK	appos	2	SENT_274	[p11l332t1796r403b1844],
6	,	,	O	,	_	0	SENT_274	[p11l332t1796r403b1844],
7	Liu	NNP	PERSON	Liu	nn	8	SENT_274	[p11l417t1794r489b1837],
8	YC	NNP	PERSON	YC	appos	5	SENT_274	[p11l500t1796r574b1844],
9	,	,	O	,	_	0	SENT_274	[p11l500t1796r574b1844],
10	Chang	NNP	PERSON	Chang	nn	11	SENT_274	[p11l589t1794r741b1848],
11	YC	NNP	O	YC	appos	5	SENT_274	[p11l752t1796r825b1844],
12	,	,	O	,	_	0	SENT_274	[p11l752t1796r825b1844],
13	Huang	NNP	PERSON	Huang	nn	14	SENT_274	[p11l840t1796r1000b1848],
14	CH	NN	PERSON	ch	appos	5	SENT_274	[p11l1013t1796r1093b1844],
15	,	,	O	,	_	0	SENT_274	[p11l1013t1796r1093b1844],
16	Chang	NNP	PERSON	Chang	nn	17	SENT_274	[p11l1107t1794r1260b1848],
17	WH	NNP	PERSON	WH	appos	5	SENT_274	[p11l1270t1796r1377b1838],
18	.	.	O	.	_	0	SENT_274	[p11l1270t1796r1377b1838],

1	Dopamine	NN	O	dopamine	_	0	SENT_275	[p11l1392t1794r1644b1848],
2	D3	NN	O	d3	dep	1	SENT_275	[p11l1659t1796r1722b1837],
3	receptor	NN	O	receptor	dep	2	SENT_275	[p11l1738t1800r1944b1848],
4	Ser9Gly	NN	O	ser9gly	nn	5	SENT_275	[p11l1955t1794r2146b1848],
5	polymorphism	NN	O	polymorphism	dobj	3	SENT_275	[p11l109t1860r471b1915],
6	and	CC	O	and	_	0	SENT_275	[p11l489t1860r578b1904],
7	risperidone	NN	O	risperidone	nn	8	SENT_275	[p11l597t1860r877b1915],
8	response	NN	O	response	dobj	3	SENT_275	[p11l896t1863r1157b1915],
9	.	.	O	.	_	0	SENT_275	[p11l896t1863r1157b1915],
10	]	SYM	O	]	dep	5	SENT_275	[p11l896t1863r1157b1915],

1	Clin	NNP	O	Clin	nn	2	SENT_276	[p11l1175t1860r1269b1904],
2	Psychopharmacol	NNP	O	Psychopharmacol	_	0	SENT_276	[p11l1287t1860r1720b1915],
3	2005	CD	DATE	2005	num	2	SENT_276	[p11l1738t1862r2087b1910],
4	;	:	O	;	_	0	SENT_276	[p11l1738t1862r2087b1910],
5	25:6	CD	NUMBER	25:6	number	6	SENT_276	[p11l1738t1862r2087b1910],
6	—	CD	NUMBER	—	dep	2	SENT_276	[p11l1738t1862r2087b1910],
7	11	CD	NUMBER	11	dep	6	SENT_276	[p11l1738t1862r2087b1910],
8	.	.	O	.	_	0	SENT_276	[p11l1738t1862r2087b1910],

1	Lavalaye	NN	PERSON	lavalaye	nn	2	SENT_277	[p11l8t1926r213b1980],
2	J	NN	PERSON	j	_	0	SENT_277	[p11l230t1928r261b1980],
3	,	,	O	,	_	0	SENT_277	[p11l230t1928r261b1980],
4	Linszen	NNP	O	Linszen	nn	5	SENT_277	[p11l286t1926r469b1969],
5	DH	NNP	O	DH	appos	2	SENT_277	[p11l493t1928r580b1976],
6	,	,	O	,	_	0	SENT_277	[p11l493t1928r580b1976],
7	Booij	NNP	PERSON	Booij	nn	8	SENT_277	[p11l605t1926r723b1980],
8	J	NNP	PERSON	J	appos	2	SENT_277	[p11l743t1928r774b1980],
9	,	,	O	,	_	0	SENT_277	[p11l743t1928r774b1980],
10	Reneman	NNP	O	Reneman	nn	11	SENT_277	[p11l799t1928r1027b1969],
11	L	NNP	O	L	appos	2	SENT_277	[p11l1051t1928r1086b1976],
12	,	,	O	,	_	0	SENT_277	[p11l1051t1928r1086b1976],
13	Gersons	NNP	ORGANIZATION	Gersons	nn	14	SENT_277	[p11l1110t1928r1305b1969],
14	BP	NNP	ORGANIZATION	BP	appos	2	SENT_277	[p11l1330t1928r1396b1976],
15	,	,	O	,	_	0	SENT_277	[p11l1330t1928r1396b1976],
16	van	NNP	PERSON	van	nn	17	SENT_277	[p11l1419t1938r1506b1969],
17	Royen	NNP	PERSON	Royen	appos	2	SENT_277	[p11l1531t1928r1678b1980],
18	EA	NN	O	ea	dep	17	SENT_277	[p11l1703t1927r1777b1969],
19	.	.	O	.	_	0	SENT_277	[p11l1703t1927r1777b1969],

1	Dopamine	NN	O	dopamine	nn	4	SENT_278	[p11l1802t1926r2054b1980],
2	D2	NN	O	d2	nn	4	SENT_278	[p11l2079t1928r2143b1969],
3	receptor	NN	O	receptor	nn	4	SENT_278	[p11l109t1998r315b2046],
4	occupancy	NN	O	occupancy	_	0	SENT_278	[p11l337t2005r596b2046],
5	by	IN	O	by	_	0	SENT_278	[p11l619t1992r678b2046],
6	olanzapine	NN	O	olanzapine	prep_by	4	SENT_278	[p11l700t1992r967b2046],
7	or	CC	O	or	_	0	SENT_278	[p11l992t2005r1043b2036],
8	risperidone	NN	O	risperidone	prep_by	4	SENT_278	[p11l1065t1992r1345b2046],
9	in	IN	O	in	_	0	SENT_278	[p11l1371t1993r1416b2035],
10	young	JJ	O	young	amod	11	SENT_278	[p11l1437t2005r1590b2046],
11	patients	NNS	O	patient	prep_in	4	SENT_278	[p11l1613t1993r1809b2046],
12	with	IN	O	with	_	0	SENT_278	[p11l1834t1992r1946b2036],
13	schizophrenia	NN	O	schizophrenia	prep_with	4	SENT_278	[p11l1971t1992r2144b2036, p11l109t2058r309b2113],
14	.	.	O	.	_	0	SENT_278	[p11l1971t1992r2144b2036, p11l109t2058r309b2113],

1	Psychiatry	NNP	O	Psychiatry	nn	2	SENT_279	[p11l328t2058r581b2113],
2	Res	NNP	O	Res	_	0	SENT_279	[p11l599t2061r679b2102],
3	1999	CD	DATE	1999	num	2	SENT_279	[p11l700t2060r1084b2108],
4	;	:	O	;	_	0	SENT_279	[p11l700t2060r1084b2108],
5	92:33	CD	NUMBER	92:33	number	6	SENT_279	[p11l700t2060r1084b2108],
6	—	CD	NUMBER	—	dep	2	SENT_279	[p11l700t2060r1084b2108],
7	44	CD	NUMBER	44	dep	6	SENT_279	[p11l700t2060r1084b2108],
8	.	.	O	.	_	0	SENT_279	[p11l700t2060r1084b2108],

1	Lencz	NNP	ORGANIZATION	Lencz	nn	2	SENT_280	[p11l8t2127r143b2167],
2	T	NN	ORGANIZATION	t	_	0	SENT_280	[p11l162t2127r200b2174],
3	,	,	O	,	_	0	SENT_280	[p11l162t2127r200b2174],
4	Robinson	NNP	ORGANIZATION	Robinson	nn	5	SENT_280	[p11l222t2124r448b2167],
5	DG	NNS	ORGANIZATION	dg	appos	2	SENT_280	[p11l469t2126r554b2174],
6	,	,	O	,	_	0	SENT_280	[p11l469t2126r554b2174],
7	Xu	NNP	PERSON	Xu	nn	8	SENT_280	[p11l574t2126r641b2167],
8	K	NNP	PERSON	K	appos	5	SENT_280	[p11l661t2127r704b2174],
9	,	,	O	,	_	0	SENT_280	[p11l661t2127r704b2174],
10	Ekholm	NNP	O	Ekholm	nn	11	SENT_280	[p11l726t2124r913b2167],
11	J	NNP	O	J	appos	5	SENT_280	[p11l926t2127r957b2178],
12	,	,	O	,	_	0	SENT_280	[p11l926t2127r957b2178],
13	Sevy	NNP	PERSON	Sevy	nn	14	SENT_280	[p11l979t2126r1093b2178],
14	S	NNP	O	S	appos	5	SENT_280	[p11l1113t2126r1149b2174],
15	,	,	O	,	_	0	SENT_280	[p11l1113t2126r1149b2174],
16	Gunduz-Bruce	NNP	O	Gunduz-Bruce	nn	17	SENT_280	[p11l1171t2124r1524b2167],
17	H	NNP	O	H	appos	5	SENT_280	[p11l1546t2127r1594b2174],
18	,	,	O	,	_	0	SENT_280	[p11l1546t2127r1594b2174],
19	et	FW	O	et	nn	20	SENT_280	[p11l1615t2130r1661b2167],
20	al.	FW	O	al.	appos	5	SENT_280	[p11l1681t2124r1733b2168],
21	.	.	O	.	_	0	SENT_280	[p11l1681t2124r1733b2168],

1	DRD2	NN	O	drd2	nn	4	SENT_281	[p11l1756t2126r1891b2167],
2	promoter	NN	O	promoter	nn	4	SENT_281	[p11l1914t2130r2147b2178],
3	region	NN	O	region	nn	4	SENT_281	[p11l110t2190r265b2244],
4	variation	NN	O	variation	_	0	SENT_281	[p11l278t2190r497b2233],
5	as	IN	O	as	_	0	SENT_281	[p11l513t2202r561b2233],
6	a	DT	O	a	det	7	SENT_281	[p11l578t2202r603b2233],
7	predictor	NN	O	predictor	prep_as	4	SENT_281	[p11l618t2189r844b2244],
8	of	IN	O	of	_	0	SENT_281	[p11l858t2189r909b2233],
9	sustained	JJ	O	sustained	amod	10	SENT_281	[p11l919t2189r1151b2233],
10	response	NN	O	response	prep_of	7	SENT_281	[p11l1168t2202r1386b2244],
11	to	TO	O	to	_	0	SENT_281	[p11l1402t2196r1449b2233],
12	antipsychotic	JJ	O	antipsychotic	amod	13	SENT_281	[p11l1465t2189r1793b2244],
13	medication	NN	O	medication	prep_to	4	SENT_281	[p11l1808t2189r2084b2233],
14	in	IN	O	in	_	0	SENT_281	[p11l2100t2190r2145b2233],
15	ﬁrst	JJ	O	ﬁrst	amod	19	SENT_281	[p11l110t2255r418b2310],
16	—	NN	O	—	nn	19	SENT_281	[p11l110t2255r418b2310],
17	episode	NN	O	episode	nn	19	SENT_281	[p11l110t2255r418b2310],
18	schizophrenia	NN	O	schizophrenia	nn	19	SENT_281	[p11l439t2256r783b2310],
19	patients	NNS	O	patient	prep_in	4	SENT_281	[p11l802t2256r1010b2310],
20	.	.	O	.	_	0	SENT_281	[p11l802t2256r1010b2310],

1	Am	VBP	O	be	dep	3	SENT_282	[p11l1029t2258r1146b2310],
2	]	CD	NUMBER	]	num	3	SENT_282	[p11l1029t2258r1146b2310],
3	Psychiatry	NNP	O	Psychiatry	_	0	SENT_282	[p11l1166t2256r1419b2310],
4	2006	CD	DATE	2006	num	3	SENT_282	[p11l1438t2258r1881b2306],
5	;	:	O	;	_	0	SENT_282	[p11l1438t2258r1881b2306],
6	163:529	CD	NUMBER	163:529	dep	3	SENT_282	[p11l1438t2258r1881b2306],
7	—	CD	NUMBER	—	num	8	SENT_282	[p11l1438t2258r1881b2306],
8	31	CD	NUMBER	31	dep	6	SENT_282	[p11l1438t2258r1881b2306],
9	.	.	O	.	_	0	SENT_282	[p11l1438t2258r1881b2306],

1	Lima	NNP	LOCATION	Lima	nn	2	SENT_283	[p11l8t2323r124b2366],
2	NR	NNP	O	NR	_	0	SENT_283	[p11l151t2325r232b2373],
3	,	,	O	,	_	0	SENT_283	[p11l151t2325r232b2373],
4	Pereira	NNP	PERSON	Pereira	nn	5	SENT_283	[p11l260t2323r432b2366],
5	W	NNP	PERSON	W	appos	2	SENT_283	[p11l455t2325r519b2372],
6	,	,	O	,	_	0	SENT_283	[p11l455t2325r519b2372],
7	Reis	NNP	ORGANIZATION	Reis	nn	8	SENT_283	[p11l547t2323r643b2366],
8	AM	NNP	ORGANIZATION	AM	appos	2	SENT_283	[p11l668t2324r765b2372],
9	,	,	O	,	_	0	SENT_283	[p11l668t2324r765b2372],
10	Coimbra	NNP	ORGANIZATION	Coimbra	nn	11	SENT_283	[p11l793t2322r999b2366],
11	CC	NN	ORGANIZATION	cc	appos	2	SENT_283	[p11l1025t2324r1098b2372],
12	,	,	O	,	_	0	SENT_283	[p11l1025t2324r1098b2372],
13	Marubayashi	NNP	O	Marubayashi	nn	16	SENT_283	[p11l1126t2322r1442b2377],
14	U.	NNP	O	U.	nn	16	SENT_283	[p11l1468t2325r1514b2366],
15	Prolactin	NN	O	prolactin	nn	16	SENT_283	[p11l1542t2322r1759b2366],
16	release	NN	O	release	appos	2	SENT_283	[p11l1786t2322r1956b2366],
17	during	IN	O	during	_	0	SENT_283	[p11l1983t2322r2145b2377],
18	exercise	NN	O	exercise	prep_during	16	SENT_283	[p11l109t2389r305b2432],
19	in	IN	O	in	_	0	SENT_283	[p11l330t2389r375b2432],
20	normal	JJ	O	normal	amod	24	SENT_283	[p11l400t2388r575b2432],
21	and	CC	O	and	_	0	SENT_283	[p11l600t2388r690b2432],
22	adrenodemedullated	JJ	O	adrenodemedullated	conj_and	20	SENT_283	[p11l714t2388r1227b2432],
23	untrained	JJ	O	untrained	amod	24	SENT_283	[p11l1252t2388r1492b2432],
24	rats	NNS	O	rat	prep_in	18	SENT_283	[p11l1517t2395r1607b2432],
25	submitted	VBN	O	submit	partmod	24	SENT_283	[p11l1632t2388r1880b2432],
26	to	TO	O	to	_	0	SENT_283	[p11l1905t2395r1952b2432],
27	central	JJ	O	central	amod	29	SENT_283	[p11l1977t2388r2145b2432],
28	cholinergic	JJ	O	cholinergic	amod	29	SENT_283	[p11l109t2455r381b2509],
29	blockade	NN	O	blockade	prep_to	25	SENT_283	[p11l400t2455r618b2499],
30	with	IN	O	with	_	0	SENT_283	[p11l636t2455r749b2499],
31	atropine	NN	O	atropine	prep_with	25	SENT_283	[p11l768t2456r986b2509],
32	.	.	O	.	_	0	SENT_283	[p11l768t2456r986b2509],

1	Horm	NNP	O	Horm	nn	2	SENT_284	[p11l1007t2458r1146b2499],
2	Behav	NNP	O	Behav	_	0	SENT_284	[p11l1166t2455r1313b2499],
3	2001	CD	DATE	2001	num	2	SENT_284	[p11l1331t2457r1446b2499],
4	;	:	O	;	_	0	SENT_284	[p11l1459t2457r1751b2505],
5	40:526	CD	NUMBER	40:526	number	6	SENT_284	[p11l1459t2457r1751b2505],
6	—	CD	NUMBER	—	dep	2	SENT_284	[p11l1459t2457r1751b2505],
7	32	CD	NUMBER	32	dep	6	SENT_284	[p11l1459t2457r1751b2505],
8	.	.	O	.	_	0	SENT_284	[p11l1459t2457r1751b2505],

1	Lorenzo	NNP	O	Lorenzo	nn	2	SENT_285	[p11l8t2524r201b2565],
2	CV	NNP	O	CV	_	0	SENT_285	[p11l231t2523r307b2571],
3	,	,	O	,	_	0	SENT_285	[p11l231t2523r307b2571],
4	Baca-Garcia	NNP	PERSON	Baca-Garcia	nn	5	SENT_285	[p11l338t2522r627b2565],
5	E	NNP	PERSON	E	appos	2	SENT_285	[p11l657t2524r696b2571],
6	,	,	O	,	_	0	SENT_285	[p11l657t2524r696b2571],
7	Hernandez	NNP	PERSON	Hernandez	nn	8	SENT_285	[p11l727t2521r995b2565],
8	MD	NNP	O	MD	appos	5	SENT_285	[p11l1025t2524r1123b2571],
9	,	,	O	,	_	0	SENT_285	[p11l1025t2524r1123b2571],
10	Martin	NNP	PERSON	Martin	nn	11	SENT_285	[p11l1154t2522r1319b2565],
11	CB	NNP	O	CB	appos	5	SENT_285	[p11l1349t2523r1422b2571],
12	,	,	O	,	_	0	SENT_285	[p11l1349t2523r1422b2571],
13	Perez-Rodriguez	NNP	O	Perez-Rodriguez	nn	14	SENT_285	[p11l1453t2521r1857b2575],
14	MM	NN	O	mm	appos	5	SENT_285	[p11l1887t2524r1996b2571],
15	,	,	O	,	_	0	SENT_285	[p11l1887t2524r1996b2571],
16	SaizGonzalez	NNP	O	SaizGonzalez	nn	17	SENT_285	[p11l2028t2522r2144b2565, p11l109t2587r332b2630],
17	MD	NNP	O	MD	appos	5	SENT_285	[p11l361t2589r458b2637],
18	,	,	O	,	_	0	SENT_285	[p11l361t2589r458b2637],
19	et	FW	O	et	nn	20	SENT_285	[p11l488t2593r534b2630],
20	al.	FW	O	al.	appos	5	SENT_285	[p11l562t2587r614b2631],
21	.	.	O	.	_	0	SENT_285	[p11l562t2587r614b2631],

1	No	DT	O	no	det	2	SENT_286	[p11l643t2589r709b2630],
2	association	NN	O	association	_	0	SENT_286	[p11l738t2587r1009b2630],
3	between	IN	O	between	_	0	SENT_286	[p11l1037t2587r1250b2630],
4	the	DT	O	the	det	6	SENT_286	[p11l1277t2587r1355b2630],
5	Ser9Gly	NN	O	ser9gly	nn	6	SENT_286	[p11l1385t2587r1576b2641],
6	polymorphism	NN	O	polymorphism	prep_between	2	SENT_286	[p11l1603t2587r1965b2641],
7	of	IN	O	of	_	0	SENT_286	[p11l1993t2587r2044b2630],
8	the	DT	O	the	det	12	SENT_286	[p11l2066t2587r2144b2630],
9	dopamine	NN	O	dopamine	nn	12	SENT_286	[p11l109t2653r355b2708],
10	D3	NN	O	d3	nn	12	SENT_286	[p11l383t2655r446b2697],
11	receptor	NN	O	receptor	nn	12	SENT_286	[p11l476t2660r681b2708],
12	gene	NN	O	gene	prep_of	2	SENT_286	[p11l706t2666r822b2708],
13	and	CC	O	and	_	0	SENT_286	[p11l848t2653r937b2697],
14	schizophrenia	NN	O	schizophrenia	conj_and	12	SENT_286	[p11l965t2653r1308b2708],
15	in	IN	O	in	_	0	SENT_286	[p11l1335t2654r1380b2696],
16	a	DT	O	a	det	18	SENT_286	[p11l1407t2666r1431b2697],
17	Spanish	JJ	MISC	spanish	amod	18	SENT_286	[p11l1458t2653r1648b2708],
18	sample	NN	O	sample	prep_in	2	SENT_286	[p11l1676t2653r1861b2708],
19	.	.	O	.	_	0	SENT_286	[p11l1676t2653r1861b2708],

1	Am	VBP	O	be	dep	2	SENT_287	[p11l1886t2655r2010b2708],
2	]	CD	NUMBER	]	_	0	SENT_287	[p11l1886t2655r2010b2708],
3	Med	NNP	O	Med	nn	7	SENT_287	[p11l2037t2653r2144b2697],
4	Genet	NNP	PERSON	Genet	nn	7	SENT_287	[p11l109t2721r254b2762],
5	B	NNP	PERSON	B	nn	7	SENT_287	[p11l273t2721r301b2762],
6	Neuropsychiatr	NNP	PERSON	Neuropsychiatr	nn	7	SENT_287	[p11l322t2718r700b2773],
7	Genet	NNP	PERSON	Genet	dep	2	SENT_287	[p11l718t2721r863b2762],
8	2007	CD	DATE	2007	dep	7	SENT_287	[p11l882t2721r1301b2769],
9	;	:	O	;	_	0	SENT_287	[p11l882t2721r1301b2769],
10	144:344	CD	NUMBER	144:344	dep	8	SENT_287	[p11l882t2721r1301b2769],
11	—	CD	NUMBER	—	num	12	SENT_287	[p11l882t2721r1301b2769],
12	6	CD	NUMBER	6	dep	10	SENT_287	[p11l882t2721r1301b2769],
13	.	.	O	.	_	0	SENT_287	[p11l882t2721r1301b2769],

1	Linkowski	NNP	PERSON	Linkowski	nn	2	SENT_288	[p11l8t2785r249b2829],
2	P	NN	PERSON	p	_	0	SENT_288	[p11l261t2788r294b2835],
3	,	,	O	,	_	0	SENT_288	[p11l261t2788r294b2835],
4	Hubain	NNP	PERSON	Hubain	nn	5	SENT_288	[p11l307t2785r481b2829],
5	P	NN	PERSON	p	appos	2	SENT_288	[p11l492t2788r525b2835],
6	,	,	O	,	_	0	SENT_288	[p11l492t2788r525b2835],
7	von	NN	PERSON	von	nn	9	SENT_288	[p11l537t2798r626b2829],
8	Frenckell	NN	PERSON	frenckell	nn	9	SENT_288	[p11l638t2785r852b2829],
9	R	NN	PERSON	r	appos	2	SENT_288	[p11l864t2788r905b2835],
10	,	,	O	,	_	0	SENT_288	[p11l864t2788r905b2835],
11	Mendlewicz	NNP	O	Mendlewicz	appos	2	SENT_288	[p11l918t2785r1246b2839],
12	]	CD	NUMBER	]	num	11	SENT_288	[p11l918t2785r1246b2839],
13	.	.	O	.	_	0	SENT_288	[p11l918t2785r1246b2839],

1	Haloperidol	NNP	O	Haloperidol	_	0	SENT_289	[p11l1258t2785r1539b2839],
2	plasma	NN	O	plasma	nn	3	SENT_289	[p11l1550t2785r1722b2839],
3	levels	NNS	O	level	dep	1	SENT_289	[p11l1733t2785r1866b2829],
4	and	CC	O	and	_	0	SENT_289	[p11l1878t2785r1966b2829],
5	clinical	JJ	O	clinical	amod	6	SENT_289	[p11l1979t2785r2145b2829],
6	response	NN	O	response	dep	1	SENT_289	[p11l110t2864r321b2906],
7	in	IN	O	in	_	0	SENT_289	[p11l337t2852r383b2894],
8	paranoid	JJ	O	paranoid	amod	9	SENT_289	[p11l396t2851r607b2906],
9	schizophrenics	NNS	O	schizophrenic	prep_in	1	SENT_289	[p11l623t2851r989b2906],
10	.	.	O	.	_	0	SENT_289	[p11l623t2851r989b2906],

1	Eur	NNP	O	Eur	nn	5	SENT_290	[p11l1005t2854r1086b2895],
2	Arch	NNP	O	Arch	nn	5	SENT_290	[p11l1097t2851r1210b2895],
3	Psychiatry	NNP	O	Psychiatry	nn	5	SENT_290	[p11l1225t2851r1473b2906],
4	Neurol	NNP	O	Neurol	nn	5	SENT_290	[p11l1486t2851r1645b2895],
5	Sci	NNP	O	Sci	_	0	SENT_290	[p11l1661t2852r1725b2895],
6	1984	CD	DATE	1984	num	5	SENT_290	[p11l1743t2853r2066b2901],
7	;	:	O	;	_	0	SENT_290	[p11l1743t2853r2066b2901],
8	234:231	CD	NUMBER	234:231	number	9	SENT_290	[p11l1743t2853r2066b2901],
9	-6	CD	NUMBER	-6	dep	5	SENT_290	[p11l2075t2853r2145b2895],
10	.	.	O	.	_	0	SENT_290	[p11l2075t2853r2145b2895],

1	Meltzer	NNP	PERSON	Meltzer	nn	2	SENT_291	[p11l8t2917r197b2960],
2	HY	NNP	O	HY	_	0	SENT_291	[p11l211t2920r289b2967],
3	,	,	O	,	_	0	SENT_291	[p11l211t2920r289b2967],
4	Busch	NNP	ORGANIZATION	Busch	nn	5	SENT_291	[p11l306t2917r449b2960],
5	DA	NNP	ORGANIZATION	DA	appos	2	SENT_291	[p11l465t2919r546b2967],
6	,	,	O	,	_	0	SENT_291	[p11l465t2919r546b2967],
7	Fang	NNP	PERSON	Fang	amod	10	SENT_291	[p11l563t2920r676b2971],
8	VS.	NNP	O	VS.	amod	10	SENT_291	[p11l689t2919r763b2961],
9	Serum	NN	O	serum	dep	10	SENT_291	[p11l780t2919r938b2960],
10	neuroleptic	JJ	O	neuroleptic	appos	2	SENT_291	[p11l954t2917r1233b2971],
11	and	CC	O	and	_	0	SENT_291	[p11l1248t2917r1338b2960],
12	prolactin	NN	O	prolactin	nn	13	SENT_291	[p11l1354t2917r1573b2971],
13	levels	NNS	O	level	conj_and	10	SENT_291	[p11l1589t2917r1726b2960],
14	in	IN	O	in	_	0	SENT_291	[p11l1743t2918r1788b2960],
15	schizophrenic	JJ	O	schizophrenic	amod	16	SENT_291	[p11l1804t2917r2145b2971],
16	patients	NNS	O	patient	prep_in	10	SENT_291	[p11l110t2983r305b3037],
17	and	CC	O	and	_	0	SENT_291	[p11l326t2982r415b3026],
18	clinical	JJ	O	clinical	amod	19	SENT_291	[p11l435t2983r606b3026],
19	response	NN	O	response	prep_in	10	SENT_291	[p11l627t2995r857b3037],
20	.	.	O	.	_	0	SENT_291	[p11l627t2995r857b3037],

1	Psychiatry	NNP	O	Psychiatry	nn	2	SENT_292	[p11l878t2982r1131b3037],
2	Res	NNP	O	Res	_	0	SENT_292	[p11l1150t2985r1230b3026],
3	1983	CD	DATE	1983	num	2	SENT_292	[p11l1253t2985r1521b3033],
4	;	:	O	;	_	0	SENT_292	[p11l1253t2985r1521b3033],
5	9:271	CD	NUMBER	9:271	number	6	SENT_292	[p11l1253t2985r1521b3033],
6	-83	CD	NUMBER	-83	dep	2	SENT_292	[p11l1531t2985r1632b3026],
7	.	.	O	.	_	0	SENT_292	[p11l1531t2985r1632b3026],

1	Mihara	NNP	PERSON	Mihara	nn	2	SENT_293	[p11l8t3049r181b3092],
2	K	NNP	PERSON	K	_	0	SENT_293	[p11l209t3051r252b3099],
3	,	,	O	,	_	0	SENT_293	[p11l209t3051r252b3099],
4	Suzuki	NNP	PERSON	Suzuki	nn	5	SENT_293	[p11l282t3049r443b3092],
5	A	NNP	O	A	appos	2	SENT_293	[p11l470t3051r517b3099],
6	,	,	O	,	_	0	SENT_293	[p11l470t3051r517b3099],
7	Kondo	NNP	PERSON	Kondo	nn	8	SENT_293	[p11l547t3049r703b3092],
8	T	NN	O	t	appos	5	SENT_293	[p11l727t3051r764b3099],
9	,	,	O	,	_	0	SENT_293	[p11l727t3051r764b3099],
10	Yasui-Furukori	NNP	PERSON	Yasui-Furukori	nn	11	SENT_293	[p11l791t3049r1152b3092],
11	N	NNP	PERSON	N	appos	5	SENT_293	[p11l1182t3051r1230b3099],
12	,	,	O	,	_	0	SENT_293	[p11l1182t3051r1230b3099],
13	Ono	NNP	PERSON	Ono	nn	14	SENT_293	[p11l1259t3051r1357b3092],
14	S	NNP	O	S	appos	5	SENT_293	[p11l1386t3051r1423b3099],
15	,	,	O	,	_	0	SENT_293	[p11l1386t3051r1423b3099],
16	Otani	NNP	ORGANIZATION	Otani	nn	17	SENT_293	[p11l1453t3049r1583b3092],
17	K	NNP	ORGANIZATION	K	appos	5	SENT_293	[p11l1613t3051r1656b3099],
18	,	,	O	,	_	0	SENT_293	[p11l1613t3051r1656b3099],
19	et	FW	O	et	nn	20	SENT_293	[p11l1685t3055r1731b3092],
20	al.	FW	O	al.	appos	5	SENT_293	[p11l1758t3049r1810b3093],
21	.	.	O	.	_	0	SENT_293	[p11l1758t3049r1810b3093],

1	Relationship	NN	O	relationship	nsubj	9	SENT_294	[p11l1840t3049r2144b3103],
2	between	IN	O	between	_	0	SENT_294	[p11l109t3115r321b3159],
3	Taq1	NN	O	taq1	nn	5	SENT_294	[p11l352t3118r462b3170],
4	A	NN	O	a	nn	5	SENT_294	[p11l501t3117r537b3158],
5	dopamine	NN	O	dopamine	prep_between	1	SENT_294	[p11l570t3115r816b3170],
6	D2	NN	O	d2	nn	9	SENT_294	[p11l852t3117r916b3158],
7	receptor	NN	O	receptor	nn	9	SENT_294	[p11l953t3122r1159b3170],
8	(	NN	O	(	nn	9	SENT_294	[p11l1192t3115r1369b3169],
9	DRD2	NN	O	drd2	_	0	SENT_294	[p11l1192t3115r1369b3169],
10	)	CD	NUMBER	)	num	11	SENT_294	[p11l1192t3115r1369b3169],
11	polymorphism	NN	O	polymorphism	dobj	9	SENT_294	[p11l1405t3115r1767b3170],
12	and	CC	O	and	_	0	SENT_294	[p11l1801t3115r1890b3159],
13	prolactin	NN	O	prolactin	nn	14	SENT_294	[p11l1926t3115r2145b3170],
14	response	NN	O	response	conj_and	11	SENT_294	[p11l110t3193r327b3235],
15	to	TO	O	to	_	0	SENT_294	[p11l347t3187r394b3224],
16	bromperidol	NN	O	bromperidol	prep_to	9	SENT_294	[p11l413t3180r732b3235],
17	.	.	O	.	_	0	SENT_294	[p11l413t3180r732b3235],

1	Am	VBP	O	be	dep	2	SENT_295	[p11l751t3182r867b3235],
2	]	CD	NUMBER	]	_	0	SENT_295	[p11l751t3182r867b3235],
3	Med	NNP	O	Med	nn	5	SENT_295	[p11l887t3181r994b3224],
4	Genet	NNP	O	Genet	nn	5	SENT_295	[p11l1015t3183r1160b3224],
5	B	NNP	O	B	dep	2	SENT_295	[p11l1179t3183r1207b3224],
6	2001	CD	DATE	2001	dep	5	SENT_295	[p11l1227t3183r1342b3224],
7	;	:	O	;	_	0	SENT_295	[p11l1355t3183r1640b3231],
8	105:271	CD	NUMBER	105:271	dep	6	SENT_295	[p11l1355t3183r1640b3231],
9	—	CD	NUMBER	—	num	10	SENT_295	[p11l1355t3183r1640b3231],
10	4	CD	NUMBER	4	dep	8	SENT_295	[p11l1355t3183r1640b3231],
11	.	.	O	.	_	0	SENT_295	[p11l1355t3183r1640b3231],

1	Mihara	NNP	PERSON	Mihara	nn	2	SENT_296	[p11l8t3247r181b3291],
2	K	NNP	PERSON	K	_	0	SENT_296	[p11l198t3250r242b3297],
3	,	,	O	,	_	0	SENT_296	[p11l198t3250r242b3297],
4	Kondo	NNP	PERSON	Kondo	nn	5	SENT_296	[p11l261t3247r417b3291],
5	T	NN	O	t	appos	2	SENT_296	[p11l431t3250r469b3297],
6	,	,	O	,	_	0	SENT_296	[p11l431t3250r469b3297],
7	Yasui-Furukori	NNP	ORGANIZATION	Yasui-Furukori	nn	8	SENT_296	[p11l485t3247r847b3291],
8	N	NNP	ORGANIZATION	N	appos	5	SENT_296	[p11l866t3250r914b3297],
9	,	,	O	,	_	0	SENT_296	[p11l866t3250r914b3297],
10	Suzuki	NNP	PERSON	Suzuki	nn	11	SENT_296	[p11l933t3247r1095b3291],
11	A	NNP	O	A	appos	5	SENT_296	[p11l1111t3249r1158b3297],
12	,	,	O	,	_	0	SENT_296	[p11l1111t3249r1158b3297],
13	Ishida	NNP	PERSON	Ishida	nn	14	SENT_296	[p11l1178t3247r1323b3291],
14	M	NNP	O	M	appos	5	SENT_296	[p11l1341t3250r1400b3297],
15	,	,	O	,	_	0	SENT_296	[p11l1341t3250r1400b3297],
16	Ono	NNP	PERSON	Ono	nn	17	SENT_296	[p11l1419t3249r1517b3291],
17	S	NNP	O	S	appos	5	SENT_296	[p11l1536t3249r1573b3297],
18	,	,	O	,	_	0	SENT_296	[p11l1536t3249r1573b3297],
19	et	FW	O	et	nn	20	SENT_296	[p11l1592t3253r1637b3291],
20	al.	FW	O	al.	appos	5	SENT_296	[p11l1655t3247r1707b3291],
21	.	.	O	.	_	0	SENT_296	[p11l1655t3247r1707b3291],

1	Effects	NNS	O	effect	_	0	SENT_297	[p11l1726t3247r1885b3291],
2	of	IN	O	of	_	0	SENT_297	[p11l1904t3247r1955b3291],
3	various	JJ	O	various	amod	5	SENT_297	[p11l1966t3248r2144b3291],
4	CYP2D6	NN	O	cyp2d6	nn	5	SENT_297	[p11l109t3315r303b3356],
5	genotypes	NNS	O	genotype	prep_of	1	SENT_297	[p11l317t3319r567b3367],
6	on	IN	O	on	_	0	SENT_297	[p11l583t3325r643b3356],
7	the	DT	O	the	det	10	SENT_297	[p11l657t3313r734b3356],
8	steady-state	JJ	O	steady-state	amod	10	SENT_297	[p11l750t3313r1047b3367],
9	plasma	NN	O	plasma	nn	10	SENT_297	[p11l1063t3313r1236b3367],
10	concentrations	NNS	O	concentration	prep_on	1	SENT_297	[p11l1251t3313r1615b3356],
11	of	IN	O	of	_	0	SENT_297	[p11l1630t3312r1680b3356],
12	risperidone	NN	O	risperidone	prep_of	10	SENT_297	[p11l1689t3313r1969b3367],
13	and	CC	O	and	_	0	SENT_297	[p11l1985t3313r2073b3356],
14	its	PRP$	O	its	poss	16	SENT_297	[p11l2089t3313r2144b3356],
15	active	JJ	O	active	amod	16	SENT_297	[p11l109t3379r251b3422],
16	metabolite	NN	O	metabolite	conj_and	10	SENT_297	[p11l272t3379r547b3429],
17	,	,	O	,	_	0	SENT_297	[p11l272t3379r547b3429],
18	9-hydroxyrisperidone	NN	O	9-hydroxyrisperidone	appos	16	SENT_297	[p11l568t3379r1117b3433],
19	,	,	O	,	_	0	SENT_297	[p11l568t3379r1117b3433],
20	in	IN	O	in	_	0	SENT_297	[p11l1139t3379r1184b3422],
21	Japanese	JJ	MISC	japanese	amod	22	SENT_297	[p11l1198t3381r1418b3433],
22	patients	NNS	O	patient	prep_in	16	SENT_297	[p11l1440t3379r1635b3433],
23	with	IN	O	with	_	0	SENT_297	[p11l1655t3379r1768b3422],
24	schizophrenia	NN	O	schizophrenia	prep_with	1	SENT_297	[p11l1790t3379r2144b3433],
25	.	.	O	.	_	0	SENT_297	[p11l1790t3379r2144b3433],

1	Ther	NNP	O	Ther	nn	3	SENT_298	[p11l107t3445r221b3489],
2	Drug	NNP	O	Drug	nn	3	SENT_298	[p11l239t3448r358b3500],
3	Monit	NNP	O	Monit	_	0	SENT_298	[p11l378t3446r525b3489],
4	2003	CD	DATE	2003	num	3	SENT_298	[p11l543t3447r965b3495],
5	;	:	O	;	_	0	SENT_298	[p11l543t3447r965b3495],
6	25:287	CD	NUMBER	25:287	number	7	SENT_298	[p11l543t3447r965b3495],
7	—	CD	NUMBER	—	dep	3	SENT_298	[p11l543t3447r965b3495],
8	93	CD	NUMBER	93	dep	7	SENT_298	[p11l543t3447r965b3495],
9	.	.	O	.	_	0	SENT_298	[p11l543t3447r965b3495],

1	Mo	NN	PERSON	mo	nn	2	SENT_299	[p11l8t3513r84b3554],
2	GH	NN	PERSON	gh	_	0	SENT_299	[p11l102t3513r188b3561],
3	,	,	O	,	_	0	SENT_299	[p11l102t3513r188b3561],
4	Lai	NNP	LOCATION	Lai	nn	5	SENT_299	[p11l206t3511r272b3554],
5	IC	NN	LOCATION	ic	appos	2	SENT_299	[p11l289t3513r346b3561],
6	,	,	O	,	_	0	SENT_299	[p11l289t3513r346b3561],
7	Wang	NNP	PERSON	Wang	nn	8	SENT_299	[p11l361t3513r505b3565],
8	YC	NNP	PERSON	YC	appos	5	SENT_299	[p11l519t3513r593b3561],
9	,	,	O	,	_	0	SENT_299	[p11l519t3513r593b3561],
10	Chen	NNP	PERSON	Chen	nn	11	SENT_299	[p11l611t3510r734b3554],
11	JY	NN	PERSON	jy	appos	5	SENT_299	[p11l744t3513r804b3565],
12	,	,	O	,	_	0	SENT_299	[p11l744t3513r804b3565],
13	Lin	NNP	O	Lin	nn	14	SENT_299	[p11l822t3511r894b3554],
14	CY	NNP	O	CY	appos	5	SENT_299	[p11l910t3513r980b3561],
15	,	,	O	,	_	0	SENT_299	[p11l910t3513r980b3561],
16	Chen	NNP	ORGANIZATION	Chen	nn	17	SENT_299	[p11l998t3511r1121b3554],
17	TT	NN	ORGANIZATION	tt	appos	5	SENT_299	[p11l1134t3513r1201b3561],
18	,	,	O	,	_	0	SENT_299	[p11l1134t3513r1201b3561],
19	et	FW	O	et	nn	20	SENT_299	[p11l1219t3517r1265b3554],
20	al.	FW	O	al.	appos	5	SENT_299	[p11l1280t3510r1332b3554],
21	.	.	O	.	_	0	SENT_299	[p11l1280t3510r1332b3554],

1	Support	NN	O	support	_	0	SENT_300	[p11l1350t3513r1545b3565],
2	for	IN	O	for	_	0	SENT_300	[p11l1561t3510r1629b3554],
3	an	DT	O	a	det	4	SENT_300	[p11l1643t3523r1701b3554],
4	association	NN	O	association	prep_for	1	SENT_300	[p11l1717t3511r1988b3554],
5	of	IN	O	of	_	0	SENT_300	[p11l2005t3510r2056b3554],
6	the	DT	O	the	det	8	SENT_300	[p11l2066t3510r2144b3554],
7	C939T	NN	O	c939t	nn	8	SENT_300	[p11l109t3579r264b3621],
8	polymorphism	NN	O	polymorphism	prep_of	4	SENT_300	[p11l300t3577r664b3631],
9	in	IN	O	in	_	0	SENT_300	[p11l702t3578r747b3620],
10	the	DT	O	the	det	13	SENT_300	[p11l785t3577r864b3621],
11	human	JJ	O	human	amod	13	SENT_300	[p11l902t3577r1075b3621],
12	DRD2	NN	O	drd2	nn	13	SENT_300	[p11l1113t3579r1250b3620],
13	gene	NN	O	gene	prep_in	1	SENT_300	[p11l1289t3590r1405b3631],
14	with	IN	O	with	_	0	SENT_300	[p11l1442t3577r1556b3621],
15	tardive	JJ	O	tardive	amod	16	SENT_300	[p11l1593t3577r1765b3621],
16	dyskinesia	NN	O	dyskinesium	prep_with	13	SENT_300	[p11l1803t3577r2061b3631],
17	in	IN	O	in	_	0	SENT_300	[p11l2100t3578r2145b3620],
18	schizophrenia	NN	O	schizophrenia	prep_in	1	SENT_300	[p11l110t3643r464b3698],
19	.	.	O	.	_	0	SENT_300	[p11l110t3643r464b3698],

1	Schizophr	NNP	O	Schizophr	nn	2	SENT_301	[p11l485t3643r730b3698],
2	Res	NNP	O	Res	_	0	SENT_301	[p11l748t3646r828b3687],
3	2007	CD	DATE	2007	num	2	SENT_301	[p11l849t3645r1234b3694],
4	;	:	O	;	_	0	SENT_301	[p11l849t3645r1234b3694],
5	97:302	CD	NUMBER	97:302	number	6	SENT_301	[p11l849t3645r1234b3694],
6	—	CD	NUMBER	—	dep	2	SENT_301	[p11l849t3645r1234b3694],
7	4	CD	NUMBER	4	dep	6	SENT_301	[p11l849t3645r1234b3694],
8	.	.	O	.	_	0	SENT_301	[p11l849t3645r1234b3694],

1	Nakazono	NNP	MISC	Nakazono	nn	2	SENT_302	[p11l8t3709r249b3752],
2	Y	NN	O	y	_	0	SENT_302	[p11l277t3712r317b3759],
3	,	,	O	,	_	0	SENT_302	[p11l277t3712r317b3759],
4	Abe	NN	PERSON	abe	nn	5	SENT_302	[p11l345t3709r438b3752],
5	H	NN	PERSON	h	appos	2	SENT_302	[p11l469t3712r517b3759],
6	,	,	O	,	_	0	SENT_302	[p11l469t3712r517b3759],
7	Murakami	NNP	PERSON	Murakami	nn	8	SENT_302	[p11l548t3709r800b3752],
8	H	NNP	PERSON	H	appos	2	SENT_302	[p11l830t3712r878b3759],
9	,	,	O	,	_	0	SENT_302	[p11l830t3712r878b3759],
10	Koyabu	NNP	PERSON	Koyabu	nn	11	SENT_302	[p11l908t3709r1089b3763],
11	N	NNP	O	N	appos	2	SENT_302	[p11l1118t3712r1166b3759],
12	,	,	O	,	_	0	SENT_302	[p11l1118t3712r1166b3759],
13	lsaka	FW	O	lsaka	appos	2	SENT_302	[p11l1197t3709r1320b3752],
14	Y	NN	O	y	dep	13	SENT_302	[p11l1347t3712r1387b3759],
15	,	,	O	,	_	0	SENT_302	[p11l1347t3712r1387b3759],
16	Nemoto	NNP	PERSON	Nemoto	nn	17	SENT_302	[p11l1417t3712r1611b3752],
17	Y	NN	PERSON	y	appos	2	SENT_302	[p11l1639t3712r1678b3759],
18	,	,	O	,	_	0	SENT_302	[p11l1639t3712r1678b3759],
19	et	FW	O	et	nn	20	SENT_302	[p11l1709t3715r1755b3752],
20	al.	FW	O	al.	appos	2	SENT_302	[p11l1783t3709r1836b3753],
21	.	.	O	.	_	0	SENT_302	[p11l1783t3709r1836b3753],

1	Association	NNP	O	Association	_	0	SENT_303	[p11l1864t3710r2144b3752],
2	between	IN	O	between	_	0	SENT_303	[p11l109t3774r321b3818],
3	neuroleptic	JJ	O	neuroleptic	amod	6	SENT_303	[p11l343t3775r622b3829],
4	drug-induced	JJ	O	drug-induced	amod	6	SENT_303	[p11l644t3774r977b3829],
5	extrapyramidal	JJ	O	extrapyramidal	amod	6	SENT_303	[p11l1001t3774r1376b3829],
6	symptoms	NNS	O	symptom	prep_between	1	SENT_303	[p11l1399t3781r1653b3829],
7	and	CC	O	and	_	0	SENT_303	[p11l1676t3774r1764b3818],
8	dopamine	NN	O	dopamine	nn	9	SENT_303	[p11l1787t3774r2033b3829],
9	D2receptor	NN	O	d2receptor	prep_between	1	SENT_303	[p11l2057t3777r2144b3818, p12l110t22r315b70],

1	polymorphisms	NNS	O	polymorphism	_	0	SENT_304	[p12l336t16r721b70],
2	in	IN	O	in	_	0	SENT_304	[p12l745t16r789b59],
3	Japanese	JJ	MISC	japanese	amod	5	SENT_304	[p12l805t18r1025b70],
4	schizophrenic	JJ	O	schizophrenic	amod	5	SENT_304	[p12l1049t16r1391b70],
5	patients	NNS	O	patient	prep_in	1	SENT_304	[p12l1413t16r1621b70],
6	.	.	O	.	_	0	SENT_304	[p12l1413t16r1621b70],

1	Int	NN	O	int	nn	5	SENT_305	[p12l1645t18r1746b70],
2	]	CD	NUMBER	]	num	5	SENT_305	[p12l1645t18r1746b70],
3	Clin	NNP	O	Clin	nn	5	SENT_305	[p12l1769t16r1862b59],
4	Pharmacol	NNP	O	Pharmacol	nn	5	SENT_305	[p12l1886t16r2144b59],
5	Ther	NNP	O	Ther	_	0	SENT_305	[p12l107t82r221b126],
6	2005	CD	DATE	2005	dep	5	SENT_305	[p12l239t84r651b132],
7	;	:	O	;	_	0	SENT_305	[p12l239t84r651b132],
8	43:163	CD	NUMBER	43:163	number	9	SENT_305	[p12l239t84r651b132],
9	—	CD	NUMBER	—	dep	5	SENT_305	[p12l239t84r651b132],
10	71	CD	NUMBER	71	dep	9	SENT_305	[p12l239t84r651b132],
11	.	.	O	.	_	0	SENT_305	[p12l239t84r651b132],

1	Nordstrom	NNP	ORGANIZATION	Nordstrom	nn	2	SENT_306	[p12l8t148r273b192],
2	AL	NNP	ORGANIZATION	AL	_	0	SENT_306	[p12l295t150r368b198],
3	,	,	O	,	_	0	SENT_306	[p12l295t150r368b198],
4	Farde	NNP	O	Farde	nn	7	SENT_306	[p12l394t148r526b192],
5	L.	NNP	O	L.	nn	7	SENT_306	[p12l550t151r585b192],
6	Plasma	NN	O	plasma	nn	7	SENT_306	[p12l611t148r783b192],
7	prolactin	NN	O	prolactin	conj_and	2	SENT_306	[p12l808t148r1026b203],
8	and	CC	O	and	_	0	SENT_306	[p12l1051t148r1139b192],
9	central	JJ	O	central	amod	10	SENT_306	[p12l1164t148r1333b192],
10	D2	NN	O	d2	conj_and	2	SENT_306	[p12l1358t150r1422b191],
11	receptor	NN	O	receptor	nn	12	SENT_306	[p12l1449t155r1655b203],
12	occupancy	NN	O	occupancy	dep	2	SENT_306	[p12l1677t161r1936b203],
13	in	IN	O	in	_	0	SENT_306	[p12l1960t149r2005b191],
14	antipsychotic	JJ	O	antipsychotic	prep_in	12	SENT_306	[p12l2030t149r2144b192, p12l109t214r341b268],

1	drug-treated	JJ	O	drug-treated	amod	2	SENT_307	[p12l360t214r671b268],
2	patients	NNS	O	patient	_	0	SENT_307	[p12l691t215r934b268],
3	.	.	O	.	_	0	SENT_307	[p12l691t215r934b268],
4	]	SYM	O	]	dep	2	SENT_307	[p12l691t215r934b268],

1	Clin	NNP	O	Clin	nn	2	SENT_308	[p12l953t214r1047b258],
2	Psychopharmacol	NNP	O	Psychopharmacol	_	0	SENT_308	[p12l1067t214r1499b268],
3	1998	CD	DATE	1998	num	2	SENT_308	[p12l1522t216r1928b264],
4	;	:	O	;	_	0	SENT_308	[p12l1522t216r1928b264],
5	18:305	CD	NUMBER	18:305	number	6	SENT_308	[p12l1522t216r1928b264],
6	—	CD	NUMBER	—	dep	2	SENT_308	[p12l1522t216r1928b264],
7	10	CD	NUMBER	10	dep	6	SENT_308	[p12l1522t216r1928b264],
8	.	.	O	.	_	0	SENT_308	[p12l1522t216r1928b264],

1	Qian	JJ	MISC	qian	amod	2	SENT_309	[p12l7t280r119b332],
2	Q	NNP	O	Q	_	0	SENT_309	[p12l136t282r183b332],
3	,	,	O	,	_	0	SENT_309	[p12l136t282r183b332],
4	Wang	NNP	PERSON	Wang	nn	5	SENT_309	[p12l198t282r342b334],
5	Y	NN	PERSON	y	appos	2	SENT_309	[p12l357t282r396b330],
6	,	,	O	,	_	0	SENT_309	[p12l357t282r396b330],
7	Zhou	NNP	PERSON	Zhou	nn	8	SENT_309	[p12l413t280r537b323],
8	R	NNP	PERSON	R	appos	2	SENT_309	[p12l555t282r596b330],
9	,	,	O	,	_	0	SENT_309	[p12l555t282r596b330],
10	Yang	NNP	PERSON	Yang	nn	11	SENT_309	[p12l612t282r731b334],
11	L	NNP	PERSON	L	appos	2	SENT_309	[p12l748t282r782b330],
12	,	,	O	,	_	0	SENT_309	[p12l748t282r782b330],
13	Faraone	NNP	PERSON	Faraone	nn	14	SENT_309	[p12l800t282r991b323],
14	SV	NNP	O	SV	appos	2	SENT_309	[p12l1008t282r1080b324],
15	.	.	O	.	_	0	SENT_309	[p12l1008t282r1080b324],

1	Family-based	JJ	O	family-based	nsubj	20	SENT_310	[p12l1098t280r1422b334],
2	and	CC	O	and	_	0	SENT_310	[p12l1440t280r1529b323],
3	case	NN	O	case	conj_and	1	SENT_310	[p12l1547t280r1857b323],
4	—	CD	NUMBER	—	num	7	SENT_310	[p12l1547t280r1857b323],
5	control	NN	O	control	nn	7	SENT_310	[p12l1547t280r1857b323],
6	association	NN	O	association	nn	7	SENT_310	[p12l1874t280r2144b323],
7	studies	NNS	O	study	dep	3	SENT_310	[p12l110t346r281b389],
8	of	IN	O	of	_	0	SENT_310	[p12l312t345r363b389],
9	DRD4	NN	O	drd4	nn	12	SENT_310	[p12l388t348r526b389],
10	and	CC	O	and	_	0	SENT_310	[p12l556t346r646b389],
11	DAT1	NN	O	dat1	nn	12	SENT_310	[p12l677t348r799b389],
12	polymorphisms	NNS	O	polymorphism	prep_of	7	SENT_310	[p12l836t346r1220b400],
13	in	IN	O	in	_	0	SENT_310	[p12l1251t346r1297b389],
14	Chinese	JJ	MISC	chinese	amod	19	SENT_310	[p12l1327t346r1518b389],
15	attention	NN	O	attention	nn	19	SENT_310	[p12l1548t346r1773b389],
16	deﬁcit	NN	O	deﬁcit	nn	19	SENT_310	[p12l1803t345r1956b389],
17	hyperactivity	NN	O	hyperactivity	nn	19	SENT_310	[p12l1986t346r2144b400, p12l109t413r291b467],
18	disorder	NN	O	disorder	nn	19	SENT_310	[p12l314t412r520b456],
19	patients	NNS	O	patient	prep_in	12	SENT_310	[p12l543t413r739b467],
20	suggest	VBP	O	suggest	_	0	SENT_310	[p12l766t419r950b467],
21	long	JJ	O	long	amod	22	SENT_310	[p12l974t412r1080b467],
22	repeats	NNS	O	repeat	nsubj	23	SENT_310	[p12l1105t419r1282b467],
23	contribute	VBP	O	contribute	ccomp	20	SENT_310	[p12l1308t412r1563b456],
24	to	TO	O	to	_	0	SENT_310	[p12l1587t419r1634b456],
25	genetic	JJ	O	genetic	amod	26	SENT_310	[p12l1659t413r1837b467],
26	risk	NN	O	risk	prep_to	23	SENT_310	[p12l1862t412r1951b456],
27	for	IN	O	for	_	0	SENT_310	[p12l1976t412r2043b456],
28	the	DT	O	the	det	29	SENT_310	[p12l2066t412r2144b456],
29	disorder	NN	O	disorder	prep_for	26	SENT_310	[p12l109t477r321b521],
30	.	.	O	.	_	0	SENT_310	[p12l109t477r321b521],

1	Am	VBP	O	be	dep	2	SENT_311	[p12l340t479r457b532],
2	]	CD	NUMBER	]	_	0	SENT_311	[p12l340t479r457b532],
3	Med	NNP	O	Med	nn	5	SENT_311	[p12l477t477r583b521],
4	Genet	NNP	PERSON	Genet	nn	5	SENT_311	[p12l604t480r749b521],
5	B	NNP	O	B	dep	2	SENT_311	[p12l768t480r796b521],
6	2004	CD	DATE	2004	dep	5	SENT_311	[p12l816t480r1205b528],
7	;	:	O	;	_	0	SENT_311	[p12l816t480r1205b528],
8	128:84	CD	NUMBER	128:84	dep	6	SENT_311	[p12l816t480r1205b528],
9	—	CD	NUMBER	—	num	10	SENT_311	[p12l816t480r1205b528],
10	9	CD	NUMBER	9	dep	8	SENT_311	[p12l816t480r1205b528],
11	.	.	O	.	_	0	SENT_311	[p12l816t480r1205b528],

1	Otani	NNP	ORGANIZATION	Otani	nn	2	SENT_312	[p12l7t545r138b588],
2	K	NNP	ORGANIZATION	K	_	0	SENT_312	[p12l160t547r203b594],
3	,	,	O	,	_	0	SENT_312	[p12l160t547r203b594],
4	Kondo	NNP	PERSON	Kondo	nn	5	SENT_312	[p12l225t544r381b588],
5	T	NN	O	t	appos	2	SENT_312	[p12l398t547r435b594],
6	,	,	O	,	_	0	SENT_312	[p12l398t547r435b594],
7	Yausi	NN	ORGANIZATION	yausus	nn	8	SENT_312	[p12l454t545r582b588],
8	N	NN	ORGANIZATION	n	appos	5	SENT_312	[p12l603t547r651b594],
9	,	,	O	,	_	0	SENT_312	[p12l603t547r651b594],
10	Suzuki	NNP	PERSON	Suzuki	nn	11	SENT_312	[p12l673t544r834b588],
11	A	NNP	O	A	appos	5	SENT_312	[p12l853t546r900b594],
12	,	,	O	,	_	0	SENT_312	[p12l853t546r900b594],
13	Furukori	NNP	PERSON	Furukori	nn	14	SENT_312	[p12l922t544r1130b588],
14	H	NNP	PERSON	H	appos	5	SENT_312	[p12l1151t547r1200b594],
15	,	,	O	,	_	0	SENT_312	[p12l1151t547r1200b594],
16	Kaneko	NNP	PERSON	Kaneko	nn	17	SENT_312	[p12l1222t544r1402b588],
17	S	NNP	O	S	appos	5	SENT_312	[p12l1424t546r1460b594],
18	,	,	O	,	_	0	SENT_312	[p12l1424t546r1460b594],
19	et	FW	O	et	nn	20	SENT_312	[p12l1482t550r1528b588],
20	al.	FW	O	al.	appos	5	SENT_312	[p12l1547t544r1600b588],
21	.	.	O	.	_	0	SENT_312	[p12l1547t544r1600b588],

1	Prolactin	NN	O	prolactin	nn	2	SENT_313	[p12l1621t544r1839b588],
2	response	NN	O	response	_	0	SENT_313	[p12l1859t557r2077b598],
3	to	TO	O	to	_	0	SENT_313	[p12l2098t550r2145b588],
4	nemonapride	NN	O	nemonapride	prep_to	2	SENT_313	[p12l110t610r450b665],
5	,	,	O	,	_	0	SENT_313	[p12l110t610r450b665],
6	a	DT	O	a	det	9	SENT_313	[p12l478t623r503b654],
7	new	JJ	O	new	amod	9	SENT_313	[p12l530t623r635b654],
8	antipsychotic	JJ	O	antipsychotic	amod	9	SENT_313	[p12l659t610r987b665],
9	drug	NN	O	drug	appos	2	SENT_313	[p12l1012t610r1137b665],
10	,	,	O	,	_	0	SENT_313	[p12l1012t610r1137b665],
11	in	IN	O	in	_	0	SENT_313	[p12l1165t611r1210b653],
12	schizophrenic	JJ	O	schizophrenic	amod	13	SENT_313	[p12l1237t610r1579b665],
13	patients	NNS	O	patient	prep_in	2	SENT_313	[p12l1605t611r1813b665],
14	.	.	O	.	_	0	SENT_313	[p12l1605t611r1813b665],

1	Hum	NNP	O	Hum	nn	2	SENT_314	[p12l1842t613r1961b654],
2	Psycopharmacol	NNP	O	Psycopharmacol	_	0	SENT_314	[p12l1987t613r2144b665, p12l109t676r370b730],
3	1997	CD	DATE	1997	num	2	SENT_314	[p12l393t678r770b726],
4	;	:	O	;	_	0	SENT_314	[p12l393t678r770b726],
5	12:591	CD	NUMBER	12:591	number	6	SENT_314	[p12l393t678r770b726],
6	—	CD	NUMBER	—	dep	2	SENT_314	[p12l393t678r770b726],
7	4	CD	NUMBER	4	dep	6	SENT_314	[p12l393t678r770b726],
8	.	.	O	.	_	0	SENT_314	[p12l393t678r770b726],

1	Otani	NNP	ORGANIZATION	Otani	nn	2	SENT_315	[p12l7t742r138b785],
2	K	NNP	ORGANIZATION	K	_	0	SENT_315	[p12l167t744r210b792],
3	,	,	O	,	_	0	SENT_315	[p12l167t744r210b792],
4	Kondo	NNP	PERSON	Kondo	nn	5	SENT_315	[p12l240t741r396b785],
5	T	NN	O	t	appos	2	SENT_315	[p12l419t744r456b792],
6	,	,	O	,	_	0	SENT_315	[p12l419t744r456b792],
7	Kaneko	NNP	PERSON	Kaneko	nn	8	SENT_315	[p12l486t741r666b785],
8	S	NNP	O	S	appos	2	SENT_315	[p12l695t744r731b792],
9	,	,	O	,	_	0	SENT_315	[p12l695t744r731b792],
10	Ishida	NNP	PERSON	Ishida	nn	11	SENT_315	[p12l761t741r906b785],
11	M	NNP	O	M	appos	2	SENT_315	[p12l935t744r993b792],
12	,	,	O	,	_	0	SENT_315	[p12l935t744r993b792],
13	Fukushima	NNP	PERSON	Fukushima	nn	15	SENT_315	[p12l1022t742r1291b785],
14	Y.	NNP	O	Y.	nn	15	SENT_315	[p12l1317t744r1356b785],
15	Correlation	NN	O	correlation	appos	2	SENT_315	[p12l1385t741r1660b785],
16	between	IN	O	between	_	0	SENT_315	[p12l1687t741r1899b785],
17	prolactin	NN	O	prolactin	nn	18	SENT_315	[p12l1926t741r2145b796],
18	response	NN	O	response	prep_between	15	SENT_315	[p12l110t820r327b862],
19	to	TO	O	to	_	0	SENT_315	[p12l342t814r389b851],
20	zetepine	NN	O	zetepine	prep_to	18	SENT_315	[p12l405t808r613b862],
21	in	IN	O	in	_	0	SENT_315	[p12l629t808r674b851],
22	schizophrenic	JJ	O	schizophrenic	amod	23	SENT_315	[p12l691t808r1032b862],
23	patients	NNS	O	patient	prep_in	20	SENT_315	[p12l1047t808r1255b862],
24	.	.	O	.	_	0	SENT_315	[p12l1047t808r1255b862],

1	Hum	NNP	O	Hum	nn	2	SENT_316	[p12l1272t810r1391b851],
2	Psycopharmacol	NNP	O	Psycopharmacol	_	0	SENT_316	[p12l1406t808r1806b862],
3	1993	CD	DATE	1993	num	2	SENT_316	[p12l1824t810r2144b858],
4	;	:	O	;	_	0	SENT_316	[p12l1824t810r2144b858],
5	8:35	CD	TIME	8:35	dep	2	SENT_316	[p12l1824t810r2144b858],
6	—	CD	NUMBER	—	number	7	SENT_316	[p12l1824t810r2144b858],
7	9	CD	NUMBER	9	dep	5	SENT_316	[p12l1824t810r2144b858],
8	.	.	O	.	_	0	SENT_316	[p12l1824t810r2144b858],

1	Petty	JJ	O	petty	amod	2	SENT_317	[p12l8t877r133b929],
2	RG	NN	O	rg	_	0	SENT_317	[p12l149t876r227b918],
3	.	.	O	.	_	0	SENT_317	[p12l149t876r227b918],

1	Prolactin	NN	O	prolactin	nn	4	SENT_318	[p12l245t874r462b918],
2	and	CC	O	and	_	0	SENT_318	[p12l479t874r567b918],
3	antipsychotic	JJ	O	antipsychotic	nn	4	SENT_318	[p12l585t874r913b929],
4	medications	NNS	O	medication	_	0	SENT_318	[p12l929t874r1242b918],
5	:	:	O	:	_	0	SENT_318	[p12l929t874r1242b918],
6	mechanism	NN	O	mechanism	dep	4	SENT_318	[p12l1264t874r1547b918],
7	of	IN	O	of	_	0	SENT_318	[p12l1563t874r1615b918],
8	action	NN	O	action	prep_of	6	SENT_318	[p12l1625t875r1786b918],
9	.	.	O	.	_	0	SENT_318	[p12l1625t875r1786b918],

1	Schizophr	NNP	O	Schizophr	nn	2	SENT_319	[p12l1804t874r2048b929],
2	Res	NNP	O	Res	_	0	SENT_319	[p12l2064t877r2144b918],

1	1999	CD	DATE	1999	num	3	SENT_320	[p12l112t941r506b990],
2	;	:	O	;	_	0	SENT_320	[p12l112t941r506b990],
3	35	CD	NUMBER	35	_	0	SENT_320	[p12l112t941r506b990],
4	:	:	O	:	_	0	SENT_320	[p12l112t941r506b990],
5	S67	CD	NUMBER	s67	number	6	SENT_320	[p12l112t941r506b990],
6	—	CD	NUMBER	—	dep	3	SENT_320	[p12l112t941r506b990],
7	73	CD	NUMBER	73	num	8	SENT_320	[p12l112t941r506b990],
8	Suppl	NN	O	suppl	dep	6	SENT_320	[p12l529t939r678b994],
9	.	.	O	.	_	0	SENT_320	[p12l529t939r678b994],

1	Popli	NNP	MISC	Popli	nn	2	SENT_321	[p12l8t1006r129b1060],
2	A	NNP	MISC	A	_	0	SENT_321	[p12l153t1008r200b1056],
3	,	,	O	,	_	0	SENT_321	[p12l153t1008r200b1056],
4	Gupta	NNP	PERSON	Gupta	nn	5	SENT_321	[p12l228t1008r375b1060],
5	S	NNP	O	S	appos	2	SENT_321	[p12l401t1008r437b1056],
6	,	,	O	,	_	0	SENT_321	[p12l401t1008r437b1056],
7	Rangwani	NNP	O	Rangwani	nn	8	SENT_321	[p12l465t1007r706b1060],
8	SR.	NNP	O	SR.	appos	5	SENT_321	[p12l733t1008r803b1050],
9	.	.	O	.	_	0	SENT_321	[p12l733t1008r803b1050],

1	Risperidone-induced	JJ	O	risperidone-induced	amod	2	SENT_322	[p12l831t1006r1344b1060],
2	galactorrhea	NN	O	galactorrhea	nsubj	3	SENT_322	[p12l1371t1006r1677b1060],
3	associated	VBN	O	associate	_	0	SENT_322	[p12l1704t1006r1955b1050],
4	with	IN	O	with	_	0	SENT_322	[p12l1981t1006r2094b1050],
5	a	DT	O	a	det	7	SENT_322	[p12l2120t1019r2145b1050],
6	prolactin	NN	O	prolactin	nn	7	SENT_322	[p12l109t1072r328b1126],
7	elevation	NN	O	elevation	prep_with	3	SENT_322	[p12l348t1072r583b1116],
8	.	.	O	.	_	0	SENT_322	[p12l348t1072r583b1116],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_323	[p12l602t1074r702b1115],
2	Clin	NNP	PERSON	Clin	nn	3	SENT_323	[p12l722t1072r815b1115],
3	Psychiatry	NNP	O	Psychiatry	_	0	SENT_323	[p12l835t1072r1089b1126],
4	1998	CD	DATE	1998	num	3	SENT_323	[p12l1110t1074r1456b1122],
5	;	:	O	;	_	0	SENT_323	[p12l1110t1074r1456b1122],
6	10:31	CD	TIME	10:31	number	7	SENT_323	[p12l1110t1074r1456b1122],
7	—	CD	NUMBER	—	dep	3	SENT_323	[p12l1110t1074r1456b1122],
8	3	CD	NUMBER	3	dep	7	SENT_323	[p12l1110t1074r1456b1122],
9	.	.	O	.	_	0	SENT_323	[p12l1110t1074r1456b1122],

1	Rubin	NNP	ORGANIZATION	Rubin	_	0	SENT_324	[p12l8t1138r149b1181],
2	RT	NN	ORGANIZATION	rt	dep	1	SENT_324	[p12l164t1141r232b1182],
3	.	.	O	.	_	0	SENT_324	[p12l164t1141r232b1182],

1	Prolactin	NN	O	prolactin	_	0	SENT_325	[p12l249t1138r466b1181],
2	and	CC	O	and	_	0	SENT_325	[p12l480t1138r569b1181],
3	schizophrenia	NN	O	schizophrenia	conj_and	1	SENT_325	[p12l585t1138r940b1192],
4	.	.	O	.	_	0	SENT_325	[p12l585t1138r940b1192],

1	In	IN	O	in	dep	4	SENT_326	[p12l956t1141r1016b1182],
2	:	:	O	:	_	0	SENT_326	[p12l956t1141r1016b1182],
3	Meltzer	NNP	PERSON	Meltzer	nn	4	SENT_326	[p12l1035t1138r1225b1181],
4	HY	NNP	O	HY	_	0	SENT_326	[p12l1239t1141r1316b1188],
5	,	,	O	,	_	0	SENT_326	[p12l1239t1141r1316b1188],
6	editor	NN	O	editor	amod	4	SENT_326	[p12l1331t1138r1486b1182],
7	.	.	O	.	_	0	SENT_326	[p12l1331t1138r1486b1182],

1	Psychopharmacology	NNP	O	Psychopharmacology	_	0	SENT_327	[p12l1502t1138r2039b1192],
2	:	:	O	:	_	0	SENT_327	[p12l1502t1138r2039b1192],
3	The	DT	O	the	dep	1	SENT_327	[p12l2055t1138r2144b1181],

1	Third	NNP	ORDINAL	Third	nn	2	SENT_328	[p12l107t1203r238b1247],
2	Generation	NNP	O	Generation	_	0	SENT_328	[p12l258t1204r531b1247],
3	of	IN	O	of	_	0	SENT_328	[p12l550t1203r601b1247],
4	progress	NN	O	progress	prep_of	2	SENT_328	[p12l615t1216r834b1258],
5	.	.	O	.	_	0	SENT_328	[p12l615t1216r834b1258],

1	New	NNP	LOCATION	New	nn	2	SENT_329	[p12l855t1206r967b1247],
2	York	NNP	LOCATION	York	_	0	SENT_329	[p12l983t1203r1109b1247],
3	:	:	O	:	_	0	SENT_329	[p12l983t1203r1109b1247],
4	Raven	NN	ORGANIZATION	raven	nn	5	SENT_329	[p12l1132t1206r1279b1247],
5	Press	NNP	ORGANIZATION	Press	dep	2	SENT_329	[p12l1299t1206r1439b1254],
6	;	:	O	;	_	0	SENT_329	[p12l1299t1206r1439b1254],
7	1987	CD	DATE	1987	dep	5	SENT_329	[p12l1464t1206r1586b1247],
8	.	.	O	.	_	0	SENT_329	[p12l1464t1206r1586b1247],

1	p.	NN	O	p.	_	0	SENT_330	[p12l1607t1216r1648b1258],
2	803-8	CD	NUMBER	803-8	dep	1	SENT_330	[p12l1669t1206r1832b1247],
3	.	.	O	.	_	0	SENT_330	[p12l1669t1206r1832b1247],

1	N.	NNP	PERSON	N.	nn	2	SENT_331	[p12l214t1335r237b1355],
2	Yasui-Furukori	NNP	PERSON	Yasui-Furukori	_	0	SENT_331	[p12l249t1333r418b1355],
3	et	FW	O	et	nn	4	SENT_331	[p12l428t1337r450b1355],
4	al.	FW	O	al.	dep	2	SENT_331	[p12l459t1333r483b1355],
5	/	:	O	/	punct	6	SENT_331	[p12l492t1333r504b1360],
6	Progress	NNP	O	Progress	dep	4	SENT_331	[p12l512t1335r608b1360],
7	in	IN	O	in	_	0	SENT_331	[p12l618t1334r639b1355],
8	Neuro	NNP	O	Neuro	prep_in	4	SENT_331	[p12l649t1333r974b1360],
9	.	.	O	.	_	0	SENT_331	[p12l649t1333r974b1360],

1	—	NN	O	—	_	0	SENT_332	[p12l649t1333r974b1360],
2	.	.	O	.	_	0	SENT_332	[p12l649t1333r974b1360],

1	Psychopharmacolugy	JJ	O	psychopharmacolugy	amod	5	SENT_333	[p12l649t1333r974b1360],
2	€	NN	O	€	nn	5	SENT_333	[p12l984t1334r1006b1355],
3	r	NN	O	r	nn	5	SENT_333	[p12l984t1334r1006b1355],
4	Biological	JJ	O	biological	amod	5	SENT_333	[p12l1013t1333r1125b1360],
5	Psychiatry	NNP	O	Psychiatry	_	0	SENT_333	[p12l1134t1333r1254b1360],
6	32	CD	NUMBER	32	number	7	SENT_333	[p12l1263t1334r1292b1355],
7	(	CD	NUMBER	(	dep	5	SENT_333	[p12l1302t1333r1379b1360],
8	2008	CD	DATE	2008	dep	7	SENT_333	[p12l1302t1333r1379b1360],
9	)	CD	NUMBER	)	num	10	SENT_333	[p12l1302t1333r1379b1360],
10	1491-1495 1495	CD	DURATION	1491-1495 1495	dep	5	SENT_333	[p12l1889t1334r1945b1355],[p12l1392t1334r1516b1355],

1	Sawamura	NNP	ORGANIZATION	Sawamura	nn	2	SENT_334	[p12l9t1464r266b1505],
2	T	NN	ORGANIZATION	t	_	0	SENT_334	[p12l291t1464r328b1512],
3	,	,	O	,	_	0	SENT_334	[p12l291t1464r328b1512],
4	Suzuki	NNP	PERSON	Suzuki	nn	5	SENT_334	[p12l357t1462r518b1505],
5	Y	NN	PERSON	y	appos	2	SENT_334	[p12l544t1464r584b1512],
6	,	,	O	,	_	0	SENT_334	[p12l544t1464r584b1512],
7	Fukui	NNP	ORGANIZATION	Fukui	nn	8	SENT_334	[p12l614t1462r747b1505],
8	N	NNP	ORGANIZATION	N	appos	2	SENT_334	[p12l775t1464r823b1512],
9	,	,	O	,	_	0	SENT_334	[p12l775t1464r823b1512],
10	Sugai	NNP	ORGANIZATION	Sugai	nn	16	SENT_334	[p12l851t1462r981b1516],
11	T	NN	ORGANIZATION	t	nn	16	SENT_334	[p12l1007t1464r1044b1512],
12	,	,	O	,	_	0	SENT_334	[p12l1007t1464r1044b1512],
13	Someya	NNP	PERSON	Someya	dep	16	SENT_334	[p12l1073t1464r1263b1516],
14	T.	NNP	O	T.	nn	16	SENT_334	[p12l1287t1464r1325b1506],
15	Gender	NN	O	gender	nn	16	SENT_334	[p12l1354t1462r1534b1505],
16	differences	NNS	O	difference	appos	2	SENT_334	[p12l1560t1461r1828b1505],
17	in	IN	O	in	_	0	SENT_334	[p12l1857t1462r1901b1505],
18	prolactin	NN	O	prolactin	nn	19	SENT_334	[p12l1929t1462r2147b1516],
19	elevation	NN	O	elevation	prep_in	16	SENT_334	[p12l111t1528r336b1572],
20	induced	VBN	O	induce	partmod	16	SENT_334	[p12l363t1528r557b1572],
21	by	IN	O	by	_	0	SENT_334	[p12l585t1528r644b1583],
22	olanzapine	NN	O	olanzapine	agent	20	SENT_334	[p12l668t1528r934b1583],
23	in	IN	O	in	_	0	SENT_334	[p12l962t1529r1007b1571],
24	Japanese	JJ	MISC	japanese	amod	27	SENT_334	[p12l1027t1531r1247b1583],
25	drug-naive	JJ	O	drug-naive	amod	27	SENT_334	[p12l1275t1528r1543b1583],
26	schizophrenic	JJ	O	schizophrenic	amod	27	SENT_334	[p12l1570t1528r1912b1583],
27	patients	NNS	O	patient	prep_in	22	SENT_334	[p12l1937t1529r2146b1583],
28	.	.	O	.	_	0	SENT_334	[p12l1937t1529r2146b1583],

1	Prog	NN	O	prog	_	0	SENT_335	[p12l112t1596r221b1648],
2	Neuropsychopharmacol	NNP	O	Neuropsychopharmacol	nn	4	SENT_335	[p12l240t1594r826b1648],
3	Biol	NNP	O	Biol	nn	4	SENT_335	[p12l846t1594r937b1637],
4	Psychiatry	NNP	O	Psychiatry	dep	1	SENT_335	[p12l957t1594r1211b1648],
5	2006	CD	DATE	2006	num	4	SENT_335	[p12l1230t1596r1639b1644],
6	;	:	O	;	_	0	SENT_335	[p12l1230t1596r1639b1644],
7	30:1511	CD	NUMBER	30:1511	number	8	SENT_335	[p12l1230t1596r1639b1644],
8	—	CD	NUMBER	—	dep	1	SENT_335	[p12l1230t1596r1639b1644],
9	4	CD	NUMBER	4	dep	8	SENT_335	[p12l1230t1596r1639b1644],
10	.	.	O	.	_	0	SENT_335	[p12l1230t1596r1639b1644],

1	Scharfetter	NN	O	scharfetter	nn	2	SENT_336	[p12l9t1660r279b1704],
2	J	NN	O	j	_	0	SENT_336	[p12l288t1663r319b1714],
3	,	,	O	,	_	0	SENT_336	[p12l288t1663r319b1714],
4	Chaudhry	NNP	O	Chaudhry	nn	5	SENT_336	[p12l336t1660r576b1714],
5	HR	NNP	DURATION	HR	appos	2	SENT_336	[p12l591t1663r672b1710],
6	,	,	O	,	_	0	SENT_336	[p12l591t1663r672b1710],
7	Hornik	NNP	PERSON	Hornik	nn	8	SENT_336	[p12l690t1660r859b1704],
8	K	NNP	PERSON	K	appos	2	SENT_336	[p12l875t1663r918b1710],
9	,	,	O	,	_	0	SENT_336	[p12l875t1663r918b1710],
10	Fuchs	NNP	PERSON	Fuchs	nsubj	12	SENT_336	[p12l935t1660r1072b1704],
11	I	PRP	O	I	dep	10	SENT_336	[p12l1089t1663r1132b1710],
12	(	VBP	O	(	dep	2	SENT_336	[p12l1089t1663r1132b1710],
13	,	,	O	,	_	0	SENT_336	[p12l1089t1663r1132b1710],
14	Sieghart	NNP	PERSON	Sieghart	nn	15	SENT_336	[p12l1149t1660r1352b1714],
15	W	NNP	PERSON	W	appos	2	SENT_336	[p12l1364t1663r1428b1710],
16	,	,	O	,	_	0	SENT_336	[p12l1364t1663r1428b1710],
17	Kasper	NNP	PERSON	Kasper	nn	18	SENT_336	[p12l1446t1663r1613b1714],
18	S	NNP	O	S	appos	2	SENT_336	[p12l1628t1662r1664b1710],
19	,	,	O	,	_	0	SENT_336	[p12l1628t1662r1664b1710],
20	et	FW	O	et	nn	21	SENT_336	[p12l1682t1666r1728b1704],
21	al.	FW	O	al.	appos	2	SENT_336	[p12l1742t1660r1794b1704],
22	.	.	O	.	_	0	SENT_336	[p12l1742t1660r1794b1704],

1	Dopamine	NN	O	dopamine	nn	5	SENT_337	[p12l1812t1661r2064b1714],
2	D3	NN	O	d3	nn	5	SENT_337	[p12l2081t1662r2144b1704],
3	receptor	NN	O	receptor	nn	5	SENT_337	[p12l112t1733r317b1781],
4	gene	NN	O	gene	nn	5	SENT_337	[p12l332t1739r448b1781],
5	polymorphism	NN	O	polymorphism	_	0	SENT_337	[p12l466t1726r828b1781],
6	and	CC	O	and	_	0	SENT_337	[p12l846t1726r934b1770],
7	response	NN	O	response	conj_and	5	SENT_337	[p12l953t1739r1171b1781],
8	to	TO	O	to	_	0	SENT_337	[p12l1189t1733r1235b1770],
9	clozapine	NN	O	clozapine	prep_to	5	SENT_337	[p12l1254t1726r1485b1781],
10	in	IN	O	in	_	0	SENT_337	[p12l1504t1727r1550b1769],
11	schizophrenic	JJ	O	schizophrenic	amod	13	SENT_337	[p12l1568t1726r1910b1781],
12	Pakistani	JJ	MISC	pakistani	amod	13	SENT_337	[p12l1927t1726r2147b1770],
13	patients	NNS	O	patient	prep_in	5	SENT_337	[p12l111t1793r320b1846],
14	.	.	O	.	_	0	SENT_337	[p12l111t1793r320b1846],

1	Eur	NNP	MISC	Eur	nn	2	SENT_338	[p12l340t1795r424b1835],
2	Neuropsychopharmacol	NNP	MISC	Neuropsychopharmacol	_	0	SENT_338	[p12l442t1792r1028b1846],
3	1999	CD	DATE	1999	num	2	SENT_338	[p12l1051t1794r1425b1842],
4	;	:	O	;	_	0	SENT_338	[p12l1051t1794r1425b1842],
5	10:17	CD	TIME	10:17	number	6	SENT_338	[p12l1051t1794r1425b1842],
6	—	CD	NUMBER	—	dep	2	SENT_338	[p12l1051t1794r1425b1842],
7	20	CD	NUMBER	20	dep	6	SENT_338	[p12l1051t1794r1425b1842],
8	.	.	O	.	_	0	SENT_338	[p12l1051t1794r1425b1842],

1	Schotte	NNP	PERSON	Schotte	nn	2	SENT_339	[p12l9t1858r189b1902],
2	A	NNP	O	A	_	0	SENT_339	[p12l206t1860r253b1908],
3	,	,	O	,	_	0	SENT_339	[p12l206t1860r253b1908],
4	Bonaventure	NNP	PERSON	Bonaventure	nn	5	SENT_339	[p12l273t1861r584b1902],
5	P	NN	PERSON	p	appos	2	SENT_339	[p12l602t1861r636b1908],
6	,	,	O	,	_	0	SENT_339	[p12l602t1861r636b1908],
7	Janssen	NNP	ORGANIZATION	Janssen	nn	8	SENT_339	[p12l649t1861r838b1912],
8	PFM	NNP	ORGANIZATION	PFM	appos	2	SENT_339	[p12l857t1861r973b1908],
9	,	,	O	,	_	0	SENT_339	[p12l857t1861r973b1908],
10	Leysen	NNP	PERSON	Leysen	nn	11	SENT_339	[p12l992t1861r1158b1912],
11	JE	NNP	O	JE	appos	2	SENT_339	[p12l1169t1861r1231b1912],
12	.	.	O	.	_	0	SENT_339	[p12l1169t1861r1231b1912],

1	In	FW	O	in	nn	3	SENT_340	[p12l1250t1861r1296b1901],
2	vitro	FW	O	vitro	nn	3	SENT_340	[p12l1313t1859r1428b1902],
3	receptor	NN	O	receptor	nn	15	SENT_340	[p12l1447t1864r1653b1912],
4	binding	NN	O	binding	dep	3	SENT_340	[p12l1669t1858r1857b1912],
5	and	CC	O	and	_	0	SENT_340	[p12l1874t1858r1963b1902],
6	in	FW	O	in	nn	7	SENT_340	[p12l1983t1859r2028b1901],
7	vivo	FW	O	vivo	advmod	9	SENT_340	[p12l2045t1859r2146b1902],
8	receptor	NN	O	receptor	nn	9	SENT_340	[p12l112t1930r317b1978],
9	occupancy	NN	O	occupancy	nn	15	SENT_340	[p12l350t1936r610b1978],
10	in	IN	O	in	_	0	SENT_340	[p12l644t1924r689b1967],
11	rat	NN	O	rat	nn	14	SENT_340	[p12l725t1930r792b1967],
12	and	CC	O	and	_	0	SENT_340	[p12l825t1924r914b1967],
13	guinea	NN	O	guinea	conj_and	11	SENT_340	[p12l949t1924r1114b1978],
14	pig	NN	O	pig	prep_in	9	SENT_340	[p12l1149t1924r1224b1978],
15	brain	NN	O	brain	_	0	SENT_340	[p12l1258t1924r1400b1968],
16	:	:	O	:	_	0	SENT_340	[p12l1258t1924r1400b1968],
17	risperidone	NN	O	risperidone	dep	15	SENT_340	[p12l1439t1924r1719b1978],
18	compared	VBN	O	compare	_	0	SENT_340	[p12l1755t1924r2000b1978],
19	with	IN	O	with	prepc_compared_with	17	SENT_340	[p12l2034t1924r2147b1967],
20	antipsychotic	JJ	O	antipsychotic	pobj	17	SENT_340	[p12l111t1990r439b2045],
21	hitherto	RB	O	hitherto	advmod	22	SENT_340	[p12l458t1990r656b2034],
22	used	VBN	O	use	amod	20	SENT_340	[p12l676t1990r801b2034],
23	.	.	O	.	_	0	SENT_340	[p12l676t1990r801b2034],

1	Jpn	NNP	O	Jpn	nn	3	SENT_341	[p12l815t1993r933b2045],
2	]	NNP	O	]	nn	3	SENT_341	[p12l815t1993r933b2045],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_341	[p12l952t1990r1211b2034],
4	1995	CD	DATE	1995	num	3	SENT_341	[p12l1234t1992r1674b2040],
5	;	:	O	;	_	0	SENT_341	[p12l1234t1992r1674b2040],
6	69:399	CD	NUMBER	69:399	number	7	SENT_341	[p12l1234t1992r1674b2040],
7	-412	CD	NUMBER	-412	dep	3	SENT_341	[p12l1234t1992r1674b2040],
8	.	.	O	.	_	0	SENT_341	[p12l1234t1992r1674b2040],

1	Segman	NNP	MISC	Segman	nn	2	SENT_342	[p12l9t2058r202b2111],
2	RH	NNP	MISC	RH	_	0	SENT_342	[p12l238t2059r319b2107],
3	,	,	O	,	_	0	SENT_342	[p12l238t2059r319b2107],
4	Goltser	NNP	PERSON	Goltser	nn	5	SENT_342	[p12l355t2056r531b2100],
5	T	NN	O	t	appos	2	SENT_342	[p12l562t2059r600b2106],
6	,	,	O	,	_	0	SENT_342	[p12l562t2059r600b2106],
7	Heresco-Levy	JJ	ORGANIZATION	heresco-levy	amod	8	SENT_342	[p12l635t2059r967b2111],
8	U	NNP	ORGANIZATION	U	appos	5	SENT_342	[p12l1000t2059r1046b2106],
9	,	,	O	,	_	0	SENT_342	[p12l1000t2059r1046b2106],
10	Finkel	NNP	PERSON	Finkel	nn	11	SENT_342	[p12l1081t2056r1228b2100],
11	B	NNP	PERSON	B	appos	5	SENT_342	[p12l1263t2059r1304b2106],
12	,	,	O	,	_	0	SENT_342	[p12l1263t2059r1304b2106],
13	Shalem	NNP	ORGANIZATION	Shalem	nn	14	SENT_342	[p12l1339t2056r1519b2100],
14	R	NNP	ORGANIZATION	R	appos	5	SENT_342	[p12l1554t2059r1595b2107],
15	,	,	O	,	_	0	SENT_342	[p12l1554t2059r1595b2107],
16	Schlafman	NNP	O	Schlafman	nn	17	SENT_342	[p12l1631t2056r1886b2100],
17	M	NNP	O	M	appos	5	SENT_342	[p12l1921t2059r1979b2107],
18	,	,	O	,	_	0	SENT_342	[p12l1921t2059r1979b2107],
19	et	FW	O	et	nn	20	SENT_342	[p12l2015t2063r2061b2100],
20	al.	FW	O	al.	appos	5	SENT_342	[p12l2094t2056r2146b2100],
21	.	.	O	.	_	0	SENT_342	[p12l2094t2056r2146b2100],

1	Association	NNP	O	Association	_	0	SENT_343	[p12l109t2123r390b2166],
2	of	IN	O	of	_	0	SENT_343	[p12l418t2122r469b2166],
3	dopaminergic	JJ	O	dopaminergic	amod	6	SENT_343	[p12l492t2122r832b2176],
4	and	CC	O	and	_	0	SENT_343	[p12l859t2122r949b2166],
5	serotonergic	JJ	O	serotonergic	amod	6	SENT_343	[p12l978t2123r1283b2176],
6	genes	NNS	O	gene	prep_of	1	SENT_343	[p12l1309t2135r1449b2176],
7	with	IN	O	with	_	0	SENT_343	[p12l1476t2122r1589b2166],
8	tardive	JJ	O	tardive	amod	9	SENT_343	[p12l1617t2122r1789b2166],
9	dyskinesia	NN	O	dyskinesium	prep_with	1	SENT_343	[p12l1817t2122r2074b2176],
10	in	IN	O	in	_	0	SENT_343	[p12l2102t2123r2147b2165],
11	patients	NNS	O	patient	prep_in	1	SENT_343	[p12l111t2189r308b2242],
12	with	IN	O	with	_	0	SENT_343	[p12l327t2188r440b2232],
13	chronic	JJ	O	chronic	amod	14	SENT_343	[p12l459t2188r642b2232],
14	schizophrenia	NN	O	schizophrenia	prep_with	11	SENT_343	[p12l661t2188r1016b2242],
15	.	.	O	.	_	0	SENT_343	[p12l661t2188r1016b2242],

1	Pharmacogenomics	NNS	MISC	pharmacogenomic	nsubj	2	SENT_344	[p12l1036t2188r1548b2242],
2	]	VBP	O	]	_	0	SENT_344	[p12l1036t2188r1548b2242],
3	2003	CD	DATE	2003	dobj	2	SENT_344	[p12l1568t2190r1957b2238],
4	;	:	O	;	_	0	SENT_344	[p12l1568t2190r1957b2238],
5	3:277	CD	NUMBER	3:277	number	6	SENT_344	[p12l1568t2190r1957b2238],
6	—	CD	NUMBER	—	dep	3	SENT_344	[p12l1568t2190r1957b2238],
7	83	CD	NUMBER	83	dep	6	SENT_344	[p12l1568t2190r1957b2238],
8	.	.	O	.	_	0	SENT_344	[p12l1568t2190r1957b2238],

1	Shiwach	NNP	O	Shiwach	nn	2	SENT_345	[p12l9t2254r214b2297],
2	RS	NN	O	r	_	0	SENT_345	[p12l248t2256r318b2304],
3	,	,	O	,	_	0	SENT_345	[p12l248t2256r318b2304],
4	Carmody	NNP	PERSON	Carmody	nn	6	SENT_345	[p12l353t2254r575b2308],
5	T	NN	O	t	nn	6	SENT_345	[p12l606t2256r662b2308],
6	]	NN	O	]	appos	2	SENT_345	[p12l606t2256r662b2308],
7	.	.	O	.	_	0	SENT_345	[p12l606t2256r662b2308],

1	Prolactogenic	JJ	O	prolactogenic	amod	2	SENT_346	[p12l698t2254r1029b2308],
2	effects	NNS	O	effect	_	0	SENT_346	[p12l1061t2253r1218b2297],
3	of	IN	O	of	_	0	SENT_346	[p12l1253t2253r1304b2297],
4	risperidone	NN	O	risperidone	prep_of	2	SENT_346	[p12l1332t2254r1612b2308],
5	in	IN	O	in	_	0	SENT_346	[p12l1647t2254r1692b2297],
6	male	JJ	O	male	amod	7	SENT_346	[p12l1726t2254r1843b2297],
7	patients	NNS	O	patient	prep_in	2	SENT_346	[p12l1878t2254r2147b2308],
8	—	IN	O	—	_	0	SENT_346	[p12l1878t2254r2147b2308],
9	a	DT	O	a	det	11	SENT_346	[p12l1878t2254r2147b2308],
10	preliminary	JJ	O	preliminary	amod	11	SENT_346	[p12l111t2320r401b2375],
11	study	NN	O	study	prep_—	2	SENT_346	[p12l419t2320r562b2375],
12	.	.	O	.	_	0	SENT_346	[p12l419t2320r562b2375],

1	Acta	NNP	O	Acta	nn	3	SENT_347	[p12l581t2322r689b2364],
2	Psychiatr	NNP	O	Psychiatr	nn	3	SENT_347	[p12l708t2320r932b2375],
3	Scand	NNP	O	Scand	_	0	SENT_347	[p12l951t2320r1093b2364],
4	1998	CD	DATE	1998	num	3	SENT_347	[p12l1116t2322r1468b2371],
5	;	:	O	;	_	0	SENT_347	[p12l1116t2322r1468b2371],
6	98:81	CD	NUMBER	98:81	number	7	SENT_347	[p12l1116t2322r1468b2371],
7	—	CD	NUMBER	—	dep	3	SENT_347	[p12l1116t2322r1468b2371],
8	3	CD	NUMBER	3	dep	7	SENT_347	[p12l1116t2322r1468b2371],
9	.	.	O	.	_	0	SENT_347	[p12l1116t2322r1468b2371],

1	Suzuki	NNP	PERSON	Suzuki	nn	2	SENT_348	[p12l9t2385r171b2429],
2	A	NNP	O	A	_	0	SENT_348	[p12l191t2387r238b2436],
3	,	,	O	,	_	0	SENT_348	[p12l191t2387r238b2436],
4	Mihara	NNP	PERSON	Mihara	nn	5	SENT_348	[p12l262t2386r435b2429],
5	K	NNP	PERSON	K	appos	2	SENT_348	[p12l457t2388r500b2436],
6	,	,	O	,	_	0	SENT_348	[p12l457t2388r500b2436],
7	Kondo	NNP	PERSON	Kondo	nn	8	SENT_348	[p12l523t2385r679b2429],
8	T	NN	O	t	appos	5	SENT_348	[p12l697t2388r734b2436],
9	,	,	O	,	_	0	SENT_348	[p12l697t2388r734b2436],
10	Tanaka	NNP	ORGANIZATION	Tanaka	nn	11	SENT_348	[p12l755t2385r927b2429],
11	O	NNP	ORGANIZATION	O	appos	5	SENT_348	[p12l949t2388r996b2436],
12	,	,	O	,	_	0	SENT_348	[p12l949t2388r996b2436],
13	Nagashima	NNP	ORGANIZATION	Nagashima	nn	14	SENT_348	[p12l1020t2386r1291b2440],
14	U	NNP	ORGANIZATION	U	appos	5	SENT_348	[p12l1312t2388r1357b2436],
15	,	,	O	,	_	0	SENT_348	[p12l1312t2388r1357b2436],
16	Otani	NNP	ORGANIZATION	Otani	nn	17	SENT_348	[p12l1381t2386r1511b2429],
17	K	NNP	ORGANIZATION	K	appos	5	SENT_348	[p12l1535t2388r1578b2436],
18	,	,	O	,	_	0	SENT_348	[p12l1535t2388r1578b2436],
19	et	FW	O	et	nn	20	SENT_348	[p12l1600t2392r1647b2429],
20	al.	FW	O	al.	appos	5	SENT_348	[p12l1668t2386r1719b2429],
21	.	.	O	.	_	0	SENT_348	[p12l1668t2386r1719b2429],

1	The	DT	O	the	det	2	SENT_349	[p12l1740t2386r1830b2429],
2	relationship	NN	O	relationship	_	0	SENT_349	[p12l1853t2385r2147b2440],
3	between	IN	O	between	_	0	SENT_349	[p12l111t2452r323b2496],
4	dopamine	NN	O	dopamine	nn	7	SENT_349	[p12l339t2452r585b2506],
5	D2	NN	O	d2	nn	7	SENT_349	[p12l602t2454r666b2495],
6	receptor	NN	O	receptor	nn	7	SENT_349	[p12l685t2458r891b2506],
7	polymorphism	NN	O	polymorphism	prep_between	2	SENT_349	[p12l906t2452r1268b2506],
8	at	IN	O	at	_	0	SENT_349	[p12l1284t2458r1329b2496],
9	the	DT	O	the	det	12	SENT_349	[p12l1344t2452r1422b2496],
10	Taq1	NN	O	taq1	nn	12	SENT_349	[p12l1436t2454r1547b2506],
11	A	NN	O	a	nn	12	SENT_349	[p12l1567t2454r1604b2495],
12	locus	NN	O	locus	prep_at	7	SENT_349	[p12l1619t2452r1742b2496],
13	and	CC	O	and	_	0	SENT_349	[p12l1760t2452r1848b2496],
14	therapeutic	JJ	O	therapeutic	amod	15	SENT_349	[p12l1865t2452r2148b2506],
15	response	NN	O	response	prep_between	2	SENT_349	[p12l112t2531r329b2573],
16	to	TO	O	to	_	0	SENT_349	[p12l365t2525r412b2562],
17	nemonapride	NN	O	nemonapride	prep_to	15	SENT_349	[p12l449t2518r790b2573],
18	,	,	O	,	_	0	SENT_349	[p12l449t2518r790b2573],
19	a	DT	O	a	det	22	SENT_349	[p12l827t2531r852b2562],
20	selective	JJ	O	selective	amod	22	SENT_349	[p12l889t2518r1098b2562],
21	dopamine	NN	O	dopamine	nn	22	SENT_349	[p12l1135t2518r1381b2573],
22	antagonist	NN	O	antagonist	appos	2	SENT_349	[p12l1418t2519r1687b2573],
23	,	,	O	,	_	0	SENT_349	[p12l1418t2519r1687b2573],
24	in	IN	O	in	_	0	SENT_349	[p12l1724t2519r1769b2561],
25	schizophrenic	JJ	O	schizophrenic	amod	26	SENT_349	[p12l1806t2518r2148b2573],
26	patients	NNS	O	patient	prep_in	2	SENT_349	[p12l111t2585r320b2638],
27	.	.	O	.	_	0	SENT_349	[p12l111t2585r320b2638],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_350	[p12l340t2584r787b2638],
2	2000	CD	DATE	2000	num	1	SENT_350	[p12l807t2586r1219b2634],
3	;	:	O	;	_	0	SENT_350	[p12l807t2586r1219b2634],
4	10:335	CD	NUMBER	10:335	number	5	SENT_350	[p12l807t2586r1219b2634],
5	—	CD	NUMBER	—	dep	1	SENT_350	[p12l807t2586r1219b2634],
6	41	CD	NUMBER	41	dep	5	SENT_350	[p12l807t2586r1219b2634],
7	.	.	O	.	_	0	SENT_350	[p12l807t2586r1219b2634],

1	Suzuki	NNP	PERSON	Suzuki	nn	2	SENT_351	[p12l9t2649r171b2693],
2	A	NNP	O	A	_	0	SENT_351	[p12l187t2651r233b2700],
3	,	,	O	,	_	0	SENT_351	[p12l187t2651r233b2700],
4	Kondo	NNP	PERSON	Kondo	nn	5	SENT_351	[p12l252t2650r408b2693],
5	T	NN	O	t	appos	2	SENT_351	[p12l421t2652r458b2700],
6	,	,	O	,	_	0	SENT_351	[p12l421t2652r458b2700],
7	Otani	NNP	ORGANIZATION	Otani	nn	8	SENT_351	[p12l477t2650r607b2693],
8	K	NNP	ORGANIZATION	K	appos	5	SENT_351	[p12l625t2652r668b2700],
9	,	,	O	,	_	0	SENT_351	[p12l625t2652r668b2700],
10	Mihara	NNP	PERSON	Mihara	nn	11	SENT_351	[p12l687t2650r860b2693],
11	K	NNP	PERSON	K	appos	5	SENT_351	[p12l877t2652r920b2700],
12	,	,	O	,	_	0	SENT_351	[p12l877t2652r920b2700],
13	Yasui-Furukori	NNP	PERSON	Yasui-Furukori	nn	14	SENT_351	[p12l936t2650r1298b2693],
14	N	NNP	PERSON	N	appos	5	SENT_351	[p12l1316t2652r1364b2700],
15	,	,	O	,	_	0	SENT_351	[p12l1316t2652r1364b2700],
16	Sano	NNP	PERSON	Sano	nn	17	SENT_351	[p12l1382t2652r1497b2693],
17	A	NNP	O	A	appos	5	SENT_351	[p12l1513t2651r1560b2700],
18	,	,	O	,	_	0	SENT_351	[p12l1513t2651r1560b2700],
19	et	FW	O	et	nn	20	SENT_351	[p12l1578t2656r1624b2693],
20	al.	FW	O	al.	appos	5	SENT_351	[p12l1640t2649r1692b2693],
21	.	.	O	.	_	0	SENT_351	[p12l1640t2649r1692b2693],

1	Association	NNP	O	Association	nsubj	12	SENT_352	[p12l1708t2650r1989b2693],
2	of	IN	O	of	_	0	SENT_352	[p12l2007t2649r2058b2693],
3	the	DT	O	the	det	6	SENT_352	[p12l2069t2650r2147b2693],
4	Taql	NNP	MISC	Taql	nn	6	SENT_352	[p12l109t2718r210b2770],
5	A	NNP	O	A	nn	6	SENT_352	[p12l230t2718r267b2759],
6	polymorphism	NN	O	polymorphism	prep_of	1	SENT_352	[p12l286t2716r649b2770],
7	of	IN	O	of	_	0	SENT_352	[p12l670t2716r721b2759],
8	the	DT	O	the	det	10	SENT_352	[p12l736t2716r814b2759],
9	dopamine	NN	O	dopamine	nn	10	SENT_352	[p12l836t2716r1081b2770],
10	D	NN	O	d	prep_of	6	SENT_352	[p12l1104t2716r1209b2770],
11	(	CD	NUMBER	(	num	12	SENT_352	[p12l1104t2716r1209b2770],
12	2	CD	NUMBER	2	_	0	SENT_352	[p12l1104t2716r1209b2770],
13	)	NN	O	)	nn	15	SENT_352	[p12l1104t2716r1209b2770],
14	receptor	NN	O	receptor	nn	15	SENT_352	[p12l1232t2722r1438b2770],
15	gene	NN	O	gene	dobj	12	SENT_352	[p12l1456t2728r1572b2770],
16	with	IN	O	with	_	0	SENT_352	[p12l1592t2716r1705b2759],
17	predisposition	NN	O	predisposition	prep_with	15	SENT_352	[p12l1726t2716r2079b2770],
18	to	TO	O	to	_	0	SENT_352	[p12l2100t2722r2147b2759],
19	neuroleptic	JJ	O	neuroleptic	amod	21	SENT_352	[p12l112t2782r391b2837],
20	malignant	JJ	O	malignant	amod	21	SENT_352	[p12l411t2782r660b2837],
21	syndrome	NN	O	syndrome	prep_to	12	SENT_352	[p12l679t2782r936b2837],
22	.	.	O	.	_	0	SENT_352	[p12l679t2782r936b2837],

1	Am	VBP	O	be	dep	4	SENT_353	[p12l954t2784r1072b2837],
2	]	CD	NUMBER	]	num	4	SENT_353	[p12l954t2784r1072b2837],
3	Psychiatry	NNP	O	Psychiatry	nn	4	SENT_353	[p12l1091t2782r1345b2837],
4	2001a	NN	O	2001a	_	0	SENT_353	[p12l1364t2784r1828b2832],
5	;	:	O	;	_	0	SENT_353	[p12l1364t2784r1828b2832],
6	158:1714	CD	NUMBER	158:1714	dep	4	SENT_353	[p12l1364t2784r1828b2832],
7	—	CD	NUMBER	—	num	8	SENT_353	[p12l1364t2784r1828b2832],
8	6	CD	NUMBER	6	dep	6	SENT_353	[p12l1364t2784r1828b2832],
9	.	.	O	.	_	0	SENT_353	[p12l1364t2784r1828b2832],

1	Suzuki	NNP	PERSON	Suzuki	nn	2	SENT_354	[p12l9t2848r171b2892],
2	A	NNP	O	A	_	0	SENT_354	[p12l184t2850r231b2898],
3	,	,	O	,	_	0	SENT_354	[p12l184t2850r231b2898],
4	Kondo	NNP	PERSON	Kondo	nn	5	SENT_354	[p12l247t2848r403b2892],
5	T	NN	O	t	appos	2	SENT_354	[p12l414t2851r451b2898],
6	,	,	O	,	_	0	SENT_354	[p12l414t2851r451b2898],
7	Mihara	NNP	PERSON	Mihara	nn	8	SENT_354	[p12l467t2848r640b2892],
8	K	NNP	PERSON	K	appos	5	SENT_354	[p12l655t2851r698b2898],
9	,	,	O	,	_	0	SENT_354	[p12l655t2851r698b2898],
10	Yasui-Furukori	NNP	PERSON	Yasui-Furukori	nn	11	SENT_354	[p12l711t2848r1073b2892],
11	N	NNP	O	N	appos	5	SENT_354	[p12l1089t2851r1136b2898],
12	,	,	O	,	_	0	SENT_354	[p12l1089t2851r1136b2898],
13	Ishida	NNP	PERSON	Ishida	nn	14	SENT_354	[p12l1153t2848r1298b2892],
14	M	NNP	O	M	appos	5	SENT_354	[p12l1313t2851r1371b2899],
15	,	,	O	,	_	0	SENT_354	[p12l1313t2851r1371b2899],
16	Furukori	NNP	PERSON	Furukori	nn	17	SENT_354	[p12l1387t2848r1596b2892],
17	H	NNP	PERSON	H	appos	5	SENT_354	[p12l1611t2851r1659b2898],
18	,	,	O	,	_	0	SENT_354	[p12l1611t2851r1659b2898],
19	et	FW	O	et	nn	20	SENT_354	[p12l1675t2855r1721b2892],
20	al.	FW	O	al.	appos	5	SENT_354	[p12l1735t2848r1787b2892],
21	.	.	O	.	_	0	SENT_354	[p12l1735t2848r1787b2892],

1	The	DT	O	the	det	4	SENT_355	[p12l1801t2848r1890b2892],
2	-141	CD	NUMBER	-141	num	4	SENT_355	[p12l1905t2850r2005b2891],
3	C	NN	O	c	nn	4	SENT_355	[p12l2015t2850r2044b2892],
4	Ins	NNS	O	in	nsubjpass	17	SENT_355	[p12l2059t2848r2146b2903],
5	/	:	O	/	punct	7	SENT_355	[p12l2059t2848r2146b2903],
6	Del	NNP	O	Del	nn	7	SENT_355	[p12l111t2914r190b2958],
7	polymorphism	NN	O	polymorphism	dep	4	SENT_355	[p12l205t2914r568b2968],
8	in	IN	O	in	_	0	SENT_355	[p12l582t2915r628b2957],
9	the	DT	O	the	det	15	SENT_355	[p12l642t2914r720b2958],
10	dopamine	NN	O	dopamine	nn	15	SENT_355	[p12l735t2914r981b2968],
11	D2	NN	O	d2	nn	15	SENT_355	[p12l997t2916r1061b2957],
12	receptor	NN	O	receptor	nn	15	SENT_355	[p12l1078t2920r1284b2968],
13	gene	NN	O	gene	nn	15	SENT_355	[p12l1297t2927r1413b2968],
14	promoter	NN	O	promoter	nn	15	SENT_355	[p12l1428t2920r1661b2968],
15	region	NN	O	region	prep_in	7	SENT_355	[p12l1674t2915r1829b2968],
16	is	VBZ	O	be	auxpass	17	SENT_355	[p12l1844t2915r1879b2958],
17	associated	VBN	O	associate	_	0	SENT_355	[p12l1895t2914r2146b2958],
18	with	IN	O	with	_	0	SENT_355	[p12l110t2980r223b3024],
19	anxiolytic	NN	O	anxiolytic	nn	22	SENT_355	[p12l262t2980r504b3034],
20	and	CC	O	and	_	0	SENT_355	[p12l541t2980r630b3024],
21	antidepressive	JJ	O	antidepressive	conj_and	19	SENT_355	[p12l670t2980r1027b3034],
22	effects	NNS	O	effect	prep_with	17	SENT_355	[p12l1066t2980r1224b3024],
23	during	IN	O	during	_	0	SENT_355	[p12l1263t2980r1426b3034],
24	treatment	NN	O	treatment	prep_during	17	SENT_355	[p12l1463t2986r1711b3024],
25	with	IN	O	with	_	0	SENT_355	[p12l1747t2980r1861b3024],
26	dopamine	NN	O	dopamine	nn	27	SENT_355	[p12l1899t2980r2146b3034],
27	antagonists	NNS	O	antagonist	prep_with	17	SENT_355	[p12l111t3046r391b3100],
28	in	IN	O	in	_	0	SENT_355	[p12l412t3046r457b3089],
29	schizophrenic	JJ	O	schizophrenic	amod	30	SENT_355	[p12l477t3046r819b3100],
30	patients	NNS	O	patient	prep_in	27	SENT_355	[p12l838t3046r1046b3100],
31	.	.	O	.	_	0	SENT_355	[p12l838t3046r1046b3100],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_356	[p12l1067t3046r1513b3100],
2	2001b	CD	NUMBER	2001b	num	1	SENT_356	[p12l1534t3046r1979b3096],
3	;	:	O	;	_	0	SENT_356	[p12l1534t3046r1979b3096],
4	11:545	CD	NUMBER	11:545	number	5	SENT_356	[p12l1534t3046r1979b3096],
5	—	CD	NUMBER	—	dep	1	SENT_356	[p12l1534t3046r1979b3096],
6	50	CD	NUMBER	50	dep	5	SENT_356	[p12l1534t3046r1979b3096],
7	.	.	O	.	_	0	SENT_356	[p12l1534t3046r1979b3096],

1	Vijayan	NNP	PERSON	Vijayan	nn	2	SENT_357	[p12l7t3113r188b3167],
2	NN	NNP	O	NN	_	0	SENT_357	[p12l205t3115r293b3162],
3	,	,	O	,	_	0	SENT_357	[p12l205t3115r293b3162],
4	Bhaskaran	NNP	ORGANIZATION	Bhaskaran	nn	5	SENT_357	[p12l310t3112r564b3156],
5	S	NNP	ORGANIZATION	S	appos	2	SENT_357	[p12l580t3114r616b3162],
6	,	,	O	,	_	0	SENT_357	[p12l580t3114r616b3162],
7	Koshy	NNP	ORGANIZATION	Koshy	nn	8	SENT_357	[p12l634t3112r780b3167],
8	LV	NNP	ORGANIZATION	LV	appos	5	SENT_357	[p12l796t3115r863b3162],
9	,	,	O	,	_	0	SENT_357	[p12l796t3115r863b3162],
10	Natarajan	NNP	PERSON	Natarajan	nn	11	SENT_357	[p12l881t3113r1116b3167],
11	C	NNP	PERSON	C	appos	5	SENT_357	[p12l1133t3114r1173b3162],
12	,	,	O	,	_	0	SENT_357	[p12l1133t3114r1173b3162],
13	Srinivas	NNP	PERSON	Srinivas	nn	14	SENT_357	[p12l1191t3113r1381b3156],
14	L	NNP	PERSON	L	appos	5	SENT_357	[p12l1398t3115r1433b3162],
15	,	,	O	,	_	0	SENT_357	[p12l1398t3115r1433b3162],
16	Nair	NNP	PERSON	Nair	nn	17	SENT_357	[p12l1451t3113r1553b3156],
17	CM	NN	O	cm	appos	5	SENT_357	[p12l1568t3114r1659b3162],
18	,	,	O	,	_	0	SENT_357	[p12l1568t3114r1659b3162],
19	et	FW	O	et	nn	20	SENT_357	[p12l1676t3119r1722b3156],
20	al.	FW	O	al.	appos	5	SENT_357	[p12l1737t3112r1790b3156],
21	.	.	O	.	_	0	SENT_357	[p12l1737t3112r1790b3156],

1	Association	NNP	O	Association	_	0	SENT_358	[p12l1805t3113r2086b3156],
2	of	IN	O	of	_	0	SENT_358	[p12l2102t3112r2153b3156],
3	dopamine	NN	O	dopamine	nn	5	SENT_358	[p12l111t3177r357b3232],
4	receptor	NN	O	receptor	nn	5	SENT_358	[p12l374t3184r579b3232],
5	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_358	[p12l594t3177r978b3232],
6	with	IN	O	with	_	0	SENT_358	[p12l993t3178r1106b3221],
7	schizophrenia	NN	O	schizophrenia	nn	10	SENT_358	[p12l1122t3177r1466b3232],
8	and	CC	O	and	_	0	SENT_358	[p12l1480t3177r1570b3221],
9	antipsychotic	JJ	O	antipsychotic	nn	10	SENT_358	[p12l1586t3177r1914b3232],
10	response	NN	O	response	prep_with	1	SENT_358	[p12l1929t3190r2147b3232],
11	in	IN	O	in	_	0	SENT_358	[p12l112t3245r157b3287],
12	a	DT	O	a	det	15	SENT_358	[p12l176t3257r201b3288],
13	South	NNP	MISC	South	nn	15	SENT_358	[p12l221t3244r361b3288],
14	Indian	NNP	MISC	Indian	nn	15	SENT_358	[p12l381t3244r535b3288],
15	population	NN	O	population	prep_in	10	SENT_358	[p12l554t3244r833b3298],
16	.	.	O	.	_	0	SENT_358	[p12l554t3244r833b3298],

1	Behav	NNP	O	Behav	nn	3	SENT_359	[p12l853t3244r1001b3288],
2	Brain	NNP	O	Brain	nn	3	SENT_359	[p12l1019t3245r1146b3288],
3	Funct	NNP	O	Funct	_	0	SENT_359	[p12l1166t3247r1301b3288],
4	2007	CD	DATE	2007	num	3	SENT_359	[p12l1319t3246r1584b3294],
5	;	:	O	;	_	0	SENT_359	[p12l1319t3246r1584b3294],
6	3:34	CD	TIME	3:34	dep	3	SENT_359	[p12l1319t3246r1584b3294],
7	.	.	O	.	_	0	SENT_359	[p12l1319t3246r1584b3294],

1	Virgos	NNPS	O	Virgos	nn	2	SENT_360	[p12l7t3311r163b3365],
2	C	NNP	O	C	_	0	SENT_360	[p12l186t3312r226b3361],
3	,	,	O	,	_	0	SENT_360	[p12l186t3312r226b3361],
4	Martorell	NNP	PERSON	Martorell	nn	5	SENT_360	[p12l250t3310r479b3354],
5	L	NNP	PERSON	L	appos	2	SENT_360	[p12l502t3313r536b3361],
6	,	,	O	,	_	0	SENT_360	[p12l502t3313r536b3361],
7	Valero	NNP	ORGANIZATION	Valero	nn	8	SENT_360	[p12l558t3310r717b3354],
8	J	NNP	ORGANIZATION	J	appos	5	SENT_360	[p12l733t3313r764b3365],
9	,	,	O	,	_	0	SENT_360	[p12l733t3313r764b3365],
10	Figuera	NNP	PERSON	Figuera	nn	11	SENT_360	[p12l789t3311r968b3365],
11	L	NNP	O	L	appos	5	SENT_360	[p12l990t3313r1025b3361],
12	,	,	O	,	_	0	SENT_360	[p12l990t3313r1025b3361],
13	Civeira	NNP	O	Civeira	nn	14	SENT_360	[p12l1049t3311r1217b3354],
14	F	NN	O	f	appos	5	SENT_360	[p12l1239t3313r1271b3360],
15	,	,	O	,	_	0	SENT_360	[p12l1239t3313r1271b3360],
16	Joven	NNP	PERSON	Joven	nn	17	SENT_360	[p12l1289t3313r1429b3365],
17	J	NNP	PERSON	J	appos	5	SENT_360	[p12l1445t3313r1476b3365],
18	,	,	O	,	_	0	SENT_360	[p12l1445t3313r1476b3365],
19	et	FW	O	et	nn	20	SENT_360	[p12l1500t3317r1546b3354],
20	al.	FW	O	al.	appos	5	SENT_360	[p12l1567t3310r1620b3354],
21	.	.	O	.	_	0	SENT_360	[p12l1567t3310r1620b3354],

1	Association	NNP	O	Association	nn	2	SENT_361	[p12l1641t3311r1922b3354],
2	study	NN	O	study	_	0	SENT_361	[p12l1946t3310r2081b3365],
3	of	IN	O	of	_	0	SENT_361	[p12l2102t3310r2153b3354],
4	schizophrenia	NN	O	schizophrenia	prep_of	2	SENT_361	[p12l112t3376r467b3430],
5	with	IN	O	with	_	0	SENT_361	[p12l504t3376r620b3419],
6	polymorphisms	NNS	O	polymorphism	prep_with	2	SENT_361	[p12l660t3376r1057b3430],
7	at	IN	O	at	_	0	SENT_361	[p12l1097t3382r1144b3419],
8	six	CD	NUMBER	six	num	10	SENT_361	[p12l1183t3377r1252b3419],
9	candidate	NN	O	candidate	nn	10	SENT_361	[p12l1290t3376r1535b3419],
10	genes	NNS	O	gene	prep_at	6	SENT_361	[p12l1575t3388r1732b3430],
11	.	.	O	.	_	0	SENT_361	[p12l1575t3388r1732b3430],

1	Schizophr	NNP	O	Schizophr	nn	2	SENT_362	[p12l1772t3376r2025b3430],
2	Res	NNP	O	Res	_	0	SENT_362	[p12l2064t3379r2146b3419],
3	2001	CD	DATE	2001	num	2	SENT_362	[p12l111t3444r494b3492],
4	;	:	O	;	_	0	SENT_362	[p12l111t3444r494b3492],
5	49:65	CD	NUMBER	49:65	number	6	SENT_362	[p12l111t3444r494b3492],
6	—	CD	NUMBER	—	dep	2	SENT_362	[p12l111t3444r494b3492],
7	71	CD	NUMBER	71	dep	6	SENT_362	[p12l111t3444r494b3492],
8	.	.	O	.	_	0	SENT_362	[p12l111t3444r494b3492],

1	Weickert	NNP	O	Weickert	nn	2	SENT_363	[p12l7t3508r231b3551],
2	TW	NNP	O	TW	_	0	SENT_363	[p12l245t3510r342b3558],
3	,	,	O	,	_	0	SENT_363	[p12l245t3510r342b3558],
4	Goldberg	NNP	ORGANIZATION	Goldberg	nn	5	SENT_363	[p12l360t3508r585b3562],
5	TE	NNP	ORGANIZATION	TE	appos	2	SENT_363	[p12l599t3510r670b3558],
6	,	,	O	,	_	0	SENT_363	[p12l599t3510r670b3558],
7	Mishara	NNP	O	Mishara	nn	8	SENT_363	[p12l689t3508r886b3551],
8	A	NNP	O	A	appos	5	SENT_363	[p12l901t3510r947b3558],
9	,	,	O	,	_	0	SENT_363	[p12l901t3510r947b3558],
10	Apud	NNP	O	Apud	nn	11	SENT_363	[p12l964t3508r1094b3562],
11	JA	NNP	O	JA	appos	5	SENT_363	[p12l1106t3509r1173b3562],
12	,	,	O	,	_	0	SENT_363	[p12l1106t3509r1173b3562],
13	Kolachana	NNP	O	Kolachana	nn	14	SENT_363	[p12l1192t3508r1443b3551],
14	BS	NNP	O	BS	appos	5	SENT_363	[p12l1460t3510r1529b3558],
15	,	,	O	,	_	0	SENT_363	[p12l1460t3510r1529b3558],
16	Egan	NNP	PERSON	Egan	nn	17	SENT_363	[p12l1547t3510r1664b3562],
17	MF	NN	O	mf	appos	5	SENT_363	[p12l1682t3510r1765b3558],
18	,	,	O	,	_	0	SENT_363	[p12l1682t3510r1765b3558],
19	et	FW	O	et	nn	20	SENT_363	[p12l1783t3514r1829b3551],
20	al.	FW	O	al.	appos	5	SENT_363	[p12l1845t3508r1897b3552],
21	.	.	O	.	_	0	SENT_363	[p12l1845t3508r1897b3552],

1	CatecholO-methyltransferase	JJ	O	catecholo-methyltransferase	amod	3	SENT_364	[p12l1916t3508r2147b3551, p12l112t3574r614b3629],
2	val108/158met	NN	O	val108/158met	nn	3	SENT_364	[p12l632t3574r1000b3629],
3	genotype	NN	O	genotype	nsubj	4	SENT_364	[p12l1017t3581r1244b3629],
4	predicts	VBZ	O	predict	_	0	SENT_364	[p12l1265t3574r1460b3629],
5	working	VBG	O	work	xcomp	4	SENT_364	[p12l1479t3574r1684b3629],
6	memory	NN	O	memory	nn	7	SENT_364	[p12l1703t3587r1911b3629],
7	response	NN	O	response	dobj	5	SENT_364	[p12l1929t3587r2147b3629],
8	to	TO	O	to	_	0	SENT_364	[p12l111t3647r158b3684],
9	antipsychotic	JJ	O	antipsychotic	amod	10	SENT_364	[p12l177t3640r506b3695],
10	medications	NNS	O	medication	prep_to	5	SENT_364	[p12l525t3640r835b3684],
11	.	.	O	.	_	0	SENT_364	[p12l525t3640r835b3684],

1	Biol	NNP	O	Biol	nn	2	SENT_365	[p12l856t3640r946b3684],
2	Psychiatry	NNP	O	Psychiatry	_	0	SENT_365	[p12l967t3640r1221b3695],
3	2004	CD	DATE	2004	num	2	SENT_365	[p12l1239t3642r1660b3691],
4	;	:	O	;	_	0	SENT_365	[p12l1239t3642r1660b3691],
5	56:677	CD	NUMBER	56:677	number	6	SENT_365	[p12l1239t3642r1660b3691],
6	—	CD	NUMBER	—	dep	2	SENT_365	[p12l1239t3642r1660b3691],
7	82	CD	NUMBER	82	dep	6	SENT_365	[p12l1239t3642r1660b3691],
8	.	.	O	.	_	0	SENT_365	[p12l1239t3642r1660b3691],

1	Wu	NNP	O	Wu	nn	2	SENT_366	[p12l7t3709r94b3749],
2	S	NNP	O	S	_	0	SENT_366	[p12l114t3708r151b3756],
3	,	,	O	,	_	0	SENT_366	[p12l114t3708r151b3756],
4	Xing	NNP	O	Xing	nn	7	SENT_366	[p12l171t3707r284b3760],
5	Q.	NNP	O	Q.	nn	7	SENT_366	[p12l305t3708r351b3758],
6	Gao	NNP	O	Gao	nn	7	SENT_366	[p12l373t3708r465b3749],
7	R	NNP	O	R	appos	2	SENT_366	[p12l487t3709r528b3756],
8	,	,	O	,	_	0	SENT_366	[p12l487t3709r528b3756],
9	Li	NNP	PERSON	Li	nn	10	SENT_366	[p12l550t3707r588b3749],
10	X	NNP	PERSON	X	appos	7	SENT_366	[p12l608t3709r654b3756],
11	,	,	O	,	_	0	SENT_366	[p12l608t3709r654b3756],
12	Gu	NNP	PERSON	Gu	nn	13	SENT_366	[p12l676t3708r743b3749],
13	N	NNP	PERSON	N	appos	7	SENT_366	[p12l764t3709r811b3756],
14	,	,	O	,	_	0	SENT_366	[p12l764t3709r811b3756],
15	Feng	NNP	O	Feng	nn	16	SENT_366	[p12l833t3709r949b3760],
16	G	NNP	O	G	appos	7	SENT_366	[p12l968t3708r1014b3756],
17	,	,	O	,	_	0	SENT_366	[p12l968t3708r1014b3756],
18	et	FW	O	et	nn	19	SENT_366	[p12l1036t3712r1082b3749],
19	al.	FW	O	al.	appos	7	SENT_366	[p12l1101t3706r1153b3750],
20	.	.	O	.	_	0	SENT_366	[p12l1101t3706r1153b3750],

1	Response	NN	O	response	nsubjpass	7	SENT_367	[p12l1175t3709r1403b3760],
2	to	TO	O	to	_	0	SENT_367	[p12l1424t3712r1471b3749],
3	chlorpromazine	NN	O	chlorpromazine	nn	4	SENT_367	[p12l1492t3706r1881b3760],
4	treatment	NN	O	treatment	prep_to	1	SENT_367	[p12l1901t3712r2148b3749],
5	may	MD	O	may	aux	7	SENT_367	[p12l112t3785r216b3826],
6	be	VB	O	be	auxpass	7	SENT_367	[p12l230t3772r286b3816],
7	associated	VBN	O	associate	_	0	SENT_367	[p12l302t3772r553b3816],
8	with	IN	O	with	_	0	SENT_367	[p12l568t3772r681b3816],
9	polymorphisms	NNS	O	polymorphism	prep_with	7	SENT_367	[p12l697t3772r1082b3826],
10	of	IN	O	of	_	0	SENT_367	[p12l1098t3772r1149b3816],
11	the	DT	O	the	det	13	SENT_367	[p12l1159t3772r1237b3816],
12	DRD2	NN	O	drd2	nn	13	SENT_367	[p12l1253t3774r1389b3815],
13	gene	NN	O	gene	prep_of	9	SENT_367	[p12l1406t3785r1522b3826],
14	in	IN	O	in	_	0	SENT_367	[p12l1538t3773r1583b3815],
15	Chinese	JJ	MISC	chinese	amod	17	SENT_367	[p12l1599t3772r1789b3816],
16	schizophrenic	JJ	O	schizophrenic	amod	17	SENT_367	[p12l1806t3772r2148b3826],
17	patients	NNS	O	patient	prep_in	13	SENT_367	[p13l111t15r320b69],
18	.	.	O	.	_	0	SENT_367	[p13l111t15r320b69],

1	Neurosci	NNP	PERSON	Neurosci	nn	2	SENT_368	[p13l341t15r554b58],
2	Lett	NNP	PERSON	Lett	_	0	SENT_368	[p13l574t17r666b58],
3	2005	CD	DATE	2005	num	2	SENT_368	[p13l685t17r1040b65],
4	;	:	O	;	_	0	SENT_368	[p13l685t17r1040b65],
5	376:1	CD	NUMBER	376:1	number	6	SENT_368	[p13l685t17r1040b65],
6	—	CD	NUMBER	—	dep	2	SENT_368	[p13l685t17r1040b65],
7	4	CD	NUMBER	4	dep	6	SENT_368	[p13l685t17r1040b65],
8	.	.	O	.	_	0	SENT_368	[p13l685t17r1040b65],

1	Wu	NNP	O	Wu	nn	2	SENT_369	[p13l7t83r94b124],
2	SN	NNP	O	SN	_	0	SENT_369	[p13l109t83r185b131],
3	,	,	O	,	_	0	SENT_369	[p13l109t83r185b131],
4	Gao	NNP	O	Gao	nn	5	SENT_369	[p13l201t83r294b124],
5	R	NNP	O	R	appos	2	SENT_369	[p13l310t83r351b131],
6	,	,	O	,	_	0	SENT_369	[p13l310t83r351b131],
7	Xing	NNP	O	Xing	nn	8	SENT_369	[p13l365t81r479b135],
8	QH	NNP	O	QH	appos	5	SENT_369	[p13l494t83r580b133],
9	,	,	O	,	_	0	SENT_369	[p13l494t83r580b133],
10	Li	NNP	PERSON	Li	nn	11	SENT_369	[p13l597t81r635b124],
11	HF	NN	O	hf	appos	5	SENT_369	[p13l651t83r724b131],
12	,	,	O	,	_	0	SENT_369	[p13l651t83r724b131],
13	Shen	NNP	ORGANIZATION	Shen	nn	14	SENT_369	[p13l740t81r859b124],
14	YF	NNP	ORGANIZATION	YF	appos	5	SENT_369	[p13l872t83r940b131],
15	,	,	O	,	_	0	SENT_369	[p13l872t83r940b131],
16	Gu	NNP	O	Gu	nn	17	SENT_369	[p13l956t83r1022b124],
17	NF	NN	ORGANIZATION	nf	appos	5	SENT_369	[p13l1038t83r1110b131],
18	,	,	O	,	_	0	SENT_369	[p13l1038t83r1110b131],
19	et	FW	O	et	nn	20	SENT_369	[p13l1126t87r1172b124],
20	al.	FW	O	al.	appos	5	SENT_369	[p13l1186t81r1238b125],
21	.	.	O	.	_	0	SENT_369	[p13l1186t81r1238b125],

1	Association	NNP	O	Association	_	0	SENT_370	[p13l1252t81r1532b124],
2	of	IN	O	of	_	0	SENT_370	[p13l1548t80r1599b124],
3	DRD2	NN	O	drd2	nn	4	SENT_370	[p13l1608t83r1744b124],
4	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_370	[p13l1762t81r2146b135],
5	and	CC	O	and	_	0	SENT_370	[p13l111t147r200b191],
6	chlorpromazine-induced	JJ	O	chlorpromazine-induced	amod	8	SENT_370	[p13l224t147r834b202],
7	extrapyramidal	JJ	O	extrapyramidal	amod	8	SENT_370	[p13l857t147r1232b202],
8	syndrome	NN	O	syndrome	prep_of	1	SENT_370	[p13l1256t147r1501b202],
9	in	IN	O	in	_	0	SENT_370	[p13l1524t148r1569b190],
10	Chinese	JJ	MISC	chinese	amod	12	SENT_370	[p13l1592t147r1782b191],
11	schizophrenic	JJ	O	schizophrenic	amod	12	SENT_370	[p13l1806t147r2148b202],
12	patients	NNS	O	patient	prep_in	1	SENT_370	[p13l112t213r320b267],
13	.	.	O	.	_	0	SENT_370	[p13l112t213r320b267],

1	Acta	NNP	O	Acta	nn	3	SENT_371	[p13l339t214r446b256],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_371	[p13l466t212r724b256],
3	Sin	NNP	O	Sin	_	0	SENT_371	[p13l745t213r818b256],
4	2006	CD	DATE	2006	num	3	SENT_371	[p13l838t215r1256b263],
5	;	:	O	;	_	0	SENT_371	[p13l838t215r1256b263],
6	27:966	CD	NUMBER	27:966	number	7	SENT_371	[p13l838t215r1256b263],
7	—	CD	NUMBER	—	dep	3	SENT_371	[p13l838t215r1256b263],
8	70	CD	NUMBER	70	dep	7	SENT_371	[p13l838t215r1256b263],
9	.	.	O	.	_	0	SENT_371	[p13l838t215r1256b263],

1	Xing	VBG	O	xing	_	0	SENT_372	[p13l8t280r121b333],
2	Q	NNP	O	Q	dobj	1	SENT_372	[p13l150t281r197b331],
3	,	,	O	,	_	0	SENT_372	[p13l150t281r197b331],
4	Qian	NNP	PERSON	Qian	nn	5	SENT_372	[p13l227t280r339b331],
5	X	NNP	PERSON	X	appos	2	SENT_372	[p13l366t282r413b329],
6	,	,	O	,	_	0	SENT_372	[p13l366t282r413b329],
7	Li	NNP	PERSON	Li	nn	8	SENT_372	[p13l444t280r482b322],
8	H	NNP	PERSON	H	appos	2	SENT_372	[p13l511t282r560b329],
9	,	,	O	,	_	0	SENT_372	[p13l511t282r560b329],
10	Wong	NNP	LOCATION	Wong	nn	11	SENT_372	[p13l588t282r735b333],
11	S	NNP	LOCATION	S	appos	2	SENT_372	[p13l764t281r800b329],
12	,	,	O	,	_	0	SENT_372	[p13l764t281r800b329],
13	Wu	NNP	O	Wu	nn	14	SENT_372	[p13l828t282r915b323],
14	S	NNP	O	S	appos	2	SENT_372	[p13l945t281r981b329],
15	,	,	O	,	_	0	SENT_372	[p13l945t281r981b329],
16	Feng	NNP	O	Feng	nn	17	SENT_372	[p13l1012t282r1127b333],
17	G	NNP	O	G	appos	2	SENT_372	[p13l1154t281r1200b329],
18	,	,	O	,	_	0	SENT_372	[p13l1154t281r1200b329],
19	et	FW	O	et	nn	20	SENT_372	[p13l1231t285r1277b323],
20	al.	FW	O	al.	appos	2	SENT_372	[p13l1305t279r1357b323],
21	.	.	O	.	_	0	SENT_372	[p13l1305t279r1357b323],

1	The	DT	O	the	det	2	SENT_373	[p13l1385t279r1475b323],
2	relationship	NN	O	relationship	_	0	SENT_373	[p13l1505t279r1799b333],
3	between	IN	O	between	_	0	SENT_373	[p13l1828t279r2040b323],
4	the	DT	O	the	det	6	SENT_373	[p13l2069t279r2146b323],
5	therapeutic	JJ	O	therapeutic	amod	6	SENT_373	[p13l111t345r394b400],
6	response	NN	O	response	prep_between	2	SENT_373	[p13l411t358r629b400],
7	to	TO	O	to	_	0	SENT_373	[p13l646t352r693b389],
8	risperidone	NN	O	risperidone	prep_to	6	SENT_373	[p13l712t345r992b400],
9	and	CC	O	and	_	0	SENT_373	[p13l1011t345r1100b389],
10	the	DT	O	the	det	14	SENT_373	[p13l1118t345r1196b389],
11	dopamine	NN	O	dopamine	nn	14	SENT_373	[p13l1214t345r1460b400],
12	D2	NN	O	d2	nn	14	SENT_373	[p13l1479t347r1543b388],
13	receptor	NN	O	receptor	nn	14	SENT_373	[p13l1564t352r1769b400],
14	polymorphism	NN	O	polymorphism	prep_to	6	SENT_373	[p13l1785t345r2148b400],
15	in	IN	O	in	_	0	SENT_373	[p13l112t412r157b454],
16	Chinese	JJ	MISC	chinese	amod	18	SENT_373	[p13l177t411r366b454],
17	schizophrenia	NN	O	schizophrenia	nn	18	SENT_373	[p13l388t411r731b465],
18	patients	NNS	O	patient	prep_in	2	SENT_373	[p13l750t411r959b465],
19	.	.	O	.	_	0	SENT_373	[p13l750t411r959b465],

1	IntJ	NN	O	intj	_	0	SENT_374	[p13l980t414r1078b465],
2	Neuropsychopharmacol	NNP	O	Neuropsychopharmacol	dep	1	SENT_374	[p13l1098t411r1684b465],
3	2007	CD	DATE	2007	num	2	SENT_374	[p13l1704t413r2084b461],
4	;	:	O	;	_	0	SENT_374	[p13l1704t413r2084b461],
5	10:631	CD	NUMBER	10:631	num	6	SENT_374	[p13l1704t413r2084b461],
6	—	NN	O	—	dep	1	SENT_374	[p13l1704t413r2084b461],
7	7	CD	NUMBER	7	dep	6	SENT_374	[p13l1704t413r2084b461],
8	.	.	O	.	_	0	SENT_374	[p13l1704t413r2084b461],

1	Yamanouchi	NNP	PERSON	Yamanouchi	nn	2	SENT_375	[p13l7t477r310b520],
2	Y	NN	PERSON	y	_	0	SENT_375	[p13l327t480r367b527],
3	,	,	O	,	_	0	SENT_375	[p13l327t480r367b527],
4	Iwata	NNP	ORGANIZATION	Iwata	nn	5	SENT_375	[p13l386t480r520b520],
5	N	NNP	ORGANIZATION	N	conj_and	2	SENT_375	[p13l538t480r585b527],
6	,	,	O	,	_	0	SENT_375	[p13l538t480r585b527],
7	Suzuki	NNP	ORGANIZATION	Suzuki	nn	8	SENT_375	[p13l605t477r766b520],
8	T	NN	ORGANIZATION	t	conj_and	2	SENT_375	[p13l782t480r820b527],
9	,	,	O	,	_	0	SENT_375	[p13l782t480r820b527],
10	Kitajima	NNP	ORGANIZATION	Kitajima	nn	11	SENT_375	[p13l839t478r1042b531],
11	T	NN	ORGANIZATION	t	conj_and	2	SENT_375	[p13l1058t480r1095b527],
12	,	,	O	,	_	0	SENT_375	[p13l1058t480r1095b527],
13	Ikeda	NNP	PERSON	Ikeda	nn	14	SENT_375	[p13l1114t477r1245b520],
14	M	NNP	PERSON	M	conj_and	2	SENT_375	[p13l1264t480r1322b527],
15	,	,	O	,	_	0	SENT_375	[p13l1264t480r1322b527],
16	Ozaki	NNP	PERSON	Ozaki	nn	18	SENT_375	[p13l1341t477r1476b520],
17	N.	NNP	O	N.	nn	18	SENT_375	[p13l1495t480r1543b521],
18	Effect	NN	O	effect	conj_and	2	SENT_375	[p13l1562t477r1699b520],
19	of	IN	O	of	_	0	SENT_375	[p13l1715t477r1766b520],
20	DRD2	NN	O	drd2	prep_of	18	SENT_375	[p13l1778t479r1928b527],
21	,	,	O	,	_	0	SENT_375	[p13l1778t479r1928b527],
22	5-HT2A	NN	O	5-ht2a	conj_and	2	SENT_375	[p13l1947t479r2146b527],
23	,	,	O	,	_	0	SENT_375	[p13l1947t479r2146b527],
24	and	CC	O	and	_	0	SENT_375	[p13l111t542r201b586],
25	COMT	NN	ORGANIZATION	comt	nn	26	SENT_375	[p13l226t545r376b586],
26	genes	NNS	O	gene	conj_and	2	SENT_375	[p13l394t555r534b597],
27	on	IN	O	on	_	0	SENT_375	[p13l559t555r619b586],
28	antipsychotic	JJ	O	antipsychotic	amod	29	SENT_375	[p13l644t543r972b597],
29	response	NN	O	response	prep_on	26	SENT_375	[p13l997t555r1214b597],
30	to	TO	O	to	_	0	SENT_375	[p13l1239t549r1286b586],
31	risperidone	NN	O	risperidone	prep_to	29	SENT_375	[p13l1312t542r1603b597],
32	.	.	O	.	_	0	SENT_375	[p13l1312t542r1603b597],

1	PharmacogenomicsJ	NN	O	pharmacogenomicsj	_	0	SENT_376	[p13l1630t542r2147b597],
2	2003	CD	DATE	2003	num	1	SENT_376	[p13l111t611r495b659],
3	;	:	O	;	_	0	SENT_376	[p13l111t611r495b659],
4	3:356	CD	NUMBER	3:356	number	5	SENT_376	[p13l111t611r495b659],
5	—	CD	NUMBER	—	dep	1	SENT_376	[p13l111t611r495b659],
6	61	CD	NUMBER	61	dep	5	SENT_376	[p13l111t611r495b659],
7	.	.	O	.	_	0	SENT_376	[p13l111t611r495b659],

1	Yasui	NNP	PERSON	Yasui	nn	2	SENT_377	[p13l7t676r133b719],
2	N	NNP	O	N	_	0	SENT_377	[p13l159t678r207b725],
3	,	,	O	,	_	0	SENT_377	[p13l159t678r207b725],
4	Kondo	NNP	PERSON	Kondo	nn	5	SENT_377	[p13l234t675r388b719],
5	T	NN	O	t	appos	2	SENT_377	[p13l410t678r446b725],
6	,	,	O	,	_	0	SENT_377	[p13l410t678r446b725],
7	Otani	NNP	ORGANIZATION	Otani	nn	8	SENT_377	[p13l473t676r602b719],
8	K	NNP	ORGANIZATION	K	appos	5	SENT_377	[p13l629t678r671b726],
9	,	,	O	,	_	0	SENT_377	[p13l629t678r671b726],
10	Ishida	NNP	PERSON	Ishida	nn	11	SENT_377	[p13l699t675r842b719],
11	M	NNP	O	M	appos	5	SENT_377	[p13l867t678r926b725],
12	,	,	O	,	_	0	SENT_377	[p13l867t678r926b725],
13	Mihara	NNP	PERSON	Mihara	nn	14	SENT_377	[p13l953t675r1122b719],
14	K	NNP	PERSON	K	appos	5	SENT_377	[p13l1149t678r1192b726],
15	,	,	O	,	_	0	SENT_377	[p13l1149t678r1192b726],
16	Suzuki	NNP	PERSON	Suzuki	nn	17	SENT_377	[p13l1219t675r1377b719],
17	A	NNP	O	A	appos	5	SENT_377	[p13l1402t677r1448b725],
18	,	,	O	,	_	0	SENT_377	[p13l1402t677r1448b725],
19	et	FW	O	et	nn	20	SENT_377	[p13l1475t682r1522b719],
20	al.	FW	O	al.	appos	5	SENT_377	[p13l1546t675r1596b719],
21	.	.	O	.	_	0	SENT_377	[p13l1546t675r1596b719],

1	Prolactin	NN	O	prolactin	nn	2	SENT_378	[p13l1624t675r1836b719],
2	response	NN	O	response	_	0	SENT_378	[p13l1862t688r2074b730],
3	to	TO	O	to	_	0	SENT_378	[p13l2101t682r2147b719],
4	bromperidol	NN	O	bromperidol	nn	5	SENT_378	[p13l111t741r410b795],
5	treatment	NN	O	treatment	prep_to	2	SENT_378	[p13l428t747r668b784],
6	in	IN	O	in	_	0	SENT_378	[p13l685t742r730b784],
7	schizophrenic	JJ	O	schizophrenic	amod	8	SENT_378	[p13l747t741r1080b795],
8	patients	NNS	O	patient	prep_in	2	SENT_378	[p13l1096t742r1298b795],
9	.	.	O	.	_	0	SENT_378	[p13l1096t742r1298b795],

1	Pharmacol	NNP	O	Pharmacol	nn	2	SENT_379	[p13l1317t741r1569b784],
2	Toxicol	NNP	O	Toxicol	_	0	SENT_379	[p13l1585t741r1753b784],
3	1998	CD	DATE	1998	num	2	SENT_379	[p13l1773t743r2143b791],
4	;	:	O	;	_	0	SENT_379	[p13l1773t743r2143b791],
5	82:153	CD	NUMBER	82:153	number	6	SENT_379	[p13l1773t743r2143b791],
6	—	CD	NUMBER	—	dep	2	SENT_379	[p13l1773t743r2143b791],
7	6	CD	NUMBER	6	dep	6	SENT_379	[p13l1773t743r2143b791],
8	.	.	O	.	_	0	SENT_379	[p13l1773t743r2143b791],

1	Yasui-Furukori	JJ	PERSON	yasui-furukori	amod	2	SENT_380	[p13l7t807r369b851],
2	N	NN	O	n	_	0	SENT_380	[p13l385t810r433b857],
3	,	,	O	,	_	0	SENT_380	[p13l385t810r433b857],
4	Mihara	NNP	PERSON	Mihara	nn	5	SENT_380	[p13l450t807r623b851],
5	K	NNP	PERSON	K	appos	2	SENT_380	[p13l639t810r682b857],
6	,	,	O	,	_	0	SENT_380	[p13l639t810r682b857],
7	Kondo	NNP	PERSON	Kondo	nn	8	SENT_380	[p13l699t807r855b851],
8	T	NN	O	t	appos	5	SENT_380	[p13l867t810r904b857],
9	,	,	O	,	_	0	SENT_380	[p13l867t810r904b857],
10	Kubota	NNP	ORGANIZATION	Kubota	nn	11	SENT_380	[p13l921t807r1093b851],
11	T	NN	ORGANIZATION	t	appos	5	SENT_380	[p13l1106t810r1143b857],
12	,	,	O	,	_	0	SENT_380	[p13l1106t810r1143b857],
13	Iga	NN	O	iga	nn	14	SENT_380	[p13l1160t810r1231b861],
14	T	NN	O	t	appos	5	SENT_380	[p13l1244t810r1281b857],
15	,	,	O	,	_	0	SENT_380	[p13l1244t810r1281b857],
16	Takarada	NNP	PERSON	Takarada	nn	17	SENT_380	[p13l1296t807r1518b851],
17	Y	NN	PERSON	y	appos	5	SENT_380	[p13l1531t810r1570b857],
18	,	,	O	,	_	0	SENT_380	[p13l1531t810r1570b857],
19	et	FW	O	et	nn	20	SENT_380	[p13l1587t813r1633b851],
20	al.	FW	O	al.	appos	5	SENT_380	[p13l1648t807r1700b851],
21	.	.	O	.	_	0	SENT_380	[p13l1648t807r1700b851],

1	Effects	NNS	O	effect	_	0	SENT_381	[p13l1717t807r1876b851],
2	of	IN	O	of	_	0	SENT_381	[p13l1892t807r1943b851],
3	CYP2D6	NN	O	cyp2d6	nn	4	SENT_381	[p13l1953t809r2147b851],
4	genotypes	NNS	O	genotype	prep_of	1	SENT_381	[p13l110t879r364b927],
5	on	IN	O	on	_	0	SENT_381	[p13l404t885r465b916],
6	plasma	NN	O	plasma	nn	7	SENT_381	[p13l502t873r678b927],
7	concentrations	NNS	O	concentration	prep_on	1	SENT_381	[p13l716t873r1085b916],
8	of	IN	O	of	_	0	SENT_381	[p13l1125t873r1176b916],
9	risperidone	NN	O	risperidone	prep_of	1	SENT_381	[p13l1209t873r1493b927],
10	and	CC	O	and	_	0	SENT_381	[p13l1532t873r1622b916],
11	enantiomers	NNS	O	enantiomer	prep_of	1	SENT_381	[p13l1661t873r1973b916],
12	of	IN	O	of	_	0	SENT_381	[p13l2013t872r2064b916],
13	9hydroxyrisperidone	NN	O	9hydroxyrisperidone	prep_of	1	SENT_381	[p13l2097t875r2146b916, p13l112t939r595b994],
14	in	IN	O	in	_	0	SENT_381	[p13l629t940r674b982],
15	Japanese	JJ	MISC	japanese	amod	16	SENT_381	[p13l700t942r920b994],
16	patients	NNS	O	patient	prep_in	1	SENT_381	[p13l953t940r1149b994],
17	with	IN	O	with	_	0	SENT_381	[p13l1182t939r1295b983],
18	schizophrenia	NN	O	schizophrenia	prep_with	1	SENT_381	[p13l1328t939r1683b994],
19	.	.	O	.	_	0	SENT_381	[p13l1328t939r1683b994],

1	J	NNP	O	J	nn	3	SENT_382	[p13l1709t942r1729b994],
2	Clin	NNP	O	Clin	nn	3	SENT_382	[p13l1761t939r1855b983],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_382	[p13l1888t939r2146b983],
4	2003	CD	DATE	2003	num	3	SENT_382	[p13l111t1007r495b1055],
5	;	:	O	;	_	0	SENT_382	[p13l111t1007r495b1055],
6	43:122	CD	NUMBER	43:122	num	7	SENT_382	[p13l111t1007r495b1055],
7	—	NN	O	—	dep	3	SENT_382	[p13l111t1007r495b1055],
8	7	CD	NUMBER	7	dep	7	SENT_382	[p13l111t1007r495b1055],
9	.	.	O	.	_	0	SENT_382	[p13l111t1007r495b1055],

1	Yasui-Furukori	JJ	PERSON	yasui-furukori	amod	2	SENT_383	[p13l7t1071r369b1115],
2	N	NN	PERSON	n	_	0	SENT_383	[p13l389t1074r437b1121],
3	,	,	O	,	_	0	SENT_383	[p13l389t1074r437b1121],
4	Kondo	NNP	PERSON	Kondo	nn	5	SENT_383	[p13l458t1071r614b1115],
5	T	NN	O	t	appos	2	SENT_383	[p13l629t1074r666b1121],
6	,	,	O	,	_	0	SENT_383	[p13l629t1074r666b1121],
7	Suzuki	NNP	PERSON	Suzuki	nn	8	SENT_383	[p13l687t1071r848b1115],
8	A	NNP	O	A	appos	5	SENT_383	[p13l866t1073r913b1121],
9	,	,	O	,	_	0	SENT_383	[p13l866t1073r913b1121],
10	Mihara	NNP	PERSON	Mihara	nn	11	SENT_383	[p13l934t1071r1107b1115],
11	K	NNP	PERSON	K	appos	5	SENT_383	[p13l1126t1074r1170b1121],
12	,	,	O	,	_	0	SENT_383	[p13l1126t1074r1170b1121],
13	Tokinaga	NNP	ORGANIZATION	Tokinaga	nn	14	SENT_383	[p13l1188t1071r1409b1125],
14	N	NNP	ORGANIZATION	N	appos	5	SENT_383	[p13l1429t1074r1477b1121],
15	,	,	O	,	_	0	SENT_383	[p13l1429t1074r1477b1121],
16	Inoue	NNP	O	Inoue	nn	17	SENT_383	[p13l1497t1074r1633b1115],
17	Y	NN	O	y	appos	5	SENT_383	[p13l1651t1074r1692b1121],
18	,	,	O	,	_	0	SENT_383	[p13l1651t1074r1692b1121],
19	et	FW	O	et	nn	20	SENT_383	[p13l1712t1077r1758b1115],
20	al.	FW	O	al.	appos	5	SENT_383	[p13l1776t1071r1829b1115],
21	.	.	O	.	_	0	SENT_383	[p13l1776t1071r1829b1115],

1	Effect	NN	O	effect	nsubj	12	SENT_384	[p13l1850t1071r1986b1115],
2	of	IN	O	of	_	0	SENT_384	[p13l2004t1071r2055b1115],
3	the	DT	O	the	det	5	SENT_384	[p13l2069t1071r2146b1115],
4	CYP2D6	NN	O	cyp2d6	nn	5	SENT_384	[p13l112t1139r305b1181],
5	genotype	NN	O	genotype	prep_of	1	SENT_384	[p13l334t1144r562b1192],
6	on	IN	O	on	_	0	SENT_384	[p13l591t1150r652b1181],
7	prolactin	NN	O	prolactin	nn	8	SENT_384	[p13l681t1137r900b1192],
8	concentration	NN	O	concentration	prep_on	5	SENT_384	[p13l929t1138r1270b1181],
9	in	IN	O	in	_	0	SENT_384	[p13l1300t1138r1345b1180],
10	schizophrenic	JJ	O	schizophrenic	amod	11	SENT_384	[p13l1375t1137r1717b1192],
11	patients	NNS	O	patient	prep_in	8	SENT_384	[p13l1746t1138r1942b1192],
12	treated	VBN	O	treat	_	0	SENT_384	[p13l1973t1137r2146b1181],
13	with	IN	O	with	_	0	SENT_384	[p13l110t1203r223b1246],
14	haloperidol	NN	O	haloperidol	prep_with	12	SENT_384	[p13l243t1203r535b1257],
15	.	.	O	.	_	0	SENT_384	[p13l243t1203r535b1257],

1	Schizophr	NNP	O	Schizophr	nn	2	SENT_385	[p13l556t1203r801b1257],
2	Res	NNP	O	Res	_	0	SENT_385	[p13l819t1206r900b1246],
3	2001	CD	DATE	2001	num	2	SENT_385	[p13l920t1205r1337b1253],
4	;	:	O	;	_	0	SENT_385	[p13l920t1205r1337b1253],
5	52:139	CD	NUMBER	52:139	number	6	SENT_385	[p13l920t1205r1337b1253],
6	—	CD	NUMBER	—	dep	2	SENT_385	[p13l920t1205r1337b1253],
7	42	CD	NUMBER	42	dep	6	SENT_385	[p13l920t1205r1337b1253],
8	.	.	O	.	_	0	SENT_385	[p13l920t1205r1337b1253],

1	Yasui-Furukori	JJ	PERSON	yasui-furukori	amod	2	SENT_386	[p13l8t1268r353b1312],
2	N	NN	O	n	_	0	SENT_386	[p13l373t1271r420b1319],
3	,	,	O	,	_	0	SENT_386	[p13l373t1271r420b1319],
4	Mihara	NNP	PERSON	Mihara	nn	5	SENT_386	[p13l441t1269r607b1312],
5	K	NNP	PERSON	K	appos	2	SENT_386	[p13l627t1271r668b1319],
6	,	,	O	,	_	0	SENT_386	[p13l627t1271r668b1319],
7	Takahata	NNP	ORGANIZATION	Takahata	nn	8	SENT_386	[p13l686t1268r898b1312],
8	T	NN	ORGANIZATION	t	appos	5	SENT_386	[p13l915t1271r951b1319],
9	,	,	O	,	_	0	SENT_386	[p13l915t1271r951b1319],
10	Suzuki	NNP	ORGANIZATION	Suzuki	nn	11	SENT_386	[p13l971t1268r1127b1312],
11	A	NNP	ORGANIZATION	A	appos	5	SENT_386	[p13l1145t1270r1190b1319],
12	,	,	O	,	_	0	SENT_386	[p13l1145t1270r1190b1319],
13	Nakagami	NNP	ORGANIZATION	Nakagami	nn	14	SENT_386	[p13l1211t1269r1446b1323],
14	T	NN	ORGANIZATION	t	appos	5	SENT_386	[p13l1463t1271r1499b1319],
15	,	,	O	,	_	0	SENT_386	[p13l1463t1271r1499b1319],
16	De	NNP	ORGANIZATION	De	nn	18	SENT_386	[p13l1519t1271r1581b1312],
17	Vries	NNP	ORGANIZATION	Vries	nn	18	SENT_386	[p13l1599t1269r1718b1312],
18	R	NNP	ORGANIZATION	R	appos	5	SENT_386	[p13l1738t1271r1779b1319],
19	,	,	O	,	_	0	SENT_386	[p13l1738t1271r1779b1319],
20	et	FW	O	et	nn	21	SENT_386	[p13l1799t1275r1844b1312],
21	al.	FW	O	al.	appos	5	SENT_386	[p13l1861t1268r1911b1312],
22	.	.	O	.	_	0	SENT_386	[p13l1861t1268r1911b1312],

1	Effects	NNS	O	effect	_	0	SENT_387	[p13l1932t1268r2084b1312],
2	of	IN	O	of	_	0	SENT_387	[p13l2104t1268r2153b1312],
3	various	JJ	O	various	amod	4	SENT_387	[p13l110t1335r282b1378],
4	factors	NNS	O	factor	prep_of	1	SENT_387	[p13l309t1334r465b1378],
5	on	IN	O	on	_	0	SENT_387	[p13l491t1347r550b1378],
6	steady-state	JJ	O	steady-state	amod	8	SENT_387	[p13l577t1334r862b1389],
7	plasma	NN	O	plasma	nn	8	SENT_387	[p13l888t1334r1056b1389],
8	concentrations	NNS	O	concentration	prep_on	4	SENT_387	[p13l1083t1335r1431b1378],
9	of	IN	O	of	_	0	SENT_387	[p13l1458t1334r1508b1378],
10	risperidone	NN	O	risperidone	prep_of	8	SENT_387	[p13l1529t1334r1797b1389],
11	and	CC	O	and	_	0	SENT_387	[p13l1824t1334r1911b1378],
12	9hydroxyrisperidone	NN	O	9hydroxyrisperidone	prep_of	8	SENT_387	[p13l1938t1334r2146b1389, p13l110t1401r451b1455],
13	:	:	O	:	_	0	SENT_387	[p13l1938t1334r2146b1389, p13l110t1401r451b1455],
14	lack	NN	O	lack	dep	1	SENT_387	[p13l467t1401r560b1445],
15	of	IN	O	of	_	0	SENT_387	[p13l570t1401r620b1445],
16	impact	NN	O	impact	prep_of	14	SENT_387	[p13l626t1402r789b1455],
17	of	IN	O	of	_	0	SENT_387	[p13l799t1401r849b1445],
18	MDR-1	NN	O	mdr-1	nn	19	SENT_387	[p13l854t1403r1014b1444],
19	genotypes	NNS	O	genotype	prep_of	16	SENT_387	[p13l1031t1407r1283b1455],
20	.	.	O	.	_	0	SENT_387	[p13l1031t1407r1283b1455],

1	BrJ	NN	O	brj	nn	2	SENT_388	[p13l1296t1404r1370b1455],
2	Clin	NN	O	clin	_	0	SENT_388	[p13l1383t1401r1474b1445],
3	Pharmacol	NNP	O	Pharmacol	dep	2	SENT_388	[p13l1484t1401r1734b1445],
4	2004	CD	DATE	2004	num	3	SENT_388	[p13l1746t1403r2146b1451],
5	;	:	O	;	_	0	SENT_388	[p13l1746t1403r2146b1451],
6	57:569	CD	NUMBER	57:569	number	7	SENT_388	[p13l1746t1403r2146b1451],
7	—	CD	NUMBER	—	dep	2	SENT_388	[p13l1746t1403r2146b1451],
8	75	CD	NUMBER	75	dep	7	SENT_388	[p13l1746t1403r2146b1451],
9	.	.	O	.	_	0	SENT_388	[p13l1746t1403r2146b1451],

1	Young	NNP	O	Young	nn	2	SENT_389	[p13l7t1470r160b1522],
2	RM	NN	O	rm	_	0	SENT_389	[p13l175t1470r266b1517],
3	,	,	O	,	_	0	SENT_389	[p13l175t1470r266b1517],
4	Lawford	NNP	PERSON	Lawford	nn	5	SENT_389	[p13l283t1467r476b1511],
5	BR	NNP	O	BR	appos	2	SENT_389	[p13l494t1470r566b1517],
6	,	,	O	,	_	0	SENT_389	[p13l494t1470r566b1517],
7	Barnes	NNP	ORGANIZATION	Barnes	nn	8	SENT_389	[p13l584t1470r744b1511],
8	M	NNP	ORGANIZATION	M	appos	5	SENT_389	[p13l761t1470r819b1517],
9	,	,	O	,	_	0	SENT_389	[p13l761t1470r819b1517],
10	Burton	NNP	ORGANIZATION	Burton	nn	11	SENT_389	[p13l837t1470r998b1511],
11	SC	NNP	ORGANIZATION	SC	appos	5	SENT_389	[p13l1015t1469r1083b1517],
12	,	,	O	,	_	0	SENT_389	[p13l1015t1469r1083b1517],
13	Ritchie	NNP	PERSON	Ritchie	nn	14	SENT_389	[p13l1101t1467r1264b1511],
14	T	NN	O	t	appos	5	SENT_389	[p13l1279t1470r1314b1517],
15	,	,	O	,	_	0	SENT_389	[p13l1279t1470r1314b1517],
16	Ward	NNP	ORGANIZATION	Ward	nn	17	SENT_389	[p13l1330t1467r1462b1511],
17	WK	NNP	ORGANIZATION	WK	appos	5	SENT_389	[p13l1477t1470r1578b1517],
18	,	,	O	,	_	0	SENT_389	[p13l1477t1470r1578b1517],
19	et	FW	O	et	nn	20	SENT_389	[p13l1595t1474r1642b1511],
20	al.	FW	O	al.	appos	5	SENT_389	[p13l1656t1467r1707b1511],
21	.	.	O	.	_	0	SENT_389	[p13l1656t1467r1707b1511],

1	Prolactin	NN	O	prolactin	nn	2	SENT_390	[p13l1724t1467r1936b1511],
2	levels	NNS	O	level	_	0	SENT_390	[p13l1952t1467r2086b1511],
3	in	IN	O	in	_	0	SENT_390	[p13l2103t1468r2148b1510],
4	antipsychotic	JJ	O	antipsychotic	amod	5	SENT_390	[p13l111t1533r431b1587],
5	treatment	NN	O	treatment	prep_in	2	SENT_390	[p13l448t1539r689b1576],
6	of	IN	O	of	_	0	SENT_390	[p13l705t1533r756b1576],
7	patients	NNS	O	patient	prep_of	5	SENT_390	[p13l767t1534r959b1587],
8	with	IN	O	with	_	0	SENT_390	[p13l977t1533r1087b1576],
9	schizophrenia	NN	O	schizophrenia	prep_with	7	SENT_390	[p13l1107t1533r1441b1587],
10	carrying	VBG	O	carry	partmod	2	SENT_390	[p13l1459t1534r1657b1587],
11	the	DT	O	the	det	15	SENT_390	[p13l1673t1533r1750b1576],
12	DRD2	NN	O	drd2	nn	15	SENT_390	[p13l1769t1533r1985b1576],
13	*	CD	NUMBER	*	num	15	SENT_390	[p13l1769t1533r1985b1576],
14	A1	NN	O	a1	nn	15	SENT_390	[p13l1769t1533r1985b1576],
15	allele	NN	O	allele	dobj	10	SENT_390	[p13l2011t1533r2147b1577],
16	.	.	O	.	_	0	SENT_390	[p13l2011t1533r2147b1577],

1	Br	NN	O	br	_	0	SENT_391	[p13l112t1602r192b1653],
2	]	CD	NUMBER	]	num	1	SENT_391	[p13l112t1602r192b1653],
3	Psychiatry	NNP	O	Psychiatry	dep	1	SENT_391	[p13l209t1599r464b1653],
4	.	.	O	.	_	0	SENT_391	[p13l209t1599r464b1653],

1	2004	CD	DATE	2004	_	0	SENT_392	[p13l482t1601r906b1649],
2	;	:	O	;	_	0	SENT_392	[p13l482t1601r906b1649],
3	185:147	CD	NUMBER	185:147	number	4	SENT_392	[p13l482t1601r906b1649],
4	—	CD	NUMBER	—	dep	1	SENT_392	[p13l482t1601r906b1649],
5	51	CD	NUMBER	51	dep	4	SENT_392	[p13l482t1601r906b1649],
6	.	.	O	.	_	0	SENT_392	[p13l482t1601r906b1649],

1	Zai	NNP	ORGANIZATION	Zai	nn	2	SENT_393	[p13l9t1665r80b1708],
2	CC	NN	ORGANIZATION	cc	_	0	SENT_393	[p13l105t1667r178b1715],
3	,	,	O	,	_	0	SENT_393	[p13l105t1667r178b1715],
4	Hwang	NNP	PERSON	Hwang	nn	5	SENT_393	[p13l204t1667r377b1719],
5	RW	NNP	O	RW	appos	2	SENT_393	[p13l401t1667r495b1715],
6	,	,	O	,	_	0	SENT_393	[p13l401t1667r495b1715],
7	De	NNP	PERSON	De	nn	9	SENT_393	[p13l521t1667r583b1708],
8	Luca	NNP	PERSON	Luca	nn	9	SENT_393	[p13l609t1667r717b1708],
9	V	NNP	PERSON	V	appos	5	SENT_393	[p13l740t1667r786b1715],
10	,	,	O	,	_	0	SENT_393	[p13l740t1667r786b1715],
11	Muller	NNP	PERSON	Muller	nn	13	SENT_393	[p13l812t1665r974b1708],
12	D	NNP	O	D	nn	13	SENT_393	[p13l998t1667r1060b1719],
13	]	NN	O	]	appos	5	SENT_393	[p13l998t1667r1060b1719],
14	,	,	O	,	_	0	SENT_393	[p13l998t1667r1060b1719],
15	King	NNP	O	King	nn	16	SENT_393	[p13l1085t1665r1196b1719],
16	N	NNP	O	N	appos	5	SENT_393	[p13l1220t1667r1268b1715],
17	,	,	O	,	_	0	SENT_393	[p13l1220t1667r1268b1715],
18	Zai	NNP	O	Zai	nn	19	SENT_393	[p13l1293t1665r1364b1708],
19	GC	NN	O	gc	appos	5	SENT_393	[p13l1389t1667r1467b1715],
20	,	,	O	,	_	0	SENT_393	[p13l1389t1667r1467b1715],
21	et	FW	O	et	nn	22	SENT_393	[p13l1493t1671r1539b1708],
22	al.	FW	O	al.	appos	5	SENT_393	[p13l1562t1665r1614b1709],
23	.	.	O	.	_	0	SENT_393	[p13l1562t1665r1614b1709],

1	Association	NNP	O	Association	nn	2	SENT_394	[p13l1638t1665r1919b1708],
2	study	NN	O	study	_	0	SENT_394	[p13l1945t1665r2080b1719],
3	of	IN	O	of	_	0	SENT_394	[p13l2102t1664r2153b1708],
4	tardive	JJ	O	tardive	amod	5	SENT_394	[p13l111t1731r282b1775],
5	dyskinesia	NN	O	dyskinesium	prep_of	2	SENT_394	[p13l298t1731r555b1786],
6	and	CC	O	and	_	0	SENT_394	[p13l569t1731r658b1775],
7	twelve	CD	NUMBER	twelve	num	9	SENT_394	[p13l674t1731r837b1775],
8	DRD2	NN	O	drd2	nn	9	SENT_394	[p13l853t1733r990b1774],
9	polymorphisms	NNS	O	polymorphism	conj_and	5	SENT_394	[p13l1007t1731r1392b1786],
10	in	IN	O	in	_	0	SENT_394	[p13l1408t1732r1453b1774],
11	schizophrenia	NN	O	schizophrenia	nn	12	SENT_394	[p13l1469t1731r1812b1786],
12	patients	NNS	O	patient	prep_in	2	SENT_394	[p13l1827t1732r2036b1786],
13	.	.	O	.	_	0	SENT_394	[p13l1827t1732r2036b1786],

1	IntJ	NN	O	intj	_	0	SENT_395	[p13l2053t1734r2147b1786],
2	Neuropsychopharmacol	NNP	O	Neuropsychopharmacol	dep	1	SENT_395	[p13l112t1796r697b1851],
3	2007	CD	DATE	2007	num	2	SENT_395	[p13l718t1799r855b1847],
4	;	:	O	;	_	0	SENT_395	[p13l718t1799r855b1847],
5	102639-51	CD	NUMBER	102639-51	dep	1	SENT_395	[p13l865t1799r1128b1840],
6	.	.	O	.	_	0	SENT_395	[p13l865t1799r1128b1840],

1	Zalsman	NNP	O	Zalsman	nn	2	SENT_396	[p13l9t1863r210b1907],
2	G	NNP	O	G	_	0	SENT_396	[p13l226t1865r272b1913],
3	,	,	O	,	_	0	SENT_396	[p13l226t1865r272b1913],
4	Frisch	NNP	PERSON	Frisch	nn	5	SENT_396	[p13l287t1863r426b1907],
5	A	NNP	O	A	appos	2	SENT_396	[p13l440t1865r486b1913],
6	,	,	O	,	_	0	SENT_396	[p13l440t1865r486b1913],
7	Lev-Ran	NNP	PERSON	Lev-Ran	nn	8	SENT_396	[p13l502t1866r695b1907],
8	S	NNP	O	S	appos	5	SENT_396	[p13l709t1865r746b1913],
9	,	,	O	,	_	0	SENT_396	[p13l709t1865r746b1913],
10	Martin	NNP	PERSON	Martin	nn	11	SENT_396	[p13l762t1864r923b1907],
11	A	NNP	O	A	appos	5	SENT_396	[p13l936t1865r982b1913],
12	,	,	O	,	_	0	SENT_396	[p13l936t1865r982b1913],
13	Michaelovsky	NNP	PERSON	Michaelovsky	nn	14	SENT_396	[p13l998t1863r1327b1917],
14	E	NNP	O	E	appos	5	SENT_396	[p13l1341t1866r1379b1913],
15	,	,	O	,	_	0	SENT_396	[p13l1341t1866r1379b1913],
16	Bensason	NNP	PERSON	Bensason	nn	17	SENT_396	[p13l1395t1866r1619b1907],
17	D	NNP	O	D	appos	5	SENT_396	[p13l1634t1866r1681b1913],
18	,	,	O	,	_	0	SENT_396	[p13l1634t1866r1681b1913],
19	et	FW	O	et	nn	20	SENT_396	[p13l1696t1869r1742b1907],
20	al.	FW	O	al.	appos	5	SENT_396	[p13l1756t1863r1806b1907],
21	.	.	O	.	_	0	SENT_396	[p13l1756t1863r1806b1907],

1	DRD4	NN	O	drd4	nn	2	SENT_397	[p13l1823t1865r1959b1906],
2	exon	NN	O	exon	_	0	SENT_397	[p13l1974t1876r2087b1907],
3	III	CD	NUMBER	iii	num	4	SENT_397	[p13l2103t1866r2146b1906],
4	polymorphism	NN	O	polymorphism	dep	2	SENT_397	[p13l112t1929r466b1984],
5	and	CC	O	and	_	0	SENT_397	[p13l480t1929r568b1973],
6	response	NN	O	response	conj_and	2	SENT_397	[p13l583t1942r795b1984],
7	to	TO	O	to	_	0	SENT_397	[p13l811t1936r856b1973],
8	risperidone	NN	O	risperidone	prep_to	6	SENT_397	[p13l872t1929r1145b1984],
9	in	IN	O	in	_	0	SENT_397	[p13l1161t1930r1206b1972],
10	Israeli	JJ	MISC	israeli	amod	11	SENT_397	[p13l1220t1929r1362b1973],
11	adolescents	NNS	O	adolescent	prep_in	8	SENT_397	[p13l1377t1929r1654b1973],
12	with	IN	O	with	_	0	SENT_397	[p13l1669t1929r1780b1973],
13	schizophrenia	NN	O	schizophrenia	prep_with	11	SENT_397	[p13l1796t1929r2143b1984],
14	:	:	O	:	_	0	SENT_397	[p13l1796t1929r2143b1984],
15	a	DT	O	a	det	16	SENT_397	[p13l111t2007r136b2038],
16	pilot	NN	O	pilot	dep	2	SENT_397	[p13l153t1995r262b2049],
17	pharmacogenetic	JJ	O	pharmacogenetic	amod	18	SENT_397	[p13l278t1995r694b2049],
18	study	NN	O	study	dep	16	SENT_397	[p13l710t1995r849b2049],
19	.	.	O	.	_	0	SENT_397	[p13l710t1995r849b2049],

1	Eur	NNP	MISC	Eur	nn	2	SENT_398	[p13l868t1998r950b2038],
2	Neuropsychopharmacol	NNP	MISC	Neuropsychopharmacol	_	0	SENT_398	[p13l965t1995r1537b2049],
3	2003	CD	DATE	2003	num	2	SENT_398	[p13l1554t1997r1927b2045],
4	;	:	O	;	_	0	SENT_398	[p13l1554t1997r1927b2045],
5	13:183	CD	NUMBER	13:183	number	6	SENT_398	[p13l1554t1997r1927b2045],
6	—	CD	NUMBER	—	dep	2	SENT_398	[p13l1554t1997r1927b2045],
7	5	CD	NUMBER	5	dep	6	SENT_398	[p13l1554t1997r1927b2045],
8	.	.	O	.	_	0	SENT_398	[p13l1554t1997r1927b2045],

1	Zhang	NNP	PERSON	Zhang	nn	2	SENT_399	[p13l9t2060r161b2115],
2	ZJ	NNP	O	ZJ	_	0	SENT_399	[p13l178t2063r234b2115],
3	,	,	O	,	_	0	SENT_399	[p13l178t2063r234b2115],
4	Yao	NNP	O	Yao	nn	6	SENT_399	[p13l253t2063r339b2104],
5	Z	NNP	O	Z	nn	6	SENT_399	[p13l358t2063r414b2115],
6	]	NN	O	]	appos	2	SENT_399	[p13l358t2063r414b2115],
7	,	,	O	,	_	0	SENT_399	[p13l358t2063r414b2115],
8	Zhang	NNP	PERSON	Zhang	nn	9	SENT_399	[p13l434t2061r586b2115],
9	XB	NNP	O	XB	appos	6	SENT_399	[p13l603t2063r682b2111],
10	,	,	O	,	_	0	SENT_399	[p13l603t2063r682b2111],
11	Chen	NNP	LOCATION	Chen	nn	12	SENT_399	[p13l702t2060r825b2104],
12	JF	NNP	LOCATION	JF	appos	6	SENT_399	[p13l838t2063r894b2115],
13	,	,	O	,	_	0	SENT_399	[p13l838t2063r894b2115],
14	Sun	NNP	PERSON	Sun	nn	15	SENT_399	[p13l914t2063r1004b2104],
15	J	NNP	PERSON	J	appos	6	SENT_399	[p13l1017t2063r1049b2115],
16	,	,	O	,	_	0	SENT_399	[p13l1017t2063r1049b2115],
17	Yao	NNP	PERSON	Yao	nn	18	SENT_399	[p13l1067t2063r1153b2104],
18	H	NNP	O	H	appos	6	SENT_399	[p13l1173t2063r1222b2111],
19	,	,	O	,	_	0	SENT_399	[p13l1173t2063r1222b2111],
20	et	FW	O	et	nn	21	SENT_399	[p13l1242t2067r1288b2104],
21	al.	FW	O	al.	appos	6	SENT_399	[p13l1307t2061r1359b2104],
22	.	.	O	.	_	0	SENT_399	[p13l1307t2061r1359b2104],

1	No	DT	O	no	det	2	SENT_400	[p13l1380t2063r1445b2104],
2	association	NN	O	association	_	0	SENT_400	[p13l1465t2061r1736b2104],
3	of	IN	O	of	_	0	SENT_400	[p13l1755t2060r1806b2104],
4	antipsychotic	JJ	O	antipsychotic	amod	7	SENT_400	[p13l1820t2060r2148b2115],
5	agent-induced	JJ	O	agent-induced	amod	7	SENT_400	[p13l111t2127r467b2181],
6	weight	NN	O	weight	nn	7	SENT_400	[p13l482t2127r653b2181],
7	gain	NN	O	gain	prep_of	2	SENT_400	[p13l666t2127r769b2181],
8	with	IN	O	with	_	0	SENT_400	[p13l782t2127r895b2170],
9	a	DT	O	a	det	13	SENT_400	[p13l910t2139r935b2170],
10	DA	NN	O	da	nn	13	SENT_400	[p13l950t2129r1020b2170],
11	receptor	NN	O	receptor	nn	13	SENT_400	[p13l1035t2133r1240b2181],
12	gene	NN	O	gene	nn	13	SENT_400	[p13l1252t2139r1369b2181],
13	polymorphism	NN	O	polymorphism	prep_with	7	SENT_400	[p13l1384t2127r1746b2181],
14	and	CC	O	and	_	0	SENT_400	[p13l1761t2127r1850b2170],
15	therapeutic	JJ	O	therapeutic	amod	16	SENT_400	[p13l1865t2127r2148b2181],
16	response	NN	O	response	conj_and	13	SENT_400	[p13l112t2206r342b2248],
17	.	.	O	.	_	0	SENT_400	[p13l112t2206r342b2248],

1	Acta	NNP	O	Acta	nn	3	SENT_401	[p13l360t2195r468b2237],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_401	[p13l487t2193r745b2237],
3	Sin	NNP	O	Sin	_	0	SENT_401	[p13l766t2194r839b2237],
4	2003	CD	DATE	2003	num	3	SENT_401	[p13l859t2195r1279b2243],
5	;	:	O	;	_	0	SENT_401	[p13l859t2195r1279b2243],
6	24:235	CD	NUMBER	24:235	number	7	SENT_401	[p13l859t2195r1279b2243],
7	—	CD	NUMBER	—	dep	3	SENT_401	[p13l859t2195r1279b2243],
8	40	CD	NUMBER	40	dep	7	SENT_401	[p13l859t2195r1279b2243],
9	.	.	O	.	_	0	SENT_401	[p13l859t2195r1279b2243],

